Disease on EC 2.7.7.49 - RNA-directed DNA polymerase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE 
TITLE OF PUBLICATION
LINK TO PUBMED
Abnormalities, Multiple
Dyskeratosis congenita: a disorder of defective telomere maintenance?
Abnormalities, Multiple
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Abortion, Spontaneous
Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
Acidosis
High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.
Acidosis
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.
Acidosis
Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors.
Acidosis
Validation of the Accutrend((R)) lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting.
Acidosis, Lactic
A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Acidosis, Lactic
A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context.
Acidosis, Lactic
Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients.
Acidosis, Lactic
Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases.
Acidosis, Lactic
Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.
Acidosis, Lactic
Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient.
Acidosis, Lactic
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia.
Acidosis, Lactic
Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis.
Acidosis, Lactic
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
Acidosis, Lactic
Lactic acidosis associated with nucleoside reverse transcriptase inhibitors.
Acidosis, Lactic
Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.
Acidosis, Lactic
Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
Acidosis, Lactic
Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy.
Acidosis, Lactic
Metabolic complications and treatment of perinatally HIV-infected children and adolescents.
Acidosis, Lactic
Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.
Acidosis, Lactic
Mutations of mtDNA polymerase-? and hyperlactataemia in the HIV-infected Zulu population of South Africa.
Acidosis, Lactic
Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment.
Acidosis, Lactic
Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature.
Acidosis, Lactic
Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment.
Acidosis, Lactic
Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.
Acidosis, Lactic
Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Acidosis, Lactic
Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.
Acidosis, Lactic
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.
Acidosis, Lactic
The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Acidosis, Lactic
Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis.
Acidosis, Lactic
Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.
Acidosis, Lactic
[Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy]
Acidosis, Lactic
[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors]
Acidosis, Renal Tubular
Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors.
Acquired Immunodeficiency Syndrome
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
Acquired Immunodeficiency Syndrome
A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Acquired Immunodeficiency Syndrome
A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
Acquired Immunodeficiency Syndrome
A nanoparticle-encapsulated non-nucleoside reverse-transcriptase inhibitor with enhanced anti-HIV-1 activity and prolonged circulation time in plasma.
Acquired Immunodeficiency Syndrome
A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.
Acquired Immunodeficiency Syndrome
A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Acquired Immunodeficiency Syndrome
A novel vaginal drug delivery system: anti-HIV bioadhesive film containing abacavir.
Acquired Immunodeficiency Syndrome
A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma.
Acquired Immunodeficiency Syndrome
Accelerated replicative senescence of the peripheral immune system induced by HIV infection.
Acquired Immunodeficiency Syndrome
Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity.
Acquired Immunodeficiency Syndrome
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Acquired Immunodeficiency Syndrome
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.
Acquired Immunodeficiency Syndrome
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
Acquired Immunodeficiency Syndrome
Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting.
Acquired Immunodeficiency Syndrome
Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy.
Acquired Immunodeficiency Syndrome
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Acquired Immunodeficiency Syndrome
Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase.
Acquired Immunodeficiency Syndrome
Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions.
Acquired Immunodeficiency Syndrome
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
Acquired Immunodeficiency Syndrome
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Acquired Immunodeficiency Syndrome
Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance.
Acquired Immunodeficiency Syndrome
Covalent coupling of nucleosides to low density lipoprotein (LDL) generates macrophage specific (drug)-carriers.
Acquired Immunodeficiency Syndrome
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
Acquired Immunodeficiency Syndrome
Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.
Acquired Immunodeficiency Syndrome
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.
Acquired Immunodeficiency Syndrome
Designed multiple ligands: an emerging anti-HIV drug discovery paradigm.
Acquired Immunodeficiency Syndrome
Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.
Acquired Immunodeficiency Syndrome
DNA polymerases versus HIV reverse transcriptase in AIDS therapy.
Acquired Immunodeficiency Syndrome
Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.
Acquired Immunodeficiency Syndrome
Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.
Acquired Immunodeficiency Syndrome
Electronic transduction of HIV-1 drug resistance in AIDS patients.
Acquired Immunodeficiency Syndrome
Evaluation of viral resistance to reverse transcriptase inhibitors (RTI) in HIV-1-infected patients before and after 6 months of single or double antiretroviral therapy.
Acquired Immunodeficiency Syndrome
Expression of the human immunodeficiency virus gag gene in insect cells.
Acquired Immunodeficiency Syndrome
Further characterization of sulfated homopolysaccharides as anti-HIV agents.
Acquired Immunodeficiency Syndrome
Genetic variants in telomerase-associated protein 1 are associated with telomere damage in PAH-exposed workers.
Acquired Immunodeficiency Syndrome
Genotype and phenotype patterns of drug-resistant HIV-1 subtype B' (Thai B) isolated from patients failing antiretroviral therapy in China.
Acquired Immunodeficiency Syndrome
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.
Acquired Immunodeficiency Syndrome
High Incidence of Zidovudine Induced Anaemia in HIV Infected Patients in Southern Odisha.
Acquired Immunodeficiency Syndrome
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.
Acquired Immunodeficiency Syndrome
HIV reverse transcriptase structure-function relationships.
Acquired Immunodeficiency Syndrome
HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.
Acquired Immunodeficiency Syndrome
HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
Acquired Immunodeficiency Syndrome
HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors.
Acquired Immunodeficiency Syndrome
HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
Acquired Immunodeficiency Syndrome
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.
Acquired Immunodeficiency Syndrome
HTLV-III gag protein is processed in yeast cells by the virus pol-protease.
Acquired Immunodeficiency Syndrome
Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
Acquired Immunodeficiency Syndrome
Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4).
Acquired Immunodeficiency Syndrome
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Acquired Immunodeficiency Syndrome
Impaired CD4+ T-Cell Restoration in the Small Versus Large Intestine of HIV-1-Positive South Africans Receiving Combination Antiretroviral Therapy.
Acquired Immunodeficiency Syndrome
Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
Acquired Immunodeficiency Syndrome
In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
Acquired Immunodeficiency Syndrome
In vitro interaction of nucleoside reverse transcriptase inhibitor, didanosine with calf-thymus DNA: Insights from spectroscopic studies.
Acquired Immunodeficiency Syndrome
In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.
Acquired Immunodeficiency Syndrome
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
Acquired Immunodeficiency Syndrome
Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
Acquired Immunodeficiency Syndrome
Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy.
Acquired Immunodeficiency Syndrome
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
Acquired Immunodeficiency Syndrome
Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study.
Acquired Immunodeficiency Syndrome
Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy.
Acquired Immunodeficiency Syndrome
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
Acquired Immunodeficiency Syndrome
Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP.
Acquired Immunodeficiency Syndrome
Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
Acquired Immunodeficiency Syndrome
Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
Acquired Immunodeficiency Syndrome
Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.
Acquired Immunodeficiency Syndrome
Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective.
Acquired Immunodeficiency Syndrome
Molecular dynamics model of unliganded HIV-1 reverse transcriptase.
Acquired Immunodeficiency Syndrome
Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding.
Acquired Immunodeficiency Syndrome
Mutagenesis by human immunodeficiency virus reverse transcriptase: incorporation of O6-methyldeoxyguanosine triphosphate.
Acquired Immunodeficiency Syndrome
Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis.
Acquired Immunodeficiency Syndrome
Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.
Acquired Immunodeficiency Syndrome
Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation.
Acquired Immunodeficiency Syndrome
Non-nucleoside inhibitors of HIV reverse transcriptase: screening successes--clinical failures.
Acquired Immunodeficiency Syndrome
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
Acquired Immunodeficiency Syndrome
Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide.
Acquired Immunodeficiency Syndrome
Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Acquired Immunodeficiency Syndrome
Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance.
Acquired Immunodeficiency Syndrome
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations.
Acquired Immunodeficiency Syndrome
Peptide inhibition of HIV-1: current status and future potential.
Acquired Immunodeficiency Syndrome
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Acquired Immunodeficiency Syndrome
Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases.
Acquired Immunodeficiency Syndrome
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.
Acquired Immunodeficiency Syndrome
Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection.
Acquired Immunodeficiency Syndrome
Recent discoveries in HIV-1 reverse transcriptase inhibitors.
Acquired Immunodeficiency Syndrome
Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2',3'-dideoxycytidine.
Acquired Immunodeficiency Syndrome
Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
Acquired Immunodeficiency Syndrome
Solution characterization of [methyl-(13)C]methionine HIV-1 reverse transcriptase by NMR spectroscopy.
Acquired Immunodeficiency Syndrome
Spindle cells from Acquired Immune Deficiency Syndrome (AIDS)-associated Kaposi's sarcoma (KS) lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor (FGF)-2.
Acquired Immunodeficiency Syndrome
Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.
Acquired Immunodeficiency Syndrome
Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity.
Acquired Immunodeficiency Syndrome
Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis.
Acquired Immunodeficiency Syndrome
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.
Acquired Immunodeficiency Syndrome
Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals.
Acquired Immunodeficiency Syndrome
Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies.
Acquired Immunodeficiency Syndrome
Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.
Acquired Immunodeficiency Syndrome
Telomere-regulating genes and the telomere interactome in familial cancers.
Acquired Immunodeficiency Syndrome
The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.
Acquired Immunodeficiency Syndrome
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.
Acquired Immunodeficiency Syndrome
The emergence of different resistance mechanisms toward nucleoside inhibitors is explained by the properties of the wild type HIV-1 reverse transcriptase.
Acquired Immunodeficiency Syndrome
The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections.
Acquired Immunodeficiency Syndrome
The HIV-1 reverse transcription (RT) process as target for RT inhibitors.
Acquired Immunodeficiency Syndrome
The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
Acquired Immunodeficiency Syndrome
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Acquired Immunodeficiency Syndrome
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
Acquired Immunodeficiency Syndrome
Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.
Acquired Immunodeficiency Syndrome
Trapping of a catalytic HIV reverse transcriptase*template:primer complex through a disulfide bond.
Acquired Immunodeficiency Syndrome
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
Acquired Immunodeficiency Syndrome
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection.
Acquired Immunodeficiency Syndrome
[Impacts of HIV-1 resistance mutations associated with nucleoside reverse transcriptase inhibitors on viral fitness].
Acquired Immunodeficiency Syndrome
[Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS]
Acquired Immunodeficiency Syndrome
[Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy]
Acromegaly
Expression of growth hormone receptor isoform exon-3-excluding and exon-3-retaining messenger RNAs in peripheral lymphocytes from normal and acromegalic subjects.
Acute Coronary Syndrome
Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial.
Acute Coronary Syndrome
The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.
Acute Coronary Syndrome
The role of the terc-63g>a and tert-1327c>t telomerase polymorphisms in the study of men with acute coronary syndrome.
Acute-On-Chronic Liver Failure
Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
Adenocarcinoma
A Combination of ?-Tocotrienol and Ferulic Acid Synergistically Inhibits Telomerase Activity in DLD-1 Human Colorectal Adenocarcinoma Cells.
Adenocarcinoma
Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.
Adenocarcinoma
Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
Adenocarcinoma
Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells.
Adenocarcinoma
Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Adenocarcinoma
Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Adenocarcinoma
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Adenocarcinoma
Cellular proliferative and telomerase activity in canine mammary gland tumors.
Adenocarcinoma
Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Adenocarcinoma
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy.
Adenocarcinoma
Correspondence re: Seki et al., Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
Adenocarcinoma
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Adenocarcinoma
Decreasing telomerase activity of adenocarcinoma cancer cell line (AGS) is associated with different concentrations of sodium selenite and cadmium chloride and selenium l methionine.
Adenocarcinoma
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Adenocarcinoma
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.
Adenocarcinoma
Detection of hTERT mRNA in colonic brush specimens as an adjunct to cytopathologic diagnosis of colonic adenocarcinoma.
Adenocarcinoma
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Adenocarcinoma
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration.
Adenocarcinoma
Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Adenocarcinoma
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Adenocarcinoma
Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma.
Adenocarcinoma
Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol.
Adenocarcinoma
Dual mechanisms for telomerase inhibition in DLD-1 human colorectal adenocarcinoma cells by polyunsaturated fatty acids.
Adenocarcinoma
Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.
Adenocarcinoma
Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.
Adenocarcinoma
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Adenocarcinoma
Elevated level of microRNA-21 in the serum of patients with colorectal cancer.
Adenocarcinoma
Evaluation of telomerase in the development and progression of colon cancer.
Adenocarcinoma
Evidence for Enhanced Telomerase Activity in Barrett's Esophagus with Dysplasia and Adenocarcinoma.
Adenocarcinoma
Expression of telomerase & its significance in the diagnosis of pancreatic cancer.
Adenocarcinoma
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.
Adenocarcinoma
Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
Adenocarcinoma
Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells.
Adenocarcinoma
Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.
Adenocarcinoma
Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Adenocarcinoma
GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Adenocarcinoma
Htert gene expression levels and telomerase activity in drug resistant mcf-7 cells.
Adenocarcinoma
HTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa.
Adenocarcinoma
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
Adenocarcinoma
Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa.
Adenocarcinoma
Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.
Adenocarcinoma
In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Adenocarcinoma
In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.
Adenocarcinoma
Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells.
Adenocarcinoma
Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.
Adenocarcinoma
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Adenocarcinoma
Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Adenocarcinoma
Inhibition of telomerase by site-specific ribonucleases in gastric and esophageal adenocarcinoma.
Adenocarcinoma
Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines.
Adenocarcinoma
Linoleic Acid-Induced Growth Inhibition of Human Gastric Epithelial Adenocarcinoma AGS Cells is Associated with Down-Regulation of Prostaglandin E2 Synthesis and Telomerase Activity.
Adenocarcinoma
Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
Adenocarcinoma
Molecular Imaging of MDM2 Messenger RNA with 99mTc-Labeled Antisense Oligonucleotides in Experimental Human Breast Cancer Xenografts.
Adenocarcinoma
Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Adenocarcinoma
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
Adenocarcinoma
Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis.
Adenocarcinoma
Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach.
Adenocarcinoma
Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
Adenocarcinoma
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Adenocarcinoma
Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
Adenocarcinoma
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Adenocarcinoma
Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
Adenocarcinoma
Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma.
Adenocarcinoma
Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines.
Adenocarcinoma
Study of genetic variants in chromosome 5p15.33 region in non-smoker lung cancer patients.
Adenocarcinoma
Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.
Adenocarcinoma
Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis.
Adenocarcinoma
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Adenocarcinoma
Telomerase activation--one step on the road to carcinoma of the gall bladder.
Adenocarcinoma
Telomerase activity and alterations in telomere length in human brain tumors.
Adenocarcinoma
Telomerase activity and patient survival after surgery for gastric and oesophageal cancer.
Adenocarcinoma
Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis.
Adenocarcinoma
Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Adenocarcinoma
Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Adenocarcinoma
Telomerase Activity in Gastric Adenocarcinomas: Frozen Tissues Versus Methacarn-fixed Paraffin-embedded Tissues.
Adenocarcinoma
Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas.
Adenocarcinoma
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Adenocarcinoma
Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
Adenocarcinoma
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Adenocarcinoma
Telomerase activity in thymomas and mammary gland adenocarcinomas induced by polyoma virus in AKR mice.
Adenocarcinoma
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Adenocarcinoma
Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Adenocarcinoma
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Adenocarcinoma
Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
Adenocarcinoma
Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.
Adenocarcinoma
Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
Adenocarcinoma
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.
Adenocarcinoma
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Adenocarcinoma
Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Adenocarcinoma
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Adenocarcinoma
Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Adenocarcinoma
Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
Adenocarcinoma
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Adenocarcinoma
The association between telomerase, p53, and clinical staging in colorectal cancer.
Adenocarcinoma
The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration.
Adenocarcinoma
Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma.
Adenocarcinoma
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Adenocarcinoma
[Effect of selenium dioxide on proliferation, apoptosis, and elomerase activity of human lung cancer cell line in vitro]
Adenocarcinoma
[General rules for the study of pancreatic cancer by molecular biological aspect]
Adenocarcinoma
[Telomerase activity in association with the pathological differentiation of prostate cancer]
Adenocarcinoma
[Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach]
Adenocarcinoma of Lung
A novel method to generate single-cell-derived cancer-associated fibroblast clones.
Adenocarcinoma of Lung
Bidirectional regulation of telomerase activity in a subline derived from human lung adenocarcinoma.
Adenocarcinoma of Lung
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Adenocarcinoma of Lung
Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR.
Adenocarcinoma of Lung
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Adenocarcinoma of Lung
Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde.
Adenocarcinoma of Lung
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Adenocarcinoma of Lung
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Adenocarcinoma of Lung
Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study.
Adenocarcinoma of Lung
Functional impairment of telomerase in sublines derived from human lung adenocarcinoma exposed to mild oxidative stress.
Adenocarcinoma of Lung
Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma.
Adenocarcinoma of Lung
High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
Adenocarcinoma of Lung
HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas.
Adenocarcinoma of Lung
Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
Adenocarcinoma of Lung
Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
Adenocarcinoma of Lung
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Adenocarcinoma of Lung
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values.
Adenocarcinoma of Lung
Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line.
Adenocarcinoma of Lung
n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity.
Adenocarcinoma of Lung
Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma.
Adenocarcinoma of Lung
Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells.
Adenocarcinoma of Lung
Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
Adenocarcinoma of Lung
Silencing tankyrase and telomerase promotes A549 human lung adenocarcinoma cell apoptosis and inhibits proliferation.
Adenocarcinoma of Lung
Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
Adenocarcinoma of Lung
Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinomas.
Adenocarcinoma of Lung
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Adenocarcinoma of Lung
The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Adenocarcinoma of Lung
Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Adenocarcinoma of Lung
[A study on effects of cisplatin and its mechanisms on human lung adenocarcinoma SLC-89 cells.]
Adenocarcinoma of Lung
[Effect of tankyrase antisense oligonucleotide combined human telomerase reverse transcriptase antisense oligonucleotide on telomere dynamics in human lung adenocarcinoma A549 cells]
Adenocarcinoma of Lung
[Effects of matrine on the growth inhibition, c-myc and hTERT protein expression in human adenocarcinoma lung cancer cell line A549.]
Adenocarcinoma of Lung
[Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro].
Adenocarcinoma of Lung
[Expression of hTERT mRNA in Anip973 and Anip973/NVB cell detected by quantitative real-time PCR]
Adenocarcinoma of Lung
[Expression of telomerase activity in thymoma and thymiccarcinoma tissues; a clinicopathological study]
Adenocarcinoma of Lung
[Significant correlation of telomerase activity in lung adenocarcinomas with cell differentiation and chromosome aberration]
Adenocarcinoma, Bronchiolo-Alveolar
Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Adenocarcinoma, Bronchiolo-Alveolar
Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung.
Adenocarcinoma, Bronchiolo-Alveolar
Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.
Adenocarcinoma, Follicular
A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
Adenocarcinoma, Follicular
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Adenocarcinoma, Follicular
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
Adenocarcinoma, Follicular
Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Adenocarcinoma, Follicular
Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Adenocarcinoma, Mucinous
Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Adenocarcinoma, Scirrhous
[Telomerase activity in benign proliferative breast disease and breast cancer]
Adenoma
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Adenoma
Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.
Adenoma
Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Adenoma
Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Adenoma
Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe.
Adenoma
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.
Adenoma
Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma.
Adenoma
Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
Adenoma
Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Adenoma
Human telomerase reverse transcriptase, p53 and Ki-67 expression and apoptosis in colorectal serrated adenoma.
Adenoma
Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.
Adenoma
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas.
Adenoma
Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.
Adenoma
Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Adenoma
Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.
Adenoma
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Adenoma
Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology.
Adenoma
Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
Adenoma
Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Adenoma
Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.
Adenoma
Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
Adenoma
Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
Adenoma
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Adenoma
Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Adenoma
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid.
Adenoma
Telomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesions.
Adenoma
Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Adenoma
Telomerase activity and microsatellite instability in colorectal cancer and adenoma.
Adenoma
Telomerase activity and telomere length in benign and malignant human thyroid tissues.
Adenoma
Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Adenoma
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Adenoma
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.
Adenoma
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Adenoma
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
Adenoma
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Adenoma
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.
Adenoma
The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
Adenoma
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Adenoma
[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice]
Adenoma
[Telomerase activity in lung cancer and adjacent peritumoral tissues determined by TRAP-SYBR green assay]
Adenoma
[Telomerase expression in colorectal tubular adenoma determined by immunohistochemical staining]
Adenoma
[Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach]
Adenoma, Liver Cell
Absence of correlation between telomerase activity and hepatic neoplasia in B6C3F1 mice.
Adenoma, Pleomorphic
Immunohistochemical evaluation of salivary gland tumors differentiation and proliferation by using calponin and telomerase.
Adenomatous Polyposis Coli
Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.
Adenomatous Polyposis Coli
Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Adenomatous Polyposis Coli
Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.
Adenomatous Polyposis Coli
Telomerase activity and p53 gene mutation in familial polyposis coli.
Adenomatous Polyps
Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Adenomatous Polyps
Evaluation of telomerase in the development and progression of colon cancer.
Adenomatous Polyps
Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Adenomatous Polyps
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Adenoviridae Infections
Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts.
Adrenal Cortex Neoplasms
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
Adrenal Cortex Neoplasms
Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells.
Adrenocortical Adenoma
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Adrenocortical Carcinoma
Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Adrenocortical Carcinoma
Telomerase activity as an indicator of potentially malignant adrenal tumors.
Adrenocortical Carcinoma
TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
African Swine Fever
Assessing the value of PCR assays in oral fluid samples for detecting African swine fever, classical swine fever, and foot-and-mouth disease in U.S. swine.
Agammaglobulinemia
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita.
Aggressive Periodontitis
Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect.
Aggressive Periodontitis
Telomerase Expression in Subjects With Chronic and Aggressive Periodontitis.
AIDS Dementia Complex
HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
AIDS-Related Complex
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
Alopecia
Telomere dysfunction impairs epidermal stem cell specification and differentiation by disrupting BMP/pSmad/P63 signaling.
Alopecia
[Experimental and clinical studies of mechanisms of the anti-aging effects of chemical compounds in Astragalus membranaceus (review).]
alpha-Thalassemia
alpha-and beta-Globin complementary deoxyribonucleic acids of human and rabbit. Specificity of hybridization.
alpha-Thalassemia
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.
alpha-Thalassemia
Hb Charlieu [alpha106(G13)Leu-->Pro (alpha1)]: a new phenotypically silent hemoglobin variant associated with a mild alpha-thalassemia phenotype.
alpha-Thalassemia
Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
Alveolitis, Extrinsic Allergic
New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?
Alveolitis, Extrinsic Allergic
Telomere shortening and DNA damage in culprit cells of different types of progressive fibrosing interstitial lung disease.
Alveolitis, Extrinsic Allergic
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Alzheimer Disease
Beta-carotene, telomerase activity and Alzheimer's disease in old age subjects.
Alzheimer Disease
Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Alzheimer Disease
Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice.
Alzheimer Disease
Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease.
Alzheimer Disease
Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease.
Alzheimer Disease
Double negative (CD19(+)IgG(+)IgD(-)CD27(-)) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients.
Alzheimer Disease
Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy.
Alzheimer Disease
Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
Alzheimer Disease
New horizons for diagnostics and therapeutic applications of graphene and graphene oxide.
Alzheimer Disease
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Alzheimer Disease
Telomeres and telomerase in Alzheimer's disease: Epiphenomena or a new focus for therapeutic strategy?
Alzheimer Disease
The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis.
Alzheimer Disease
The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro.
Ameloblastoma
Association between clincopathological characteristics and hTERT expression as well as telomere length in ameloblastoma.
Ameloblastoma
Establishment of human dental epithelial cell lines expressing ameloblastin and enamelin by transfection of hTERT and cdk4 cDNAs.
Ameloblastoma
Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics.
Ameloblastoma
Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas.
Ameloblastoma
The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture.
Ameloblastoma
[Characterization of growth and proliferation in a telomerase-immortalized ameloblastoma cell line]
Ameloblastoma
[Expression of human telomerase reverse transcriptase and bcl-2 in ameloblastoma]
Ameloblastoma
[Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma]
Amyotrophic Lateral Sclerosis
Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.
Amyotrophic Lateral Sclerosis
Telomerase expression in amyotrophic lateral sclerosis (ALS) patients.
Amyotrophic Lateral Sclerosis
Telomere shortening leads to earlier age of onset in ALS mice.
Anaphylaxis
Large defects of type I allergic response in telomerase reverse transcriptase knockout mice.
Anemia
Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.
Anemia
DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.
Anemia
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Anemia
High Incidence of Zidovudine Induced Anaemia in HIV Infected Patients in Southern Odisha.
Anemia
High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.
Anemia
Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia.
Anemia
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Anemia
Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
Anemia, Aplastic
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria.
Anemia, Aplastic
A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Anemia, Aplastic
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Anemia, Aplastic
Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells.
Anemia, Aplastic
Comprehensive structure-function analysis of the core domain of human telomerase RNA.
Anemia, Aplastic
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Anemia, Aplastic
Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.
Anemia, Aplastic
Detection of mutations in TERT, the genes for telomerase reverse transcriptase, in Indian patients of aplastic anaemia: a pilot study.
Anemia, Aplastic
Disease-associated human telomerase RNA variants show loss of function for telomere synthesis without dominant-negative interference.
Anemia, Aplastic
Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
Anemia, Aplastic
Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.
Anemia, Aplastic
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Anemia, Aplastic
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Anemia, Aplastic
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Anemia, Aplastic
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
Anemia, Aplastic
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.
Anemia, Aplastic
Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Anemia, Aplastic
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Anemia, Aplastic
Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age.
Anemia, Aplastic
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Anemia, Aplastic
Making the most of a little: dosage effects in eukaryotic telomere length maintenance.
Anemia, Aplastic
Many disease-associated variants of hTERT retain high telomerase enzymatic activity.
Anemia, Aplastic
Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
Anemia, Aplastic
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Anemia, Aplastic
Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA.
Anemia, Aplastic
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Anemia, Aplastic
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.
Anemia, Aplastic
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Anemia, Aplastic
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.
Anemia, Aplastic
Telomerase activity and its correlation with the proliferative potential of bone marrow in aplastic anemia in children.
Anemia, Aplastic
Telomerase gene mutation screening in Chinese patients with aplastic anemia.
Anemia, Aplastic
Telomerase gene therapy rescues telomere length, bone marrow aplasia and survival in mice with aplastic anemia.
Anemia, Aplastic
Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes.
Anemia, Aplastic
Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging.
Anemia, Aplastic
Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
Anemia, Aplastic
Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres.
Anemia, Aplastic
Understanding telomere diseases through analysis of patient-derived iPS cells.
Anemia, Aplastic
[Expression of telomerase activity and its related genes in the marrow hemopoietic stem cells of children with aplastic anemia].
Anemia, Aplastic
[The relationship of telomere and telomerase activity with outcome of aplastic anemia after immunesu pysessive therapy.]
Anemia, Hemolytic
alpha-and beta-Globin complementary deoxyribonucleic acids of human and rabbit. Specificity of hybridization.
Aneurysm
Polymorphisms of Pro-Inflammatory IL-6 and IL-1? Cytokines in Ascending Aortic Aneurysms as Genetic Modifiers and Predictive and Prognostic Biomarkers.
Aneurysm
Red Blood Cell Distribution Width, Vascular Aging Biomarkers, and Endothelial Progenitor Cells for Predicting Vascular Aging and Diagnosing/Prognosing Age-Related Degenerative Arterial Diseases.
Angiomyolipoma
Hepatic angiomyolipoma in a 26-year-old Caucasian woman with a history of tibial osteosarcoma.
Angiomyolipoma
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.
Anthrax
Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
Aortic Aneurysm
Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm.
Aortic Aneurysm, Abdominal
Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation.
Aortic Aneurysm, Abdominal
Telomerase expression on aortic wall endothelial cells is attenuated in abdominal aortic aneurysms compared to healthy nonaneurysmal aortas.
Arrhythmias, Cardiac
Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
Arrhythmias, Cardiac
[Animal in vivo model of arrhythmia for genes target identification for 5-amino-exo-3-azatricyclo[5.2.1.0(2,6)]decan-4-one].
Arthritis
Amelioration of experimental arthritis by a telomerase-dependent conditionally replicating adenovirus that targets synovial fibroblasts.
Arthritis, Rheumatoid
Abatacept suppresses the telomerase activity of lymphocytes in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect.
Arthritis, Rheumatoid
Autoantibodies targeting telomere-associated proteins in systemic sclerosis.
Arthritis, Rheumatoid
Basic FGF-induced activation of telomerase in rheumatoid synoviocytes.
Arthritis, Rheumatoid
Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation.
Arthritis, Rheumatoid
Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.
Arthritis, Rheumatoid
Evidence in patients with systemic lupus erythematosus of the presence of antibodies against RNA-dependent DNA polymerase of baboon endogenous virus.
Arthritis, Rheumatoid
Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients.
Arthritis, Rheumatoid
Longterm Culture of Telomerase-Transduced Rheumatoid Arthritis Fibroblast-like Synoviocytes Display a Distinct Gene Expression Pattern.
Arthritis, Rheumatoid
Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis.
Arthritis, Rheumatoid
Telomerase activity in rheumatoid synovium correlates with the mononuclear cell infiltration level and disease aggressiveness of rheumatoid arthritis.
Arthritis, Rheumatoid
Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.
Arthritis, Rheumatoid
The role of telomerase in joint deterioration in rheumatoid arthritis.
Asbestosis
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis.
Asthma
Activation of telomerase is induced by a natural antigen in allergen-specific memory T lymphocytes in bronchial asthma.
Asthma
PINX1 and TERT Are Required for TNF-?-Induced Airway Smooth Muscle Chemokine Gene Expression.
Astrocytoma
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Astrocytoma
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
Astrocytoma
Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Astrocytoma
Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.
Astrocytoma
Expression of Telomeres in Astrocytoma WHO Grade 2 to 4: TERRA Level Correlates with Telomere Length, Telomerase Activity, and Advanced Clinical Grade.
Astrocytoma
Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth.
Astrocytoma
Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.
Astrocytoma
Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats.
Astrocytoma
Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel.
Astrocytoma
Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis.
Astrocytoma
Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres.
Astrocytoma
Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level.
Astrocytoma
PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.
Astrocytoma
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Astrocytoma
Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
Astrocytoma
RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population.
Astrocytoma
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Astrocytoma
Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
Astrocytoma
Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Astrocytoma
Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Astrocytoma
Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas.
Astrocytoma
The role of aldehyde reductase AKR1A1 in the metabolism of gamma-hydroxybutyrate in 1321N1 human astrocytoma cells.
Ataxia
Introduction of Telomerase to Ataxia Teleangiectasia Cells Can Extend Shortend Telomere and Bypass Replicative Senescence.
Ataxia
Riccardin D, a Macrocyclic Bisbibenzy, Inhibits Human Breast Cancer Growth through the Suppression of Telomerase Activity.
Ataxia Telangiectasia
Arabidopsis ATM and ATR kinases prevent propagation of genome damage caused by telomere dysfunction.
Ataxia Telangiectasia
Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
Ataxia Telangiectasia
Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression.
Ataxia Telangiectasia
Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells.
Ataxia Telangiectasia
Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion.
Ataxia Telangiectasia
Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
Ataxia Telangiectasia
DNA Repair Defect in AT Cells and their Hypersensitivity to Low-Dose-Rate Radiation.
Ataxia Telangiectasia
Establishment of immortal normal and ataxia telangiectasia fibroblast cell lines by introduction of the hTERT gene.
Ataxia Telangiectasia
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
Ataxia Telangiectasia
Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis.
Ataxia Telangiectasia
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.
Ataxia Telangiectasia
Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Atherosclerosis
Activation of telomerase and expression of human telomerase reverse transcriptase in coronary atherosclerosis.
Atherosclerosis
Endogenous oxidative stress prevents telomerase-dependent immortalization of human endothelial cells.
Atherosclerosis
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems.
Atherosclerosis
Evaluation of Energy Balance on Human Telomerase Reverse Transcriptase (hTERT) Alternative Splicing by Semi-quantitative RT-PCR in Human Umbilical Vein Endothelial Cells.
Atherosclerosis
Evaluation of TERT mRNA alternative spliced variants in aortic endothelial cells of the rabbit, in the fatty streaks stage of atherosclerosis.
Atherosclerosis
HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model.
Atherosclerosis
Injection of hTERT-Transduced Endothelial Progenitor Cells Promotes Beneficial Aortic Changes in a High-Fat Dietary Model of Early Atherosclerosis.
Atherosclerosis
MicroRNA-216a promotes M1 macrophages polarization and atherosclerosis progression by activating telomerase via the Smad3/NF-?B pathway.
Atherosclerosis
Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment.
Atherosclerosis
Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C.
Atherosclerosis
Remnant like particles may induce atherosclerosis via accelerating endothelial progenitor cells senescence.
Atherosclerosis
Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study.
Atherosclerosis
Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice.
Atherosclerosis
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Atherosclerosis
Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages.
Atherosclerosis
Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.
Atherosclerosis
Telomerase, telomere length, and coronary artery calcium in black and white men in the CARDIA study.
Atherosclerosis
The GG Genotype of Telomerase Reverse Transcriptase at Genetic Locus rs2736100 Is Associated with Human Atherosclerosis Risk in the Han Chinese Population.
Atherosclerosis
Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.
Atherosclerosis
[Effects of Chinese herbal medicine Shoushen Granule on telomere length and telomerase activity of peripheral white blood cells and vascular cells in rats with atherosclerosis].
Atypical Squamous Cells of the Cervix
Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
Atypical Squamous Cells of the Cervix
Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Atypical Squamous Cells of the Cervix
Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.
Atypical Squamous Cells of the Cervix
Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
Autoimmune Diseases
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19.
Autoimmune Diseases
Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients.
Autoimmune Diseases
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Autoimmune Diseases
Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis.
Avian Leukosis
Comparison of the RNA-dependent DNA polymerase of an endogenous avian leukosis virus to the polymerase of an exogenous avian leukosis virus.
Avian Leukosis
Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus.
Avian Leukosis
Isolation and characterization of a virus-specific ribonucleoprotein complex from reticuloendotheliosis virus-transformed chicken bone marrow cells.
Avian Leukosis
Joint treatment with azidothymidine and antiserum for eradication of avian leukosis virus subgroup a contamination in vaccine virus seeds.
Avian Leukosis
Marker rescue of endogenous cellular genetic information related to the avian leukosis virus gene encoding RNA-directed DNA polymerase.
Avian Leukosis
Mutual regulation between chicken telomerase reverse transcriptase and the Wnt/?-catenin signalling pathway inhibits apoptosis and promotes the replication of ALV-J in LMH cells.
Avian Leukosis
Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
Avian Leukosis
Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.
Avian Leukosis
Reverse transcriptase associated with avian sarcoma-leukosis viruses. II. Comparison of subunit structure and catalytic properties.
Avian Leukosis
Specific antigenic relationships between the RNA-dependent DNA polymerases of avian reticuloendotheliosis viruses and mammalian type C retroviruses.
Avian Leukosis
Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.
Avian Leukosis
trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
Azoospermia
Quantification of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) mRNA in testicular tissue of infertile patients.
Azoospermia
Quantification of the expression level of the gene encoding the catalytic subunit of telomerase in testicular tissue specimens predicts successful sperm recovery.
Azoospermia
Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients.
Bacteremia
The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy.
Bacterial Infections
Immortalization of Fetal Bovine Colon Epithelial Cells by Expression of Human Cyclin D1, Mutant Cyclin Dependent Kinase 4, and Telomerase Reverse Transcriptase: An In Vitro Model for Bacterial Infection.
Bacterial Infections
Stable expression in a Chinese hamster ovary (CHO) cell line of bioactive recombinant chelonianin, which plays an important role in protecting fish against pathogenic infection.
Barrett Esophagus
Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
Barrett Esophagus
Cytotoxicity of chronic exposure to 4 cigarette smoke condensates in 2 cell lines.
Barrett Esophagus
Evidence for Enhanced Telomerase Activity in Barrett's Esophagus with Dysplasia and Adenocarcinoma.
Barrett Esophagus
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.
Barrett Esophagus
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus.
Barrett Esophagus
In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Barrett Esophagus
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation.
Barrett Esophagus
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.
Barrett Esophagus
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Barrett Esophagus
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.
beta-Thalassemia
alpha-and beta-Globin complementary deoxyribonucleic acids of human and rabbit. Specificity of hybridization.
beta-Thalassemia
Expression of human telomerase reverse transcriptase in bone marrow CD34+ cells from patients with beta-thalassemia major.
beta-Thalassemia
Premature senescence of T lymphocytes from patients with beta-thalassemia major.
Bile Duct Diseases
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Biliary Atresia
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Biliary Tract Diseases
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Biliary Tract Neoplasms
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Biliary Tract Neoplasms
Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
Biliary Tract Neoplasms
Detection of telomerase activity in exfoliated cancer cells obtained from bile.
Biliary Tract Neoplasms
Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Blast Crisis
Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1.
Blast Crisis
Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.
Blast Crisis
Cross-talk between Bcr-Abl tyrosine kinase, protein kinase C and telomerase-a potential reason for resistance to Glivec in chronic myelogenous leukaemia.
Blast Crisis
Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
Blast Crisis
Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
Blast Crisis
Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia.
Blast Crisis
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Blister
Human skin lymph derived from irritant and allergic contact dermatitis: interleukin 10 is increased selectively in elicitation reactions.
Blister
In vivo and in vitro evidence for autocrine DCoH/HNF-1alpha transcription of albumin in the human epidermis.
Bloom Syndrome
Telomerase activity in cell lines and lymphoma originating from Bloom syndrome.
Bluetongue
Bluetongue virus detection: a safer reverse-transcriptase polymerase chain reaction for prediction of viremia in sheep.
Bluetongue
Identification of a novel bluetongue virus vector species of Culicoides in Sicily.
Bluetongue
Identification of bluetongue virus serotype 2 (Corsican strain) by reverse-transcriptase PCR reaction analysis of segment 2 of the genome.
Bone Cysts, Aneurysmal
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness.
Bone Diseases, Metabolic
Circular RNA hsa_circ_0001445 in plasma as a novel biomarker for osteoporosis in postmenopausal women.
Bone Diseases, Metabolic
Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study.
Bone Marrow Failure Disorders
A case of laryngeal carcinoma in a young adult with dyskeratosis congenita.
Bone Marrow Failure Disorders
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria.
Bone Marrow Failure Disorders
A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome.
Bone Marrow Failure Disorders
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
Bone Marrow Failure Disorders
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of Dyskeratosis congenita.
Bone Marrow Failure Disorders
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Bone Marrow Failure Disorders
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia.
Bone Marrow Failure Disorders
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.
Bone Marrow Failure Disorders
Diminished telomeric 3' overhangs are associated with telomere dysfunction in hoyeraal-hreidarsson syndrome.
Bone Marrow Failure Disorders
Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.
Bone Marrow Failure Disorders
DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.
Bone Marrow Failure Disorders
Dyskeratosis congenita: a disorder of defective telomere maintenance?
Bone Marrow Failure Disorders
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Bone Marrow Failure Disorders
Dyskerin is a component of the arabidopsis telomerase RNP required for telomere maintenance.
Bone Marrow Failure Disorders
Engineered telomere degradation models dyskeratosis congenita.
Bone Marrow Failure Disorders
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Bone Marrow Failure Disorders
Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611.
Bone Marrow Failure Disorders
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Bone Marrow Failure Disorders
Functional characterization of telomerase RNA variants found in patients with hematologic disorders.
Bone Marrow Failure Disorders
Hematopoietic stem cell development, aging and functional failure.
Bone Marrow Failure Disorders
Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.
Bone Marrow Failure Disorders
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.
Bone Marrow Failure Disorders
Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants.
Bone Marrow Failure Disorders
Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Bone Marrow Failure Disorders
Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
Bone Marrow Failure Disorders
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Bone Marrow Failure Disorders
Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.
Bone Marrow Failure Disorders
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.
Bone Marrow Failure Disorders
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Bone Marrow Failure Disorders
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
Bone Marrow Failure Disorders
Pulmonary fibrosis, bone marrow failure, and telomerase mutation.
Bone Marrow Failure Disorders
Senescence of hematopoietic stem cells and bone marrow failure.
Bone Marrow Failure Disorders
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.
Bone Marrow Failure Disorders
Short telomere syndromes cause a primary T cell immunodeficiency.
Bone Marrow Failure Disorders
Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside.
Bone Marrow Failure Disorders
Short telomeres are sufficient to cause the degenerative defects associated with aging.
Bone Marrow Failure Disorders
Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Bone Marrow Failure Disorders
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Bone Marrow Failure Disorders
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.
Bone Marrow Failure Disorders
Telomerase as a clinical target: current strategies and potential applications.
Bone Marrow Failure Disorders
Telomerase enzyme activity in Egyptian children with bone marrow failure and response to immunosuppressive therapy.
Bone Marrow Failure Disorders
Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia.
Bone Marrow Failure Disorders
Telomerase gene mutation screening in Chinese patients with aplastic anemia.
Bone Marrow Failure Disorders
Telomerase gene mutations are associated with cirrhosis formation.
Bone Marrow Failure Disorders
Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
Bone Marrow Failure Disorders
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Bone Marrow Failure Disorders
Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.
Bone Marrow Failure Disorders
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Bone Marrow Failure Disorders
TERC mutations in children with refractory cytopenia.
Bone Marrow Failure Disorders
[Bone marrow failure due to telomerase complex gene mutations]
Bone Marrow Failure Disorders
[Study on telomerase gene mutation in northern Chinese patients with acquired bone marrow failure syndromes.]
Bone Marrow Failure Disorders
[Telomere length measurement of 10 Chinese patients with bone marrow failure syndrome.]
Bone Neoplasms
Enhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain.
Bone Neoplasms
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Bowen's Disease
The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
Brain Abscess
Distinct cytokine pattern in response to different bacterial pathogens in human brain abscess.
Brain Injuries
Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity.
Brain Injuries
Metallothionein (MT) -I and MT-II Expression Are Induced and Cause Zinc Sequestration in the Liver after Brain Injury.
Brain Injuries
Neuroprotective signaling mechanisms of telomerase are regulated by brain-derived neurotrophic factor in rat spinal cord motor neurons.
Brain Injuries
Seizures and tissue injury induce telomerase in hippocampal microglial cells.
Brain Injuries
Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain injury.
Brain Injuries
Telomerase reverse transcriptase: A novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury.
Brain Injuries
Umbilical cord blood mesenchymal stem cells co-modified by TERT and BDNF: A novel neuroprotective therapy for neonatal hypoxic-ischemic brain damage.
Brain Injuries
[Effect of telomerase activation on biological behaviors of neural stem cells in rats with hypoxic-ischemic insults].
Brain Injuries
[The neuroprotective role of exogenous TERT gene in neonatal rats with hypoxic-ischemic brain damage].
Brain Injuries, Traumatic
Sexually Dimorphic Behavioral and Genetic Outcomes Associated With Administration of TA65 (A Telomerase Activator) Following Repetitive Traumatic Brain Injury: A Pilot Study.
Brain Injuries, Traumatic
Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V(1a) receptor.
Brain Ischemia
Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.
Brain Ischemia
Immortalized Human Bone Marrow Derived Stromal Cells in Treatment of Transient Cerebral Ischemia in Rats.
Brain Ischemia
[Effects of cerebellar fastigial nucleus electrical stimulation on telomerase reverse transcriptase expression and mitochondrial apoptotic pathway in rats with focal cerebral ischemia and reperfusion].
Brain Neoplasms
Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma.
Brain Neoplasms
Cellular immortality in brain tumours: An integration of the cancer stem cell paradigm.
Brain Neoplasms
Changes in the Expression of Pre-Replicative Complex Genes in hTERT and ALT Pediatric Brain Tumors.
Brain Neoplasms
Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.
Brain Neoplasms
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay.
Brain Neoplasms
Differential telomerase expression and telomere length in primary intracranial tumors.
Brain Neoplasms
Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Brain Neoplasms
Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.
Brain Neoplasms
Glioblastoma induces vascular endothelial cells to express telomerase in vitro.
Brain Neoplasms
Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells.
Brain Neoplasms
Immunohistochemical expression of h-telomerase reverse transcriptase in canine and feline meningiomas.
Brain Neoplasms
Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats.
Brain Neoplasms
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Brain Neoplasms
Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
Brain Neoplasms
Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
Brain Neoplasms
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
Brain Neoplasms
Part I. Telomerase levels in human metastatic brain tumors show four-fold logarithmic variability but no correlation with tumor type or interval to patient demise.
Brain Neoplasms
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Brain Neoplasms
Particles with RNA of high molecular weight and RNA-directed DNA polymerase in human brain tumors.
Brain Neoplasms
Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells.
Brain Neoplasms
Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level.
Brain Neoplasms
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness.
Brain Neoplasms
Presence of telomerase activity with undetectable p16 gene mutation in Malaysian patients with brain tumor.
Brain Neoplasms
Prognostic implication of telomerase activity in patients with brain tumors.
Brain Neoplasms
Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Brain Neoplasms
Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.
Brain Neoplasms
Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.
Brain Neoplasms
Telomerase activity and alterations in telomere length in human brain tumors.
Brain Neoplasms
Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Brain Neoplasms
Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation.
Brain Neoplasms
Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Brain Neoplasms
Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery.
Brain Neoplasms
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours.
Brain Neoplasms
The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas.
Breast Diseases
Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Breast Diseases
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Breast Diseases
[Telomerase activity in benign proliferative breast disease and breast cancer]
Breast Neoplasms
1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
Breast Neoplasms
A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
Breast Neoplasms
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR.
Breast Neoplasms
A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Breast Neoplasms
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Breast Neoplasms
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.
Breast Neoplasms
A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.
Breast Neoplasms
A novel and exploitable antifungal peptide from kale (Brassica alboglabra) seeds.
Breast Neoplasms
A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells.
Breast Neoplasms
A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer.
Breast Neoplasms
A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.
Breast Neoplasms
A robust cysteine-deficient chitinase-like antifungal protein from inner shoots of the edible chive Allium tuberosum.
Breast Neoplasms
A stable trypsin inhibitor from Chinese dull black soybeans with potentially exploitable activities.
Breast Neoplasms
A Static Magnetic Field Inhibits the Migration and Telomerase Function of Mouse Breast Cancer Cells.
Breast Neoplasms
A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.
Breast Neoplasms
A trypsin-chymotrypsin inhibitor with antiproliferative activity from small glossy black soybeans.
Breast Neoplasms
Abcg2/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine.
Breast Neoplasms
Accuracy of telomerase in estimating breast cancer risk: a systematic review and meta-analysis.
Breast Neoplasms
Aloe emodin inhibits telomerase activity in breast cancer cells: transcriptional and enzymological mechanism.
Breast Neoplasms
AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone.
Breast Neoplasms
Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer.
Breast Neoplasms
An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells.
Breast Neoplasms
An ultrasensitive and point-of-care sensor for the telomerase activity detection.
Breast Neoplasms
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Breast Neoplasms
Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells.
Breast Neoplasms
Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle.
Breast Neoplasms
Antitumor and HIV-1 Reverse Transcriptase Inhibitory Activities of a Hemagglutinin and a Protease Inhibitor from Mini-Black Soybean.
Breast Neoplasms
Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer.
Breast Neoplasms
Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
Breast Neoplasms
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Breast Neoplasms
Biomarkers of aging associated with past treatments in breast cancer survivors.
Breast Neoplasms
Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Breast Neoplasms
Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations.
Breast Neoplasms
Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
Breast Neoplasms
Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.
Breast Neoplasms
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
Breast Neoplasms
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.
Breast Neoplasms
Changes of Telomerase Activity and Proliferation by Inhibition of Reverse Transcriptase Activity in Human Cancer Cell.
Breast Neoplasms
Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients.
Breast Neoplasms
Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.
Breast Neoplasms
Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
Breast Neoplasms
Clinical relevance of telomerase polymorphism for breast cancer: A systematic review.
Breast Neoplasms
Cognitive performance in survivors of breast cancer and markers of biological aging.
Breast Neoplasms
Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.
Breast Neoplasms
Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer.
Breast Neoplasms
Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.
Breast Neoplasms
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Breast Neoplasms
Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining method.
Breast Neoplasms
Correspondence re: S. M. Melana et al., Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res., 4: 693-696, 1998.
Breast Neoplasms
Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells.
Breast Neoplasms
Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line.
Breast Neoplasms
Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-kappaB and HDAC in breast cancer.
Breast Neoplasms
Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer.
Breast Neoplasms
Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.
Breast Neoplasms
Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.
Breast Neoplasms
Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
Breast Neoplasms
Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
Breast Neoplasms
Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Breast Neoplasms
Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
Breast Neoplasms
Detection of telomerase activity in breast masses by fine-needle aspiration.
Breast Neoplasms
Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Breast Neoplasms
Determination of telomerase activity in stem cells and non-stem cells of breast cancer.
Breast Neoplasms
Development of a quantitative luminometric hybridization assay for the determination of telomerase activity.
Breast Neoplasms
Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer.
Breast Neoplasms
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Breast Neoplasms
Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.
Breast Neoplasms
DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Breast Neoplasms
Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.
Breast Neoplasms
Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.
Breast Neoplasms
Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Breast Neoplasms
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.
Breast Neoplasms
Effect of bisphenols on telomerase expression and activity in breast cancer cell lines.
Breast Neoplasms
Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells.
Breast Neoplasms
Effect of procathepsin D activation peptide on gene expression of breast cancer cells.
Breast Neoplasms
Effective Targeted Gene Knockdown in Mammalian Cells Using the piggyBac Transposase-based Delivery System.
Breast Neoplasms
Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
Breast Neoplasms
Effects of Ganoderma lucidum (Higher Basidiomycetes) Extracts on the miRNA Profile and Telomerase Activity of the MCF-7 Breast Cancer Cell Line.
Breast Neoplasms
Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells.
Breast Neoplasms
Effects of Reverse Transcriptase Inhibitors on Proliferation, Apoptosis, and Migration in Breast Carcinoma Cells.
Breast Neoplasms
Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Breast Neoplasms
Effects of tamoxifen on telomerase activity in breast carcinoma cell lines.
Breast Neoplasms
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Breast Neoplasms
Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent?
Breast Neoplasms
Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Breast Neoplasms
Enterolactone Reduces Telomerase Activity and The Level of Its Catalytic Subunit in Breast Cancer Cells.
Breast Neoplasms
Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.
Breast Neoplasms
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.
Breast Neoplasms
Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent ?-H2AX and telomerase regulation in triple-negative breast cancer.
Breast Neoplasms
Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
Breast Neoplasms
Establishment and characterization of a new cell line derived from a human primary breast carcinoma.
Breast Neoplasms
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Breast Neoplasms
Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers.
Breast Neoplasms
Evidence for two forms of reverse transcriptase in human placenta of a patient with breast cancer. Purification and biochemical characterization of the enzymes.
Breast Neoplasms
Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.
Breast Neoplasms
Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Breast Neoplasms
Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics.
Breast Neoplasms
Expression of human sequences related to those of mouse mammary tumor virus.
Breast Neoplasms
Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Breast Neoplasms
Expression of telomerase genes in cancer development in atypical hyperplasia of the mammary duct.
Breast Neoplasms
Expression of the breast cancer resistance protein and 5-fluorouracil resistance in clinical breast cancer tissue specimens.
Breast Neoplasms
Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells.
Breast Neoplasms
Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
Breast Neoplasms
Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells.
Breast Neoplasms
Genetic polymorphisms in human telomerase reverse transcriptase (hTERT) gene polymorphisms do not associated with breast cancer in patients in a turkish population: hospital-based case-control study.
Breast Neoplasms
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
Breast Neoplasms
Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532.
Breast Neoplasms
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) induces cancer cell senescence by interacting with telomerase RNA component.
Breast Neoplasms
Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines.
Breast Neoplasms
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning Approach.
Breast Neoplasms
hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.
Breast Neoplasms
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Breast Neoplasms
hTERT mRNA expression correlates with telomerase activity in human breast cancer.
Breast Neoplasms
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer.
Breast Neoplasms
hTERT regulation by NF-?B and c-myc in irradiated HER2-positive breast cancer cells.
Breast Neoplasms
Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
Breast Neoplasms
Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Breast Neoplasms
Identification of an RNA aptamer binding hTERT-derived peptide and inhibiting telomerase activity in MCF7 cells.
Breast Neoplasms
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.
Breast Neoplasms
Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Breast Neoplasms
In vitro quantification of the cytotoxic T lymphocyte response against human telomerase reverse transcriptase in breast cancer.
Breast Neoplasms
Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.
Breast Neoplasms
Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein.
Breast Neoplasms
Influence of Mindfulness-Based Stress Reduction (MBSR) on Telomerase Activity in Women With Breast Cancer (BC).
Breast Neoplasms
Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.
Breast Neoplasms
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Breast Neoplasms
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
Breast Neoplasms
Inhibition of Human Telomerase Reverse Transcritpase (hTERT) and Telomerase Activity by Curcumin in Human Mammary Epithelial and Breast Carcinoma Cell Lines.
Breast Neoplasms
Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Breast Neoplasms
Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells.
Breast Neoplasms
Intercellular traffic of human immunodeficiency virus type 1 transactivator protein defined by monoclonal antibodies.
Breast Neoplasms
Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells.
Breast Neoplasms
Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer?
Breast Neoplasms
Isolation and characterization of a lectin with potentially exploitable activities from caper (Capparis spinosa) seeds.
Breast Neoplasms
Isolation and Characterization of Juncin, an Antifungal Protein from Seeds of Japanese Takana ( Brassica juncea Var. integrifolia).
Breast Neoplasms
Isolation and identification of a novel polysaccharide-peptide complex with antioxidant, antiproliferative, and hypoglycemic activities from the abalone mushroom.
Breast Neoplasms
Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells.
Breast Neoplasms
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Breast Neoplasms
Lipid transfer proteins from Brassica campestris and mung bean surpass mung bean chitinase in exploitability.
Breast Neoplasms
Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab.
Breast Neoplasms
Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells.
Breast Neoplasms
Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Breast Neoplasms
Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase.
Breast Neoplasms
Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.
Breast Neoplasms
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Breast Neoplasms
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Breast Neoplasms
Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Breast Neoplasms
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Breast Neoplasms
MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Breast Neoplasms
Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Breast Neoplasms
Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice.
Breast Neoplasms
p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
Breast Neoplasms
PES1 is a critical component of telomerase assembly and regulates cellular senescence.
Breast Neoplasms
Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Breast Neoplasms
Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.
Breast Neoplasms
Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.
Breast Neoplasms
Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
Breast Neoplasms
Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.
Breast Neoplasms
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Breast Neoplasms
Prognostic significance of reactivation of telomerase in breast core biopsy specimens.
Breast Neoplasms
Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: possible relationship to steroid hormone receptors.
Breast Neoplasms
Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells.
Breast Neoplasms
Purification and characterization of a laccase from the edible wild mushroom Tricholoma mongolicum.
Breast Neoplasms
Purification and Characterization of an Antifungal Peptide with Potent Antifungal Activity but Devoid of Antiproliferative and HIV Reverse Transcriptase Activities from Legumi Secchi Beans.
Breast Neoplasms
Purification of melibiose-binding lectins from two cultivars of Chinese black soybeans.
Breast Neoplasms
Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Breast Neoplasms
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.
Breast Neoplasms
Re: Poremba et al Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 2002; 198: 181-189.
Breast Neoplasms
Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay.
Breast Neoplasms
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Breast Neoplasms
Relationship between dyskerin expression and telomerase activity in human breast cancer.
Breast Neoplasms
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
Breast Neoplasms
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
Breast Neoplasms
Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.
Breast Neoplasms
Retraction. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
Breast Neoplasms
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination.
Breast Neoplasms
Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Breast Neoplasms
Riccardin D, a Macrocyclic Bisbibenzy, Inhibits Human Breast Cancer Growth through the Suppression of Telomerase Activity.
Breast Neoplasms
RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line.
Breast Neoplasms
RNA-directed DNA polymerase activity in human breast cancer biopsy specimens. Relation to estrogen receptor protein.
Breast Neoplasms
Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.
Breast Neoplasms
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
Breast Neoplasms
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Breast Neoplasms
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Breast Neoplasms
Sequence homology of deoxyribonucleic acid to mouse mammary tumor virus genome in human breast tumors.
Breast Neoplasms
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis.
Breast Neoplasms
Serum tRNA-derived fragments (tRFs) as potential candidates for diagnosis of nontriple negative breast cancer.
Breast Neoplasms
Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
Breast Neoplasms
siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.
Breast Neoplasms
Stratification Using hTERT and Stem Cell Markers Confers a Good Prognosis in Invasive Breast Cancer.
Breast Neoplasms
Studies on the purification of polypeptide from sika antler plate and activities of antitumor.
Breast Neoplasms
Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Breast Neoplasms
SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion.
Breast Neoplasms
Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.
Breast Neoplasms
Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models.
Breast Neoplasms
Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.
Breast Neoplasms
Targeted Expression of BikDD Eliminates Breast Cancer with Virtually No Toxicity in Noninvasive Imaging Models.
Breast Neoplasms
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes.
Breast Neoplasms
Telomerase activation in neoplastic cell immortalization and tumour progression.
Breast Neoplasms
Telomerase activity and survival of patients with node-positive breast cancer.
Breast Neoplasms
Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
Breast Neoplasms
Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
Breast Neoplasms
Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
Breast Neoplasms
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.
Breast Neoplasms
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype.
Breast Neoplasms
Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Breast Neoplasms
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
Breast Neoplasms
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Breast Neoplasms
Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer.
Breast Neoplasms
Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Breast Neoplasms
Telomerase activity levels for evaluating the surgical margin in breast-conserving surgery.
Breast Neoplasms
Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients.
Breast Neoplasms
Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.
Breast Neoplasms
Telomerase as a Possible Candidate Targeting Therapy in Different Breast Cancer Cell Lines.
Breast Neoplasms
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Breast Neoplasms
Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner.
Breast Neoplasms
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Breast Neoplasms
Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells.
Breast Neoplasms
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.
Breast Neoplasms
Telomerase expression in human breast cancer with and without lymph node metastases.
Breast Neoplasms
Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells.
Breast Neoplasms
Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
Breast Neoplasms
Telomerase is controlled by protein kinase Calpha in human breast cancer cells.
Breast Neoplasms
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells.
Breast Neoplasms
Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells.
Breast Neoplasms
Telomerase RNA as a detection marker in the serum of breast cancer patients.
Breast Neoplasms
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Breast Neoplasms
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.
Breast Neoplasms
Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.
Breast Neoplasms
TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Breast Neoplasms
TERT regulates cell survival independent of telomerase enzymatic activity.
Breast Neoplasms
TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
Breast Neoplasms
The association between telomerase activity and expression of its RNA component (hTR) in breast cancer patients: the importance of DNase treatment.
Breast Neoplasms
The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
Breast Neoplasms
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer.
Breast Neoplasms
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Breast Neoplasms
The co-expression of telomerase and ALT pathway in human breast cancer tissues.
Breast Neoplasms
The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell line.
Breast Neoplasms
The differential regulation of human telomerase reverse transcriptase and vascular endothelial growth factor may contribute to the clinically more aggressive behavior of p63-positive breast carcinomas.
Breast Neoplasms
The effect of environmental Bisphenol A exposure on breast cancer associated with obesity.
Breast Neoplasms
The effect of raloxifene on telomerase expression in breast carcinoma samples from postmenopausal women.
Breast Neoplasms
The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Breast Neoplasms
The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.
Breast Neoplasms
The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
Breast Neoplasms
The role of interferon-gamma and vitamin-A in modulating telomerase activity in breast cancer patients.
Breast Neoplasms
The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2(+) breast cancer cells.
Breast Neoplasms
The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
Breast Neoplasms
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer.
Breast Neoplasms
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Breast Neoplasms
Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines.
Breast Neoplasms
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
Breast Neoplasms
Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
Breast Neoplasms
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).
Breast Neoplasms
Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
Breast Neoplasms
Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Breast Neoplasms
ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.
Breast Neoplasms
[Changes in telomerase activity decreases in MCF-7 cells during apoptosis induced by sodium butyrate]
Breast Neoplasms
[Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells]
Breast Neoplasms
[Clinical implications of telomerase activity in breast cancer fine-needle aspirates]
Breast Neoplasms
[Construction of an expression vector carrying short hairpin RNA targeting hTERT gene and its effects on breast cancer cell telomerase activity and proliferation in vivo]
Breast Neoplasms
[Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction]
Breast Neoplasms
[Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells]
Breast Neoplasms
[Effects of a novel antiprogestin derivative ZXH951 on proliferation and telomerase activity of human breast carcinoma cell lines]
Breast Neoplasms
[Enhanced thymidine kinase gene vector and its killing effect on nasopharyngeal carcinoma in vitro and in vivo].
Breast Neoplasms
[Inhibitory effect of telomerase inhibitors combined with X-irradiation on bone marrow hematopoiesis in mice]
Breast Neoplasms
[Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer]
Breast Neoplasms
[Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia]
Breast Neoplasms
[Significance of telomerase activity detection by fine-needle aspiration in patients with breast cancer]
Breast Neoplasms
[Significance of telomerase expression in diagnosis and treatment of breast tumor]
Breast Neoplasms
[Study on the relationship between TK gene regulated by enhanced suicide gene vector and telomerase activity in nasopharyngeal carcinoma cells]
Breast Neoplasms
[Telomerase activity in benign proliferative breast disease and breast cancer]
Breast Neoplasms
[Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications]
Breast Neoplasms
[The inhibitory effect of antisense adenovirus vector of telomerase on telomerase activity in breast cancer cells MCF-7]
Bronchiolitis, Viral
Viral Bronchiolitis is Associated with Altered Cytokine Gene Expression and Lymphocyte Activation Status.
Bronchitis
Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Bronchitis, Chronic
[Determination of telomerase activity in BALF cells from lung cancer patients]
Burkitt Lymphoma
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.
Burkitt Lymphoma
Atypical protein-kinase Czeta, but neither conventional Ca2+ -dependent protein-kinase C isoenzymes nor Ca2+ -calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells.
Burkitt Lymphoma
Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line.
Burkitt Lymphoma
Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.
Burkitt Lymphoma
Telomere dysfunction and inactivation of the p16(INK4a)/Rb pathway in pyothorax-associated lymphoma.
Burkitt Lymphoma
Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
Burkitt Lymphoma
[Telomere DNA and telomerase of lymphoma-derived cell lines--telomere hypothesis for cell growth control]
Caliciviridae Infections
Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.
Caliciviridae Infections
Apparently non-specific results found using a norovirus antigen immunoassay for fecal specimens from neonates.
Candidiasis
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects.
Capsule Opacification
[Expression and significance of telomerase activity of lens epithelial cells in posterior capsule opacification of rabbits]
Carcinogenesis
9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.
Carcinogenesis
A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis.
Carcinogenesis
A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin.
Carcinogenesis
A comparative study of telomerase activity and malignant phenotype in multistage carcinogenesis of esophageal epithelial cells induced by human papillomavirus.
Carcinogenesis
A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis.
Carcinogenesis
A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Carcinogenesis
A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Carcinogenesis
A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Carcinogenesis
A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer.
Carcinogenesis
A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters.
Carcinogenesis
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Carcinogenesis
Aberrant telomerase expression in the endometrium of infertile women with deep endometriosis.
Carcinogenesis
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Carcinogenesis
Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
Carcinogenesis
Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.
Carcinogenesis
Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc.
Carcinogenesis
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.
Carcinogenesis
Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Carcinogenesis
Airborne polychlorinated biphenyls (PCBs) reduce telomerase activity and shorten telomere length in immortal human skin keratinocytes (HaCat).
Carcinogenesis
Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions.
Carcinogenesis
Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Carcinogenesis
Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma.
Carcinogenesis
Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo.
Carcinogenesis
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.
Carcinogenesis
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Carcinogenesis
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Carcinogenesis
Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer.
Carcinogenesis
Amplification of the telomerase RNA component gene in the process of human esophageal carcinogenesis.
Carcinogenesis
An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cells.
Carcinogenesis
Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis.
Carcinogenesis
Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Carcinogenesis
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Carcinogenesis
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Carcinogenesis
Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta.
Carcinogenesis
Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells.
Carcinogenesis
Anticancer Potential and Mechanism of Action of Mango Ginger (Curcuma amada Roxb.) Supercritical CO2 Extract in Human Glioblastoma Cells.
Carcinogenesis
Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Carcinogenesis
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
Carcinogenesis
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation.
Carcinogenesis
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Carcinogenesis
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors.
Carcinogenesis
Antitumor efficacy of human telomerase reverse transcriptase gene antisense oligonucleotide in pancreatic cancer cells.
Carcinogenesis
Arsenic inhibition of telomerase transcription leads to genetic instability.
Carcinogenesis
ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.
Carcinogenesis
Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk.
Carcinogenesis
Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Carcinogenesis
ATM protein overexpression in prostate tumors: possible role in telomere maintenance.
Carcinogenesis
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Carcinogenesis
Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
Carcinogenesis
Biological characterization of long-term cultured human mesenchymal stem cells.
Carcinogenesis
BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells.
Carcinogenesis
Bronchogenic and alveologenic tumors in mice induced by N-nitrosopiperidine.
Carcinogenesis
C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro.
Carcinogenesis
c-MYC and h-TERT co-expression in colon adenocarcinoma: a tissue microarray digitized image analysis.
Carcinogenesis
C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
Carcinogenesis
Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.
Carcinogenesis
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.
Carcinogenesis
Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.
Carcinogenesis
Cascaded Electrochemiluminescence Signal Amplifier for the Detection of Telomerase Activity from Tumor Cells and Tissues.
Carcinogenesis
CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Carcinogenesis
Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation.
Carcinogenesis
Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis.
Carcinogenesis
Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
Carcinogenesis
Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis.
Carcinogenesis
Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Carcinogenesis
Clinical Significance of Human Telomerase RNA Gene (hTERC) Amplification in Cervical Squamous Cell Lesions Detected by Fluorescence in Situ Hybridization.
Carcinogenesis
Clinical significance of telomerase genes (hTERC and hTERT) amplification in patients with acute myeloid leukemia.
Carcinogenesis
Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
Carcinogenesis
Cloning of hTERT cDNA fragment and application of anti-hTERT monoclonal antibody in mechanism of laryngeal carcinogenesis.
Carcinogenesis
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
Carcinogenesis
Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Carcinogenesis
Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion.
Carcinogenesis
Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Carcinogenesis
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Carcinogenesis
Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
Carcinogenesis
Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.
Carcinogenesis
Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer.
Carcinogenesis
Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
Carcinogenesis
Correlation of dyskerin expression with active proliferation independent of telomerase.
Carcinogenesis
Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Carcinogenesis
Correlation of telomerase activity to apoptosis and survival in adult acute lymphoblastic leukemia: an Egyptian single-center study.
Carcinogenesis
Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Carcinogenesis
Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer.
Carcinogenesis
Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Carcinogenesis
CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Carcinogenesis
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
Carcinogenesis
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.
Carcinogenesis
Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity.
Carcinogenesis
Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.
Carcinogenesis
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Carcinogenesis
Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.
Carcinogenesis
Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Carcinogenesis
Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.
Carcinogenesis
Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma.
Carcinogenesis
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Carcinogenesis
Detection of DNA strand breaks, DNA-protein crosslinks, and telomerase activity in nickel-transformed BALB/c-3T3 cells.
Carcinogenesis
Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Carcinogenesis
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma.
Carcinogenesis
Detection of telomerase activity in tissues and primary cultured lymphoid cells of Penaeus japonicus.
Carcinogenesis
Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
Carcinogenesis
Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Carcinogenesis
Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
Carcinogenesis
Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Carcinogenesis
Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer.
Carcinogenesis
Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
Carcinogenesis
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Carcinogenesis
Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Carcinogenesis
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Carcinogenesis
Differential Lysis of Tumors by Polyclonal T Cell Lines and T Cell Clones Specific for hTERT.
Carcinogenesis
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.
Carcinogenesis
Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Carcinogenesis
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
Carcinogenesis
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Carcinogenesis
Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
Carcinogenesis
DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.
Carcinogenesis
DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.
Carcinogenesis
DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Carcinogenesis
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Carcinogenesis
Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression.
Carcinogenesis
E2F1 acts as a negative feedback regulator of c-Myc?induced hTERT transcription during tumorigenesis.
Carcinogenesis
Editorial Comment from Dr Kurobe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Carcinogenesis
Editorial Comment from Dr Urabe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Carcinogenesis
Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.
Carcinogenesis
Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
Carcinogenesis
Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes.
Carcinogenesis
Effects of genomic imbalances on telomerase activity in gastric cancer: clues to telomerase regulation.
Carcinogenesis
Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Carcinogenesis
Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.
Carcinogenesis
Effects of telomerase activity on carcinogenesis and survival in laryngeal carcinoma.
Carcinogenesis
Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
Carcinogenesis
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.
Carcinogenesis
Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.
Carcinogenesis
Elevated human telomerase reverse transcriptase gene expression in blood cells associated with chronic arsenic exposure in Inner Mongolia, China.
Carcinogenesis
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Carcinogenesis
Endogenous Telomerase Reverse Transcriptase N-Terminal Tagging Affects Human Telomerase Function at Telomeres In Vivo.
Carcinogenesis
Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells.
Carcinogenesis
Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
Carcinogenesis
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems.
Carcinogenesis
Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review).
Carcinogenesis
Epigenetic suppression of human telomerase (hTERT) is mediated by the metastasis suppressor NME2 in a G-quadruplex-dependent fashion.
Carcinogenesis
Epigenetic targets of bioactive dietary components for cancer prevention and therapy.
Carcinogenesis
Establishing Cell-Based Reporter Systems for the Analysis of hTERT Expression.
Carcinogenesis
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.
Carcinogenesis
Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
Carcinogenesis
Evaluation of combined telomerase and c-myc expression in non-small cell lung carcinomas using tissue microarrays and computerized image analysis.
Carcinogenesis
Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter.
Carcinogenesis
Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers.
Carcinogenesis
Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.
Carcinogenesis
Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Carcinogenesis
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Carcinogenesis
Expression of human telomerase catalytic protein in gallbladder carcinogenesis.
Carcinogenesis
Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions.
Carcinogenesis
Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Carcinogenesis
Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
Carcinogenesis
Expression of human telomerase RNA is an early event of stomach carcinogenesis.
Carcinogenesis
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Carcinogenesis
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Carcinogenesis
Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Carcinogenesis
Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions.
Carcinogenesis
Expression of p16 and hTERT protein is associated with the presence of high-risk human papillomavirus in Bowenoid papulosis.
Carcinogenesis
Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.
Carcinogenesis
Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas.
Carcinogenesis
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.
Carcinogenesis
Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
Carcinogenesis
Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.
Carcinogenesis
Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
Carcinogenesis
Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.
Carcinogenesis
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
Carcinogenesis
Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Carcinogenesis
Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Carcinogenesis
Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.
Carcinogenesis
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress.
Carcinogenesis
Extracellular Superoxide Dismutase Induces Mouse Embryonic Fibroblast Proliferative Burst, Growth Arrest, Immortalization, and Consequent In Vivo Tumorigenesis.
Carcinogenesis
Fascinating chemo preventive story of wogonin: A chance to hit on the head in cancer treatment.
Carcinogenesis
Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
Carcinogenesis
Frequent loss of heterozygosity on chromosome 10p15, a putative telomerase repressor/senescence gene locus, in gastric cancer.
Carcinogenesis
FRET investigation toward DNA tetrahedron-based ratiometric analysis of intracellular telomerase activity.
Carcinogenesis
Functional and mechanistic analysis of telomerase: An antitumor drug target.
Carcinogenesis
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Carcinogenesis
Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Carcinogenesis
Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells.
Carcinogenesis
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
Carcinogenesis
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.
Carcinogenesis
Genetic variant rs401681 at 5p15.33 modifies susceptibility to lung cancer but not esophageal squamous cell carcinoma.
Carcinogenesis
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Carcinogenesis
Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).
Carcinogenesis
Growth-related signaling regulates activation of telomerase in regenerating hepatocytes.
Carcinogenesis
H. pylori induces a novel NF-?B/Lin28A/let-7a/hTERT axis to promote gastric carcinogenesis.
Carcinogenesis
HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
Carcinogenesis
Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.
Carcinogenesis
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Carcinogenesis
High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization.
Carcinogenesis
High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Carcinogenesis
High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis.
Carcinogenesis
Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.
Carcinogenesis
Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
Carcinogenesis
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells.
Carcinogenesis
Hormones and growth factors regulate telomerase activity in ageing and cancer.
Carcinogenesis
How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.
Carcinogenesis
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.
Carcinogenesis
htert expression correlates with MYC over-expression in human prostate cancer.
Carcinogenesis
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Carcinogenesis
hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines.
Carcinogenesis
hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells.
Carcinogenesis
hTERT rs2736098 genetic variants and susceptibility of hepatocellular carcinoma in the Chinese population: a case-control study.
Carcinogenesis
Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor.
Carcinogenesis
Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis.
Carcinogenesis
Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Carcinogenesis
Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Carcinogenesis
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells.
Carcinogenesis
Human telomerase reverse transcriptase expression in oral carcinogenesis--a preliminary report.
Carcinogenesis
Human telomerase reverse transcriptase is a novel target of Hippo-YAP pathway.
Carcinogenesis
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Carcinogenesis
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Carcinogenesis
Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
Carcinogenesis
ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!
Carcinogenesis
Identification and functional characterization of nuclear mortalin in human carcinogenesis.
Carcinogenesis
Identification of GdRFC1 as a novel regulator of telomerase in Giardia duodenalis.
Carcinogenesis
Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene.
Carcinogenesis
Immortalized mouse mammary cells in vivo do not exhibit increased telomerase activity.
Carcinogenesis
Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Carcinogenesis
Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths.
Carcinogenesis
Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.
Carcinogenesis
Immunohistochemical expression of h-telomerase reverse transcriptase in canine and feline meningiomas.
Carcinogenesis
Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
Carcinogenesis
Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence.
Carcinogenesis
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Carcinogenesis
In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Carcinogenesis
In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis.
Carcinogenesis
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Carcinogenesis
In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.
Carcinogenesis
In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion.
Carcinogenesis
In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
Carcinogenesis
In vivo imaging of human cancer with telomerase-specific replication-selective adenovirus.
Carcinogenesis
Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
Carcinogenesis
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells.
Carcinogenesis
Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.
Carcinogenesis
Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats.
Carcinogenesis
Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Carcinogenesis
Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.
Carcinogenesis
Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1.
Carcinogenesis
Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion.
Carcinogenesis
Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT.
Carcinogenesis
Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
Carcinogenesis
Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells.
Carcinogenesis
Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Carcinogenesis
Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
Carcinogenesis
Inhibition of telomerase activity by NME2: impact on metastasis suppression?
Carcinogenesis
Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway.
Carcinogenesis
Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component.
Carcinogenesis
Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
Carcinogenesis
Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.
Carcinogenesis
Inhibitor of the human telomerase reverse trancriptase (hTERT) gene promoter induces cell apoptosis via a mitochondrial-dependent pathway.
Carcinogenesis
Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Carcinogenesis
Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells.
Carcinogenesis
Involvement of the NFX1-repressor complex in PKC-?-induced repression of hTERT transcription.
Carcinogenesis
Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (Review).
Carcinogenesis
Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study.
Carcinogenesis
Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT).
Carcinogenesis
Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
Carcinogenesis
JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells.
Carcinogenesis
Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
Carcinogenesis
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Carcinogenesis
Lack of correlation of betel nut chewing, tobacco smoking, and alcohol consumption with telomerase activity and the severity of oral cancer.
Carcinogenesis
Large defects of type I allergic response in telomerase reverse transcriptase knockout mice.
Carcinogenesis
Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering.
Carcinogenesis
Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis.
Carcinogenesis
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Carcinogenesis
Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein.
Carcinogenesis
Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Carcinogenesis
MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene.
Carcinogenesis
Measuring telomerase activity in various human tumors in routine histology and cytology.
Carcinogenesis
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses.
Carcinogenesis
Mechanisms of telomerase induction during vascular smooth muscle cell proliferation.
Carcinogenesis
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Carcinogenesis
Mechanixm of Carcinogenesis By RNA Tumor Viruses, I. An RNA-Dependent DNA Polymerase In Murine Sarcoma Viruses.
Carcinogenesis
Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells.
Carcinogenesis
miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT.
Carcinogenesis
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse.
Carcinogenesis
Modulation of telomerase expression and function by miRNAs: Anti-cancer potential.
Carcinogenesis
Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells.
Carcinogenesis
Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection.
Carcinogenesis
Molecular mechanisms by which oxidative DNA damage promotes telomerase activity.
Carcinogenesis
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Carcinogenesis
Muse Cells: Nontumorigenic Pluripotent Stem Cells Present in Adult Tissues-A Paradigm Shift in Tissue Regeneration and Evolution.
Carcinogenesis
Mutation of TP53 gene is involved in carcinogenesis of hepatic undifferentiated (embryonal) sarcoma of the adult, in contrast with Wnt or telomerase pathways: an immunohistochemical study of three cases with genomic relation in two cases.
Carcinogenesis
Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cells.
Carcinogenesis
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Carcinogenesis
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Carcinogenesis
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.
Carcinogenesis
Neoplastic transformation and cytogenetic changes after Gamma irradiation of human epithelial cells expressing telomerase.
Carcinogenesis
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Carcinogenesis
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
Carcinogenesis
Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis.
Carcinogenesis
Nucleolar localization of TERT is unrelated to telomerase function in human cells.
Carcinogenesis
Overexpression of human telomerase RNA in Helicobacter pylori-infected human gastric mucosa.
Carcinogenesis
Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis.
Carcinogenesis
P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Carcinogenesis
Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Carcinogenesis
PES1 is a critical component of telomerase assembly and regulates cellular senescence.
Carcinogenesis
PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis.
Carcinogenesis
Pluripotent nontumorigenic multilineage differentiating stress enduring cells (Muse cells): a seven-year retrospective.
Carcinogenesis
Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.
Carcinogenesis
Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
Carcinogenesis
Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.
Carcinogenesis
Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level.
Carcinogenesis
Presence of telomerase activity with undetectable p16 gene mutation in Malaysian patients with brain tumor.
Carcinogenesis
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Carcinogenesis
Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas.
Carcinogenesis
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Carcinogenesis
Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis.
Carcinogenesis
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Carcinogenesis
Proinflammatory cytokine TNF? promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Carcinogenesis
Prompt activation of telomerase by chemical carcinogens in rats detected with a modified TRAP assay.
Carcinogenesis
Proteomics: the tool to bridge the gap between the facts and fables of telomerase.
Carcinogenesis
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
Carcinogenesis
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells.
Carcinogenesis
Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Carcinogenesis
Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Carcinogenesis
Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas.
Carcinogenesis
Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line.
Carcinogenesis
Real-time PCR hTERT mRNA pattern in tumor core, edge, resection margin, and lymph nodes in laryngeal tumors: relation to proliferative index and impact on prognosis.
Carcinogenesis
Reappraisal of analysis of the DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis.
Carcinogenesis
Rearrangement of upstream sequences of the hTERT gene during cellular immortalization.
Carcinogenesis
Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.
Carcinogenesis
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
Carcinogenesis
Recurrent epimutations activate gene body promoters in primary glioblastoma.
Carcinogenesis
Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1-stimulated clone 22.
Carcinogenesis
Regulation of telomerase during human placental differentiation: a role for TGFbeta1.
Carcinogenesis
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.
Carcinogenesis
Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma.
Carcinogenesis
Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
Carcinogenesis
Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Carcinogenesis
Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Carcinogenesis
Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer.
Carcinogenesis
Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Carcinogenesis
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Carcinogenesis
RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells.
Carcinogenesis
Role of DNA methylation and CpG sites in the viral telomerase RNA promoter during Gallid herpesvirus 2 pathogenesis.
Carcinogenesis
Role of GLTSCR2 in the regulation of telomerase activity and chromosome stability.
Carcinogenesis
Role of menin in the regulation of telomerase activity in normal and cancer cells.
Carcinogenesis
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and FISH.
Carcinogenesis
Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Carcinogenesis
Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Carcinogenesis
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
Carcinogenesis
Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Carcinogenesis
Shortened telomere length is demonstrated in T-cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis.
Carcinogenesis
ShRNA-mediated BMI-1 gene silencing inhibits gastrointestinal stromal tumor cell telomerase activity and enhances apoptosis.
Carcinogenesis
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.
Carcinogenesis
Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells.
Carcinogenesis
Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Carcinogenesis
Stanozolol administration combined with exercise leads to decreased telomerase activity possibly associated with liver aging.
Carcinogenesis
Successful immortalization of endometrial glandular cells with normal structural and functional characteristics.
Carcinogenesis
Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.
Carcinogenesis
Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms.
Carcinogenesis
Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
Carcinogenesis
Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
Carcinogenesis
Synergistic Effect of Free and Nano-encapsulated Chrysin-Curcumin on Inhibition of hTERT Gene Expression in SW480 Colorectal Cancer Cell Line.
Carcinogenesis
Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer.
Carcinogenesis
Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models.
Carcinogenesis
Tandem Application of Virtual Screening and NMR Experiments in the Discovery of Brand New DNA Quadruplex Groove Binders.
Carcinogenesis
Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies.
Carcinogenesis
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
Carcinogenesis
Telomerase activates transcription of cyclin D1 gene through the interaction with NOL1.
Carcinogenesis
Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Carcinogenesis
Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.
Carcinogenesis
Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.
Carcinogenesis
Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
Carcinogenesis
Telomerase activation in neoplastic cell immortalization and tumour progression.
Carcinogenesis
Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study.
Carcinogenesis
Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage.
Carcinogenesis
Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Carcinogenesis
Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Carcinogenesis
Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.
Carcinogenesis
Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Carcinogenesis
Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Carcinogenesis
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Carcinogenesis
Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.
Carcinogenesis
Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Carcinogenesis
Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis.
Carcinogenesis
Telomerase activity and microsatellite instability in colorectal cancer and adenoma.
Carcinogenesis
Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Carcinogenesis
Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas.
Carcinogenesis
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Carcinogenesis
Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Carcinogenesis
Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Carcinogenesis
Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.
Carcinogenesis
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Carcinogenesis
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Carcinogenesis
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.
Carcinogenesis
Telomerase Activity Detection with Amplification-Free Single Molecule Stochastic Binding Assay.
Carcinogenesis
Telomerase activity in condyloma acuminatum tissue with different HPV types.
Carcinogenesis
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
Carcinogenesis
Telomerase Activity in Gastric Adenocarcinomas: Frozen Tissues Versus Methacarn-fixed Paraffin-embedded Tissues.
Carcinogenesis
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Carcinogenesis
Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.
Carcinogenesis
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Carcinogenesis
Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Carcinogenesis
Telomerase activity in Indian patients with carcinomas of the aerodigestive tract.
Carcinogenesis
Telomerase activity in juxtacortical and conventional high-grade osteosarcomas: correlation with grade, proliferative activity and clinical response to chemotherapy.
Carcinogenesis
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Carcinogenesis
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Carcinogenesis
Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Carcinogenesis
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.
Carcinogenesis
Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Carcinogenesis
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Carcinogenesis
Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Carcinogenesis
Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.
Carcinogenesis
Telomerase activity in thymomas and mammary gland adenocarcinomas induced by polyoma virus in AKR mice.
Carcinogenesis
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Carcinogenesis
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.
Carcinogenesis
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.
Carcinogenesis
Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues.
Carcinogenesis
Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.
Carcinogenesis
Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Carcinogenesis
Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Carcinogenesis
Telomerase and telomere length in normal and malignant human endometrium as prognostic markers.
Carcinogenesis
Telomerase and telomeres in aging theory and chronographic aging theory (Review).
Carcinogenesis
Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Carcinogenesis
Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
Carcinogenesis
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.
Carcinogenesis
Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Carcinogenesis
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Carcinogenesis
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Carcinogenesis
Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits.
Carcinogenesis
Telomerase flies the coop: the telomerase RNA component as a viral-encoded oncogene.
Carcinogenesis
Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Carcinogenesis
Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
Carcinogenesis
Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
Carcinogenesis
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.
Carcinogenesis
Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells.
Carcinogenesis
Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells.
Carcinogenesis
Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.
Carcinogenesis
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.
Carcinogenesis
Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells.
Carcinogenesis
Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity.
Carcinogenesis
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Carcinogenesis
Telomerase reverse transcriptase (TERT) is a novel target of Wnt/?-catenin pathway in human cancer.
Carcinogenesis
Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Carcinogenesis
Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity.
Carcinogenesis
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Carcinogenesis
Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
Carcinogenesis
Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Carcinogenesis
Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1.
Carcinogenesis
Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres.
Carcinogenesis
Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Carcinogenesis
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.
Carcinogenesis
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
Carcinogenesis
Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance.
Carcinogenesis
Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.
Carcinogenesis
Telomerase: is it the future diagnostic and prognostic tool in human cancer?
Carcinogenesis
Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.
Carcinogenesis
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Carcinogenesis
Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.
Carcinogenesis
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
Carcinogenesis
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
Carcinogenesis
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.
Carcinogenesis
Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.
Carcinogenesis
Telomere length in Chernobyl accident recovery workers in the late period after the disaster.
Carcinogenesis
Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
Carcinogenesis
Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer.
Carcinogenesis
Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Carcinogenesis
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Carcinogenesis
Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Carcinogenesis
Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Carcinogenesis
Telomere structure and shortening in telomerase-deficient Trypanosoma brucei.
Carcinogenesis
Telomere structure and telomerase expression during mouse development and tumorigenesis.
Carcinogenesis
Telomere Terminal G/C Strand Synthesis: Measuring Telomerase Action and C-Rich Fill-In.
Carcinogenesis
Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing.
Carcinogenesis
Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis.
Carcinogenesis
Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis and aging.
Carcinogenesis
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Carcinogenesis
Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.
Carcinogenesis
Telomeres and telomerase influence the course of human diseases, aging and carcinogenesis.
Carcinogenesis
Telomeres and telomerase: pharmacological targets for new anticancer strategies?
Carcinogenesis
Telomeres and Telomerase: Role in Marek's Disease Virus Pathogenesis, Integration and Tumorigenesis.
Carcinogenesis
TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
Carcinogenesis
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Carcinogenesis
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.
Carcinogenesis
TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.
Carcinogenesis
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.
Carcinogenesis
TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publications.
Carcinogenesis
The ?-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype.
Carcinogenesis
The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice.
Carcinogenesis
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer.
Carcinogenesis
The clinical implications of telomerase activity in upper tract urothelial cancer and washings.
Carcinogenesis
The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.
Carcinogenesis
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas.
Carcinogenesis
The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter.
Carcinogenesis
The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation.
Carcinogenesis
The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.
Carcinogenesis
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Carcinogenesis
The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Carcinogenesis
The interaction of telomere DNA G-quadruplex with three bis-benzyltetrahydroisoquinoline alkaloids.
Carcinogenesis
The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Carcinogenesis
The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus.
Carcinogenesis
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications.
Carcinogenesis
The role of interferon-gamma and vitamin-A in modulating telomerase activity in breast cancer patients.
Carcinogenesis
The role of telomerase activation in the regulation of vascular smooth muscle cell proliferation.
Carcinogenesis
The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Carcinogenesis
The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies.
Carcinogenesis
The scaffold protein WRAP53? orchestrates the ubiquitin response critical for DNA double-strand break repair.
Carcinogenesis
The significance of telomerase activation and cellular immortalization in human cancer.
Carcinogenesis
The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines.
Carcinogenesis
The telomerase activities in several organs and strains of rats with ageing.
Carcinogenesis
The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice.
Carcinogenesis
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Carcinogenesis
The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.
Carcinogenesis
Three molecular determinants of malignant conversion and their potential as therapeutic targets.
Carcinogenesis
Transcriptional activation of hTERT, the catalytic subunit of telomerase, by NFAT.
Carcinogenesis
Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
Carcinogenesis
Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Carcinogenesis
Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts.
Carcinogenesis
TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts.
Carcinogenesis
Triptolide inhibits human telomerase reverse transcriptase by downregulating translation factors SP1 and c-Myc in Epstein-Barr virus-positive B lymphocytes.
Carcinogenesis
Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Carcinogenesis
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Carcinogenesis
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
Carcinogenesis
Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
Carcinogenesis
Up-regulation of telomerase activity in Herpesvirus saimiri immortalized human T-lymphocytes.
Carcinogenesis
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.
Carcinogenesis
Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.
Carcinogenesis
Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells.
Carcinogenesis
Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Carcinogenesis
Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan Assays in Combination for Diagnosing High-Grade Cervical Lesions and Malignant Tumors.
Carcinogenesis
Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.
Carcinogenesis
Utilizing murine inducible telomerase alleles in the studies of tissue degeneration/regeneration and cancer.
Carcinogenesis
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Carcinogenesis
Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-Pi and telomerase in the early diagnosis of esophageal carcinoma.
Carcinogenesis
Vertebrate marine species as model systems for studying telomeres and telomerase.
Carcinogenesis
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Carcinogenesis
[Changes of alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis]
Carcinogenesis
[Clinical Application and Challenges of Telomere and Telomerase Research ?in Lung Cancer].
Carcinogenesis
[Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma]
Carcinogenesis
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Carcinogenesis
[Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer]
Carcinogenesis
[Diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer]
Carcinogenesis
[Effect of hepatitis C virus nonstructural protein NS3 on telomerase activity]
Carcinogenesis
[Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721.]
Carcinogenesis
[Effects of matrine on the growth inhibition, c-myc and hTERT protein expression in human adenocarcinoma lung cancer cell line A549.]
Carcinogenesis
[Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma]
Carcinogenesis
[Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma]
Carcinogenesis
[Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis]
Carcinogenesis
[Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]
Carcinogenesis
[Identification of telomerase activity in the experimental carcinogenesis of oral cavity]
Carcinogenesis
[Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)]
Carcinogenesis
[Inhibitory effect of yiqijiedu powder to telomerase and telomerase RNA in nasopharyngeal tumorigenesis of rats]
Carcinogenesis
[Preliminary study on the alternative splicing pattern of human telomerase reverse transcriptase gene during gastric carcinogenesis.]
Carcinogenesis
[Profile of telomerase and telomerase RNA expression in nasopharyngeal carcinogenesis of rats induced by N, N'dinitrosopiperazine (DNP)]
Carcinogenesis
[Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer]
Carcinogenesis
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Carcinogenesis
[Relationship among telomerase activity, expression of human telomerase reverse transcriptase (hTERT), and expression of c-myc in acute leukemia]
Carcinogenesis
[Research on expression of human papillomavirus type 16 and telomerase in oral lesions]
Carcinogenesis
[Study and detection of telomerase activity in oral squamous cell carcinomas and precancerous lesions]
Carcinogenesis
[Study on the correlation between the different papillomavirus type and telomerase in cervical cancer]
Carcinogenesis
[Study on the relationship between telomerase gene and telomerase activity in lung cancer tissue.]
Carcinogenesis
[Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues]
Carcinogenesis
[Telomerase expression in colorectal tubular adenoma determined by immunohistochemical staining]
Carcinogenesis
[Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach]
Carcinogenesis
[The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines]
Carcinogenesis
[The effect of shRNA targeting hTERT on telomerase and the expression of PCNA and Caspase-3 in nasopharyngeal carcinoma cells]
Carcinogenesis
[The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer]
Carcinogenesis
[The expression and significance of human telomerase reverse transcriptase protein and gene in bile duct carcinomas and their adjacent tissues]
Carcinogenesis
[The study on the role of telomerase activity in human nasopharyngeal carcinoma]
Carcinogenesis
[Theranostic application of telomerase-specific oncolytic adenovirus for human cancer]
Carcinoid Tumor
Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
Carcinoid Tumor
Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Carcinoid Tumor
Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype (MS-0060).
Carcinoid Tumor
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Carcinoma
3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Carcinoma
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.
Carcinoma
?-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression.
Carcinoma
A case of gallbladder carcinoma diagnosed preoperatively by the detection of human telomerase reverse transcriptase mRNA in endoscopically obtained gallbladder bile.
Carcinoma
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
Carcinoma
A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Carcinoma
A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Carcinoma
A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Carcinoma
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Carcinoma
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Carcinoma
A Telomerase Responsive DNA-icosahedron for Precise Delivery of Platinum-nanodrug to Cisplatin-resistance Cancer.
Carcinoma
Absence of correlation between telomerase activity and hepatic neoplasia in B6C3F1 mice.
Carcinoma
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Carcinoma
Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Carcinoma
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Carcinoma
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Carcinoma
Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.
Carcinoma
Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma.
Carcinoma
Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells.
Carcinoma
Amplification of the human telomerase gene in liquid-based preparations is associated with cervical dysplasia and carcinoma.
Carcinoma
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.
Carcinoma
Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Carcinoma
Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer.
Carcinoma
An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
Carcinoma
An ultra-sensitive colorimetric assay for reliable visual detection of telomerase activity.
Carcinoma
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Carcinoma
Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.
Carcinoma
Analysis of telomeric repeats and telomerase activity in human colon carcinoma cells with gene amplification.
Carcinoma
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.
Carcinoma
Antagonistic Interactions Between Gemcitabine and 5-Fluorouracil in the Human Pancreatic Carcinoma Cell Line Capan-2.
Carcinoma
Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Carcinoma
Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells.
Carcinoma
Antitumor Activity of Small Double-Stranded Oligodeoxynucleotides Targeting Telomerase RNA in Malignant Melanoma Cells.
Carcinoma
Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression.
Carcinoma
ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis.
Carcinoma
Association between clincopathological characteristics and hTERT expression as well as telomere length in ameloblastoma.
Carcinoma
Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
Carcinoma
Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Carcinoma
Association of telomerase expression with successful heterotransplantation of lung cancer.
Carcinoma
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Carcinoma
Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Carcinoma
Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: Plausible predictive and diagnostic markers.
Carcinoma
Autocatalytic caspase-3 driven by human telomerase reverse transcriptase promoter suppresses human ovarian carcinoma growth in vitro and in mice.
Carcinoma
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Carcinoma
Azacitidine, as a DNMT inhibitor decreases hTERT gene expression and telomerase activity more effective compared with HDAC inhibitor in human Head and neck squamous cell carcinoma cell lines.
Carcinoma
Biochemical and electron microscopical evidence for the presence of oncorna viruses in spleen tissue from two patients with haematological malignancies.
Carcinoma
Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Carcinoma
Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
Carcinoma
Biological significance of PinX1 telomerase inhibitor in esophageal carcinoma treatment.
Carcinoma
Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Carcinoma
C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.
Carcinoma
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Carcinoma
Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity.
Carcinoma
Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.
Carcinoma
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.
Carcinoma
Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: a pilot study.
Carcinoma
Change of the Expression of Human Telomerase Reverse Transcriptase mRNA and Human Telomerase RNA after Cisplatin and 5-Fluorouracil Exposure in Head and Neck Squamous Cell Carcinoma Cell Lines.
Carcinoma
Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Carcinoma
Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.
Carcinoma
Circadian telomerase activity and DNA synthesis for timing peptide administration.
Carcinoma
Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Carcinoma
Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Carcinoma
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Carcinoma
Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
Carcinoma
Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
Carcinoma
Clinical significance of telomerase activity in gastric carcinoma and peritoneal dissemination.
Carcinoma
Clinical significance of telomerase activity in peripheral blood of patients with esophageal squamous cell carcinoma.
Carcinoma
Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma.
Carcinoma
Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
Carcinoma
Clonal expansion and HPV-induced immortalization are early molecular alterations in cervical carcinogenesis.
Carcinoma
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy.
Carcinoma
Coexistence of BRAF V600E and TERT Promoter Mutations in Low-grade Serous Carcinoma of Ovary Recurring as Carcinosarcoma in a Lymph Node: Report of a Case.
Carcinoma
Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma.
Carcinoma
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Carcinoma
Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Carcinoma
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Carcinoma
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Carcinoma
Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Carcinoma
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Carcinoma
Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells.
Carcinoma
Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix.
Carcinoma
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.
Carcinoma
Correlation between morphology and telomerase activity in cells from exfoliative lung cytologic specimens.
Carcinoma
Correlation of dyskerin expression with active proliferation independent of telomerase.
Carcinoma
Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Carcinoma
Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Carcinoma
Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Carcinoma
Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.
Carcinoma
Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
Carcinoma
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Carcinoma
Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
Carcinoma
Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma.
Carcinoma
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Carcinoma
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Carcinoma
Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.
Carcinoma
Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
Carcinoma
Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Carcinoma
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.
Carcinoma
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy.
Carcinoma
Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
Carcinoma
Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
Carcinoma
Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium.
Carcinoma
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
Carcinoma
Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression.
Carcinoma
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?
Carcinoma
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.
Carcinoma
Detection of telomerase activity in saliva from oral squamous cell carcinoma patients.
Carcinoma
Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Carcinoma
Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Carcinoma
Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
Carcinoma
Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
Carcinoma
Determination of the activity of telomerase in cancer cells by using BSA-protected gold nanoclusters as a fluorescent probe.
Carcinoma
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Carcinoma
Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
Carcinoma
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Carcinoma
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Carcinoma
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Carcinoma
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Carcinoma
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.
Carcinoma
Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors.
Carcinoma
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Carcinoma
Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma.
Carcinoma
Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
Carcinoma
Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
Carcinoma
Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human prostate carcinoma cells.
Carcinoma
Dyskeratosis Congenita and Oral Cavity Squamous Cell Carcinoma: Report of a Case and Literature Review.
Carcinoma
Ectopic expression of wnt-5a in human renal cell carcinoma cells suppresses in vitro growth and telomerase activity.
Carcinoma
Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells.
Carcinoma
Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma.
Carcinoma
Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Carcinoma
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Carcinoma
Effects of telomerase activity on carcinogenesis and survival in laryngeal carcinoma.
Carcinoma
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Carcinoma
EGFR Tyrosine Kinase Inhibitor Pelitinib Regulates Radiation-Induced p65-Dependent Telomerase Activation in Squamous Cell Carcinoma.
Carcinoma
Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.
Carcinoma
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Carcinoma
Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.
Carcinoma
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma.
Carcinoma
Erucin and Benzyl Isothiocyanate Suppress Growth of Late Stage Primary Human Ovarian Carcinoma Cells and Telomerase Activity In Vitro.
Carcinoma
Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.
Carcinoma
Evaluation of combined telomerase and c-myc expression in non-small cell lung carcinomas using tissue microarrays and computerized image analysis.
Carcinoma
Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens.
Carcinoma
Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
Carcinoma
Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers.
Carcinoma
Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma.
Carcinoma
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Carcinoma
Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Carcinoma
Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression.
Carcinoma
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Carcinoma
Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Carcinoma
Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Carcinoma
Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Carcinoma
Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
Carcinoma
Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Carcinoma
Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.
Carcinoma
Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Carcinoma
Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.
Carcinoma
Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Carcinoma
Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection.
Carcinoma
Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Carcinoma
Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Carcinoma
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma
Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival.
Carcinoma
Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
Carcinoma
Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma.
Carcinoma
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
Carcinoma
Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4.
Carcinoma
Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
Carcinoma
Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Carcinoma
Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells.
Carcinoma
Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter.
Carcinoma
Genes associated with telomerase activity levels in esophageal carcinoma cell lines.
Carcinoma
Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells.
Carcinoma
Genetic control of telomerase and replicative senescence in human and rodent cells.
Carcinoma
Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
Carcinoma
Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Carcinoma
Growth inhibition of A549 human lung carcinoma cells by beta-lapachone through induction of apoptosis and inhibition of telomerase activity.
Carcinoma
High expression of circadian gene mPer2 diminishes radiosensitivity of tumor cells.
Carcinoma
High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Carcinoma
High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
Carcinoma
High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Carcinoma
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
Carcinoma
Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.
Carcinoma
hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
Carcinoma
hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
Carcinoma
Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma.
Carcinoma
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15.
Carcinoma
Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Carcinoma
Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Carcinoma
Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Carcinoma
Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Carcinoma
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.
Carcinoma
Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
Carcinoma
Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma.
Carcinoma
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.
Carcinoma
Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx.
Carcinoma
Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
Carcinoma
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.
Carcinoma
Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
Carcinoma
Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma.
Carcinoma
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis.
Carcinoma
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Carcinoma
Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.
Carcinoma
Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Carcinoma
Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Carcinoma
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Carcinoma
Improvement in detecting telomerase activity using silica-based resin treatment: An experience of urine in bladder carcinoma.
Carcinoma
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Carcinoma
In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.
Carcinoma
In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside.
Carcinoma
Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Carcinoma
Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Carcinoma
Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Carcinoma
Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells.
Carcinoma
Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris.
Carcinoma
Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation.
Carcinoma
Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation.
Carcinoma
Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
Carcinoma
Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA.
Carcinoma
Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
Carcinoma
Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Carcinoma
Inhibition of telomerase activity in renal cell carcinoma cells by doxorubicin and anti-Fas monoclonal antibody.
Carcinoma
Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.
Carcinoma
Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma.
Carcinoma
Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity.
Carcinoma
Intensive Inhibition of hTERT Expression by a Ribozyme Induces Rapid Apoptosis of Cancer Cells through a Telomere Length-Independent Pathway.
Carcinoma
Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.
Carcinoma
KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
Carcinoma
Label-free, PCR-free chip-based detection of telomerase activity in bladder cancer cells.
Carcinoma
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Carcinoma
Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix.
Carcinoma
Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues.
Carcinoma
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
Carcinoma
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Carcinoma
Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
Carcinoma
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities.
Carcinoma
Mechanism of telomerase repression during terminal differentiation of normal epithelial cells and squamous carcinoma lines.
Carcinoma
MG-132 inhibits telomerase activity, induces apoptosis and G(1) arrest associated with upregulated p27kip1 expression and downregulated survivin expression in gastric carcinoma cells.
Carcinoma
Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.
Carcinoma
miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.
Carcinoma
Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Carcinoma
Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Carcinoma
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.
Carcinoma
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
Carcinoma
Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Carcinoma
Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas.
Carcinoma
Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
Carcinoma
Molecular staging of surgical margins after radical prostatectomy by detection of telomerase activity.
Carcinoma
Negative Prognostic Implication of TERT Promoter Mutations in Human Papillomavirus-Negative Tonsillar Squamous Cell Carcinoma Under the New 8th AJCC Staging System.
Carcinoma
New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
Carcinoma
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Carcinoma
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Carcinoma
Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer.
Carcinoma
Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
Carcinoma
Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Carcinoma
Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Carcinoma
P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Carcinoma
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Carcinoma
Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Carcinoma
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Carcinoma
Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Carcinoma
PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Carcinoma
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Carcinoma
Polygala tenuifolia polysaccharide (PTP) inhibits cell proliferation by repressing Bmi-1 expression and downregulating telomerase activity.
Carcinoma
Positive expression of Lin28 is correlated with poor survival in gastric carcinoma.
Carcinoma
Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
Carcinoma
Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
Carcinoma
Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells.
Carcinoma
Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Carcinoma
Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.
Carcinoma
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Carcinoma
Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Carcinoma
Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
Carcinoma
Production of spindle cell carcinoma by transduction of H-Ras 61L into immortalized human mammary epithelial cells.
Carcinoma
Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma.
Carcinoma
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Carcinoma
Prognostic Significance of Telomerase Activity and Human Telomerase Reverse Transcriptase Expression in Ampullary Carcinoma.
Carcinoma
Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma.
Carcinoma
Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis.
Carcinoma
Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
Carcinoma
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Carcinoma
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
Carcinoma
Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas.
Carcinoma
Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma.
Carcinoma
Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Carcinoma
Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
Carcinoma
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Carcinoma
Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Carcinoma
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Carcinoma
Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Carcinoma
Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas.
Carcinoma
Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
Carcinoma
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Carcinoma
Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer.
Carcinoma
Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.
Carcinoma
Regulation of Epithelial Cell Proliferation, Differentiation, and Plasticity by Grainyhead-Like 2 During Oral Carcinogenesis.
Carcinoma
Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.
Carcinoma
Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
Carcinoma
Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Carcinoma
Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.
Carcinoma
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells.
Carcinoma
Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence.
Carcinoma
Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Carcinoma
RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.
Carcinoma
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
Carcinoma
Sarcomatoid Renal Cell Carcinoma With Unusual Metastasis to the Small Intestine Manifesting as Perforated Appendicitis.
Carcinoma
Selective suppression of autocatalytic caspase-3 driven by two-step transcriptional amplified human telomerase reverse transcriptase promoter on ovarian carcinoma growth in vitro and in mice.
Carcinoma
Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Carcinoma
Semi-quantitative analysis of telomerase activity in human urothelial cells and bladder transitional cell carcinoma.
Carcinoma
Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Carcinoma
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
Carcinoma
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Carcinoma
Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas.
Carcinoma
Short hairpin ribonucleic acid targeting the telomerase catalytic unit of messenger ribonucleic acid significantly limits the growth of laryngeal squamous cell carcinoma in nude mice.
Carcinoma
Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines.
Carcinoma
Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Carcinoma
Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.
Carcinoma
Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.
Carcinoma
Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.
Carcinoma
Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element.
Carcinoma
Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Carcinoma
Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Carcinoma
Targeted sequencing of Plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Carcinoma
Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Carcinoma
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Carcinoma
Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Carcinoma
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Carcinoma
Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.
Carcinoma
Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
Carcinoma
Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Carcinoma
Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Carcinoma
Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
Carcinoma
Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Carcinoma
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Carcinoma
Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.
Carcinoma
Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis.
Carcinoma
Telomerase activity and microsatellite instability in colorectal cancer and adenoma.
Carcinoma
Telomerase activity and survival of late-stage South African esophageal carcinoma patients.
Carcinoma
Telomerase activity and telomere length in different areas of renal cell carcinoma.
Carcinoma
Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Carcinoma
Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Carcinoma
Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
Carcinoma
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Carcinoma
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Carcinoma
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Carcinoma
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.
Carcinoma
Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Carcinoma
Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.
Carcinoma
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Carcinoma
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine.
Carcinoma
Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
Carcinoma
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
Carcinoma
Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent.
Carcinoma
Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Carcinoma
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Carcinoma
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus.
Carcinoma
Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.
Carcinoma
Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Carcinoma
Telomerase activity in Indian patients with carcinomas of the aerodigestive tract.
Carcinoma
Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.
Carcinoma
Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.
Carcinoma
Telomerase activity in non-small cell lung carcinomas correlates with smoking status.
Carcinoma
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Carcinoma
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Carcinoma
Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Carcinoma
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Carcinoma
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Carcinoma
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Carcinoma
Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.
Carcinoma
Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype (MS-0060).
Carcinoma
Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
Carcinoma
Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
Carcinoma
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid.
Carcinoma
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
Carcinoma
Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.
Carcinoma
Telomerase activity in the vaginal margins of radical hysterectomy in patients with carcinoma of the cervix: correlation with histology and human papillomavirus.
Carcinoma
Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
Carcinoma
Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens.
Carcinoma
Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
Carcinoma
Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
Carcinoma
Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
Carcinoma
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.
Carcinoma
Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.
Carcinoma
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Carcinoma
Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck.
Carcinoma
Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia.
Carcinoma
Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion.
Carcinoma
Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures.
Carcinoma
Telomerase activity of peripheral blood mononuclear cells from patients with laryngeal carcinoma.
Carcinoma
Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.
Carcinoma
Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
Carcinoma
Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
Carcinoma
Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Carcinoma
Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Carcinoma
Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Carcinoma
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Carcinoma
Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
Carcinoma
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.
Carcinoma
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Carcinoma
Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Carcinoma
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Carcinoma
Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
Carcinoma
Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Carcinoma
Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.
Carcinoma
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Carcinoma
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Carcinoma
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Carcinoma
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Carcinoma
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Carcinoma
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
Carcinoma
Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Carcinoma
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Carcinoma
Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Carcinoma
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases.
Carcinoma
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection.
Carcinoma
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Carcinoma
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Carcinoma
Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Carcinoma
Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor?related apoptosis?inducing ligand?induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.
Carcinoma
Telomerase reverse transcriptase mediates EMT through NF-?B signaling in tongue squamous cell carcinoma.
Carcinoma
Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.
Carcinoma
Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
Carcinoma
Telomerase reverse transcriptase promotes the proliferation of human laryngeal carcinoma cells through activation of the activator protein 1.
Carcinoma
Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
Carcinoma
Telomerase RNA expression and DNA ploidy as prognostic markers of prostate carcinomas.
Carcinoma
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
Carcinoma
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Carcinoma
Telomere Dysfuction Promotes Metastasis in a TERC Null Mouse Model of Head and Neck Cancer.
Carcinoma
Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
Carcinoma
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Carcinoma
Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Carcinoma
Telomere shortening in gastric carcinoma with aging despite telomerase activation.
Carcinoma
Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Carcinoma
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Carcinoma
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Carcinoma
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Carcinoma
TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Carcinoma
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.
Carcinoma
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Carcinoma
TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
Carcinoma
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Carcinoma
The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells.
Carcinoma
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer.
Carcinoma
The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
Carcinoma
The clinical implications of telomerase activity in upper tract urothelial cancer and washings.
Carcinoma
The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.
Carcinoma
The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration.
Carcinoma
The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
Carcinoma
The differential regulation of human telomerase reverse transcriptase and vascular endothelial growth factor may contribute to the clinically more aggressive behavior of p63-positive breast carcinomas.
Carcinoma
The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.
Carcinoma
The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation.
Carcinoma
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Carcinoma
The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
Carcinoma
The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
Carcinoma
The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Carcinoma
The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Carcinoma
The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Carcinoma
The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals.
Carcinoma
The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Carcinoma
The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Carcinoma
The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.
Carcinoma
The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT.
Carcinoma
The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells.
Carcinoma
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.
Carcinoma
Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Carcinoma
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Carcinoma
Treatment of lung cancer via telomerase inhibition: Self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.
Carcinoma
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Carcinoma
Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.
Carcinoma
Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
Carcinoma
Upregulated p27kip1 can Downregulate Survivin Expression and Inhibit Telomerase Activity in Gastric Carcinoma Cells.
Carcinoma
Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-Pi and telomerase in the early diagnosis of esophageal carcinoma.
Carcinoma
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Carcinoma
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
Carcinoma
YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability.
Carcinoma
[Analysis of telomerase activity in esophageal carcinoma using microdissection telomeric repeat amplification protocol assay]
Carcinoma
[Change of Bcl-2 expression and telomerase during apoptosis induced by oridonin on human hepatocelluar carcinoma cells]
Carcinoma
[Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma]
Carcinoma
[Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]
Carcinoma
[Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells]
Carcinoma
[Detection and effect of telomerase activity in oral mucosal squamous cell carcinoma]
Carcinoma
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Carcinoma
[Detection of telomerase activity in laryngeal carcinoma and the association between telomerase activity and lymphatic metastasis]
Carcinoma
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Carcinoma
[Detection of telomerase hTERT gene expression of exfoliated cell in broncho-alveolar lavage fluid]
Carcinoma
[Effect of inhibition of polyamine biosynthesis on the growth and telomerase activity of human laryngeal carcinoma cells Hep-2]
Carcinoma
[Effect of Matrine on cell cycle and human telomerase reverse transcriptase of human salivary adenoid cystic carcinoma]
Carcinoma
[Effects of wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity]
Carcinoma
[Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma]
Carcinoma
[Expression of human telomerase reverse transcriptase in renal cell carcinoma and its clinical significance]
Carcinoma
[Expression of telomerase reverse transcriptase and its relationship with expression of c-myc in laryngeal squamous cell carcinomas]
Carcinoma
[Expression of telomerase reverse transcriptase in premalignant esophageal squamous dysplasia]
Carcinoma
[General rules for the study of pancreatic cancer by molecular biological aspect]
Carcinoma
[Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]
Carcinoma
[Hormone-dependent expression of oncovirus genomes in stable mouse mammary cancer cell line GR and RIII]
Carcinoma
[hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice]
Carcinoma
[Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)]
Carcinoma
[Inhibitory effect of hTERT dsRNA on telomerase activity in lung carcinoma cell line A549]
Carcinoma
[Inhibitory effect of p53 gene on telomerase activity and proliferative activity in salivary adenoid cystic carcinoma cells]
Carcinoma
[Inhibitory Effect of Silencing hTERT Gene by Short Hairpin RNA on Growth of Human Laryngeal Squamous Cell Carcinoma Xenograft in Nude Mice.]
Carcinoma
[Modified quantitative determination of telomerase activity in human head and neck malignant tumor]
Carcinoma
[Prognostic significance of hTERT mRNA quantitative expression in resected gastric carcinomas].
Carcinoma
[Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma]
Carcinoma
[Quantitative assay of telomerase activity in head and neck squamous cell carcinoma]
Carcinoma
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Carcinoma
[Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri]
Carcinoma
[Relationship between human papillomavirus 16 infection and the expression of p33(ING1b), human telomerase reverse transcriptase in cervical squamous cell carcinoma of Uygur female in Xinjiang Uygur Autonomous Region]
Carcinoma
[Research on expression of human papillomavirus type 16 and telomerase in oral lesions]
Carcinoma
[Research on expression of telomerase hTR gene in oral precancerous lesion and squamous cell carcinoma]
Carcinoma
[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice]
Carcinoma
[Study and detection of telomerase activity in oral squamous cell carcinomas and precancerous lesions]
Carcinoma
[Study on the clinical value of telomerase activity in exfoliated cells of sputum from lung cancer patients.]
Carcinoma
[Targeted therapy of human laryngeal squamous cell carcinoma in vitro with telomerase catalytic subunit mRNA]
Carcinoma
[Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasia and its correlation to classification of koilocytosis]
Carcinoma
[Telomerase activity in colorectal carcinoma and its relationship to clinicopathological findings]
Carcinoma
[Telomerase activity in esophageal carcinoma and lesions unstained with Lugol's solution]
Carcinoma
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]
Carcinoma
[Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues]
Carcinoma
[Telomerase activity in pancreatic juice for the preoperative diagnosis of pancreatic cancer]
Carcinoma
[Telomerase in lung cancer. Testing the activity of the "immortaligy enzyme" bronchial biopsies increases the diagnostic yield in cases of suspected peripheral bronchogenic carcinomas]
Carcinoma
[Telomerase SiRNA inhibits KB cell growth in human oral squamous cell carcinoma.]
Carcinoma
[The detection and clinical significance of telomerase activity in supraglottic carcinomas]
Carcinoma
[The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines]
Carcinoma
[The effects on expressions of p53 and PCNA by inhibition of hTERT with siRNA in transplantable model of human laryngeal squamous carcinoma in nude mice]
Carcinoma
[The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]
Carcinoma
[The expression and significance of human telomerase reverse transcriptase protein and gene in bile duct carcinomas and their adjacent tissues]
Carcinoma
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Carcinoma
[To inhibit ERK for enhancing chemotherapy sensitivity of drug-resistance cell lines of leukemia and ovarian carcinoma]
Carcinoma in Situ
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Carcinoma in Situ
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Carcinoma in Situ
Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Carcinoma in Situ
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Carcinoma in Situ
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Carcinoma in Situ
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Carcinoma in Situ
Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
Carcinoma in Situ
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Carcinoma in Situ
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Carcinoma in Situ
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Carcinoma in Situ
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Carcinoma in Situ
Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Carcinoma in Situ
[Telomerase activity in pancreatic juice for the preoperative diagnosis of pancreatic cancer]
Carcinoma, Acinar Cell
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Carcinoma, Adenoid Cystic
[Effect of Matrine on cell cycle and human telomerase reverse transcriptase of human salivary adenoid cystic carcinoma]
Carcinoma, Adenoid Cystic
[Inhibitory effect of p53 gene on telomerase activity and proliferative activity in salivary adenoid cystic carcinoma cells]
Carcinoma, Adenosquamous
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Carcinoma, Basal Cell
Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
Carcinoma, Basal Cell
Detection of telomerase activity in malignant and nonmalignant skin conditions.
Carcinoma, Basal Cell
Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues.
Carcinoma, Basal Cell
Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.
Carcinoma, Basal Cell
Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia.
Carcinoma, Basal Cell
TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
Carcinoma, Bronchogenic
[Telomerase in lung cancer. Testing the activity of the "immortaligy enzyme" bronchial biopsies increases the diagnostic yield in cases of suspected peripheral bronchogenic carcinomas]
Carcinoma, Ductal
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Carcinoma, Ductal
CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Carcinoma, Ductal
Comparison of Telomere Length and Telomerase Activation between Breast Fibroadenoma and Infiltrating Ductal Carcinoma in Malaysian Women.
Carcinoma, Ductal
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Carcinoma, Ductal
Investigation of telomerase activity and apoptosis on invasive ductal carcinoma of the breast using immunohistochemical and Western blot methods.
Carcinoma, Ductal
Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Carcinoma, Ductal
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Carcinoma, Ductal
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Carcinoma, Ductal, Breast
[The diagnostic value of RNA oncomarkers in evaluation of malignant breast tumors].
Carcinoma, Embryonal
Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells.
Carcinoma, Embryonal
Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma.
Carcinoma, Embryonal
Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1.
Carcinoma, Embryonal
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Carcinoma, Embryonal
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Carcinoma, Endometrioid
High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
Carcinoma, Endometrioid
Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.
Carcinoma, Endometrioid
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Carcinoma, Giant Cell
[Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)]
Carcinoma, Hepatocellular
A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma.
Carcinoma, Hepatocellular
A novel and exploitable antifungal peptide from kale (Brassica alboglabra) seeds.
Carcinoma, Hepatocellular
A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
Carcinoma, Hepatocellular
A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Carcinoma, Hepatocellular
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
A trypsin-chymotrypsin inhibitor with antiproliferative activity from small glossy black soybeans.
Carcinoma, Hepatocellular
Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Carcinoma, Hepatocellular
Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Carcinoma, Hepatocellular
Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alteration of telomeric repeat length in hepatocellular carcinoma is independent of telomerase activity.
Carcinoma, Hepatocellular
Anti-Proliferative and Anti-Telomerase Effects of Blackberry Juice and Berry-Derived Polyphenols on HepG2 Liver Cancer Cells and Normal Human Blood Mononuclear Cells.
Carcinoma, Hepatocellular
Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis.
Carcinoma, Hepatocellular
Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.
Carcinoma, Hepatocellular
Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Antitumor and HIV-1 Reverse Transcriptase Inhibitory Activities of a Hemagglutinin and a Protease Inhibitor from Mini-Black Soybean.
Carcinoma, Hepatocellular
Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.
Carcinoma, Hepatocellular
Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition.
Carcinoma, Hepatocellular
Biopsy diagnosis of malignant versus benign liver "nodules": new helpful markers. An update.
Carcinoma, Hepatocellular
Brassiparin, an antifungal peptide from Brassica parachinensis seeds.
Carcinoma, Hepatocellular
Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells.
Carcinoma, Hepatocellular
Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.
Carcinoma, Hepatocellular
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Carcinoma, Hepatocellular
Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of telomerase activity in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Carcinoma, Hepatocellular
Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT.
Carcinoma, Hepatocellular
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
Carcinoma, Hepatocellular
Comparison between Platinum-Azidothymidine and Azidothymidine Effects on Bcl-2 and Telomerase Gene Expression in Rats with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells.
Carcinoma, Hepatocellular
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression.
Carcinoma, Hepatocellular
Depletion of sirtuin 1 (SIRT1) leads to epigenetic modifications of telomerase (TERT) gene in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Detection of telomerase activity, telomerase RNA component, and telomerase reverse transcriptase in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression.
Carcinoma, Hepatocellular
Detection of TERT promoter mutation in serum cell-free DNA using wild-type blocking PCR combined with Sanger sequencing in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.
Carcinoma, Hepatocellular
Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Carcinoma, Hepatocellular
Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Carcinoma, Hepatocellular
Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Effects of silymarin and silymarin-doxorubicin applications on telomerase activity of human hepatocellular carcinoma cell line HepG2.
Carcinoma, Hepatocellular
Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats.
Carcinoma, Hepatocellular
Exploring the Interplay of Telomerase Reverse Transcriptase and ?-Catenin in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity.
Carcinoma, Hepatocellular
Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.
Carcinoma, Hepatocellular
Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.
Carcinoma, Hepatocellular
Expression of telomerase component genes in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Expression of telomerase in normal and malignant rat hepatic epithelia.
Carcinoma, Hepatocellular
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Carcinoma, Hepatocellular
Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA.
Carcinoma, Hepatocellular
Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase.
Carcinoma, Hepatocellular
Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Carcinoma, Hepatocellular
Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
Carcinoma, Hepatocellular
Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Carcinoma, Hepatocellular
Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase.
Carcinoma, Hepatocellular
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Carcinoma, Hepatocellular
Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.
Carcinoma, Hepatocellular
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Carcinoma, Hepatocellular
High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Carcinoma, Hepatocellular
HIV-Tat-mediated Delivery of an LPTS Functional Fragment Inhibits Telomerase Activity and Tumorigenecity of Hepatoma Cells.
Carcinoma, Hepatocellular
Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
Carcinoma, Hepatocellular
Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
Carcinoma, Hepatocellular
Immunological features of T cells induced by human telomerase reverse transcriptase-derived peptides in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Impact of mitochondrial telomerase over-expression on drug resistance of hepatocellular carcinoma.
Carcinoma, Hepatocellular
In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis.
Carcinoma, Hepatocellular
In vitro effects on proliferation, telomerase activity and apoptosis of an eremophilanoid sesquiterpene from Senecio oldhamianus maxim in cultured human tumor cell lines.
Carcinoma, Hepatocellular
Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis.
Carcinoma, Hepatocellular
Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats.
Carcinoma, Hepatocellular
Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice.
Carcinoma, Hepatocellular
Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells.
Carcinoma, Hepatocellular
Inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell proliferation.
Carcinoma, Hepatocellular
Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Carcinoma, Hepatocellular
Isolation and characterization of a lectin with potentially exploitable activities from caper (Capparis spinosa) seeds.
Carcinoma, Hepatocellular
Isolation and Characterization of Juncin, an Antifungal Protein from Seeds of Japanese Takana ( Brassica juncea Var. integrifolia).
Carcinoma, Hepatocellular
Isolation and identification of a novel polysaccharide-peptide complex with antioxidant, antiproliferative, and hypoglycemic activities from the abalone mushroom.
Carcinoma, Hepatocellular
Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
Carcinoma, Hepatocellular
Knockdown of NHP2 inhibits hepatitis B virus X protein-induced hepatocarcinogenesis via repressing TERT expression and disrupting the stability of telomerase complex.
Carcinoma, Hepatocellular
Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Carcinoma, Hepatocellular
Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
Carcinoma, Hepatocellular
Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.
Carcinoma, Hepatocellular
Lipid transfer proteins from Brassica campestris and mung bean surpass mung bean chitinase in exploitability.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.
Carcinoma, Hepatocellular
Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
Carcinoma, Hepatocellular
Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.
Carcinoma, Hepatocellular
Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus.
Carcinoma, Hepatocellular
Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
Carcinoma, Hepatocellular
miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Carcinoma, Hepatocellular
Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.
Carcinoma, Hepatocellular
Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Musa acuminata (Del Monte banana) lectin is a fructose-binding lectin with cytokine-inducing activity.
Carcinoma, Hepatocellular
Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.
Carcinoma, Hepatocellular
NAC selectively inhibit cancer telomerase activity: A higher redox homeostasis threshold exists in cancer cells.
Carcinoma, Hepatocellular
Nanocurcumin-Mediated Down-Regulation of Telomerase Via Stimulating TGF?1 Signaling Pathway in Hepatocellular Carcinoma Cells
Carcinoma, Hepatocellular
NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG? hepatoma cell line.
Carcinoma, Hepatocellular
Nuclear telomerase is less accessible to antibody probing than known nuclear antigens: retrieval with new immunostaining buffer.
Carcinoma, Hepatocellular
Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis.
Carcinoma, Hepatocellular
Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis.
Carcinoma, Hepatocellular
Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation.
Carcinoma, Hepatocellular
PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis.
Carcinoma, Hepatocellular
Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Carcinoma, Hepatocellular
Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA.
Carcinoma, Hepatocellular
Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.
Carcinoma, Hepatocellular
Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity.
Carcinoma, Hepatocellular
PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Purification and characterization of a laccase from the edible wild mushroom Tricholoma mongolicum.
Carcinoma, Hepatocellular
Purification and Characterization of a Laccase with Inhibitory Activity toward HIV-1 Reverse Transcriptase and Tumor Cells from an Edible Mushroom (Pleurotus cornucopiae).
Carcinoma, Hepatocellular
Purification and Characterization of an Antifungal Peptide with Potent Antifungal Activity but Devoid of Antiproliferative and HIV Reverse Transcriptase Activities from Legumi Secchi Beans.
Carcinoma, Hepatocellular
Purification of a trypsin-stable lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activity.
Carcinoma, Hepatocellular
Purification of melibiose-binding lectins from two cultivars of Chinese black soybeans.
Carcinoma, Hepatocellular
Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction.
Carcinoma, Hepatocellular
Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver.
Carcinoma, Hepatocellular
Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens.
Carcinoma, Hepatocellular
Radiosensitization to X-ray radiation by telomerase inhibitor MST-312 in human hepatoma HepG2 cells.
Carcinoma, Hepatocellular
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Hepatocellular
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon.
Carcinoma, Hepatocellular
Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
Carcinoma, Hepatocellular
Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Reversal of hepatoma cells resistance to anticancer drugs is correlated to cell proliferation kinetics, telomere length and telomerase activity.
Carcinoma, Hepatocellular
RNAi-hTERT Inhibition Hepatocellular Carcinoma Cell Proliferation via Decreasing Telomerase Activity.
Carcinoma, Hepatocellular
Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance.
Carcinoma, Hepatocellular
Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
Carcinoma, Hepatocellular
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.
Carcinoma, Hepatocellular
Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy.
Carcinoma, Hepatocellular
Sleeping Beauty-mediated suicide gene therapy of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway.
Carcinoma, Hepatocellular
Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity.
Carcinoma, Hepatocellular
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Carcinoma, Hepatocellular
Synthetic RNA-dependent DNA polymerase activity in normal rat liver and hepatomas.
Carcinoma, Hepatocellular
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.
Carcinoma, Hepatocellular
Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde?
Carcinoma, Hepatocellular
Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.
Carcinoma, Hepatocellular
Telomerase activity and telomere length in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activity in hepatocellular carcinoma and adjacent liver tissues.
Carcinoma, Hepatocellular
Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
Carcinoma, Hepatocellular
Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Carcinoma, Hepatocellular
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Carcinoma, Hepatocellular
Telomerase activity in peripheral blood for diagnosis of hepatoma.
Carcinoma, Hepatocellular
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
Carcinoma, Hepatocellular
Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Carcinoma, Hepatocellular
Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Carcinoma, Hepatocellular
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase assay for differentiating between malignancy-related and nonmalignant ascites.
Carcinoma, Hepatocellular
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Carcinoma, Hepatocellular
Telomerase expression and p53 status in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.
Carcinoma, Hepatocellular
Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Carcinoma, Hepatocellular
Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
Carcinoma, Hepatocellular
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase promoter methylation is related to a risk of recurrence in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.
Carcinoma, Hepatocellular
Telomere and telomerase in chronic liver disease and hepatocarcinoma.
Carcinoma, Hepatocellular
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Carcinoma, Hepatocellular
Telomere Length Variation in Tumor cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Carcinoma, Hepatocellular
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The Anticancer Efficacy of Platinum Azidothymidin on Hepatocellular Carcinoma Via Affecting the Telomerase and the BcL-2 Genes Expression.
Carcinoma, Hepatocellular
The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
Carcinoma, Hepatocellular
The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals.
Carcinoma, Hepatocellular
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Carcinoma, Hepatocellular
The role of telomeres and telomerase in cirrhosis and liver cancer.
Carcinoma, Hepatocellular
The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells.
Carcinoma, Hepatocellular
Using a non-radioisotopic, quantitative TRAP-based method detecting telomerase activities in human hepatoma cells.
Carcinoma, Hepatocellular
[A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3]
Carcinoma, Hepatocellular
[Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus]
Carcinoma, Hepatocellular
[Effects of differentially expressed proteins in hepatocellular carcinoma cell treated by different telomerase inhibitors]
Carcinoma, Hepatocellular
[Effects of hTERT RNAi on apoptosis of hepatocellular carcinoma cells induced by TRAIL]
Carcinoma, Hepatocellular
[Expression and clinical significance of telomerase hTRT in primary hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis]
Carcinoma, Hepatocellular
[Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase]
Carcinoma, Hepatocellular
[Inhibitory effect of lentivirus-mediated hTERTp-TK combined with hTERTp-tumstatin on human hepatocarcinoma HepG2 cells].
Carcinoma, Hepatocellular
[Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells]
Carcinoma, Hepatocellular
[Mechanisms of human telomerase reverse transcriptase RNAi which increases hepatocellular carcinoma cell apoptosis induced by TRAIL]
Carcinoma, Hepatocellular
[Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer]
Carcinoma, Hepatocellular
[Studies on telomerase reverse transcriptase components and liver cancer].
Carcinoma, Hepatocellular
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Carcinoma, Hepatocellular
[Telomerase activity inhibition and apoptosis induction of BEL-7404 human hepatoma cells by antisense oligonucleotides to telomerase RNA component]
Carcinoma, Hepatocellular
[Telomere length and telomerase activity in hepatocellular carcinoma]
Carcinoma, Hepatocellular
[The correlation analysis of telomerase activity and aberrant expression of telomerase subunits during the progression of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[The relationship between gene polymorphism of telomerase reverse transcriptase and susceptibility to hepatocellular carcinoma].
Carcinoma, Hepatocellular
[Usefulness of telomerase activity in the diagnosis of small hepatocellular carcinoma]
Carcinoma, Intraductal, Noninfiltrating
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Carcinoma, Intraductal, Noninfiltrating
CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Carcinoma, Intraductal, Noninfiltrating
Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient.
Carcinoma, Intraductal, Noninfiltrating
Culture models of human mammary epithelial cell transformation.
Carcinoma, Intraductal, Noninfiltrating
Expression of telomerase genes in cancer development in atypical hyperplasia of the mammary duct.
Carcinoma, Intraductal, Noninfiltrating
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Carcinoma, Intraductal, Noninfiltrating
Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
Carcinoma, Intraductal, Noninfiltrating
Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Carcinoma, Intraductal, Noninfiltrating
Telomerase activity in ductal carcinoma in situ of the breast.
Carcinoma, Intraductal, Noninfiltrating
Telomerase activity in human proliferative breast lesions.
Carcinoma, Intraductal, Noninfiltrating
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Carcinoma, Intraductal, Noninfiltrating
Telomerase activity in normal and neoplastic breast.
Carcinoma, Intraductal, Noninfiltrating
[Expression of telomerase genes in mamary atypical ductal hyperplasia]
Carcinoma, Intraductal, Noninfiltrating
[Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia]
Carcinoma, Lewis Lung
High expression of circadian gene mPer2 diminishes radiosensitivity of tumor cells.
Carcinoma, Medullary
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.
Carcinoma, Merkel Cell
Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures.
Carcinoma, Mucoepidermoid
Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Carcinoma, Mucoepidermoid
[PTEN tumor suppressor gene combined with doxycycline inhibites telomerase activity in human mucoepidermoid carcinoma cell line].
Carcinoma, Neuroendocrine
Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Carcinoma, Non-Small-Cell Lung
A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Analysis of spontaneous tumor-specific CD4 T cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
Carcinoma, Non-Small-Cell Lung
Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Carcinoma, Non-Small-Cell Lung
Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Carcinoma, Non-Small-Cell Lung
Chidamide-induced ROS accumulation and miR-129-3p-dependent cell cycle arrest in non-small lung cancer cells.
Carcinoma, Non-Small-Cell Lung
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Carcinoma, Non-Small-Cell Lung
Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Combination of multiple gene markers to detect circulating tumor cells in the peripheral blood of patients with non-small cell lung cancer using real-time PCR.
Carcinoma, Non-Small-Cell Lung
Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Carcinoma, Non-Small-Cell Lung
Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Detection of circulating carcinoma cells by telomerase activity.
Carcinoma, Non-Small-Cell Lung
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer: Results from Cancer and Leukemia Group B 159902.
Carcinoma, Non-Small-Cell Lung
Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
Carcinoma, Non-Small-Cell Lung
Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Carcinoma, Non-Small-Cell Lung
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
Carcinoma, Non-Small-Cell Lung
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Carcinoma, Non-Small-Cell Lung
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Carcinoma, Non-Small-Cell Lung
Expression of telomeric repeat binding factor 1 protein in nonsmall cell lung cancer with human telomerase reverse transcriptase positive.
Carcinoma, Non-Small-Cell Lung
Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk.
Carcinoma, Non-Small-Cell Lung
Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.
Carcinoma, Non-Small-Cell Lung
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination.
Carcinoma, Non-Small-Cell Lung
In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy.
Carcinoma, Non-Small-Cell Lung
Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
Carcinoma, Non-Small-Cell Lung
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
Carcinoma, Non-Small-Cell Lung
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Carcinoma, Non-Small-Cell Lung
LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein.
Carcinoma, Non-Small-Cell Lung
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
Carcinoma, Non-Small-Cell Lung
MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
Carcinoma, Non-Small-Cell Lung
nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice.
Carcinoma, Non-Small-Cell Lung
Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Carcinoma, Non-Small-Cell Lung
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.
Carcinoma, Non-Small-Cell Lung
Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity.
Carcinoma, Non-Small-Cell Lung
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of telomerase activity in non-small cell lung cancers.
Carcinoma, Non-Small-Cell Lung
Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic significance of telomerase polymorphism in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Non-Small-Cell Lung
Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer.
Carcinoma, Non-Small-Cell Lung
Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Carcinoma, Non-Small-Cell Lung
Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Carcinoma, Non-Small-Cell Lung
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Carcinoma, Non-Small-Cell Lung
Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.
Carcinoma, Non-Small-Cell Lung
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
Carcinoma, Non-Small-Cell Lung
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Carcinoma, Non-Small-Cell Lung
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Carcinoma, Non-Small-Cell Lung
Vorinostat represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Carcinoma, Non-Small-Cell Lung
[Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma]
Carcinoma, Non-Small-Cell Lung
[Expression of multidrug resistance-associated gene in non-small cell lung cancer and its correlations with telomerase reverse transcriptase and genes related to apoptosis]
Carcinoma, Non-Small-Cell Lung
[Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumors]
Carcinoma, Non-Small-Cell Lung
[Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[Telomerase activity in human non-small cell lung cancer (NSCLC)]
Carcinoma, Non-Small-Cell Lung
[The Expression of hTERT mRNA and p16 Protein in Non-small Cell Lung Cancer.]
Carcinoma, Ovarian Epithelial
Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Alteration of telomerase activity in ovarian cancer after chemotherapy.
Carcinoma, Ovarian Epithelial
Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity.
Carcinoma, Ovarian Epithelial
Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer.
Carcinoma, Ovarian Epithelial
Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
Carcinoma, Ovarian Epithelial
Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Carcinoma, Ovarian Epithelial
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
Carcinoma, Ovarian Epithelial
RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Carcinoma, Ovarian Epithelial
Telomerase activity in the female reproductive tract and neoplasms.
Carcinoma, Ovarian Epithelial
The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study.
Carcinoma, Ovarian Epithelial
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
Carcinoma, Pancreatic Ductal
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Carcinoma, Pancreatic Ductal
Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma.
Carcinoma, Pancreatic Ductal
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Carcinoma, Pancreatic Ductal
[The role of telomerase for pancreatic carcinogenesis in human and hamster]
Carcinoma, Papillary
Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression.
Carcinoma, Papillary
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Carcinoma, Papillary
Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Carcinoma, Papillary
Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Carcinoma, Papillary
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid.
Carcinoma, Papillary
Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Carcinoma, Renal Cell
Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation.
Carcinoma, Renal Cell
Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
Carcinoma, Renal Cell
Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: Plausible predictive and diagnostic markers.
Carcinoma, Renal Cell
Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
Carcinoma, Renal Cell
Determination of telomerase activity in multifocal renal cell carcinoma.
Carcinoma, Renal Cell
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Carcinoma, Renal Cell
Ectopic expression of wnt-5a in human renal cell carcinoma cells suppresses in vitro growth and telomerase activity.
Carcinoma, Renal Cell
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Carcinoma, Renal Cell
Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region.
Carcinoma, Renal Cell
Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers.
Carcinoma, Renal Cell
Genetic changes and telomerase activity in human renal cell carcinoma.
Carcinoma, Renal Cell
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
Carcinoma, Renal Cell
Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.
Carcinoma, Renal Cell
Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
Carcinoma, Renal Cell
Immunohistochemical expression of proliferative markers in renal cell carcinoma.
Carcinoma, Renal Cell
Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
Carcinoma, Renal Cell
Inhibition of telomerase activity in renal cell carcinoma cells by doxorubicin and anti-Fas monoclonal antibody.
Carcinoma, Renal Cell
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
Carcinoma, Renal Cell
Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
Carcinoma, Renal Cell
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.
Carcinoma, Renal Cell
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Carcinoma, Renal Cell
Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
Carcinoma, Renal Cell
Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
Carcinoma, Renal Cell
Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence.
Carcinoma, Renal Cell
Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.
Carcinoma, Renal Cell
Sarcomatoid Renal Cell Carcinoma With Unusual Metastasis to the Small Intestine Manifesting as Perforated Appendicitis.
Carcinoma, Renal Cell
Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics.
Carcinoma, Renal Cell
Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element.
Carcinoma, Renal Cell
Telomerase activity and telomere length in different areas of renal cell carcinoma.
Carcinoma, Renal Cell
Telomerase activity and telomere lengths: alterations in renal cell carcinomas.
Carcinoma, Renal Cell
Telomerase activity in human renal cell carcinoma.
Carcinoma, Renal Cell
Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
Carcinoma, Renal Cell
Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.
Carcinoma, Renal Cell
The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Carcinoma, Renal Cell
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.
Carcinoma, Renal Cell
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
Carcinoma, Renal Cell
[Expression of human telomerase reverse transcriptase in renal cell carcinoma and its clinical significance]
Carcinoma, Small Cell
Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
Carcinoma, Small Cell
Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
Carcinoma, Squamous Cell
Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.
Carcinoma, Squamous Cell
Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.
Carcinoma, Squamous Cell
Antiproliferative effects of celecoxib in Hep-2 cells through telomerase inhibition and induction of apoptosis.
Carcinoma, Squamous Cell
Azacitidine, as a DNMT inhibitor decreases hTERT gene expression and telomerase activity more effective compared with HDAC inhibitor in human Head and neck squamous cell carcinoma cell lines.
Carcinoma, Squamous Cell
Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Carcinoma, Squamous Cell
Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
Carcinoma, Squamous Cell
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Carcinoma, Squamous Cell
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.
Carcinoma, Squamous Cell
Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: a pilot study.
Carcinoma, Squamous Cell
Change of the Expression of Human Telomerase Reverse Transcriptase mRNA and Human Telomerase RNA after Cisplatin and 5-Fluorouracil Exposure in Head and Neck Squamous Cell Carcinoma Cell Lines.
Carcinoma, Squamous Cell
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Carcinoma, Squamous Cell
Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
Carcinoma, Squamous Cell
Clinical significance of telomerase activity in peripheral blood of patients with esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
Carcinoma, Squamous Cell
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy.
Carcinoma, Squamous Cell
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Carcinoma, Squamous Cell
Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix.
Carcinoma, Squamous Cell
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Carcinoma, Squamous Cell
Detection of HPV E7 Oncoviral Protein in Cervical Lesions by a New Antibody.
Carcinoma, Squamous Cell
Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium.
Carcinoma, Squamous Cell
Detection of telomerase activity in malignant and nonmalignant skin conditions.
Carcinoma, Squamous Cell
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.
Carcinoma, Squamous Cell
Determination of telomerase activity in squamous cell carcinoma of the penis.
Carcinoma, Squamous Cell
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Carcinoma, Squamous Cell
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Carcinoma, Squamous Cell
Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma.
Carcinoma, Squamous Cell
Dyskeratosis Congenita and Oral Cavity Squamous Cell Carcinoma: Report of a Case and Literature Review.
Carcinoma, Squamous Cell
Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells.
Carcinoma, Squamous Cell
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Carcinoma, Squamous Cell
EGFR Tyrosine Kinase Inhibitor Pelitinib Regulates Radiation-Induced p65-Dependent Telomerase Activation in Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.
Carcinoma, Squamous Cell
Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Carcinoma, Squamous Cell
Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.
Carcinoma, Squamous Cell
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4.
Carcinoma, Squamous Cell
Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells.
Carcinoma, Squamous Cell
High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
Carcinoma, Squamous Cell
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15.
Carcinoma, Squamous Cell
Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Carcinoma, Squamous Cell
Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma.
Carcinoma, Squamous Cell
ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!
Carcinoma, Squamous Cell
Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Carcinoma, Squamous Cell
Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Carcinoma, Squamous Cell
Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
Carcinoma, Squamous Cell
Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Carcinoma, Squamous Cell
Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.
Carcinoma, Squamous Cell
Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity.
Carcinoma, Squamous Cell
Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.
Carcinoma, Squamous Cell
Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix.
Carcinoma, Squamous Cell
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Carcinoma, Squamous Cell
Mechanism of telomerase repression during terminal differentiation of normal epithelial cells and squamous carcinoma lines.
Carcinoma, Squamous Cell
miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.
Carcinoma, Squamous Cell
Negative Prognostic Implication of TERT Promoter Mutations in Human Papillomavirus-Negative Tonsillar Squamous Cell Carcinoma Under the New 8th AJCC Staging System.
Carcinoma, Squamous Cell
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Carcinoma, Squamous Cell
Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines.
Carcinoma, Squamous Cell
Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
Carcinoma, Squamous Cell
P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Carcinoma, Squamous Cell
Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
Carcinoma, Squamous Cell
Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Carcinoma, Squamous Cell
Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Carcinoma, Squamous Cell
Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas.
Carcinoma, Squamous Cell
Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter.
Carcinoma, Squamous Cell
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Carcinoma, Squamous Cell
Radio-activation of hTERT promoter in larynx squamous carcinoma cells: an 'indirected-activator' strategy in radio-gene-therapy.
Carcinoma, Squamous Cell
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Squamous Cell
Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
Carcinoma, Squamous Cell
Resistance to telomerase inhibition by human squamous cell carcinoma cell lines.
Carcinoma, Squamous Cell
Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Carcinoma, Squamous Cell
RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.
Carcinoma, Squamous Cell
Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis.
Carcinoma, Squamous Cell
Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Carcinoma, Squamous Cell
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Carcinoma, Squamous Cell
Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Carcinoma, Squamous Cell
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Carcinoma, Squamous Cell
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Carcinoma, Squamous Cell
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
Carcinoma, Squamous Cell
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Carcinoma, Squamous Cell
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus.
Carcinoma, Squamous Cell
Telomerase activity in Indian patients with carcinomas of the aerodigestive tract.
Carcinoma, Squamous Cell
Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.
Carcinoma, Squamous Cell
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Carcinoma, Squamous Cell
Telomerase activity in the female reproductive tract and neoplasms.
Carcinoma, Squamous Cell
Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.
Carcinoma, Squamous Cell
Telomerase activity in the vaginal margins of radical hysterectomy in patients with carcinoma of the cervix: correlation with histology and human papillomavirus.
Carcinoma, Squamous Cell
Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck.
Carcinoma, Squamous Cell
Telomerase activity of peripheral blood mononuclear cells from patients with laryngeal carcinoma.
Carcinoma, Squamous Cell
Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
Carcinoma, Squamous Cell
Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Carcinoma, Squamous Cell
Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
Carcinoma, Squamous Cell
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Carcinoma, Squamous Cell
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Carcinoma, Squamous Cell
Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Carcinoma, Squamous Cell
Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
Carcinoma, Squamous Cell
Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion.
Carcinoma, Squamous Cell
Telomerase reverse transcriptase mediates EMT through NF-?B signaling in tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Telomere Dysfuction Promotes Metastasis in a TERC Null Mouse Model of Head and Neck Cancer.
Carcinoma, Squamous Cell
Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Carcinoma, Squamous Cell
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.
Carcinoma, Squamous Cell
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Carcinoma, Squamous Cell
TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
Carcinoma, Squamous Cell
The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.
Carcinoma, Squamous Cell
The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation.
Carcinoma, Squamous Cell
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Carcinoma, Squamous Cell
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Carcinoma, Squamous Cell
Ultrastructural immunolocalization of telomerase and hyaluronate in migrating keratinocytes in a case of oro-pharyngeal squamous cancer.
Carcinoma, Squamous Cell
[Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells]
Carcinoma, Squamous Cell
[Detection and effect of telomerase activity in oral mucosal squamous cell carcinoma]
Carcinoma, Squamous Cell
[Detection of telomerase activity in laryngeal carcinoma and the association between telomerase activity and lymphatic metastasis]
Carcinoma, Squamous Cell
[Effect of bufalin on cellular proliferation and apoptosis in human esophageal squamous carcinoma EC9706 cells].
Carcinoma, Squamous Cell
[Expression of telomerase reverse transcriptase and its relationship with expression of c-myc in laryngeal squamous cell carcinomas]
Carcinoma, Squamous Cell
[Expression of telomerase reverse transcriptase in premalignant esophageal squamous dysplasia]
Carcinoma, Squamous Cell
[Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]
Carcinoma, Squamous Cell
[Quantitative assay of telomerase activity in head and neck squamous cell carcinoma]
Carcinoma, Squamous Cell
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Carcinoma, Squamous Cell
[Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri]
Carcinoma, Squamous Cell
[Relationship between human papillomavirus 16 infection and the expression of p33(ING1b), human telomerase reverse transcriptase in cervical squamous cell carcinoma of Uygur female in Xinjiang Uygur Autonomous Region]
Carcinoma, Squamous Cell
[Research on expression of telomerase hTR gene in oral precancerous lesion and squamous cell carcinoma]
Carcinoma, Squamous Cell
[Short hairpin RNA silencing of vascular endothelial growth factor, telomerase reverse transcriptase, and Bcl-xl expression in human laryngeal squamous carcinoma xenografted in nude mice]
Carcinoma, Squamous Cell
[Telomerase activity in esophageal carcinoma and lesions unstained with Lugol's solution]
Carcinoma, Squamous Cell
[Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues]
Carcinoma, Squamous Cell
[Telomerase SiRNA inhibits KB cell growth in human oral squamous cell carcinoma.]
Carcinoma, Squamous Cell
[The effect of telomerase inhibitors on oral squamous carcinoma cells]
Carcinoma, Squamous Cell
[The effects on expressions of p53 and PCNA by inhibition of hTERT with siRNA in transplantable model of human laryngeal squamous carcinoma in nude mice]
Carcinoma, Squamous Cell
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Carcinoma, Squamous Cell
[The study on the role of telomerase activity in human nasopharyngeal carcinoma]
Carcinoma, Transitional Cell
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Carcinoma, Transitional Cell
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Carcinoma, Transitional Cell
Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Carcinoma, Transitional Cell
Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.
Carcinoma, Transitional Cell
Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Carcinoma, Transitional Cell
Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Carcinoma, Transitional Cell
Genetic changes and telomerase activity in human renal cell carcinoma.
Carcinoma, Transitional Cell
New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
Carcinoma, Transitional Cell
Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Carcinoma, Transitional Cell
Semi-quantitative analysis of telomerase activity in human urothelial cells and bladder transitional cell carcinoma.
Carcinoma, Transitional Cell
Significant telomere reduction in human superficial transitional cell carcinoma.
Carcinoma, Transitional Cell
Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Carcinoma, Transitional Cell
Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Carcinoma, Transitional Cell
Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
Carcinoma, Transitional Cell
Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Carcinoma, Transitional Cell
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Carcinoma, Transitional Cell
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Carcinoma, Verrucous
Determination of telomerase activity in squamous cell carcinoma of the penis.
Cardiomegaly
Associations between serum concentrations of perfluoroalkyl substances and DNA methylation in women exposed through drinking water: A pilot study in Ronneby, Sweden.
Cardiomegaly
Repetitive hyperthermia attenuates progression of left ventricular hypertrophy and increases telomerase activity in hypertensive rats.
Cardiomegaly
Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart.
Cardiomyopathies
Association of genetic variation in telomere-related SNP and telomerase with ventricular arrhythmias in ischemic cardiomyopathy.
Cardiomyopathies
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
Cardiomyopathies
Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors.
Cardiomyopathies
Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy.
Cardiomyopathies
Cardiotropic viruses in the myocardium of children with end-stage heart disease.
Cardiomyopathies
Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics.
Cardiomyopathies
Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy.
Cardiomyopathies
Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
Cardiomyopathies
Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
Cardiomyopathy, Alcoholic
Evaluation of Myocyte Proliferation in Alcoholic Cardiomyopathy: Telomerase Enzyme Activity (TERT) Compared with Ki-67 Expression.
Cardiomyopathy, Dilated
Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients.
Cardiotoxicity
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Cardiovascular Diseases
Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus.
Cardiovascular Diseases
Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases.
Cardiovascular Diseases
Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.
Cardiovascular Diseases
Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases.
Cardiovascular Diseases
Exercise, telomerase activity, and cardiovascular disease prevention.
Cardiovascular Diseases
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Cardiovascular Diseases
HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL.
Cardiovascular Diseases
Increased telomerase activity and comprehensive lifestyle changes: a pilot study.
Cardiovascular Diseases
Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.
Cardiovascular Diseases
Prognostic Association of TERC, TERT Gene Polymorphism, and Leukocyte Telomere Length in Acute Heart Failure: A Prospective Study.
Cardiovascular Diseases
Quantitative telomerase activity in circulating human leukocytes: utility of real-time telomeric repeats amplification protocol (RQ-TRAP) in a clinical/epidemiological setting.
Cardiovascular Diseases
Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study.
Cardiovascular Diseases
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Cardiovascular Diseases
Telomere length and telomerase activity in the context of menopause.
Cardiovascular Diseases
Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
Cardiovascular Diseases
Telomeres and telomerase in risk assessment of cardiovascular diseases.
Cardiovascular Diseases
Telomeres and telomerase in the fetal origins of cardiovascular disease: a review.
Cardiovascular Diseases
The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus.
Cardiovascular Diseases
The role of the terc-63g>a and tert-1327c>t telomerase polymorphisms in the study of men with acute coronary syndrome.
Cataract
Biomarkers of Oxidative Stress and Cataract. Novel Drug Delivery Therapeutic Strategies Targeting Telomere Reduction and the Expression of Telomerase Activity in the Lens Epithelial Cells with N -Acetylcarnosine Lubricant Eye Drops: Anti-Cataract which Helps to Prevent and Treat Cataracts in the Eyes of Dogs and other Animals.
Cataract
Biomarkers of oxidative stress and cataract. novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals.
Cell Transformation, Neoplastic
Spontaneous neoplastic regression: the significance of apoptosis.
Cell Transformation, Neoplastic
Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Central Nervous System Diseases
The Emerging Roles for Telomerase in the Central Nervous System.
Central Nervous System Infections
Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.
Central Nervous System Neoplasms
Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
Central Nervous System Neoplasms
Telomerase activity in Malaysian patients with central nervous system tumors.
Cerebrovascular Disorders
Aspirin inhibits human telomerase activation in unstable carotid plaques.
Cervical Intraepithelial Neoplasia
Accuracy of telomerase in cervical lesions: a systematic review.
Cervical Intraepithelial Neoplasia
Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.
Cervical Intraepithelial Neoplasia
Detection of HPV E7 Oncoviral Protein in Cervical Lesions by a New Antibody.
Cervical Intraepithelial Neoplasia
Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Cervical Intraepithelial Neoplasia
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.
Cervical Intraepithelial Neoplasia
Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
Cervical Intraepithelial Neoplasia
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Cervical Intraepithelial Neoplasia
Effect of acetic acid on telomerase activity in cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Cervical Intraepithelial Neoplasia
Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Cervical Intraepithelial Neoplasia
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Cervical Intraepithelial Neoplasia
Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Human Telomerase Gene and High-Risk Human Papillomavirus Infection are Related to Cervical Intraepithelial Neoplasia.
Cervical Intraepithelial Neoplasia
Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Cervical Intraepithelial Neoplasia
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Cervical Intraepithelial Neoplasia
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.
Cervical Intraepithelial Neoplasia
Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis.
Cervical Intraepithelial Neoplasia
Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.
Cervical Intraepithelial Neoplasia
Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.
Cervical Intraepithelial Neoplasia
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Cervical Intraepithelial Neoplasia
Telomerase activity in cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
Cervical Intraepithelial Neoplasia
Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.
Cervical Intraepithelial Neoplasia
Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.
Cervical Intraepithelial Neoplasia
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Cervical Intraepithelial Neoplasia
[Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen]
Cervical Intraepithelial Neoplasia
[Application of Van-Clear and xylene in the detection of cervical hTERC gene by fluorescence in situ hybridization].
Cervical Intraepithelial Neoplasia
[Expression of human telomerase reverse transcriptase in cervix cancer and its significance]
Cervical Intraepithelial Neoplasia
[Study on the correlation between the different papillomavirus type and telomerase in cervical cancer]
Cervical Intraepithelial Neoplasia
[Telomerase activity in cervical cancer and its precursor lesion]
Cervical Intraepithelial Neoplasia
[Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasia and its correlation to classification of koilocytosis]
Cervical Intraepithelial Neoplasia
[Telomerase activity in cervical intraepithelial neoplasia]
Chemical and Drug Induced Liver Injury
Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors.
Cholangiocarcinoma
Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.
Cholangiocarcinoma
Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment.
Cholangiocarcinoma
Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients.
Cholangiocarcinoma
Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
Cholangiocarcinoma
Detection of telomerase activity in exfoliated cancer cells obtained from bile.
Cholangiocarcinoma
Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Cholangiocarcinoma
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Cholangiocarcinoma
Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.
Cholangiocarcinoma
In situ detection of TGF betas, TGF beta receptor II mRNA and telomerase activity in rat cholangiocarcinogenesis.
Cholangiocarcinoma
In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion.
Cholangiocarcinoma
Increased telomerase activity in intrahepatic cholangiocellular carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
Cholangiocarcinoma
Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.
Cholangiocarcinoma
Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein.
Cholangiocarcinoma
Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.
Cholangiocarcinoma
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
Cholangiocarcinoma
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Cholangiocarcinoma
Telomerase activity is repressed during differentiation along the hepatocytic and biliary epithelial lineages: verification on immortal cell lines from the same origin.
Cholangiocarcinoma
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Cholangiocarcinoma
Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells.
Cholangiocarcinoma
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Cholangitis
Detection of telomerase activity in exfoliated cancer cells obtained from bile.
Cholecystitis
Detection of telomerase activity in exfoliated cancer cells obtained from bile.
Cholelithiasis
Telomerase activation--one step on the road to carcinoma of the gall bladder.
Cholelithiasis
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Cholesteatoma
Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Cholesteatoma
Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
Cholesteatoma
Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
Cholesteatoma
[Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium]
Cholesteatoma, Middle Ear
Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Cholesteatoma, Middle Ear
[Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium]
Chondroma
Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas.
Chondroma
Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy.
Chondromatosis, Synovial
Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.
Chondrosarcoma
Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Chondrosarcoma
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality.
Chondrosarcoma
Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.
Chondrosarcoma
Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy.
Chondrosarcoma
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma.
Chordoma
Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Chordoma
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note.
Chordoma
Prognostic significance of hTERT (human telomerase reverse transcriptase) promoter region mutations C228T and C250T for overall survival in spinal chordomas.
Chordoma
Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.
Choriocarcinoma
Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc.
Choriocarcinoma
Activation of Toll-like receptor 5 decreases the attachment of human trophoblast cells to endometrial cells in vitro.
Choriocarcinoma
All-trans retinoic acid (atra) inhibits telomerase expression of BeWo choriocarcinoma cell (ATCC CCL-98).
Choriocarcinoma
Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases.
Choriocarcinoma
Effect of human telomerase reverse transcriptase transfection on differentiation in BeWo choriocarcinoma cells.
Choriocarcinoma
Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors.
Choriocarcinoma
Galectin signature of the choriocarcinoma JAr cells: Galectin-1 as a modulator of invasiveness in vitro.
Choriocarcinoma
Nuclear telomerase is less accessible to antibody probing than known nuclear antigens: retrieval with new immunostaining buffer.
Choriocarcinoma
[Telomerase RNA antisense oligonucleotides inhibit growth of human choriocarcinoma xenograft in nude mice]
Choroidal Neovascularization
Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice.
Chronic Periodontitis
Telomerase Expression in Subjects With Chronic and Aggressive Periodontitis.
Chronobiology Disorders
The protective effect of cycloastragenol on aging mouse circadian rhythmic disorder induced by d-galactose.
Classical Swine Fever
Assessing the value of PCR assays in oral fluid samples for detecting African swine fever, classical swine fever, and foot-and-mouth disease in U.S. swine.
Cleft Lip
Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population.
Cleft Lip
Association of genetic polymorphisms in TERT-CLPTM1L with lung cancer in a Chinese population.
Cleft Lip
Genetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males.
Cleft Lip
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer-A case-control study in a Chinese population.
Cleft Lip
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case-control study in northeast Chinese male population.
Cleft Lip
Genetic polymorphisms of TERT and CLPTM1L, cooking oil fume exposure, and risk of lung cancer: a case-control study in a Chinese non-smoking female population.
Cleft Lip
Genetic variant rs401681 at 5p15.33 modifies susceptibility to lung cancer but not esophageal squamous cell carcinoma.
Cleft Lip
Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
Cleft Lip
Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males.
Cleft Lip
Rs401681 polymorphism in TERT-CLPTM1L was associated with bladder cancer risk: A meta-analysis.
Cleft Lip
Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population.
Cleft Lip
Study of genetic variants in chromosome 5p15.33 region in non-smoker lung cancer patients.
Coinfection
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.
Coinfection
Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?
Coinfection
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study.
Coinfection
Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus.
Coinfection
HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.
Coinfection
Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals.
Coinfection
Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1.
Coinfection
Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.
Coinfection
[Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus]
Colitis
Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED.
Colitis
Activation of the cannabinoid 2 receptor (CB(2)) protects against experimental colitis.
Colitis
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Colitis
The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey.
Colitis, Ulcerative
Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
Colitis, Ulcerative
Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis.
Colitis, Ulcerative
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
Colitis, Ulcerative
Kimura's disease associated with ulcerative colitis: detection of IL-5 mRNA expression of peripheral blood mononuclear cells and colon lesion.
Colitis, Ulcerative
Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
Colitis, Ulcerative
Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn's disease.
Colitis, Ulcerative
Telomere dysfunction instigates inflammation in inflammatory bowel disease.
Colitis, Ulcerative
[Insulin-like growth factor receptor, hepatocyte-derived growth factor receptor and telomerase expression in ulcerative colitis]
Colonic Neoplasms
6-Dithio-2'-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase.
Colonic Neoplasms
A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer.
Colonic Neoplasms
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.
Colonic Neoplasms
An overview on red algae bioactive compounds and their pharmaceutical applications.
Colonic Neoplasms
Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
Colonic Neoplasms
Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence.
Colonic Neoplasms
BRCA2 Deletion Induces Alternative Lengthening of Telomeres in Telomerase Positive Colon Cancer Cells.
Colonic Neoplasms
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.
Colonic Neoplasms
Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
Colonic Neoplasms
Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Colonic Neoplasms
CTC1-STN1 terminates telomerase while STN1-TEN1 enables C-strand synthesis during telomere replication in colon cancer cells.
Colonic Neoplasms
Cytological diagnosis and telomerase activity of cells in effusions of body cavities.
Colonic Neoplasms
Cytotoxic effect of Rosa canina extract on human colon cancer cells through repression of telomerase expression.
Colonic Neoplasms
Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis.
Colonic Neoplasms
Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.
Colonic Neoplasms
Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
Colonic Neoplasms
Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis.
Colonic Neoplasms
Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.
Colonic Neoplasms
Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.
Colonic Neoplasms
Editorial retraction. Down-regulation of human telomerase reverse transcriptase through anti-c-myc siRNA in human colon cancer Colo 320 cells.
Colonic Neoplasms
Effect of antisense oligodeoxynucleotide of telomerase RNA on telomerase activity and cell apoptosis in human colon cancer.
Colonic Neoplasms
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
Colonic Neoplasms
Effects of gamma irradiation on cell cycle, apoptosis and telomerase activity in p53 wild-type and deficient HCT116 colon cancer cell lines.
Colonic Neoplasms
Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.
Colonic Neoplasms
Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients.
Colonic Neoplasms
Evaluation of telomerase in the development and progression of colon cancer.
Colonic Neoplasms
Expression of T-STAR gene is associated with regulation of telomerase activity in human colon cancer cell line HCT-116.
Colonic Neoplasms
Genome editing through large insertion leads to the skipping of targeted exon.
Colonic Neoplasms
Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells.
Colonic Neoplasms
Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.
Colonic Neoplasms
Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
Colonic Neoplasms
Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression.
Colonic Neoplasms
Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival ?1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.
Colonic Neoplasms
Mechanisms for inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase (hTERT) down-regulation.
Colonic Neoplasms
Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.
Colonic Neoplasms
Morus Rubra Extract Induces Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells Through Endoplasmic Reticulum Stress and Telomerase.
Colonic Neoplasms
Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
Colonic Neoplasms
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network, in colon cancer cells.
Colonic Neoplasms
Purification and characterization of a novel lectin with antiphytovirus activities from the wild mushroom Paxillus involutus.
Colonic Neoplasms
Quantification of somatic mutation flow across individual cell division events by lineage sequencing.
Colonic Neoplasms
Retraction: siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.
Colonic Neoplasms
Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Colonic Neoplasms
SERS assay of telomerase activity at single-cell level and colon cancer tissues via quadratic signal amplification.
Colonic Neoplasms
Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo.
Colonic Neoplasms
siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.
Colonic Neoplasms
SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
Colonic Neoplasms
Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Colonic Neoplasms
Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
Colonic Neoplasms
Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Colonic Neoplasms
Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system.
Colonic Neoplasms
Telomerase activity and cell apoptosis in colon cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide.
Colonic Neoplasms
Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues.
Colonic Neoplasms
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Colonic Neoplasms
Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Colonic Neoplasms
Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells.
Colonic Neoplasms
Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Colonic Neoplasms
The Australian fruit Illawarra plum (Podocarpus elatus Endl., Podocarpaceae) inhibits telomerase, increases histone deacetylase activity and decreases proliferation of colon cancer cells.
Colonic Neoplasms
The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
Colonic Neoplasms
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis.
Colonic Neoplasms
Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model.
Colonic Neoplasms
[Clinical significance of human telomerase reverse transcriptase in patients with colon cancer]
Colonic Neoplasms
[Detection of telomerase activity and its clinical significance in colonic cancers by PCR-ELISA]
Colonic Neoplasms
[Effects of matrine on proliferation and telomerase activity of colon cancer SW1116 cells]
Colonic Neoplasms
[Experimental study of NK4 gene targeted therapy mediated by human telomerase reverse transcriptase promoter for colon cancer].
Colonic Neoplasms
[The effect of As2O3 on induction of apoptosis and inhibition of telomerase activity in colon cancer LS-174T cells]
Colorectal Neoplasms
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Colorectal Neoplasms
A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-?B inactivation in colorectal cancer cells.
Colorectal Neoplasms
A Rare Variant P507L in TPP1 Interrupts TPP1-TIN2 Interaction, Influences Telomere Length, and Confers Colorectal Cancer Risk in Chinese Population.
Colorectal Neoplasms
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.
Colorectal Neoplasms
Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
Colorectal Neoplasms
Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk.
Colorectal Neoplasms
Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Colorectal Neoplasms
Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116.
Colorectal Neoplasms
Blackberry Extract Inhibits Telomerase Activity in Human Colorectal Cancer Cells.
Colorectal Neoplasms
Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
Colorectal Neoplasms
Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.
Colorectal Neoplasms
Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.
Colorectal Neoplasms
Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Colorectal Neoplasms
Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
Colorectal Neoplasms
Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Colorectal Neoplasms
Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Colorectal Neoplasms
Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Colorectal Neoplasms
CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer.
Colorectal Neoplasms
Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients.
Colorectal Neoplasms
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Colorectal Neoplasms
Detection of cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
Colorectal Neoplasms
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20.
Colorectal Neoplasms
Detection of telomerase activity in biopsy samples of colorectal cancer.
Colorectal Neoplasms
Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma.
Colorectal Neoplasms
Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
Colorectal Neoplasms
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Colorectal Neoplasms
Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
Colorectal Neoplasms
Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis.
Colorectal Neoplasms
Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.
Colorectal Neoplasms
Early detection of peritoneal dissemination of gastrointestinal cancers by reverse-transcriptase polymerase chain reaction.
Colorectal Neoplasms
Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 function.
Colorectal Neoplasms
Effects of phosphorothioate anti-sense oligodeoxynucleotides on colorectal cancer cell growth and telomerase activity.
Colorectal Neoplasms
Evaluation of telomerase in the development and progression of colon cancer.
Colorectal Neoplasms
Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
Colorectal Neoplasms
Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.
Colorectal Neoplasms
High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Colorectal Neoplasms
hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer.
Colorectal Neoplasms
hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells.
Colorectal Neoplasms
hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression.
Colorectal Neoplasms
Human telomerase reverse transcriptase (hTERT) is a target gene of ?-catenin in human colorectal tumors.
Colorectal Neoplasms
Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Colorectal Neoplasms
Human telomerase reverse transcriptase recruits the ?-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer.
Colorectal Neoplasms
Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Colorectal Neoplasms
Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.
Colorectal Neoplasms
Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation.
Colorectal Neoplasms
Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Colorectal Neoplasms
Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
Colorectal Neoplasms
Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.
Colorectal Neoplasms
Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP.
Colorectal Neoplasms
MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer.
Colorectal Neoplasms
Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes.
Colorectal Neoplasms
PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation.
Colorectal Neoplasms
Penclomedine-induced DNA fragmentation and p53 accumulation correlate with reproductive cell death in colorectal carcinoma cells with altered p53 status.
Colorectal Neoplasms
PinX1 without the G-patch motif suppresses proliferation, induces senescence, but does not inhibit telomerase activity in colorectal cancer SW480 cells.
Colorectal Neoplasms
Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: application to colorectal cancers.
Colorectal Neoplasms
Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
Colorectal Neoplasms
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Colorectal Neoplasms
Proinflammatory Cytokines IL-6 and TNF-? Increased Telomerase Activity through NF-?B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells.
Colorectal Neoplasms
Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour.
Colorectal Neoplasms
Quantification of telomerase activity in sporadic colorectal carcinoma: association with tumor growth and venous invasion.
Colorectal Neoplasms
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Colorectal Neoplasms
Re: Cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
Colorectal Neoplasms
Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
Colorectal Neoplasms
Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
Colorectal Neoplasms
Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Colorectal Neoplasms
Regulation of telomerase and its hTERT messenger in colorectal cancer.
Colorectal Neoplasms
Relationship between microsatellite instability and telomere shortening in colorectal cancer.
Colorectal Neoplasms
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Colorectal Neoplasms
Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.
Colorectal Neoplasms
Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Colorectal Neoplasms
Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Colorectal Neoplasms
Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers.
Colorectal Neoplasms
SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
Colorectal Neoplasms
Study of the role of telomerase in colorectal cancer: preliminary report and literature review.
Colorectal Neoplasms
Synergistic Effect of Free and Nano-encapsulated Chrysin-Curcumin on Inhibition of hTERT Gene Expression in SW480 Colorectal Cancer Cell Line.
Colorectal Neoplasms
Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.
Colorectal Neoplasms
Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.
Colorectal Neoplasms
Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.
Colorectal Neoplasms
Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Colorectal Neoplasms
Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.
Colorectal Neoplasms
Telomerase activity and microsatellite instability in colorectal cancer and adenoma.
Colorectal Neoplasms
Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Colorectal Neoplasms
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Colorectal Neoplasms
Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
Colorectal Neoplasms
Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway.
Colorectal Neoplasms
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Colorectal Neoplasms
Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
Colorectal Neoplasms
Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.
Colorectal Neoplasms
Telomerase activity of blood samples and recurrence of colorectal cancer.
Colorectal Neoplasms
Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Colorectal Neoplasms
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Colorectal Neoplasms
Telomerase as a diagnostic and predictive marker in colorectal carcinoma.
Colorectal Neoplasms
Telomerase expression as a predictive marker of radiotherapy response in rectal cancer.
Colorectal Neoplasms
Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer.
Colorectal Neoplasms
Telomerase inhibition as a potential new therapy for colorectal cancer.
Colorectal Neoplasms
Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Colorectal Neoplasms
Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Colorectal Neoplasms
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.
Colorectal Neoplasms
Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer.
Colorectal Neoplasms
Telomerase subunit immunoreactivity and recurrence in colorectal cancer.
Colorectal Neoplasms
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Colorectal Neoplasms
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Colorectal Neoplasms
Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer.
Colorectal Neoplasms
Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Colorectal Neoplasms
Telomeres and telomerase in the clinical management of colorectal cancer.
Colorectal Neoplasms
The association between telomerase, p53, and clinical staging in colorectal cancer.
Colorectal Neoplasms
The HIV reverse transcriptase inhibitor Tenofovir suppressed DMH/HFD-induced colorectal cancer in Wistar rats.
Colorectal Neoplasms
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
Colorectal Neoplasms
The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.
Colorectal Neoplasms
TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer.
Colorectal Neoplasms
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis.
Colorectal Neoplasms
Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
Colorectal Neoplasms
[Detection of telomerase activity in intestinal lavage solution from colorectal carcinoma patients]
Colorectal Neoplasms
[Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer]
Colorectal Neoplasms
[Suppression of cell growth in colorectal cancer by inhibition of telomerase]
Colorectal Neoplasms
[Telomerase activity in colorectal cancer--a semi-quantitative procedure]
Colorectal Neoplasms
[Telomerase activity in colorectal carcinoma and its relationship to clinicopathological findings]
Colorectal Neoplasms
[The effect of As2O3 on induction of apoptosis and inhibition of telomerase activity in colon cancer LS-174T cells]
Colorectal Neoplasms, Hereditary Nonpolyposis
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Colorectal Neoplasms, Hereditary Nonpolyposis
Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.
Colorectal Neoplasms, Hereditary Nonpolyposis
Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.
Communicable Diseases
HIV-1 subtype characteristics of infected persons living in southwestern Greece.
Condylomata Acuminata
Increased telomerase activity and decreased telomere length in genital condylomata acuminata.
Confusion
Improved methods and standards for telomerase detection: quantitative histopathology using antibody staining.
Congenital Abnormalities
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
Congenital Bone Marrow Failure Syndromes
Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Congenital Bone Marrow Failure Syndromes
Nopp140-mediated concentration of telomerase in Cajal bodies regulates telomere length.
Congenital Bone Marrow Failure Syndromes
Posterior pharyngeal wall squamous cell carcinoma arising in a patient with dyskeratosis congenita.
Congenital Bone Marrow Failure Syndromes
Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
Congenital Bone Marrow Failure Syndromes
The effect of TERC haploinsufficiency on the inheritance of telomere length.
Connective Tissue Diseases
Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis.
Connective Tissue Diseases
Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
Coronary Artery Disease
Activation of telomerase and expression of human telomerase reverse transcriptase in coronary atherosclerosis.
Coronary Artery Disease
Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation.
Coronary Artery Disease
Diet and Dermatology: The Role of a Whole-food, Plant-based Diet in Preventing and Reversing Skin Aging-A Review.
Coronary Artery Disease
ISH ADA-01 Critical role of telomerase in regulating cerebral vascular function and redox environment.
Coronary Artery Disease
Potential associations of testosterone/estradiol ratio, leukocyte hTERT expression and PBMC telomerase activity with aging and the presence of coronary artery disease in men.
Coronary Artery Disease
Telomerase, telomere length, and coronary artery calcium in black and white men in the CARDIA study.
Coronary Artery Disease
The predictive role of circulating telomerase and vitamin D for long-term survival in patients undergoing coronary artery bypass grafting surgery (CABG).
Coronary Artery Disease
The role of the terc-63g>a and tert-1327c>t telomerase polymorphisms in the study of men with acute coronary syndrome.
Coronary Disease
Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?
Coronary Disease
Impact of nucleoside reverse transcriptase inhibitors on coronary heart disease.
Coronary Disease
Lack of causal relationship between leukocyte telomere length and coronary heart disease.
Coronavirus Infections
SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases.
Cough
Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea.
COVID-19
A cluster-control approach to a coronavirus disease 2019 (COVID-19) outbreak on a stroke ward with infection control considerations for dementia and vascular units.
COVID-19
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019.
COVID-19
A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing.
COVID-19
A single-center, retrospective study of COVID-19 features in children: a descriptive investigation.
COVID-19
Age, neutrophil lymphocyte ratio, and radiographic assessment of the quantity of lung edema (RALE) score to predict in-hospital mortality in COVID-19 patients: a retrospective study.
COVID-19
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.
COVID-19
Antigen-based rapid diagnostic testing or alternatives for diagnosis of symptomatic COVID-19: A simulation-based net benefit analysis.
COVID-19
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
COVID-19
Clinical features and disease severity in an Iranian population of inpatients with COVID-19.
COVID-19
Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.
COVID-19
Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database.
COVID-19
Clinical Profiles and Outcomes of COVID-19 in Kidney Transplant Recipients: Experience From a High-Volume Public Sector Transplant Center in India.
COVID-19
Clinical significance of prognostic nutrition index in hospitalized patients with COVID-19: Results from single-center experience with systematic review and meta-analysis.
COVID-19
COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results.
COVID-19
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
COVID-19
COVID-19 Stroke Apical Lung Examination Study: A Diagnostic and Prognostic Imaging Biomarker in Suspected Acute Stroke.
COVID-19
Efficacy of a Test-Retest Strategy in Residents and Health Care Personnel of a Nursing Home Facing a COVID-19 Outbreak.
COVID-19
Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
COVID-19
Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study.
COVID-19
Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
COVID-19
Evaluation of healthcare personnel exposures to patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) associated with personal protective equipment.
COVID-19
Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
COVID-19
Evaluation of sample treatments in a safe and straightforward procedure for the detection of SARS-CoV-2 in saliva.
COVID-19
Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital.
COVID-19
Expanding molecular diagnostic capacity for COVID-19 in Ethiopia: operational implications, challenges and lessons learnt.
COVID-19
Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.
COVID-19
False-Negative Nasopharyngeal Swab RT-PCR Assays in Typical COVID-19: Role of Ultra-low-dose Chest CT and Bronchoscopy in Diagnosis.
COVID-19
Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study.
COVID-19
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
COVID-19
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region.
COVID-19
Intriguing Antiviral Modified Nucleosides: A Retrospective View into the Future Treatment of COVID-19.
COVID-19
Novel Coronavirus Disease (COVID-19) in Italian Patients: Gender Differences in Presentation and Severity.
COVID-19
Pregnancy outcomes among symptomatic and asymptomatic women infected with COVID-19 in the west of Iran: a case-control study.
COVID-19
Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study.
COVID-19
Prospective Comparison of Saliva and Nasopharyngeal Swab Sampling for Mass Screening for COVID-19.
COVID-19
Rapid Antigen Test Combined with Chest Computed Tomography to Rule Out COVID-19 in Patients Admitted to the Emergency Department.
COVID-19
Reverse-transcriptase polymerase chain reaction versus chest computed tomography for detecting early symptoms of COVID-19. A diagnostic accuracy systematic review and meta-analysis.
COVID-19
Role of CT angiography in detecting acute pulmonary embolism associated with COVID-19 pneumonia.
COVID-19
Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
COVID-19
SARS Cov2 outbreak management on a landing helicopter dock: An observational retrospective study.
COVID-19
Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
COVID-19
Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
COVID-19
Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan.
COVID-19
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.
COVID-19
The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients.
COVID-19
The prognostic value of myocardial injury in COVID-19 patients and associated characteristics.
COVID-19
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19: A Review of Literature.
COVID-19
Tomographic score (RAD-Covid Score) to assess the clinical severity of the novel coronavirus infection.
COVID-19
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
COVID-19
Underperformance of Reverse-Transcriptase Polymerase Chain Reaction in Japan and Potential Implications From Diamond Princess Cruise Ship and Other Countries During the Ongoing COVID-19 Pandemic.
COVID-19
Validation of saliva sampling as an alternative to oro-nasopharyngeal swab for detection of SARS-CoV-2 using unextracted rRT-PCR with the Allplex 2019-nCoV assay.
COVID-19
Value of standard echocardiography at the bedside for COVID-19 patients in intensive care units: a Japanese single-center analysis.
COVID-19
[Oro- and nasopharyngeal swab for detection of SARS-CoV-2 - step-by-step approach].
COVID-19
[Oro- and Nasopharyngeal Swab for Detection of SARS-CoV-2 - Step-by-step Approach].
Craniopharyngioma
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.
Cri-du-Chat Syndrome
Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome.
Cri-du-Chat Syndrome
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.
Crohn Disease
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
Crohn Disease
Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
Crohn Disease
MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration.
Crohn Disease
Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
Crohn Disease
Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn's disease.
Cryptorchidism
Postmeiotic modifications of spermatogenic cells are accompanied by inhibition of telomerase activity.
Cystadenocarcinoma, Mucinous
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Cystadenofibroma
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Cystadenoma
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Cystadenoma, Mucinous
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Cystadenoma, Mucinous
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Cystadenoma, Papillary
Telomerase activity in benign and malignant epithelial ovarian tumors.
Cystadenoma, Serous
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Cystadenoma, Serous
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Cystadenoma, Serous
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Cystitis
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Cystitis
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Cysts
A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1.
Cysts
Cyst fluid telomerase activity predicts the histologic grade of cystic neoplasms of the pancreas.
Cysts
Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease.
Cysts
Microaspiration of esophageal gland cells and cDNA library construction for identifying parasitism genes of plant-parasitic nematodes.
Cysts
Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.
Cysts
Transcriptome Characterization of Reverse Development in Turritopsis dohrnii (Hydrozoa, Cnidaria).
Deafness
A C-terminal nonsense mutation links PTPRQ with autosomal-dominant hearing loss, DFNA73.
Deficiency Diseases
Drug discovery for human immunodeficiency virus infection: conquests and hurdles.
Dehydration
Continuous and discontinuous changes in the unit cell of HIV-1 reverse transcriptase crystals on dehydration.
Dehydration
Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes.
Deltaretrovirus Infections
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Dementia
A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity.
Dementia
Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease.
Dementia
Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.
Dementia
HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
Dengue
A novel method for the preparation of large cDNA fragments from dengue-3 RNA genome by long RT-PCR amplification.
Dengue
A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014-2018).
Dengue
Clinical applicability of single-tube multiplex reverse-transcriptase PCR in dengue virus diagnosis and serotyping.
Dengue
Comparison of reverse-transcriptase qPCR and droplet digital PCR for the quantification of dengue virus nucleic acid.
Dengue
Dengue Virus Seroprevalence Among Febrile Patients in Bamako, Mali: Results of a 2006 Surveillance Study.
Dengue
Detection of dengue viral RNA in Aedes aegypti (Diptera: Culicidae) exposed to sticky lures using reverse-transcriptase polymerase chain reaction.
Dengue
Development of multiplex real-time reverse-transcriptase polymerase chain reaction assay for simultaneous detection of Zika, dengue, yellow fever, and chikungunya viruses in a single tube.
Dengue
Incidence of dengue illness in Mexican people aged 6 months to 50 years old: A prospective cohort study conducted in Jalisco.
Dengue
The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection.
Dermatitis
Augmented telomerase activity and reduced telomere length in parthenium-induced contact dermatitis.
Dermatitis
Transgenic rat model of childhood-onset dermatitis by overexpressing telomerase reverse transcriptase (TERT).
Dermatitis, Atopic
Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis.
Dermatitis, Atopic
Telomerase activity is spontaneously increased in lymphocytes from patients with atopic dermatitis and correlates with cellular proliferation.
Dermatitis, Atopic
Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs.
Dermatitis, Contact
Augmented telomerase activity and reduced telomere length in parthenium-induced contact dermatitis.
Dermatitis, Contact
In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin.
Dermatitis, Toxicodendron
Detection of telomerase activity in malignant and nonmalignant skin conditions.
Desmoplastic Small Round Cell Tumor
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Diabetes Mellitus
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Diabetes Mellitus
Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters.
Diabetes Mellitus
Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Diabetes Mellitus
Effects of DHA Supplementation on Vascular Function, Telomerase Activity in PBMC, Expression of Inflammatory Cytokines, and PPAR?-LXR?-ABCA1 Pathway in Patients With Type 2 Diabetes Mellitus: Study Protocol for Randomized Controlled Clinical Trial.
Diabetes Mellitus
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Diabetes Mellitus
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Diabetes Mellitus
The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus.
Diabetes Mellitus
The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications.
Diabetes Mellitus, Type 1
Isolation and characterization of stem cells from pancreatic islet: pluripotency, differentiation potential and ultrastructural characteristics.
Diabetes Mellitus, Type 2
Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters.
Diabetes Mellitus, Type 2
Association study of leukocyte telomere length and genetic polymorphism within hTERT promoter with type 2 diabetes in Bangladeshi population.
Diabetes Mellitus, Type 2
Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes.
Diabetes Mellitus, Type 2
Effects of DHA Supplementation on Vascular Function, Telomerase Activity in PBMC, Expression of Inflammatory Cytokines, and PPAR?-LXR?-ABCA1 Pathway in Patients With Type 2 Diabetes Mellitus: Study Protocol for Randomized Controlled Clinical Trial.
Diabetes Mellitus, Type 2
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Diabetes Mellitus, Type 2
MNS16A VNTR polymorphism of human telomerase gene: Elucidation of a gender specific potential allele associated with type 2 diabetes in Bangladeshi population.
Diabetes Mellitus, Type 2
The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes.
Diabetes Mellitus, Type 2
The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.
Diabetes Mellitus, Type 2
The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus.
Diabetes, Gestational
Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes.
Diabetes, Gestational
Mitochondrial translocation of human telomerase reverse transcriptase in cord blood mononuclear cells of newborns with gestational diabetes mellitus mothers.
Diabetic Angiopathies
The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.
Diabetic Cardiomyopathies
LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis.
Diabetic Neuropathies
Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.
Diabetic Retinopathy
Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7.
Diffuse Intrinsic Pontine Glioma
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Diverticulum
Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa.
DNA Repair-Deficiency Disorders
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.
Down Syndrome
Development of noninvasive prenatal diagnosis of trisomy 21 by RT-MLPA with a new set of SNP markers.
Down Syndrome
Role of multiplex reverse-transcriptase PCR for diagnosis of Acute myelosis in an infant with Down's syndrome.
Down Syndrome
Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Drug Hypersensitivity
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Drug Hypersensitivity
Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir.
Drug-Related Side Effects and Adverse Reactions
A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Drug-Related Side Effects and Adverse Reactions
Chronic binge alcohol consumption does not diminish effectiveness of continuous antiretroviral suppression of viral load in simian immunodeficiency virus-infected macaques.
Drug-Related Side Effects and Adverse Reactions
Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics.
Drug-Related Side Effects and Adverse Reactions
Oxidative stress response in telomerase-immortalized fibroblasts from a centenarian.
Drug-Related Side Effects and Adverse Reactions
[Nucleoside induced hepatopathy in HIV patients. Diagnostic value of liver biopsy assessment]
Dyskeratosis Congenita
A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells.
Dyskeratosis Congenita
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria.
Dyskeratosis Congenita
A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish.
Dyskeratosis Congenita
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.
Dyskeratosis Congenita
A role for sister telomere cohesion in telomere elongation by telomerase.
Dyskeratosis Congenita
A telomerase component is defective in the human disease dyskeratosis congenita.
Dyskeratosis Congenita
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
Dyskeratosis Congenita
Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
Dyskeratosis Congenita
Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway.
Dyskeratosis Congenita
Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations.
Dyskeratosis Congenita
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.
Dyskeratosis Congenita
Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
Dyskeratosis Congenita
Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.
Dyskeratosis Congenita
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.
Dyskeratosis Congenita
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of Dyskeratosis congenita.
Dyskeratosis Congenita
Conformational analysis of the telomerase RNA pseudoknot hairpin by Raman spectroscopy.
Dyskeratosis Congenita
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Dyskeratosis Congenita
Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Dyskeratosis Congenita
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia.
Dyskeratosis Congenita
Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
Dyskeratosis Congenita
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia.
Dyskeratosis Congenita
Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: A promising approach for the treatment of defective telomerase disorders.
Dyskeratosis Congenita
Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders.
Dyskeratosis Congenita
Diminished telomeric 3' overhangs are associated with telomere dysfunction in hoyeraal-hreidarsson syndrome.
Dyskeratosis Congenita
Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.
Dyskeratosis Congenita
Disease-associated human telomerase RNA variants show loss of function for telomere synthesis without dominant-negative interference.
Dyskeratosis Congenita
Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.
Dyskeratosis Congenita
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.
Dyskeratosis Congenita
Dynamic behavior of the telomerase RNA hairpin structure and its relationship to dyskeratosis congenita.
Dyskeratosis Congenita
Dyskeratosis Congenita and Oral Cavity Squamous Cell Carcinoma: Report of a Case and Literature Review.
Dyskeratosis Congenita
Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge.
Dyskeratosis Congenita
Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.
Dyskeratosis Congenita
Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
Dyskeratosis Congenita
Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP.
Dyskeratosis Congenita
Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
Dyskeratosis Congenita
Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
Dyskeratosis Congenita
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Dyskeratosis Congenita
Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Dyskeratosis Congenita
Dyskerin ablation in mouse liver inhibits rRNA processing and cell division.
Dyskeratosis Congenita
Dyskerin is a component of the arabidopsis telomerase RNP required for telomere maintenance.
Dyskeratosis Congenita
Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
Dyskeratosis Congenita
Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells.
Dyskeratosis Congenita
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Dyskeratosis Congenita
GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells.
Dyskeratosis Congenita
GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.
Dyskeratosis Congenita
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.
Dyskeratosis Congenita
Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.
Dyskeratosis Congenita
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
Dyskeratosis Congenita
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.
Dyskeratosis Congenita
Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation.
Dyskeratosis Congenita
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Dyskeratosis Congenita
Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants.
Dyskeratosis Congenita
Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Dyskeratosis Congenita
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Dyskeratosis Congenita
Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita.
Dyskeratosis Congenita
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
Dyskeratosis Congenita
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Dyskeratosis Congenita
Making the most of a little: dosage effects in eukaryotic telomere length maintenance.
Dyskeratosis Congenita
Many disease-associated variants of hTERT retain high telomerase enzymatic activity.
Dyskeratosis Congenita
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.
Dyskeratosis Congenita
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Dyskeratosis Congenita
Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA.
Dyskeratosis Congenita
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Dyskeratosis Congenita
Nopp140-mediated concentration of telomerase in Cajal bodies regulates telomere length.
Dyskeratosis Congenita
PARN modulates Y RNA stability, 3' end formation and its modification.
Dyskeratosis Congenita
Phenotypes in mTERT+/- and mTERT-/- mice are due to short telomeres, not telomere-independent functions of TERT.
Dyskeratosis Congenita
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Dyskeratosis Congenita
Posterior pharyngeal wall squamous cell carcinoma arising in a patient with dyskeratosis congenita.
Dyskeratosis Congenita
Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
Dyskeratosis Congenita
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
Dyskeratosis Congenita
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
Dyskeratosis Congenita
Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.
Dyskeratosis Congenita
RETINAL VASCULAR TORTUOSITY AND EXUDATIVE RETINOPATHY IN A FAMILY WITH DYSKERATOSIS CONGENITA MASQUERADING AS FAMILIAL EXUDATIVE VITREORETINOPATHY.
Dyskeratosis Congenita
Role of telomeres and telomerase in the pathogenesis of human cancer.
Dyskeratosis Congenita
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.
Dyskeratosis Congenita
Short telomeres are sufficient to cause the degenerative defects associated with aging.
Dyskeratosis Congenita
Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Dyskeratosis Congenita
Single-Molecule Analysis of the Human Telomerase RNA.Dyskerin Interaction and the Effect of Dyskeratosis Congenita Mutations.
Dyskeratosis Congenita
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.
Dyskeratosis Congenita
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Dyskeratosis Congenita
Structural and functional consequences of a disease mutation in the telomere protein TPP1.
Dyskeratosis Congenita
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.
Dyskeratosis Congenita
Telomerase as a clinical target: current strategies and potential applications.
Dyskeratosis Congenita
Telomerase insufficiency induced telomere erosion accumulation in successive generations in dyskeratosis congenita family.
Dyskeratosis Congenita
Telomerase mutations in families with idiopathic pulmonary fibrosis.
Dyskeratosis Congenita
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.
Dyskeratosis Congenita
Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes.
Dyskeratosis Congenita
Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.
Dyskeratosis Congenita
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.
Dyskeratosis Congenita
Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
Dyskeratosis Congenita
Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
Dyskeratosis Congenita
Telomerase RNA structure and function: implications for dyskeratosis congenita.
Dyskeratosis Congenita
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Dyskeratosis Congenita
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.
Dyskeratosis Congenita
Telomere Length and Telomerase Activity Impact the UV Sensitivity Syndrome Xeroderma Pigmentosum C.
Dyskeratosis Congenita
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Dyskeratosis Congenita
Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
Dyskeratosis Congenita
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Dyskeratosis Congenita
TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity.
Dyskeratosis Congenita
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.
Dyskeratosis Congenita
The effect of TERC haploinsufficiency on the inheritance of telomere length.
Dyskeratosis Congenita
The impact of dyskeratosis congenita mutations on the structure and dynamics of the human telomerase RNA pseudoknot domain.
Dyskeratosis Congenita
The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.
Dyskeratosis Congenita
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
Dyskeratosis Congenita
The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Dyskeratosis Congenita
The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.
Dyskeratosis Congenita
TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase.
Dyskeratosis Congenita
Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita.
Dyskeratosis Congenita
Two-step mechanism involving active-site conformational changes regulates human telomerase DNA binding.
Dyskeratosis Congenita
Understanding telomere diseases through analysis of patient-derived iPS cells.
Dyskeratosis Congenita
YNMG tetraloop formation by a dyskeratosis congenita mutation in human telomerase RNA.
Dyskeratosis Congenita
[Mutation in the telomerase complex component NHP2 in dyskeratosis congenita.]
Dyslipidemias
A study of effect of anti-retroviral therapy regimen on metabolic syndrome in people living with HIV/AIDS: Post hoc analysis from a tertiary care hospital in western India.
Dyslipidemias
Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil.
Dyslipidemias
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Dysplastic Nevus Syndrome
Evaluation of telomerase activity in cutaneous melanocytic proliferations.
Dysplastic Nevus Syndrome
Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
Dysplastic Nevus Syndrome
Telomerase activity in melanocytic lesions: A potential marker of tumor biology.
Dysplastic Nevus Syndrome
[The dysplastic nevus. An Ariadne's thread through a conceptual labyrinth]
Dyspnea
Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.
Ectodermal Dysplasia
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Encephalitis
Evaluation of reverse-transcriptase PCR as a diagnostic tool to confirm Japanese encephalitis virus infection.
Encephalitis, Japanese
Evaluation of reverse-transcriptase PCR as a diagnostic tool to confirm Japanese encephalitis virus infection.
Encephalitis, Tick-Borne
A nested RT-PCR for the detection of tick-borne encephalitis virus (TBEV) in ticks in natural foci.
Encephalitis, Tick-Borne
The Langat model for tick-borne encephalitis virus. Specific detection by RT-PCR.
Encephalomyelitis, Eastern Equine
Eastern equine encephalitis in a free-ranging white-tailed deer (Odocoileus virginianus).
End Stage Liver Disease
Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
Endometrial Hyperplasia
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
Endometrial Hyperplasia
Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
Endometrial Hyperplasia
Telomerase and telomere length in normal and malignant human endometrium as prognostic markers.
Endometrial Hyperplasia
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Endometrial Neoplasms
Aberrant Dyskerin Expression Is Related to Proliferation and Poor Survival in Endometrial Cancer.
Endometrial Neoplasms
Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus.
Endometrial Neoplasms
AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways.
Endometrial Neoplasms
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Endometrial Neoplasms
Detection of hTERT mRNA in peripheral blood and its implication for diagnosis of early stage postoperative endometrial cancer micrometastasis.
Endometrial Neoplasms
Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.
Endometrial Neoplasms
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.
Endometrial Neoplasms
Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
Endometrial Neoplasms
Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.
Endometrial Neoplasms
GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
Endometrial Neoplasms
Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
Endometrial Neoplasms
Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines.
Endometrial Neoplasms
Human Endometrial Carcinogenesis Is Associated with Significant Reduction in Long Non-Coding RNA, TERRA.
Endometrial Neoplasms
Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Endometrial Neoplasms
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
Endometrial Neoplasms
Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Endometrial Neoplasms
Inhibition of telomerase activity in endometrial cancer cells by selenium-cisplatin conjugate despite suppression of its DNA-damaging activity by sodium ascorbate.
Endometrial Neoplasms
Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Endometrial Neoplasms
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells.
Endometrial Neoplasms
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.
Endometrial Neoplasms
p27, cyclin E, and CDK2 expression in normal and cancerous endometrium.
Endometrial Neoplasms
Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis.
Endometrial Neoplasms
Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.
Endometrial Neoplasms
Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells.
Endometrial Neoplasms
Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Endometrial Neoplasms
Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma.
Endometrial Neoplasms
Telomerase and telomere length in normal and malignant human endometrium as prognostic markers.
Endometrial Neoplasms
Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo.
Endometrial Neoplasms
The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
Endometrial Neoplasms
[Antisense oligodeoxynucleotides of human telomerase reverse transcriptase inhibit endometrial carcinoma cell HEC-1A proliferation]
Endometrial Neoplasms
[Expression of human telomerase reverse transcriptase and c-myc transcripts in endometrial carcinoma and its precursors]
Endometrial Neoplasms
[Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma]
Endometrial Neoplasms
[Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo]
Endometriosis
Aberrant expression of regulators of cell-fate found in eutopic endometrium is found in matched ectopic endometrium among women and in a baboon model of endometriosis.
Endometriosis
Aberrant telomerase expression in the endometrium of infertile women with deep endometriosis.
Endometriosis
Endometriosis Is Associated with a Significant Increase in hTERC and Altered Telomere/Telomerase Associated Genes in the Eutopic Endometrium, an Ex-Vivo and In Silico Study.
Endometriosis
Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length.
Endometriosis
Endometriosis: a crosstalk between epidermal growth factor (EGF) gene polymorphism and telomerase activity?
Endometriosis
Generation of immortalized human endometrial stromal cell lines with different endometriosis risk genotypes.
Endometriosis
Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential.
Endometriosis
Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis.
Endometriosis
Increased telomerase activity and human telomerase reverse transcriptase mRNA expression in the endometrium of patients with endometriosis.
Endometriosis
Is There a Balance in Oxidative-Antioxidant Status in Blood Serum of Patients with Advanced Endometriosis?
Endometriosis
Peroxisome proliferator-activated receptor ? agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis.
Endometriosis
Regulatory T cells isolated from endometriotic peritoneal fluid express a different number of Toll-like receptors.
Endometritis
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Endotoxemia
Sepsis induces telomere shortening: a potential mechanism responsible for delayed pathophysiological events in sepsis survivors?
Enteritis
Investigating turkey enteric coronavirus circulating in the Southeastern United States and Arkansas during 2012 and 2013.
Enterocolitis, Necrotizing
The effects of IGF-1 and erythropoietin on apoptosis and telomerase activity in necrotizing enterocolitis model.
Enzootic Bovine Leukosis
A reverse transcriptase assay for detection of the bovine leukemia virus.
Enzootic Bovine Leukosis
Characterization of the RNA dependent DNA polymerase of bovine leukemia virus.
Enzootic Bovine Leukosis
Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses.
Enzootic Bovine Leukosis
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Enzootic Bovine Leukosis
Purification and characterization of bovine leukemia virus DNA polymerase.
Enzootic Bovine Leukosis
Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses.
Enzootic Bovine Leukosis
[Improved test for the detection of reverse transcriptase of bovine leukosis virus]
Enzootic Bovine Leukosis
[Studies on the virus demonstration in enzootic bovine leukosis using the revertase test]
Eosinophilia
[Detection of CBF beta-MYH11 fusion transcript and inv(16)(p13;q22) in acute myelomonocytic leukemia(M4) by RT-PCR and FISH]
Ependymoma
Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups?
Ependymoma
Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas.
Ependymoma
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.
Ependymoma
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Ependymoma
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
Ependymoma
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
Ependymoma
Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma.
Epidermolysis Bullosa Simplex
Epidermolysis bullosa simplex keratinocytes with extended lifespan established by ectopic expression of telomerase.
Epilepsy
In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex.
Epstein-Barr Virus Infections
Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
Epstein-Barr Virus Infections
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
Epstein-Barr Virus Infections
Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma.
Epstein-Barr Virus Infections
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Epstein-Barr Virus Infections
Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
Epstein-Barr Virus Infections
Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.
Epstein-Barr Virus Infections
Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Equine Infectious Anemia
Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.
Equine Infectious Anemia
RNA-dependent DNA polymerase associated with equine infectious anemia virus.
Erectile Dysfunction
Re: Treatment of Diabetes Mellitus-Induced Erectile Dysfunction Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase Reverse Transcriptase.
Erectile Dysfunction
Telomerase reverse transcriptase genetically modified adipose tissue derived stem cells improves erectile dysfunction by inhibiting oxidative stress and enhancing proliferation in rat model.
Erectile Dysfunction
Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase.
Esophageal Neoplasms
Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
Esophageal Neoplasms
Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells.
Esophageal Neoplasms
Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.
Esophageal Neoplasms
Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.
Esophageal Neoplasms
Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications.
Esophageal Neoplasms
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Esophageal Neoplasms
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Esophageal Neoplasms
Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.
Esophageal Neoplasms
Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
Esophageal Neoplasms
Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia.
Esophageal Neoplasms
Genes associated with telomerase activity levels in esophageal carcinoma cell lines.
Esophageal Neoplasms
Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.
Esophageal Neoplasms
Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32.
Esophageal Neoplasms
Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent.
Esophageal Neoplasms
Telomerase activity measurement in magnetically captured epithelial cells: comparison of slab-gel and capillary electrophoresis.
Esophageal Neoplasms
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.
Esophageal Neoplasms
Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks.
Esophageal Neoplasms
Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Esophageal Neoplasms
The significance of telomerase activity in cancer lesions and the noncancerous epithelium of the esophagus.
Esophageal Neoplasms
[Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells]
Esophageal Neoplasms
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]
Esophageal Squamous Cell Carcinoma
Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Clinical significance of telomerase activity in peripheral blood of patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
Esophageal Squamous Cell Carcinoma
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium.
Esophageal Squamous Cell Carcinoma
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Esophageal Squamous Cell Carcinoma
Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Esophageal Squamous Cell Carcinoma
Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Esophageal Squamous Cell Carcinoma
Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
Esophageal Squamous Cell Carcinoma
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Esophageal Squamous Cell Carcinoma
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
Esophageal Squamous Cell Carcinoma
Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent.
Esophageal Squamous Cell Carcinoma
Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.
Esophageal Squamous Cell Carcinoma
Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
[Analysis of telomerase activity in esophageal carcinoma using microdissection telomeric repeat amplification protocol assay]
Esophageal Squamous Cell Carcinoma
[Expression of telomerase reverse transcriptase in premalignant esophageal squamous dysplasia]
Esophageal Squamous Cell Carcinoma
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]
Esophagitis, Peptic
Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Essential Hypertension
Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension.
Essential Hypertension
Shorter Leukocyte Telomere Length coupled with lower expression of Telomerase Genes in patients with Essential Hypertension.
Essential Hypertension
[Telomerase activity in peripheral blood leukocytes from patients with essential hypertension]
Esthesioneuroblastoma, Olfactory
Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma.
Exanthema
Metabolic Activation of Nevirapine in Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4.
Eye Diseases
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Fabry Disease
Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease.
Fanconi Anemia
Accelerated telomere shortening and telomerase activation in Fanconi's anaemia.
Fanconi Anemia
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Fanconi Anemia
Lack of mutations in the human telomerase RNA component (hTERC) gene in Fanconi's anemia.
Fanconi Syndrome
Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Fasciitis, Necrotizing
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.
Fatigue Syndrome, Chronic
A randomized controlled trial of qigong exercise on fatigue symptoms, functioning, and telomerase activity in persons with chronic fatigue or chronic fatigue syndrome.
Fatty Liver
A genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance.
Fatty Liver
High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Fatty Liver
High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
Fatty Liver
Influence of insulin resistance on Hepatic Fibrosis and Steatosis in HCV Monoinfected compared with HIV-HCV co-infected patients.
Fatty Liver
Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
Fatty Liver
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?
Feline Infectious Peritonitis
Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats.
Fetal Death
Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
Fetal Growth Retardation
Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation.
Fetal Growth Retardation
Telomerase activity and apoptosis as indicators of ageing in placenta with and without intrauterine growth retardation.
Fetal Growth Retardation
Telomerase and proliferative activity in placenta from women with and without fetal growth restriction.
Fetal Growth Retardation
TERC telomerase subunit gene copy number in placentas from pregnancies complicated with intrauterine growth restriction.
Fibroadenoma
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Fibroadenoma
Comparison of Telomere Length and Telomerase Activation between Breast Fibroadenoma and Infiltrating Ductal Carcinoma in Malaysian Women.
Fibroadenoma
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
Fibroadenoma
Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Fibroadenoma
Telomerase activation in neoplastic cell immortalization and tumour progression.
Fibroadenoma
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
Fibroadenoma
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Fibroadenoma
Telomerase expression in human breast cancer with and without lymph node metastases.
Fibrocystic Breast Disease
Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay.
Fibrocystic Breast Disease
[Telomerase activity in infiltration ductal carcinoma of breast]
Fibroma
Establishment of human fibroma cell lines from a MEN1 patient by introduction of either hTERT or SV40 early region.
Fibroma
Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus.
Fibromatosis, Aggressive
Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.
Fibromatosis, Aggressive
Telomere length and telomerase activity in extra-abdominal desmoid tumors.
Fibromatosis, Aggressive
Telomere length in familial adenomatous polyposis-associated desmoids.
Fibrosarcoma
An in vitro investigation of immunomodulatory properties of Lactobacillus plantarum and L. delbrueckii cells and their extracellular polysaccharides.
Fibrosarcoma
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis.
Fibrosarcoma
Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.
Fibrosarcoma
Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.
Focal Nodular Hyperplasia
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Foot Ulcer
Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters.
Foot-and-Mouth Disease
Assessing the value of PCR assays in oral fluid samples for detecting African swine fever, classical swine fever, and foot-and-mouth disease in U.S. swine.
Foot-and-Mouth Disease
[Presence of an RNA dependent DNA polymerase enzyme in the foot-and-mouth disease virus]
Fowlpox
Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus.
Fowlpox
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects.
Fowlpox
Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype.
Fragile X Syndrome
High-throughput DNA diagnostic measurements using capillary electrophoresis: p53, fragile X and telomerase.
Gallbladder Diseases
Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma.
Ganglioneuroma
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Gastritis
Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions.
Gastritis
Detection of telomerase activity in gastric lavage fluid: a novel method to detect gastric cancer.
Gastritis
Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues.
Gastritis
[Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]
Gastritis, Atrophic
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Gastritis, Atrophic
[Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]
Gastritis, Atrophic
[The significance of telomerase activity in patients with gastric cancer]
Gastroenteritis
Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.
Gastroesophageal Reflux
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus.
Gastrointestinal Diseases
Telomerase activity and human telomerase RNA component in gastrointestinal diseases.
Gastrointestinal Neoplasms
A novel peptide-nucleotide dual vaccine of human telomerase reverse transcriptase induces a potent cytotoxic T-cell response in vivo.
Gastrointestinal Neoplasms
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Gastrointestinal Neoplasms
Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers.
Gastrointestinal Neoplasms
Deregulated GSK3{beta} sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase.
Gastrointestinal Neoplasms
Early detection of peritoneal dissemination of gastrointestinal cancers by reverse-transcriptase polymerase chain reaction.
Gastrointestinal Neoplasms
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1? and VEGF receptors.
Gastrointestinal Neoplasms
Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology.
Gastrointestinal Neoplasms
Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.
Gastrointestinal Neoplasms
Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Gastrointestinal Neoplasms
Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.
Gastrointestinal Stromal Tumors
Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.
Gastrointestinal Stromal Tumors
Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms.
Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine a proliferation activity and a potential for aggressive biological behavior.
Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors of the vermiform appendix: clinicopathologic, immunohistochemical, and molecular study of 2 cases with literature review.
Gastrointestinal Stromal Tumors
Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).
Gastrointestinal Stromal Tumors
ShRNA-mediated BMI-1 gene silencing inhibits gastrointestinal stromal tumor cell telomerase activity and enhances apoptosis.
Gastrointestinal Stromal Tumors
Study of the expressions of p53 and bcl-2 genes, the telomerase activity and apoptosis in GIST patients.
Gastrointestinal Stromal Tumors
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Gastrointestinal Stromal Tumors
Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Genetic Diseases, Inborn
A phylogenetically based secondary structure for the yeast telomerase RNA.
Genetic Diseases, Inborn
Diminished telomeric 3' overhangs are associated with telomere dysfunction in hoyeraal-hreidarsson syndrome.
Genetic Diseases, Inborn
Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.
Genetic Diseases, Inborn
Phenotypes in mTERT+/- and mTERT-/- mice are due to short telomeres, not telomere-independent functions of TERT.
Genetic Diseases, Inborn
Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Genetic Diseases, Inborn
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Genetic Diseases, Inborn
Telomere and telomerase in stem cells: relevance in ageing and disease.
Genetic Diseases, Inborn
Telomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerations.
Gestational Trophoblastic Disease
Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors.
Gestational Trophoblastic Disease
Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
Gestational Trophoblastic Disease
Telomerase activity in gestational trophoblastic disease.
Giant Cell Tumor of Bone
Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Giant Cell Tumors
Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Glaucoma
A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains.
Glioblastoma
1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
Glioblastoma
A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
Glioblastoma
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
Glioblastoma
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Glioblastoma
Anticancer Potential and Mechanism of Action of Mango Ginger (Curcuma amada Roxb.) Supercritical CO2 Extract in Human Glioblastoma Cells.
Glioblastoma
Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length.
Glioblastoma
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Glioblastoma
Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.
Glioblastoma
Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma.
Glioblastoma
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
Glioblastoma
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
Glioblastoma
Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.
Glioblastoma
Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Glioblastoma
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas.
Glioblastoma
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Glioblastoma
Clinicopathological Analysis of HIF-1alpha and TERT on Survival Outcome in Glioblastoma Patients: A Prospective, Single Institution Study.
Glioblastoma
Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.
Glioblastoma
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Glioblastoma
Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Glioblastoma
Different assessments of immunohistochemically stained Ki-67 and hTERT in glioblastoma multiforme yield variable results: a study with reference to survival prognosis.
Glioblastoma
Differentiation Decreased Telomerase Activity in Rat Glioblastoma C6 Cells and Increased Sensitivity to IFN-gamma and Taxol for Apoptosis.
Glioblastoma
Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
Glioblastoma
Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.
Glioblastoma
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.
Glioblastoma
Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.
Glioblastoma
Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.
Glioblastoma
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Glioblastoma
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Glioblastoma
Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
Glioblastoma
Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
Glioblastoma
Glioblastoma induces vascular endothelial cells to express telomerase in vitro.
Glioblastoma
Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR.
Glioblastoma
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Glioblastoma
In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
Glioblastoma
In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
Glioblastoma
Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.
Glioblastoma
Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice.
Glioblastoma
Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.
Glioblastoma
Inhibition of MUC1 exerts cell-cycle arrest and telomerase suppression in glioblastoma cells.
Glioblastoma
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
Glioblastoma
Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.
Glioblastoma
Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
Glioblastoma
Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Glioblastoma
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
Glioblastoma
Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel.
Glioblastoma
Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells.
Glioblastoma
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
Glioblastoma
N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells.
Glioblastoma
New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.
Glioblastoma
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.
Glioblastoma
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Glioblastoma
Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma.
Glioblastoma
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.
Glioblastoma
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
Glioblastoma
Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.
Glioblastoma
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Glioblastoma
Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells.
Glioblastoma
RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells.
Glioblastoma
Silencing of telomere-binding protein adrenocortical dysplasia (ACD) homolog enhances radiosensitivity in glioblastoma cells.
Glioblastoma
Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.
Glioblastoma
Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
Glioblastoma
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
Glioblastoma
Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.
Glioblastoma
Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Glioblastoma
Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Glioblastoma
Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Glioblastoma
Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Glioblastoma
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts.
Glioblastoma
Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma.
Glioblastoma
Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma.
Glioblastoma
Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Glioblastoma
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
Glioblastoma
Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.
Glioblastoma
Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Glioblastoma
TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma.
Glioblastoma
TERT Promoter Mutation in Adult Glioblastomas: It's Correlation with Other Relevant Molecular Markers.
Glioblastoma
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.
Glioblastoma
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas.
Glioblastoma
The Regulation of ROS- and BECN1-Mediated Autophagy by Human Telomerase Reverse Transcriptase in Glioblastoma.
Glioblastoma
The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
Glioblastoma
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.
Glioblastoma
Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells.
Glioblastoma
[Azidothymidine inhibition of telomerase activity and proliferation of TJ905 human glioblastoma cells]
Glioblastoma
[Effect of antisense epidermal growth factor receptor cDNA transfection on telomerase activity of glioblastomas cells]
Glioma
18F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.
Glioma
A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.
Glioma
A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Glioma
A retrospective analysis of the risk factors affecting recurrence time in patients with recurrent glioblastoma.
Glioma
Activation of telomerase in glioma cells by human cytomegalovirus: another piece of the puzzle.
Glioma
Adenovirus-mediated over-expression of p21Waf-1 differentially affects the proliferation, telomerase activity, and expression of glial fibrillary acidic protein in human glioma cells.
Glioma
Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Glioma
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Glioma
Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Glioma
Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length.
Glioma
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
Glioma
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation.
Glioma
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Glioma
Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.
Glioma
Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of glioma.
Glioma
Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases.
Glioma
Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Glioma
Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
Glioma
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Glioma
Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.
Glioma
Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Glioma
Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
Glioma
Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients.
Glioma
Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas.
Glioma
Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Glioma
Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
Glioma
Combination of tamoxifen and antisense human telomerase RNA inhibits glioma cell proliferation and anti-apoptosis via suppression of telomerase activity.
Glioma
Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Glioma
Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Glioma
Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Glioma
Contralesional Structural Plasticity in Different Molecular Pathologic Subtypes of Insular Glioma.
Glioma
Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Glioma
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
Glioma
Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Glioma
Detection of IDH1 and TERT promoter mutations with droplet digital PCR in diffuse gliomas.
Glioma
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.
Glioma
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Glioma
Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas.
Glioma
Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model.
Glioma
Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody.
Glioma
Emerging interplay of genetics and epigenetics in gliomas: a new hope for targeted therapy.
Glioma
Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
Glioma
Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome X-linked monoclonal antibody AMab-6.
Glioma
Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
Glioma
Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Glioma
Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts.
Glioma
Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Glioma
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.
Glioma
Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
Glioma
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Glioma
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Glioma
Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
Glioma
Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity.
Glioma
HDAC inhibitor Scriptaid induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Glioma
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.
Glioma
High S phase kinase-associated protein 2 expression is a potential prognostic biomarker for glioma.
Glioma
Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
Glioma
Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.
Glioma
Identification of IDH and TERTp mutation status using 1 H-MRS in 112 hemispheric diffuse gliomas.
Glioma
Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Glioma
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Glioma
Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival.
Glioma
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Glioma
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.
Glioma
Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Glioma
Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Glioma
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.
Glioma
Manumycin inhibits STAT3, telomerase activity and growth of glioma cells by elevating intracellular reactive oxygen species generation.
Glioma
Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel.
Glioma
MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas.
Glioma
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.
Glioma
Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.
Glioma
Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
Glioma
PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma.
Glioma
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Glioma
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.
Glioma
Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.
Glioma
Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.
Glioma
Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.
Glioma
Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach.
Glioma
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Glioma
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Glioma
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Glioma
Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells.
Glioma
Retraction Note to: The Clinical Implications of Human Telomerase Reverse Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic Review and Meta-analysis.
Glioma
Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
Glioma
Rosette-Forming Glioneuronal Tumor Originating From the Spinal Cord: Report of 2 Cases and Literature Review.
Glioma
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
Glioma
Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cells.
Glioma
Specific gene suppression using antisense strategy for growth suppression of glioma.
Glioma
Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
Glioma
Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.
Glioma
Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.
Glioma
Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Glioma
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma.
Glioma
Telomerase activity in gliomas with the use of non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol.
Glioma
Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Glioma
Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
Glioma
Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Glioma
Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery.
Glioma
Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma.
Glioma
Telomerase reverse transcriptase (TERT) rs2736100 polymorphism contributes to increased risk of glioma: evidence from a meta-analysis.
Glioma
Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
Glioma
Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Glioma
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
Glioma
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Glioma
Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas.
Glioma
TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma.
Glioma
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Glioma
TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.
Glioma
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Glioma
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.
Glioma
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
Glioma
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
Glioma
TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.
Glioma
The Clinical Implications of Human Telomerase Reverse Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic Review and Meta-analysis.
Glioma
The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Glioma
The inhibitory effects of ginsenoside Rd on the human glioma U251 cells and its underlying mechanisms.
Glioma
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Glioma
The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Glioma
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
Glioma
The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.
Glioma
Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Glioma
Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome.
Glioma
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Glioma
Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Glioma
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Glioma
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.
Glioma
[Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo]
Glioma
[Study on expression of ING1, human telomerase reverse transcriptase and telomerase-associated protein 1 genes in human gliomas]
Glomerulosclerosis, Focal Segmental
Conditionally immortalized human podocyte cell lines established from urine.
Glucose Intolerance
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.
Glucose Intolerance
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.
Glucose Intolerance
Telomerase deficiency impairs glucose metabolism and insulin secretion.
Goiter, Nodular
[Puncture hystobiopsy with tissue telomerase activity measurement in preoperative thyroid nodes diagnostics]
Gout
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Graft vs Host Disease
Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
Graft vs Host Disease
Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Graft vs Host Disease
[Clinical application of gene technology to monitor bone marrow transplantation]
Granuloma
The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
Granulosa Cell Tumor
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Granulosa Cell Tumor
[Immunohistochemical study on telomerase activity in ovarian sex-cord stromal tumors]
Graves Disease
Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Graves Disease
Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Guillain-Barre Syndrome
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
Guillain-Barre Syndrome
Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.
Gynecomastia
Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.
Hamartoma
Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients.
Head and Neck Neoplasms
Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways.
Head and Neck Neoplasms
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer.
Head and Neck Neoplasms
Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Head and Neck Neoplasms
Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Head and Neck Neoplasms
Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
Head and Neck Neoplasms
Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells.
Head and Neck Neoplasms
hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells.
Head and Neck Neoplasms
hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
Head and Neck Neoplasms
Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Head and Neck Neoplasms
The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
Head and Neck Neoplasms
Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair.
Head and Neck Neoplasms
[Inhibitory Effect of Silencing hTERT Gene by Short Hairpin RNA on Growth of Human Laryngeal Squamous Cell Carcinoma Xenograft in Nude Mice.]
Head and Neck Neoplasms
[Prognostic and diagnostic value of telomerase in the head and neck cancer]
Head and Neck Neoplasms
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Hearing Loss
A C-terminal nonsense mutation links PTPRQ with autosomal-dominant hearing loss, DFNA73.
Hearing Loss
A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naive people.
Heart Defects, Congenital
Cardiotropic viruses in the myocardium of children with end-stage heart disease.
Heart Diseases
Cardiotropic viruses in the myocardium of children with end-stage heart disease.
Heart Diseases
In situ Analysis of Cancer Cells Based on DNA Signal Amplification and DNA Nanodevices.
Heart Diseases
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
Heart Diseases
Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury.
Heart Failure
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation.
Heart Failure
Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice.
Heart Failure
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.
Heart Failure
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
Heart Failure
Cardioprotective Effects of SIRT6 in a Mouse Model of Transverse Aortic Constriction-Induced Heart Failure.
Heart Failure
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Heart Failure
Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury.
Heart Failure
Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart.
Heart Failure
Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction.
Hemangioblastoma
Absence of tight junctions between microvascular endothelial cells in human cerebellar hemangioblastomas.
Hemangioblastoma
Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
Hemangioma
Angiogenin: a potential serum marker of infantile hemangioma revealed by cDNA microarray analysis.
Hemangiopericytoma
hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
Hemangiopericytoma
Telomerase activity and alterations in telomere length in human brain tumors.
Hemangiosarcoma
[Breast hemangiosarcoma. Contribution of a case and review of the literature. Study of viral particles and RNA dependent DNA polymerase (inverse transcriptase) activity]
Hematologic Diseases
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Hematologic Diseases
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Hematologic Diseases
Telomerase and telomere biology in hematological diseases: A new therapeutic target.
Hematologic Neoplasms
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Hematologic Neoplasms
Characterization of In Vitro G-Quadruplex Formation of Imetelstat Telomerase Inhibitor.
Hematologic Neoplasms
Clinical significance of telomerase genes (hTERC and hTERT) amplification in patients with acute myeloid leukemia.
Hematologic Neoplasms
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
Hematologic Neoplasms
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.
Hematologic Neoplasms
Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
Hematologic Neoplasms
Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies.
Hematologic Neoplasms
Telomerase activity in normal leukocytes and in hematologic malignancies.
Hematologic Neoplasms
Telomerase in Acute Myeloid Leukemia: A Molecular Update on Diagnosis, Prognosis, and Treatment.
Hematologic Neoplasms
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
Hematologic Neoplasms
Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Hematologic Neoplasms
The importance of the telomere and telomerase system in hematological malignancies.
Hematologic Neoplasms
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation.
Hematologic Neoplasms
The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies.
Hematologic Neoplasms
[Telomere length measurement of 10 Chinese patients with bone marrow failure syndrome.]
Hematologic Neoplasms
[Telomeres and telomerase activity: their role in aging and in neoplastic development]
Hematuria
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Hematuria
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Hematuria
Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity.
Hematuria
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Hemorrhagic Fever with Renal Syndrome
Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome.
Hemorrhagic Fever with Renal Syndrome
Domestically acquired seoul virus causing hemorrhagic fever with renal syndrome-Maryland, 2008.
Hemorrhagic Fever with Renal Syndrome
Utility of Nested Reverse-Transcriptase Polymerase Chain Reaction of Clinical Specimens for Early Diagnosis of Hemorrhagic Fever with Renal Syndrome.
Hemorrhagic Fever, Ebola
Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study.
Hepatic Insufficiency
Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients.
Hepatitis
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Hepatitis
Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
Hepatitis
Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides.
Hepatitis
Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
Hepatitis
Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Hepatitis
Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection.
Hepatitis
Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.
Hepatitis
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Hepatitis
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Hepatitis
Telomerase repeat amplification protocol (TRAP) activity upon recombinant expression and purification of human telomerase in a bacterial system.
Hepatitis
Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.
Hepatitis
TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
Hepatitis
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Hepatitis B
Adefovir dipivoxil loaded proliposomal powders with improved hepatoprotective activity: formulation, optimization, pharmacokinetic, and biodistribution studies.
Hepatitis B
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
Hepatitis B
cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome.
Hepatitis B
Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay.
Hepatitis B
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
Hepatitis B
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
Hepatitis B
Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Hepatitis B
Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
Hepatitis B
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
Hepatitis B
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
Hepatitis B
Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues.
Hepatitis B
Expression and purification of a functional human hepatitis B virus polymerase.
Hepatitis B
Expression of an enzymatically active polymerase of human hepatitis B virus in an coupled transcription-translation system.
Hepatitis B
Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.
Hepatitis B
Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.
Hepatitis B
Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase.
Hepatitis B
Factors influencing inadequate or suboptimal response to adefovir with or without genotypic resistance.
Hepatitis B
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting.
Hepatitis B
Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.
Hepatitis B
Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
Hepatitis B
Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Hepatitis B
Hepatitis B virus replication and mutation are autoregulated by interactions between surface antigen and HBeAg and the HBV DNA polymerase: a functional model with therapeutic implications.
Hepatitis B
Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.
Hepatitis B
Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase.
Hepatitis B
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Hepatitis B
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors.
Hepatitis B
High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Hepatitis B
HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.
Hepatitis B
Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60.
Hepatitis B
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.
Hepatitis B
In vitro Epsilon RNA-Dependent Protein Priming Activity of Human Hepatitis B Virus Polymerase.
Hepatitis B
In vitro mitochondrial toxicity of metacavir, a new nucleoside reverse transcriptase inhibitor for treatment of hepatitis B virus.
Hepatitis B
In vitro phenotyping of recombinant hepatitis B virus containing the polymerase/reverse transcriptase gene from clinical isolates.
Hepatitis B
In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
Hepatitis B
Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides.
Hepatitis B
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
Hepatitis B
Knockdown of NHP2 inhibits hepatitis B virus X protein-induced hepatocarcinogenesis via repressing TERT expression and disrupting the stability of telomerase complex.
Hepatitis B
Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.
Hepatitis B
Lopinavir/Ritonavir Pharmacokinetics, Efficacy, and Safety in HIV and Hepatitis B or C Coinfected Adults Without Symptoms of Hepatic Impairment.
Hepatitis B
Mechanism of antiviral activities of 3'-substituted L-nucleosides against 3TC-resistant HBV polymerase: a molecular modelling approach.
Hepatitis B
Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats.
Hepatitis B
Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
Hepatitis B
Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.
Hepatitis B
No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B.
Hepatitis B
Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active.
Hepatitis B
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir.
Hepatitis B
Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript.
Hepatitis B
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.
Hepatitis B
Quantification of 2'-deoxy-2'-?-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.
Hepatitis B
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development.
Hepatitis B
RNase H activity of human hepatitis B virus polymerase expressed in Escherichia coli.
Hepatitis B
Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2',3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.
Hepatitis B
Severe skin rash with lamivudine in HIV infected patients: some unusual case reports.
Hepatitis B
Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator.
Hepatitis B
Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance.
Hepatitis B
Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.
Hepatitis B
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Hepatitis B
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Hepatitis B
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Hepatitis B
The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice.
Hepatitis B
The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.
Hepatitis B
The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
Hepatitis B
Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients.
Hepatitis B
Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells.
Hepatitis B
Using PBPK Modeling to Predict Drug Exposure and Support Dosage Adjustments in Patients With Renal Impairment: An Example With Lamivudine.
Hepatitis B
Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients.
Hepatitis B
X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter.
Hepatitis B
YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
Hepatitis B
[Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus]
Hepatitis B
[Clinical emergence features and implications of hepatitis B virus rtA181T mutation].
Hepatitis B
[Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus]
Hepatitis B
[Effects of hepatitis B virus X gene on apoptosis and the activity of telomerase in HepG(2) cells]
Hepatitis B
[The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines]
Hepatitis B, Chronic
Association Between the Telomerase rs2736098_TT Genotype and a Lower Risk of Chronic Hepatitis B and Cirrhosis in Chinese Males.
Hepatitis B, Chronic
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
Hepatitis B, Chronic
Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi.
Hepatitis B, Chronic
Impact of Tenofovir Disoproxil-Induced Fanconi Syndrome on Bone Material Quality: A Case Report.
Hepatitis B, Chronic
Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Hepatitis B, Chronic
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.
Hepatitis B, Chronic
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir.
Hepatitis B, Chronic
Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Hepatitis B, Chronic
Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers
Hepatitis B, Chronic
Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
Hepatitis B, Chronic
Telomerase activity of peripheral blood lymphocytes in patients with chronic hepatitis B.
Hepatitis B, Chronic
[Telomerase activity of peripheral blood mononuclear cells in patients with acquired immune dysfunction]
Hepatitis C
A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway.
Hepatitis C
A novel nested reverse-transcriptase polymerase chain reaction method for rapid hepatitis C virus detection and genotyping.
Hepatitis C
A tale of two strands: reverse-transcriptase polymerase chain reaction detection of hepatitis C virus replication.
Hepatitis C
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.
Hepatitis C
Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct-Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse-Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.
Hepatitis C
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.
Hepatitis C
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
Hepatitis C
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Hepatitis C
Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.
Hepatitis C
Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: clinical applications of quantitative analysis.
Hepatitis C
Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques.
Hepatitis C
Development of anti-viral agents using molecular modeling and virtual screening techniques.
Hepatitis C
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
Hepatitis C
Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein.
Hepatitis C
Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
Hepatitis C
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.
Hepatitis C
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Hepatitis C
Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-kappaB pathway.
Hepatitis C
Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.
Hepatitis C
Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.
Hepatitis C
In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1.
Hepatitis C
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Hepatitis C
NTP-mediated nucleotide excision activity of hepatitis C virus RNA-dependent RNA polymerase.
Hepatitis C
Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays.
Hepatitis C
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Hepatitis C
Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals.
Hepatitis C
Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients.
Hepatitis C
Quantification of 2'-deoxy-2'-?-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.
Hepatitis C
Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.
Hepatitis C
Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management.
Hepatitis C
Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19.
Hepatitis C
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Hepatitis C
Telomere length and telomerase reverse transcriptase mRNA expression in patients with hepatitis C.
Hepatitis C
TERC telomerase subunit gene copy number in different disease stages of non-hodgkin lymphoma and in hepatitis C.
Hepatitis C
The relationship between nevirapine plasma concentrations and abnormal liver function tests.
Hepatitis C, Chronic
Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.
Hepatitis C, Chronic
La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.
Hepatitis C, Chronic
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Hepatitis C, Chronic
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Hepatitis C, Chronic
[CLINICAL AND PHARMACOECONOMIC RESULTS OF THE USAGE OF VARIOUS HIV REVERSE TRANSCRIPTASE INHIBITORS IN THE SCHEMES OF ANTIRETROVIRAL THERAPY OF PATIENT RECEIVING THERAPY FOR THE CHRONIC HEPATITIS C VIRUS].
Hepatitis E
Characterization of Seven Outbreaks of Hemorrhagic Hepatopathy Syndrome in Commercial Pullets Following the Administration of a Salmonella Enteritidis Bacterin in California.
Hepatitis, Chronic
Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
Hepatitis, Chronic
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
Hepatitis, Chronic
Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis.
Hepatitis, Chronic
Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Hepatitis, Chronic
Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.
Hepatitis, Chronic
Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma.
Hepatitis, Chronic
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Hepatitis, Chronic
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Hepatitis, Chronic
Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
Hepatitis, Chronic
Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Hepatitis, Chronic
The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma.
Hepatoblastoma
Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity.
Hepatoblastoma
High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hepatoblastoma
Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity.
Hepatoblastoma
The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of post-translational regulation.
Hepatoblastoma
Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.
Hepatoblastoma
[Effects of antisense human telomerase reverse-transcript protein subunit (hTERT) gene on biological characteristics of hepatoblastoma cell line in vitro]
Hepatoblastoma
[IL-4 gene transfer induces the differentiation of cells and inhibits the activity of telomerase in hepatoblastoma cells]
Herpes Simplex
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
Herpes Simplex
A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.
Herpes Simplex
A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase.
Herpes Simplex
Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: a new disease entity?
Herpes Simplex
Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response.
Herpes Simplex
Combination of HSV1-TK/shTERT by retrovirus vector inhibits hepatocellular carcinoma cell growth in vitro and in vivo.
Herpes Simplex
Development of genetically modified eliminable human dermal fibroblast feeder cells for ocular surface regeneration medicine.
Herpes Simplex
Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
Herpes Simplex
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Herpes Simplex
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.
Herpes Simplex
Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase.
Herpes Simplex
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T).
Herpes Simplex
Low p16(INK4a) Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.
Herpes Simplex
LY294002 Enhances Expression of Proteins Encoded by Recombinant Replication-Defective Adenoviruses via mTOR- and Non-mTOR-Dependent Mechanisms.
Herpes Simplex
Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by herpes simplex virus vector through the SDF1?/CXCR4 system in rats.
Herpes Simplex
New culture technique of human eliminable feeder-assisted target cell sheet production.
Herpes Simplex
No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.
Herpes Simplex
Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study.
Herpes Simplex
Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with Trans-Splicing Ribozyme.
Herpes Simplex
The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
Herpes Simplex
The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.
Herpes Simplex
[A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549]
Herpes Zoster
Elevated PD-1 expression and decreased telomerase activity in memory T cells of patients with symptomatic Herpes Zoster infection.
Herpes Zoster
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.
Herpes Zoster
Molecular cloning of rainbow trout (Oncorhynchus mykiss) eggshell zona radiata protein complementary DNA: mRNA expression in 17beta-estradiol- and nonylphenol-treated fish.
Histiocytoma, Malignant Fibrous
Postradiation malignant fibrous histiocytoma and osteosarcoma of a patient with high telomerase activities.
Histiocytoma, Malignant Fibrous
Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Histiocytosis
Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
Histiocytosis, Langerhans-Cell
Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
histone acetyltransferase deficiency
The circadian rhythm controls telomeres and telomerase activity.
HIV Infections
2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants.
HIV Infections
A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors.
HIV Infections
A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection.
HIV Infections
Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study.
HIV Infections
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.
HIV Infections
Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.
HIV Infections
Anti-tat hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
HIV Infections
Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol.
HIV Infections
Apricitabine--a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs.
HIV Infections
Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.
HIV Infections
Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
HIV Infections
Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase.
HIV Infections
Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.
HIV Infections
Brain and CSF entry of the novel non-nucleoside reverse transcriptase inhibitor, GW420867X.
HIV Infections
Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
HIV Infections
Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities.
HIV Infections
Co-infection of hepatic cell lines with HIV-hepatitis B virus (HBV) leads to an increase in intracellular hepatitis B surface antigen (HBsAg).
HIV Infections
Comparison of the pharmacokinetics of apricitabine in the presence and absence of ritonavir-boosted tipranavir: a phase I, open-label, controlled, single-centre study.
HIV Infections
Comprehensive analysis of the intracellular metabolism of antiretroviral nucleosides and nucleotides using liquid chromatography-tandem mass spectrometry and method improvement by using ultra performance liquid chromatography.
HIV Infections
Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States.
HIV Infections
Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
HIV Infections
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.
HIV Infections
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.
HIV Infections
Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography.
HIV Infections
Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics.
HIV Infections
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma.
HIV Infections
Different origin of adipogenic stem cells influences the response to antiretroviral drugs.
HIV Infections
Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
HIV Infections
Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
HIV Infections
Dysregulation of autophagy in rat liver with mitochondrial DNA depletion induced by the nucleoside analogue zidovudine.
HIV Infections
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
HIV Infections
Early safety of tenofovir alafenamide in patients with a history of tubulopathy on tenofovir disoproxil fumarate: a randomized controlled clinical trial.
HIV Infections
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
HIV Infections
Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis.
HIV Infections
Emtricitabine: new preparation. An antiretroviral very similar to lamivudine.
HIV Infections
Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor.
HIV Infections
Evaluation of antiretroviral effect on mitochondrial DNA depletion among HIV-infected patients in Bali.
HIV Infections
Exploring CYP2B6 activity by measuring the presence ofnevirapine hydroxy metabolites in plasma.
HIV Infections
Expression and functional activity of nucleoside transporters in human choroid plexus.
HIV Infections
Fixed Dose Combinations of Nucleoside Reverse Transcriptase Inhibitor for Naïve Patient with Hiv Infection in Russia: Cost Comparison Analysis.
HIV Infections
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
HIV Infections
Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy-Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India.
HIV Infections
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.
HIV Infections
HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and lead optimization using CoMFA and CoMSIA studies (1995-2016).
HIV Infections
Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz.
HIV Infections
Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients.
HIV Infections
In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid accumulation and survival.
HIV Infections
In vitro interaction of nucleoside reverse transcriptase inhibitor, didanosine with calf-thymus DNA: Insights from spectroscopic studies.
HIV Infections
Influence of Phosphatidylinositol-3-Kinase/Protein Kinase B-Mammalian Target of Rapamycin Signaling Pathway on the Neuropathic Pain Complicated by Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection.
HIV Infections
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection.
HIV Infections
Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol.
HIV Infections
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.
HIV Infections
Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection.
HIV Infections
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
HIV Infections
Knocking out human immunodeficiency virus through non-nucleoside reverse transcriptase inhibitors used as single agents or in combinations: a paradigm for the cure of AIDS?
HIV Infections
Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.
HIV Infections
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
HIV Infections
Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz.
HIV Infections
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
HIV Infections
Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.
HIV Infections
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation defective reverse transcriptase inhibitor.
HIV Infections
Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
HIV Infections
Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.
HIV Infections
Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
HIV Infections
Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
HIV Infections
Molecular dynamics and Monte Carlo simulations for protein-ligand binding and inhibitor design.
HIV Infections
Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors.
HIV Infections
Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications.
HIV Infections
Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patients.
HIV Infections
Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
HIV Infections
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
HIV Infections
Nonclinical Safety Profile of BMS-986001, a Nucleoside Transcriptase Inhibitor for Combination Retroviral Therapy.
HIV Infections
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.
HIV Infections
Novel peptides with HIV-1 reverse transcriptase inhibitory activity derived from the fruits of Quercus infectoria.
HIV Infections
Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants.
HIV Infections
Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.
HIV Infections
Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?
HIV Infections
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
HIV Infections
Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.
HIV Infections
Pharmacokinetics of Acetyl-L-Carnitine Given in Single or Multiple Doses to HIV-1 Infected Patients with Toxic Peripheral Polyneuropathy.
HIV Infections
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.
HIV Infections
Prevalence and factors associated with physical function limitation in older West African people living with HIV.
HIV Infections
Prevalence of and Risk Factors for Prediabetes in Patients Infected With HIV.
HIV Infections
Productively infected CD4+ cells express higher Human telomerase reverse transcriptase levels indicating a possible mechanism of persistence in HIV infection.
HIV Infections
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
HIV Infections
Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine.
HIV Infections
Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review.
HIV Infections
Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.
HIV Infections
State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2.
HIV Infections
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors.
HIV Infections
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors.
HIV Infections
Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins.
HIV Infections
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
HIV Infections
Tenofovir: a nucleotide analogue reverse-transcriptase inhibitor for treatment of HIV infection.
HIV Infections
The choice of HIV protease inhibitor: indinavir is currently the best option.
HIV Infections
The genetic toxicity effects of lamivudine and stavudine antiretroviral agents.
HIV Infections
The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell.
HIV Infections
The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
HIV Infections
Towards an early diagnosis of HIV infection: an electrochemical approach for detection of HIV-1 reverse transcriptase enzyme.
HIV Infections
Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy.
HIV Infections
[Benign symmetrical lipomatosis ("peripheral lipodystrophy") during antiretroviral therapy of HIV infection]
HIV Infections
[Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors]
HIV Infections
[Pharma-clinics. How I treat ... HIV infection. III. Non-nucleoside reverse transcriptase inhibitors]
HIV Seropositivity
Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA.
HIV-Associated Lipodystrophy Syndrome
Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
HIV-Associated Lipodystrophy Syndrome
HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting.
HIV-Associated Lipodystrophy Syndrome
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Hodgkin Disease
CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.
Hodgkin Disease
Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
Hodgkin Disease
Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Hodgkin Disease
Human recombination activating gene-1 in leukemia/lymphoma cells: expression depends on stage of lymphoid differentiation defined by phenotype and genotype.
Hodgkin Disease
Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
Hodgkin Disease
Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.
Hodgkin Disease
Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.
Hodgkin Disease
Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease.
Hodgkin Disease
The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.
Hydatidiform Mole
Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases.
Hydatidiform Mole
Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors.
Hydatidiform Mole
Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
Hydatidiform Mole
Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.
Hydatidiform Mole
Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole.
Hydatidiform Mole
Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor.
Hydatidiform Mole
Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
Hyperalgesia
Hyperalgesia induced by oral stavudine administration to rats does not depend on spinal neuronal cell death, or on spinal or systemic inflammatory cytokine secretion, or metabolic dysregulation.
Hyperalgesia
Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by herpes simplex virus vector through the SDF1?/CXCR4 system in rats.
Hyperalgesia
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Induce Pathological Pain through Wnt5a-Mediated Neuroinflammation in Aging Mice.
Hypercalcemia
A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia.
Hypercholesterolemia
Evaluation and management of dyslipidemia in patients with HIV infection.
Hypercholesterolemia
Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results.
Hypercholesterolemia
Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.
Hypercholesterolemia
Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice.
Hypercholesterolemia
[From cardiovascular prevention to anti-aging medicine: influence on telomere and cell aging].
Hyperglycemia
Differentiated PDGFR?-Positive Cells: A Novel In-Vitro Model for Functional Studies of Neuronal Nitric Oxide Synthase.
Hyperglycemia
Evidence for Telomerase Activation in VSMCs Exposed to Hyperglycemic and Hyperhomocysteinemic Conditions.
Hyperglycemia
High glucose-induced replicative senescence: point of no return and effect of telomerase.
Hyperglycemia
The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.
Hyperhomocysteinemia
Evidence for Telomerase Activation in VSMCs Exposed to Hyperglycemic and Hyperhomocysteinemic Conditions.
Hyperinsulinism
The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro.
Hyperlactatemia
A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Hyperlactatemia
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Hyperlactatemia
Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy.
Hyperlactatemia
Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.
Hyperlactatemia
Lactate levels in children with HIV/AIDS on highly active antiretroviral therapy.
Hyperlactatemia
Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.
Hyperlactatemia
Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.
Hyperlactatemia
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Hyperlactatemia
Symptomatic hyperlactatemia in a patient on nucleoside reverse transcriptase inhibitors.
Hyperlactatemia
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.
Hyperlactatemia
The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Hyperlactatemia
Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Hyperlactatemia
[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors]
Hyperlipidemias
Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era.
Hyperlipidemias
Fat redistribution in indinavir-treated patients with HIV infection: A review of postmarketing cases.
Hyperlipidemias
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?
Hyperparathyroidism
Telomerase is not activated in human hyperplastic and adenomatous parathyroid tissue.
Hyperparathyroidism, Primary
Telomerase is not activated in human hyperplastic and adenomatous parathyroid tissue.
Hypersensitivity
A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
Hypersensitivity
A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Hypersensitivity
Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir.
Hypersensitivity
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
Hypersensitivity
CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.
Hypersensitivity
Dermatologic adverse effects of antiretroviral therapy: recognition and management.
Hypersensitivity
High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.
Hypersensitivity
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.
Hypersensitivity
Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR.
Hypersensitivity
Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study).
Hypersensitivity
Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
Hypersensitivity
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
Hypersensitivity
Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity.
Hypersensitivity
Telomere protection mechanisms change during neurogenesis and neuronal maturation: newly generated neurons are hypersensitive to telomere and DNA damage.
Hypersensitivity
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Hypersensitivity
tRNA ADENOSINE DEAMINASE 3 is required for telomere maintenance in Arabidopsis thaliana.
Hypertension
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?
Hypertension
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
Hypertension
Coexistence of obstructive sleep apnea and telomerase activity, concentration of selected adipose tissue hormones and vascular endothelial function in patients with arterial hypertension.
Hypertension
DNA methylation of human telomerase reverse transcriptase associated with leukocyte telomere length shortening in hyperhomocysteinemia-type hypertension in humans and in a rat model.
Hypertension
Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure.
Hypertension
Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study.
Hypertension
Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production.
Hypertension
Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress.
Hypertension
Predictors of hypertension and changes of blood pressure in HIV-infected patients.
Hypertension
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Hypertension
Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension.
Hypertension
[Telomerase activity in peripheral blood leukocytes from patients with essential hypertension]
Hypertension, Pulmonary
Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension.
Hypertriglyceridemia
Evaluation and management of dyslipidemia in patients with HIV infection.
Hypertriglyceridemia
Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results.
Hypertriglyceridemia
Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.
Hypertriglyceridemia
[Pharmaceutical follow up of antirretroviral treatment in outpatients].
Hypertrophy, Left Ventricular
Repetitive hyperthermia attenuates progression of left ventricular hypertrophy and increases telomerase activity in hypertensive rats.
Hypophosphatemia
Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects.
Hypothyroidism
Quantification of MyoD, myogenin, MRF4 and Id-1 by reverse-transcriptase polymerase chain reaction in rat muscles--effects of hypothyroidism and chronic low-frequency stimulation.
Idiopathic Interstitial Pneumonias
Telomere shortening in familial and sporadic pulmonary fibrosis.
Idiopathic Interstitial Pneumonias
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Idiopathic Pulmonary Fibrosis
A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family.
Idiopathic Pulmonary Fibrosis
A spectrum of severe familial liver disorders associate with telomerase mutations.
Idiopathic Pulmonary Fibrosis
Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Idiopathic Pulmonary Fibrosis
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Idiopathic Pulmonary Fibrosis
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms.
Idiopathic Pulmonary Fibrosis
Increased fibroblast telomerase expression precedes myofibroblast ?-smooth muscle actin expression in idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Modeling pulmonary fibrosis by abnormal expression of telomerase/apoptosis/collagen V in experimental usual interstitial pneumonia.
Idiopathic Pulmonary Fibrosis
Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Idiopathic Pulmonary Fibrosis
Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Idiopathic Pulmonary Fibrosis
Subclinical Lung Disease, Macrocytosis and Premature Graying in Kindreds with Telomerase (TERT) Mutations.
Idiopathic Pulmonary Fibrosis
Telomerase and the Genetics of Emphysema Susceptibility. Implications for Pathogenesis Paradigms and Patient Care.
Idiopathic Pulmonary Fibrosis
Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
Idiopathic Pulmonary Fibrosis
Telomerase mutations in families with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.
Idiopathic Pulmonary Fibrosis
Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer.
Idiopathic Pulmonary Fibrosis
Telomere Length is a Determinant of Emphysema Susceptibility.
Idiopathic Pulmonary Fibrosis
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Idiopathic Pulmonary Fibrosis
Telomere shortening and DNA damage in culprit cells of different types of progressive fibrosing interstitial lung disease.
Idiopathic Pulmonary Fibrosis
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Idiopathic Pulmonary Fibrosis
The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Idiopathic Pulmonary Fibrosis
Vascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance.
Immune Reconstitution Inflammatory Syndrome
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Immune System Diseases
Activation of telomerase is induced by a natural antigen in allergen-specific memory T lymphocytes in bronchial asthma.
Infarction, Middle Cerebral Artery
Deficiency of telomerase activity aggravates the blood-brain barrier disruption and neuroinflammatory responses in a model of experimental stroke.
Infarction, Middle Cerebral Artery
Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain injury.
Infarction, Middle Cerebral Artery
Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Infections
3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.
Infections
A nanoparticle-encapsulated non-nucleoside reverse-transcriptase inhibitor with enhanced anti-HIV-1 activity and prolonged circulation time in plasma.
Infections
A Novel Approach to Helicobacter pylori Pan-Genome Analysis for Identification of Genomic Islands.
Infections
A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1.
Infections
A peptide inhibitor of HIV-1 reverse transcriptase using alpha,beta-dehydro residues: a structure-based computer model.
Infections
A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014-2018).
Infections
A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells.
Infections
A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma.
Infections
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Infections
Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
Infections
Accelerated aging in HIV/AIDS: novel biomarkers of senescent human CD8+ T cells.
Infections
Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
Infections
Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Infections
Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Infections
Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages.
Infections
Amplification of the chromosome 20q region is associated with expression of HPV-16 E7 in human airway and anogenital epithelial cells.
Infections
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.
Infections
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection.
Infections
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
Infections
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine.
Infections
Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase.
Infections
Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
Infections
Anti-CD3/28 mediated expansion of macaque CD4+ T cells is polyclonal and provides extended survival after adoptive transfer.
Infections
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Infections
Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.
Infections
Antitumor effect of COOH-terminal polypeptide of human TERT is associated with the declined expression of hTERT and NF-?B p65 in HeLa cells.
Infections
Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
Infections
Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.
Infections
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.
Infections
Association of p16(INK4a) and pRb inactivation with immortalization of human cells.
Infections
Bovine herpesvirus type 1 (BHV-1) up-regulates telomerase activity in MDBK cells.
Infections
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.
Infections
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Infections
Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
Infections
Cellular aging dynamics after acute malaria infection: A 12-month longitudinal study.
Infections
Cellulases belonging to glycoside hydrolase families 6 and 7 contribute to the virulence of Magnaporthe oryzae.
Infections
Chain-terminating dinucleoside tetraphosphates are substrates for DNA polymerization by human immunodeficiency virus type 1 reverse transcriptase with increased activity against thymidine analogue-resistant mutants.
Infections
Characterization of HeLa cells persistently infected with influenza virus B/Lee/40 with respect to telomerase activity and apoptosis.
Infections
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
Infections
Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.
Infections
Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.
Infections
Chlamydia trachomatis inhibits telomeric DNA damage signaling via transient hTERT upregulation.
Infections
Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.
Infections
Clinical features of initial cases of 2009 pandemic influenza A (H1N1) in Macau, China.
Infections
Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea.
Infections
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Infections
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection.
Infections
Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2.
Infections
Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents.
Infections
Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 Reverse Transcriptase: A Fluorine Nuclear Magnetic Resonance Study.
Infections
Container Type Influences the Relative Abundance, Body Size, and Susceptibility of Ochlerotatus triseriatus (Diptera: Culicidae) to La Crosse Virus.
Infections
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Infections
Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography.
Infections
Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.
Infections
CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.
Infections
Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells.
Infections
Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy.
Infections
Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort.
Infections
Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
Infections
Dengue Virus Seroprevalence Among Febrile Patients in Bamako, Mali: Results of a 2006 Surveillance Study.
Infections
Design of reverse transcriptase-specific nucleosides to visualize early steps of HIV-1 replication by click labeling.
Infections
Design, synthesis, and biological evaluation of new 2'-deoxy-2'-fluoro-4'-triazole cytidine nucleosides as potent antiviral agents.
Infections
Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.
Infections
Development of a reverse transcriptase loop-mediated isothermal amplification (LAMP) assay for the sensitive detection of Leishmania parasites in clinical samples.
Infections
Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.
Infections
Development of three additional Culex species-specific polymerase chain reaction primers and their application in West Nile virus surveillance in Canada.
Infections
Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
Infections
Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections.
Infections
Distinct cytokine pattern in response to different bacterial pathogens in human brain abscess.
Infections
Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Infections
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
Infections
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial.
Infections
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
Infections
Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein.
Infections
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial.
Infections
Eastern equine encephalomyelitis virus infection in six captive southern cassowaries (Casuarius casuarius).
Infections
Effect of coadministration of neurovite and Lamivudine on the histomorphology of the cerebellum of wistar rats.
Infections
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Infections
Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: a multicenter, randomized, open-label, controlled, four-period crossover trial.
Infections
Effects of Nucleopolyhedrovirus Infection on the Development of Helicoverpa armigera (Lepidoptera: Noctuidae) and Expression of Its 20-Hydroxyecdysoneand Juvenile HormoneRelated Genes
Infections
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
Infections
Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection.
Infections
Elevated PD-1 expression and decreased telomerase activity in memory T cells of patients with symptomatic Herpes Zoster infection.
Infections
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.
Infections
Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection.
Infections
Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction.
Infections
Epigallocatechin-3-Gallate, the Main Polyphenol in Green Tea, Inhibits Porcine Epidemic Diarrhea Virus In Vitro.
Infections
Eradication of human immunodeficiency virus type 1-infected cells by a combination of antimetabolic cytotoxic chemotherapy and antiviral chemotherapy in vitro: a pilot study.
Infections
Establishing Renal Proximal Tubule Epithelial-Derived Cell Lines Expressing Human Telomerase Reverse Transcriptase for Studying BK Polyomavirus.
Infections
Establishment and analysis of the prediction model for cervical squamous cell carcinoma.
Infections
Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.
Infections
Establishment of an immortalized human extravillous trophoblast cell line by retroviral infection of E6/E7/hTERT and its transcriptional profile during hypoxia and reoxygenation.
Infections
Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Infections
Evidence against the involvement of nitric oxide in the modulation of telomerase activity or replicative capacity of human endothelial cells.
Infections
Experience of an Orthopaedic Surgery Department Early During the COVID-19 Outbreak in Japan Including Real-Time Polymerase Chain Reaction Assay Results for SARS-CoV-2.
Infections
Expression of Candida albicans secreted aspartyl proteinase in acute vaginal candidiasis.
Infections
Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts.
Infections
False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases.
Infections
Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma.
Infections
Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections.
Infections
Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction.
Infections
Frequent incorporation of Ribonucleotides during HIV-1 reverse transcription and their attenuated repair in macrophages.
Infections
Full-Genome Analysis of Hepatitis C Virus in Japanese and Non-Japanese Patients Coinfected With HIV-1 in Tokyo.
Infections
Functional assessment of pharmacological telomerase activators in human T cells.
Infections
Gastric Sonic Hedgehog Acts as a Macrophage Chemoattractant During the Immune Response to Helicobacter pylori.
Infections
Gene expression profiling of a compatible interaction between Douglas-Fir and the root rot fungal pathogen Phellinus sulphurascens.
Infections
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Infections
Helicobacter pylori and telomerase activity in intestinal metaplasia of the stomach.
Infections
Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.
Infections
Helicobacter pylori infection induces telomerase activity in premalignant lesions.
Infections
Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues.
Infections
Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran.
Infections
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting.
Infections
Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi.
Infections
Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.
Infections
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Infections
High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.
Infections
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
Infections
Highly sensitive detection and localization of maternally acquired human cytomegalovirus in placental tissue by in situ polymerase chain reaction.
Infections
HIV Reverse-Transcriptase Drug Resistance Mutations During Early Infection Reveal Greater Transmission Diversity Than in Envelope Sequences.
Infections
HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity.
Infections
HIV-1 Induces Telomerase Activity in Monocyte-Derived Macrophages, Possibly Safeguarding One of Its Reservoirs.
Infections
HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level.
Infections
HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.
Infections
Hospitalization due to human parainfluenza virus-associated lower respiratory tract illness in rural Thailand.
Infections
hTERT Inhibition Triggers Epstein-Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies.
Infections
hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
Infections
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.
Infections
Human immunodeficiency virus type 1 infection requires reverse transcription of nascent viral RNA.
Infections
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes.
Infections
Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
Infections
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients.
Infections
Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression.
Infections
Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
Infections
Identification of hantavirus infection by Western blot assay and TaqMan PCR in patients hospitalized with acute kidney injury.
Infections
Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics.
Infections
Immortalization of Fetal Bovine Colon Epithelial Cells by Expression of Human Cyclin D1, Mutant Cyclin Dependent Kinase 4, and Telomerase Reverse Transcriptase: An In Vitro Model for Bacterial Infection.
Infections
Immune stimulatory and anti-HIV-1 potential of extracts derived from marine brown algae Padina tetrastromatica.
Infections
Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.
Infections
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Infections
Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Infections
Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients.
Infections
In vitro effect of some nucleoside reverse transcriptase inhibitors against HSV-1 replication.
Infections
In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
Infections
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.
Infections
Incidence and risk factors for Dengue virus (DENV) infection in the first 2 years of life in a Brazilian prospective birth cohort.
Infections
Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.
Infections
Increased in vitro glial fibrillary acidic protein expression, telomerase activity, and telomere length after productive human immunodeficiency virus-1 infection in murine astrocytes.
Infections
Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response.
Infections
Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro.
Infections
Influence of Piperine on the Pharmacokinetics of Nevirapine under Fasting Conditions : A Randomised, Crossover, Placebo-Controlled Study.
Infections
Inhibition of HIV-1 replication in human primary cells by a dolabellane diterpene isolated from the marine algae Dictyota pfaffii.
Infections
Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-?B axis during nasopharyngeal carcinoma development.
Infections
Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection - United States, 2009.
Infections
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Infections
Interactions between non-nucleoside reverse transcriptase inhibitor and nucleoside reverse transcriptase inhibitor mutations: phenotypes and mechanisms.
Infections
Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.
Infections
Intracellular pharmacokinetic study of zidovudine and its phosphorylated metabolites.
Infections
Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection.
Infections
Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity.
Infections
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
Infections
Isolation and characterization of human gastric cell lines with stem cell phenotypes.
Infections
La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.
Infections
Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis.
Infections
Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection.
Infections
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.
Infections
Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase.
Infections
Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation.
Infections
Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
Infections
Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV.
Infections
Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs.
Infections
Meteorological conditions and land cover as predictors for the prevalence of Bluetongue virus in the Inner Mongolia Autonomous Region of Mainland China.
Infections
Microbiome of the wasp Vespula pensylvanica in native and invasive populations, and associations with Moku virus.
Infections
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Infections
Minus-strand DNA is present within murine type C ecotropic retroviruses prior to infection.
Infections
Mirl is highly upregulated and localized to nuclei during infectious hyphal growth in the rice blast fungus.
Infections
Mitochondrial pathway of apoptosis and necrosis contribute to tenofovir disoproxil fumarate-induced renal damage in rats.
Infections
Mitochondrial T9098C sequence change in the MTATP6 gene and development of severe mitochondrial disease after in utero antiretroviral prophylaxis.
Infections
Mobile and accurate detection system for infection by the 2009 pandemic influenza A (H1N1) virus with a pocket-warmer reverse-transcriptase loop-mediated isothermal amplification.
Infections
Modulation of telomerase activity, bTERT and c-Myc induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin during Bovine Herpesvirus 1 infection in MDBK cells.
Infections
Molecular characterization and functional analysis of IL-12p40 from Chinese sea bass (Lateolabrax maculatus) under biotic and abiotic stresses.
Infections
Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection.
Infections
Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine.
Infections
Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.
Infections
Mutagenesis by human immunodeficiency virus reverse transcriptase: incorporation of O6-methyldeoxyguanosine triphosphate.
Infections
Mutational analysis of the "turn" of helix clamp motif of HIV-1 reverse transcriptase.
Infections
Mycobacterium tuberculosis Mce1 protein complex initiates rapid induction of transcription of genes involved in substrate trafficking.
Infections
Naringin improves zidovudine- and stavudine-induced skeletal muscle complications in rats.
Infections
Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro.
Infections
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.
Infections
Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection.
Infections
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.
Infections
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
Infections
Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection.
Infections
Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.
Infections
Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment.
Infections
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
Infections
Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.
Infections
Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Infections
Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Infections
Pandemic influenza A (H1N1) 2009: chest radiographic findings from 147 proven cases in the Montreal area.
Infections
Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Infections
Pathology and viral distribution in fatal Usutu virus infections of birds from the 2001 and 2002 outbreaks in Austria.
Infections
Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
Infections
Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina.
Infections
Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
Infections
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Infections
Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects.
Infections
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations.
Infections
Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
Infections
Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.
Infections
Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.
Infections
Possible involvement of loss of imprinting in immortalization of human fibroblasts.
Infections
Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout mice.
Infections
Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.
Infections
Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases.
Infections
Presence of HIV-1 reverse transcriptase inhibitory antibodies in the sera of some HTLV-1 carriers and absence of neutralizing antibodies against HIV-1 in the sera of HTLV-1 carriers.
Infections
Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea.
Infections
Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study.
Infections
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review.
Infections
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Infections
PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ?3 months to <6 years.
Infections
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
Infections
Properties of oncornavirus RNA-directed DNA polymerase, the RNA template, and the intracellular products formed early during infection and cell transformation.
Infections
Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens.
Infections
Purification and further characterization of an RNA-dependent DNA polymerase from the allantoic fluid of leukosis-virus-free chicken eggs.
Infections
Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
Infections
Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.
Infections
Raltegravir and Abacavir/Lamivudine in Japanese Treatment-Naïve and Treatment-Experienced Patients with HIV Infection: a 48-Week Retrospective Pilot Analysis.
Infections
Reactive aldehyde metabolites from the anti-HIV drug abacavir: amino acid adducts as possible factors in abacavir toxicity.
Infections
Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon.
Infections
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.
Infections
Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.
Infections
Relative assessment of different statistical instruments and measures for the prediction of promising outcomes using docking, virtual screening and ADMET analysis against HIV-RT.
Infections
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development.
Infections
Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.
Infections
Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells.
Infections
Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.
Infections
Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon Signaling.
Infections
Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
Infections
Reversible manipulation of telomerase expression and telomere length. Implications for the ionizing radiation response and replicative senescence of human cells.
Infections
Rickettsia parkeri colonization in Amblyomma maculatum: the role of superoxide dismutases.
Infections
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan.
Infections
Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.
Infections
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial.
Infections
Separation methods for nucleoside analogues used for treatment of HIV-1 infection.
Infections
Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
Infections
Severe skin rash with lamivudine in HIV infected patients: some unusual case reports.
Infections
siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma.
Infections
Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types.
Infections
Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management.
Infections
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.
Infections
Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.
Infections
Subcellular Localization of HIV-1 gag-pol mRNAs Regulates Sites of Virion Assembly.
Infections
Suppression of human immunodeficiency virus replication in human brain tissue by nucleoside reverse transcriptase inhibitors.
Infections
Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma.
Infections
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.
Infections
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Infections
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Infections
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Infections
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Infections
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
Infections
Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.
Infections
Telomerase activity of human peripheral blood mononuclear cells in the course of HTLV type 1 infection in vitro.
Infections
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1).
Infections
Telomerase protects adult rodent olfactory ensheathing glia from early senescence.
Infections
Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization.
Infections
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection.
Infections
Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections.
Infections
Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.
Infections
Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins.
Infections
Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells.
Infections
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro.
Infections
The combination of abundance and infection rates of Culicoides sonorensis estimates risk of subsequent bluetongue virus infection of sentinel cattle on California dairy farms.
Infections
The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.
Infections
The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.
Infections
The human immunodeficiency virus type 1 carboxyl-terminal third of capsid sequence in Gag-Pol is essential but not sufficient for efficient incorporation of Pr160(gag-pol) into virus particles.
Infections
The isoform-specific functions of the c-Jun N-terminal kinase (JNK) in a mouse model of antiretroviral-induced painful peripheral neuropathy.
Infections
The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
Infections
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Infections
The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
Infections
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
Infections
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Infections
The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.
Infections
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit.
Infections
The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.
Infections
Timing, Complications, and Safety of Tracheotomy in Critically Ill Patients With COVID-19.
Infections
TNF? is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats.
Infections
Tomographic score (RAD-Covid Score) to assess the clinical severity of the novel coronavirus infection.
Infections
Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.
Infections
Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Infections
Transmission dynamics of SARS-CoV-2 within families with children in Greece: A study of 23 clusters.
Infections
Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Infections
Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID mice.
Infections
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
Infections
Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials.
Infections
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.
Infections
Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.
Infections
Up-regulation of two Candida albicans genes in the rat model of oral candidiasis detected by differential display.
Infections
Upregulated miR-155 inhibits inflammatory response induced by C. albicans in human monocytes derived dendritic cells via targeting p65 and BCL-10.
Infections
Use of probes and amplification techniques for the diagnosis and prognosis of human immunodeficiency virus (HIV-1) infections.
Infections
Variable proteolytic cleavage of gag precursor expressed after infection of several cell lines with an HIV-2 gag-pol recombinant vaccinia virus.
Infections
Variations of telomerase activity in cultured mouse fibroblasts upon proliferation of polyomavirus.
Infections
Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2287: an animal model with implications for maternal-neonatal HIV transmission.
Infections
Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction.
Infections
Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenic E. coli in Mexico.
Infections
White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza.
Infections
Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium.
Infections
[Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen]
Infections
[Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]
Infections
[Detection and significance of HPV16, 18 infection, P53 overexpression and telomerase activity in patients with lung cancer]
Infections
[Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors]
Infections
[Expression of human immunodeficiency virus gag antigens and formation of virus-like particles in a cell culture, infected with recombinant vaccinia virus strains (an electron-microscopic study)]
Infections
[Functional changes of dendritic cells after infection by recombinant retrovirus carrying human telomerase reverse transcriptase gene fragment]
Infections
[Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells]
Infections
[Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri]
Infections
[Relationship between human papillomavirus 16 infection and the expression of p33(ING1b), human telomerase reverse transcriptase in cervical squamous cell carcinoma of Uygur female in Xinjiang Uygur Autonomous Region]
Infections
[Research on expression of human papillomavirus type 16 and telomerase in oral lesions]
Infections
[Significance of modern methods for laboratory detection of rabies agents and identification of the zoonose immunological survey].
Infections
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Infections
[Study on the correlation between the different papillomavirus type and telomerase in cervical cancer]
Infections
[Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasia and its correlation to classification of koilocytosis]
Infections
[Two patients with novel influenza A virus (H1N1) pneumonia treated with steroid therapy after an incorrect diagnosis of rapid progressive interstitial pneumonia due to the negative results of a rapid-antigen test].
Infertility
Does telomerase activity have an effect on infertility in patients with endometriosis?
Infertility
Does telomerase activity have an effect on infertility in patients with endometriosis? Methodological issues.
Infertility
Investigation of the role of serum telomerase levels in patients with occult primary ovarian insufficiency: a prospective cross-sectional study.
Infertility
Letter from original author re. Does telomerase activity have an effect on infertility in patients with endometriosis? Methodological issues.
Infertility
Mathematical model to study the aging of the human follicle according to the telomerase activity.
Infertility
Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton's Jelly, an Extraembryonic Source.
Infertility
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells.
Infertility
Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients.
Infertility, Female
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.
Infertility, Female
Telomere length and telomerase activity during folliculogenesis in mammals.
Infertility, Male
Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility.
Infertility, Male
TERT regulates telomere-related senescence and apoptosis through DNA damage response in male germ cells exposed to BPDE in vitro and to B[a]P in vivo.
Inflammatory Bowel Diseases
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
Inflammatory Bowel Diseases
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
Inflammatory Bowel Diseases
Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
Inflammatory Bowel Diseases
Strong telomerase activity of B lymphocyte from mesenteric lymph nodes of patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Ulcerative Typhlocolitis Associated With Helicobacter mastomyrinus in Telomerase-Deficient Mice.
Influenza in Birds
Avian influenza surveillance in hunter-harvested waterfowl from the Gulf Coast of Texas (November 2005-January 2006).
Influenza in Birds
Development of a multiplex real-time PCR assay using SYBR Green 1 chemistry for simultaneous detection and subtyping of H9N2 influenza virus type A.
Influenza in Birds
Proceedings Paper-Avian Diseases 10th AI Symposium Issue Development and Application of Real-Time PCR Assays for Specific Detection of Contemporary Avian Influenza Virus Subtypes N5, N6, N7, N8, and N9.
Influenza in Birds
Use of FTA sampling cards for molecular detection of avian influenza virus in wild birds.
Influenza, Human
2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
Influenza, Human
A Multiplex RT-PCR Assay for Detection and Differentiation of Avian-Origin Canine H3N2, Equine-Origin H3N8, Human-Origin H3N2, and H1N1/2009 Canine Influenza Viruses.
Influenza, Human
Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: a new disease entity?
Influenza, Human
Active surveillance for avian influenza virus infection in wild birds by analysis of avian fecal samples from the environment.
Influenza, Human
Amplification of the entire genome of influenza A virus H1N1 and H3N2 subtypes by reverse-transcription polymerase chain reaction.
Influenza, Human
An algorithm for mapping positively selected members of quasispecies-type viruses.
Influenza, Human
Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus.
Influenza, Human
Association of Human Metapneumovirus with Radiologically Diagnosed Community-Acquired Alveolar Pneumonia in Young Children.
Influenza, Human
Characterization of HeLa cells persistently infected with influenza virus B/Lee/40 with respect to telomerase activity and apoptosis.
Influenza, Human
Characterization of influenza virus among influenza like illness cases in Mumbai, India.
Influenza, Human
Clinical and Demographic Characteristics of Confirmed Cases in H1N1 (2009) Influenza.
Influenza, Human
Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: Experience from multiple tertiary paediatric centres in Turkey.
Influenza, Human
Clinical decision making in the emergency department setting using rapid PCR: Results of the CLADE study group.
Influenza, Human
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Influenza, Human
Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).
Influenza, Human
Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines- Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum-Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.
Influenza, Human
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Influenza, Human
Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.
Influenza, Human
Detection of highly pathogenic zoonotic influenza virus H5N6 by reverse-transcriptase quantitative polymerase chain reaction.
Influenza, Human
Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates.
Influenza, Human
Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques.
Influenza, Human
Development of anti-viral agents using molecular modeling and virtual screening techniques.
Influenza, Human
Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Influenza, Human
DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate.
Influenza, Human
Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.
Influenza, Human
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Influenza, Human
Effectiveness of influenza vaccination of schoolchildren in the city of São Paulo, Brazil, 2009.
Influenza, Human
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
Influenza, Human
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.
Influenza, Human
Epidemiology of Influenza in Fars Province, Southern Iran; a Population-Based Study (2015-2019).
Influenza, Human
Failure of routine diagnostic methods to detect influenza in hospitalized older adults.
Influenza, Human
Field performance of a rapid diagnostic test for influenza in an ambulatory setting.
Influenza, Human
First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea.
Influenza, Human
Free energy mapping of class I MHC molecules and structural determination of bound peptides.
Influenza, Human
Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Influenza, Human
Frozen Master Mix Modification of Commercial Reverse-transcriptase PCR for Detection of Influenza and Respiratory Syncytial Viruses.
Influenza, Human
Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics.
Influenza, Human
H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.
Influenza, Human
Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses.
Influenza, Human
In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses.
Influenza, Human
In-silico profiling of the biological activities of Amaryllidaceae alkaloids.
Influenza, Human
Incidence and Risk Factors of Pneumonia in Hospitalized Patients with Seasonal Influenza A or B.
Influenza, Human
Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia.
Influenza, Human
Mobile and accurate detection system for infection by the 2009 pandemic influenza A (H1N1) virus with a pocket-warmer reverse-transcriptase loop-mediated isothermal amplification.
Influenza, Human
Neurologic Manifestations of Novel Influenza A (H1N1) Virus Infection in Childhood.
Influenza, Human
One-Step Multiplex Reverse-Transcriptase PCR for Detecting Pandemic (H1N1) 2009 Influenza Virus.
Influenza, Human
Pandemic influenza A (H1N1) 2009: chest radiographic findings from 147 proven cases in the Montreal area.
Influenza, Human
Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
Influenza, Human
Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina.
Influenza, Human
Performance of a rapid influenza test in children during the H1N1 2009 influenza a outbreak.
Influenza, Human
Prevalence and distribution of avian influenza a(H5N1) virus clade variants in live bird markets of Vietnam, 2011-2013.
Influenza, Human
Reduction in the Incidence of Influenza A But Not Influenza B Associated With Use of Hand Sanitizer and Cough Hygiene in Schools: A Randomized Controlled Trial.
Influenza, Human
Relapse of minimal change disease following infection with the 2009 pandemic influenza (H1N1) virus.
Influenza, Human
Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness.
Influenza, Human
Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
Influenza, Human
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
Influenza, Human
Switching gears for an influenza pandemic: validation of a duplex RT-PCR for simultaneous detection and confirmation of pandemic (H1N1) 2009.
Influenza, Human
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx.
Influenza, Human
The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005.
Influenza, Human
The clinical usefulness of the SD Bioline Influenza Antigen Test® for detecting the 2009 influenza A (H1N1) virus.
Influenza, Human
The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study.
Influenza, Human
The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.
Influenza, Human
The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
Influenza, Human
Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.
Influenza, Human
White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza.
Influenza, Human
[A case of acute respiratory distress syndrome associated with pandemic influenza A (H1N1) pneumonia which was aggravated by the cessation of corticosteroid therapy].
Influenza, Human
[Case of novel influenza A (H1N1) pneumonia with shrinkage of a pulmonary lesion].
Influenza, Human
[Clinical features and outcome of 2009 H1N1 influenza in the pediatric setting. Multicenter prospective study in the ED.]
Influenza, Human
[Two patients with novel influenza A virus (H1N1) pneumonia treated with steroid therapy after an incorrect diagnosis of rapid progressive interstitial pneumonia due to the negative results of a rapid-antigen test].
Insulin Resistance
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Insulin Resistance
Brief Report: Insulin Resistance Is Affected by Increased Levels of Plasma Lactate but not Mitochondrial Alterations in Skeletal Muscle in NRTI-Exposed HIV-Infected Patients.
Insulin Resistance
Evaluation and management of dyslipidemia in patients with HIV infection.
Insulin Resistance
Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
Insulin Resistance
Improving Insulin Sensitivity via Activation of PPAR-{gamma} Increases Telomerase Activity in the Heart of OLETF rats.
Insulin Resistance
Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction.
Insulin Resistance
Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.
Insulin Resistance
Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Insulin Resistance
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?
Insulin Resistance
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Insulin Resistance
The Relationship between Vitamin D Status and HIV-Related Complications in HIV-infected Children and Young Adults.
Insulin Resistance
[Telomere biology and metabolic disorders: the role of insulin resistance and type 2 diabetes].
Insulinoma
Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy.
Intervertebral Disc Degeneration
Expression and significance of telomerase in the nucleus pulposus tissues of degenerative lumbar discs.
Intervertebral Disc Degeneration
Intervention of rAAV-hTERT-Transducted Nucleus Pulposus Cells in Early Stage of Intervertebral Disc Degeneration: A Study in Canine Model.
Iron Overload
Increased hepatic telomerase activity in a rat model of iron overload: a role for altered thiol redox state?
Ischemic Stroke
Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Joint Diseases
Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.
Keloid
Effects of hTERT antisense oligodeoxynucleotide on cell apoptosis and expression of hTERT and bcl-2 mRNA in keloid fibroblasts.
Keloid
Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA.
Keloid
PAX5 activates telomerase activity and proliferation in keloid fibroblasts by transcriptional regulation of SND1, thus promoting keloid growth in burn-injured skin.
Keloid
Wnt/?-Catenin Signaling Exacerbates Keloid Cell Proliferation by Regulating Telomerase.
Keratoacanthoma
Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Kidney Diseases
Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease.
Kidney Failure, Chronic
A retrospective evaluation of highly active antiretroviral therapy simplification in patients with end-stage renal disease receiving hemodialysis.
Kidney Failure, Chronic
Lack of seronegative hepatitis C virus infections in patients with chronic renal failure.
Kidney Failure, Chronic
Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients.
Kidney Failure, Chronic
[Telomerase activity of peripheral blood mononuclear cells in patients with acquired immune dysfunction]
Kidney Neoplasms
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Kidney Neoplasms
Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
Kidney Neoplasms
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.
Kidney Neoplasms
Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics.
Kidney Neoplasms
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Klinefelter Syndrome
Use of a highly sensitive quantitative telomerase assay in intracytoplasmic sperm injection programmes for the treatment of 47,XXY non-mosaic Klinefelter men.
Laryngeal Neoplasms
Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Laryngeal Neoplasms
Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
Laryngeal Neoplasms
Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
Laryngeal Neoplasms
microRNA?299?3p inhibits laryngeal cancer cell growth by targeting human telomerase reverse transcriptase mRNA.
Laryngeal Neoplasms
Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
Laryngeal Neoplasms
Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Laryngeal Neoplasms
Telomerase activity is upregulated in laryngeal squamous cell carcinoma.
Laryngeal Neoplasms
The Telomerase and Alternative Lengthening of Telomeres Mechanisms Regulate Laryngeal Cancer Cell Apoptosis via the PI3K/Akt Pathway.
Laryngeal Neoplasms
[Influence of RNA interference targeting against human telomerase reverse transcriptase on expression of C-myc protein]
Laryngeal Neoplasms
[Inhibition of growth and proliferation of Hep-2 cells by targeting human telomerase reverse transcriptase mRNA using RNA interference technology]
Laryngeal Neoplasms
[Telomerase activity and expression of its RNA component in laryngeal cancer]
Latent Infection
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Latent Infection
Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-?B axis during nasopharyngeal carcinoma development.
Latent Infection
Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
Lecithin Cholesterol Acyltransferase Deficiency
Lecithin: cholesterol acyltransferase deficiency: identification of two defective alleles in fibroblast cDNA.
Leiomyoma
Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics.
Leiomyoma
Karyotypic characteristics of human uterine leiomyoma and myometrial cell lines following telomerase induction.
Leiomyoma
Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
Leiomyoma
Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Leiomyoma
Telomerase expression abrogates rapamycin-induced irreversible growth arrest of uterine fibroid smooth muscle cells.
Leiomyosarcoma
Mandibular central leiomyosarcoma with high telomerase activity: a case report.
Leiomyosarcoma
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Leishmaniasis
Leishmania amazonensis: Partial purification and study of the biochemical properties of the telomerase reverse transcriptase activity from promastigote-stage.
Leishmaniasis
The putative Leishmania telomerase RNA (LeishTER) undergoes trans-splicing and contains a conserved template sequence.
Leukemia
23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells.
Leukemia
A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.
Leukemia
A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.
Leukemia
A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.
Leukemia
A host-guest approach for determining drug-DNA interactions: an example using netropsin.
Leukemia
A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes.
Leukemia
A non-radioactive assay system for screening for inhibitors of RNA-dependent reverse transcriptase activity; an analysis using aurintricarboxylic acid and plant flavonoids.
Leukemia
A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Leukemia
A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Leukemia
A novel ribonuclease with antiproliferative activity toward leukemia and lymphoma cells and HIV-1 reverse transcriptase inhibitory activity from the mushroom, Hohenbuehelia serotina.
Leukemia
A one-tube method of reverse transcription-PCR to efficiently amplify a 3-kilobase region from the RNA polymerase gene to the poly(A) tail of small round-structured viruses (Norwalk-like viruses).
Leukemia
A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Leukemia
A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells.
Leukemia
A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.
Leukemia
A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia.
Leukemia
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Leukemia
Activity of telomerase and extracellular regulated protein kinases in parental and drug resistant cells of leukemia and ovarian cancer.
Leukemia
Akt and PKC are involved not only in upregulation of telomerase activity but also in cell differentiation-related function via mTORC2 in leukemia cells.
Leukemia
Allosteric mechanism for translational repression in the Escherichia coli alpha operon.
Leukemia
Alterations in the response to erythropoietin and RNA-dependent DNA polymerase activity in mouse spleen cells infected with Friend leukemia virus.
Leukemia
Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation.
Leukemia
Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Leukemia
Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Leukemia
An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer.
Leukemia
An Inulin-Specific Lectin with Anti-HIV-1 Reverse Transcriptase, Antiproliferative, and Mitogenic Activities from the Edible Mushroom Agaricus bitorquis.
Leukemia
Analysis of Moloney murine leukemia virus revertants mutated at the gag-pol junction.
Leukemia
Analysis of plus-strand primer selection, removal, and reutilization by retroviral reverse transcriptases.
Leukemia
Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Leukemia
Analysis of the role of glutamine 190 in the catalytic mechanism of murine leukemia virus reverse transcriptase.
Leukemia
Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition.
Leukemia
Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.
Leukemia
Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
Leukemia
Apigenin decreases cell viability and telomerase activity in human leukemia cell lines.
Leukemia
Arm-specific cleavage and mutation during reverse transcription of 2?,5?-branched RNA by Moloney murine leukemia virus reverse transcriptase.
Leukemia
Association of murine leukemia virus pol with virions, independent of Gag-Pol expression.
Leukemia
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
Leukemia
Atypical protein-kinase Czeta, but neither conventional Ca2+ -dependent protein-kinase C isoenzymes nor Ca2+ -calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells.
Leukemia
Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: Plausible predictive and diagnostic markers.
Leukemia
Avian reticuloendotheliosis virus: characterization of genome structure by heteroduplex mapping.
Leukemia
Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase.
Leukemia
Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity.
Leukemia
beta-Lapachone (LAPA) Decreases Cell Viability and Telomerase Activity in Leukemia Cells: Suppression of Telomerase Activity by LAPA.
Leukemia
Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein.
Leukemia
Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
Leukemia
C-type RNA virus from hamster cells transformed in vitro by 1-B-D-arabinofuranosylcytosine.
Leukemia
Changes in telomerase activity and telomere length during human T lymphocyte senescence.
Leukemia
Characterization of an RNA-directed DNA polymerase found in association with murine intracytoplasmic A-particles.
Leukemia
Characterization of RNA strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase.
Leukemia
Characterization of Telomerase (hTERT) in Solid and Hematopoietic Cancer Cell Lines Reveals Different Expression Patterns.
Leukemia
Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation.
Leukemia
Chimeric alpha-beta oligonucleotides as antisense inhibitors of reverse transcription.
Leukemia
cis Acting RNA sequences control the gag-pol translation readthrough in murine leukemia virus.
Leukemia
Clinical significance of telomerase genes (hTERC and hTERT) amplification in patients with acute myeloid leukemia.
Leukemia
Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli.
Leukemia
Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes.
Leukemia
Coccinin, an antifungal peptide with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from large scarlet runner beans.
Leukemia
Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
Leukemia
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Leukemia
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Leukemia
Compounds that enhance the tailing activity of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents.
Leukemia
Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection.
Leukemia
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.
Leukemia
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
Leukemia
Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
Leukemia
Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT.
Leukemia
Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Leukemia
Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity.
Leukemia
Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.
Leukemia
Decreased Km to dNTPs is an essential M-MuLV reverse transcriptase adoption required to perform efficient cDNA synthesis in One-Step RT-PCR assay.
Leukemia
Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.
Leukemia
Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.
Leukemia
Detection of human immunodeficiency virus type 1 reverse transcriptase using aptamers as probes in affinity capillary electrophoresis.
Leukemia
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer: Results from Cancer and Leukemia Group B 159902.
Leukemia
Detection of naturally occurring antibodies to RNA-dependent DNA polymerase of murine leukemia virus in kidney eluates of AKR mice.
Leukemia
Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.
Leukemia
Development of a one tube-one step RT-PCR protocol for the detection of seven viroids in four genera: Apscaviroid, Hostuviroid, Pelamoviroid and Pospiviroid.
Leukemia
Development of a quantitative luminometric hybridization assay for the determination of telomerase activity.
Leukemia
Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
Leukemia
Diagnostic utility of a multiplex RT-PCR assay in detecting fusion transcripts from recurrent genetic abnormalities of acute leukemia by WHO 2008 classification.
Leukemia
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.
Leukemia
Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines.
Leukemia
Differential effects of Moloney murine leukemia virus reverse transcriptase mutations on RNase H activity in Mg2+ and Mn2+.
Leukemia
Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.
Leukemia
Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Leukemia
Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.
Leukemia
DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.
Leukemia
DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template in vitro.
Leukemia
Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.
Leukemia
Down-regulation of telomerase activity and activation of caspase-3 are responsible for tanshinone I-induced apoptosis in monocyte leukemia cells in vitro.
Leukemia
Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis.
Leukemia
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein.
Leukemia
Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
Leukemia
Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.
Leukemia
Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching.
Leukemia
Effect of antisense hTERT mRNA oligodeoxynucleotide on telomerase activity of leukemic cells.
Leukemia
Effect of ATP on the Friend Murine leukemia virus-associated endonuclease activity and the endonuclease activity of the avian myeloblastosis virus RNA-directed DNA polymerase.
Leukemia
Effect of ginseng saponin, arsenic trioxide, beta-elemene combined with CTX on telomere-telomerase system in K562 cell line.
Leukemia
Effect of UV Light on RNA-Directed DNA Polymerase Activity of Murine Oncornaviruses.
Leukemia
Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro.
Leukemia
Effects of geldanamycin and its derivatives on RNA-directed DNA polymerase and infectivity of Rauscher leukemia virus.
Leukemia
Effects of Manisa propolis on telomerase activity in leukemia cells obtained from the bone marrow of leukemia patients.
Leukemia
Effects of Poly(1-vinyluracil) and Poly(9-vinyladenine) on viral RNA-directed DNA polymerase.
Leukemia
Effects of streptovaricins and their degradation products on RNA-directed DNA polymerase of Rauscher leukemia virus.
Leukemia
Effects on DNA synthesis and translocation caused by mutations in the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Efficient marking of neural stem cell-derived neurons with a modified murine embryonic stem cell virus, MESV2.
Leukemia
Efficient N-tailing of blunt DNA ends by Moloney murine leukemia virus reverse transcriptase.
Leukemia
Endogenous Moloney leukemia virus in nonviremic Mov substrains of mice carries defects in the proviral genome.
Leukemia
Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells.
Leukemia
Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase for use in cDNA synthesis.
Leukemia
Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Leukemia
Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.
Leukemia
Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review).
Leukemia
Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors.
Leukemia
Escherichia coli DNA polymerase III epsilon subunit increases Moloney murine leukemia virus reverse transcriptase fidelity and accuracy of RT-PCR procedures.
Leukemia
Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity.
Leukemia
Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon.
Leukemia
Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities.
Leukemia
Expression in Escherichia coli of a Moloney murine leukemia virus reverse transcriptase whose structure closely resembles the viral enzyme.
Leukemia
Expression of moloney murine leukemia virus reverse transcriptase in a cell-free protein expression system.
Leukemia
Expression of Moloney murine leukemia virus RNase H rescues the growth defect of an Escherichia coli mutant.
Leukemia
Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing.
Leukemia
Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Leukemia
Free energy mapping of class I MHC molecules and structural determination of bound peptides.
Leukemia
Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.
Leukemia
Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.
Leukemia
Further increase in thermostability of Moloney murine leukemia virus reverse transcriptase by mutational combination.
Leukemia
Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants.
Leukemia
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Leukemia
Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Leukemia
Generation of thermostable Moloney murine leukemia virus reverse transcriptase variants using site saturation mutagenesis library and cell-free protein expression system.
Leukemia
Genetic encoding of DNA nanostructures and their self-assembly in living bacteria.
Leukemia
Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology.
Leukemia
Gln(84) of moloney murine leukemia virus reverse transcriptase regulates the incorporation rates of ribonucleotides and deoxyribonucleotides.
Leukemia
Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.
Leukemia
Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT.
Leukemia
H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.
Leukemia
Hematoporphyrin-sensitized photodynamic inactivation of viral RNA-dependent DNA polymerase.
Leukemia
High susceptibility of c-KIT(+)CD34 (+) precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model.
Leukemia
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.
Leukemia
Homoharringtonine-Induced Apoptosis of Human Leukemia HL-60 Cells is Associated with Down-Regulation of Telomerase.
Leukemia
Homologous recombination promoted by reverse transcriptase during copying of two distinct RNA templates.
Leukemia
hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Leukemia
Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro.
Leukemia
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells.
Leukemia
Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal.
Leukemia
Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells.
Leukemia
Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus.
Leukemia
Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening.
Leukemia
Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses.
Leukemia
Impact of gonadotropin supplementation on the expression of germ cell marker genes (MATER, ZAR1, GDF9, and BMP15) during in vitro maturation of buffalo (Bubalus bubalis) oocyte.
Leukemia
Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells.
Leukemia
Improvement of Moloney murine leukemia virus reverse transcriptase thermostability by introducing a disulfide bridge in the ribonuclease H region.
Leukemia
In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT.
Leukemia
In vitro anti-telomerase activity of novel lycopene-loaded nanospheres in the human leukemia cell line K562.
Leukemia
Inactivation of p16INK4a (inhibitor of cyclin-dependent kinase 4A) immortalizes primary human keratinocytes by maintaining cells in the stem cell compartment.
Leukemia
Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.
Leukemia
Increased thermostability and fidelity of DNA synthesis of wild-type and mutant HIV-1 group O reverse transcriptases.
Leukemia
Influence of various 2- and 2'-substituted polyadenylic acids on murine leukemia virus reverse transcriptase.
Leukemia
Influence on stability in Escherichia coli of the carboxy-terminal structure of cloned Moloney murine leukemia virus reverse transcriptase.
Leukemia
Inhibition of cyclooxygenase-2 and telomerase activities in human leukemia cells by dideoxypetrosynol A, a polyacetylene from the marine sponge Petrosia sp.
Leukemia
Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs.
Leukemia
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
Leukemia
Inhibition of Moloney murine leukemia virus reverse transcriptase activity by tetrahydroxyxanthones isolated from the Chinese herb, Tripterospermum lanceolatum (Hyata).
Leukemia
Inhibition of Moloney murine leukemia virus reverse transcriptase by alpha-anomeric oligonucleotides.
Leukemia
Inhibition of Moloney murine leukemia virus reverse transcriptase by partially 5-thiolated polyuridylic acid.
Leukemia
Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells.
Leukemia
Inhibition of RNA-directed DNA polymerase from Rauscher leukemia virus by the 5'-triphosphate of cytosine arabinoside.
Leukemia
Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells.
Leukemia
Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Leukemia
Inhibition of telomerase activity correlates with a decrease in the RNA component of telomerase during differentiation.
Leukemia
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
Leukemia
Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines.
Leukemia
Integrating retroviral cassette extends gene delivery of HSV-1 expression vectors to dividing cells.
Leukemia
Interchromosomal homology searches drive directional ALT telomere movement and synapsis.
Leukemia
Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
Leukemia
Interleukin-6, -8, and TGF-? Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/?-Catenin and P53 Pathways.
Leukemia
Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Leukemia
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison.
Leukemia
Ionophorous polymers. Interaction with polynucleotides and effects on RNA-directed DNA polymerase activity.
Leukemia
Isolation and characterization of a glucose/mannose-specific lectin with stimulatory effect on nitric oxide production by macrophages from the emperor banana.
Leukemia
Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.
Leukemia
JAK2 inhibition in JAK2V617F-bearing leukemia cells enriches CD34+ leukemic stem cells that are abolished by the telomerase inhibitor GRN163L.
Leukemia
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
Leukemia
Knockdown of hTERT Alters Biophysical Properties of K562 Cells Resulting in Decreased Migration Rate In Vitro.
Leukemia
Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells.
Leukemia
Label-Free Telomerase Activity Detection via Electrochemical Impedance Spectroscopy.
Leukemia
Lack of evidence for the involvement of type-C and type-B retroviruses in radiation leukemogenesis of NFS mice.
Leukemia
Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemia cells.
Leukemia
Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Leukemia
Localization of reverse-transcriptase in interferon-treated mouse cells chronically infected with Moloney leukemia virus.
Leukemia
Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts.
Leukemia
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.
Leukemia
Mechanism of action of Moloney murine leukemia virus RNA-directed DNA polymerase associated RNase H (RNase H I).
Leukemia
Mechanism of Human Telomerase Reverse Transcriptase (hTERT) Regulation and Clinical Impacts in Leukemia.
Leukemia
Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides.
Leukemia
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Mechanistic insights into the roles of three linked single-stranded template binding residues of MMLV reverse transcriptase in misincorporation and mispair extension fidelity of DNA synthesis.
Leukemia
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Leukemia
Model of inhibition of Thermus aquaticus polymerase and Moloney murine leukemia virus reverse transcriptase by tea polyphenols (+)-catechin and (-)-epigallocatechin-3-gallate.
Leukemia
Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR.
Leukemia
Modulation of stop codon read-through efficiency and its effect on the replication of murine leukemia virus.
Leukemia
Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Leukemia
Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats.
Leukemia
Moloney murine leukemia virus protease expressed in bacteria is enzymatically active.
Leukemia
Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
Leukemia
MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-?B pathway.
Leukemia
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.
Leukemia
Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon.
Leukemia
Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.
Leukemia
Murine sarcoma virus defectiveness. Viral polymerase expression in murine and nonmurine host cells transformed by S + L - type murine sarcoma virus.
Leukemia
Musa acuminata (Del Monte banana) lectin is a fructose-binding lectin with cytokine-inducing activity.
Leukemia
Mutant of Moloney murine leukemia virus reverse transcriptase exhibits higher resistance to common RT-qPCR inhibitors.
Leukemia
Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Leukemia
Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.
Leukemia
Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.
Leukemia
Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Leukemia
Natural UAG suppressor glutamine tRNA is elevated in mouse cells infected with Moloney murine leukemia virus.
Leukemia
Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.
Leukemia
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.
Leukemia
Novel mutations in Moloney Murine Leukemia Virus reverse transcriptase increase thermostability through tighter binding to template-primer.
Leukemia
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
Leukemia
Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
Leukemia
Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.
Leukemia
Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses.
Leukemia
Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B?cell lymphoma cells.
Leukemia
Overexpression of MiR-138 Inhibits Cell Growth and Induces Caspase-mediated Apoptosis in Acute Promyelocytic Leukemia Cell Line.
Leukemia
Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies.
Leukemia
Patensin-induced apoptosis is accompanied by decreased bcl-2 expression and telomerase activity in HL-60 cells.
Leukemia
Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation.
Leukemia
Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Leukemia
Phaseococcin, an antifungal protein with antiproliferative and anti-HIV-1 reverse transcriptase activities from small scarlet runner beans.
Leukemia
Photoaffinity labeling of the primer binding domain in murine leukemia virus reverse transcriptase.
Leukemia
Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells.
Leukemia
Podoscyphic acid, a new inhibitor of avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptase from a Podoscypha species.
Leukemia
Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua.
Leukemia
Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled.
Leukemia
Polypurine tract primer generation and utilization by Moloney murine leukemia virus reverse transcriptase.
Leukemia
Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy.
Leukemia
Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.
Leukemia
Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Preparation of RNA-directed DNA polymerase from spleens of Balb-c mice infected with Rauscher leukemia virus.
Leukemia
Proceedings: Inhibition of mouse leukemia virus RNA-dependent DNA polymerase by 2'-OH-substituted polynucleotides.
Leukemia
Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications.
Leukemia
Purification and Characterization of a Laccase with Inhibitory Activity toward HIV-1 Reverse Transcriptase and Tumor Cells from an Edible Mushroom (Pleurotus cornucopiae).
Leukemia
Purification and properties of Rauscher leukemia virus DNA polymerase and selective inhibition of mammalian viral reverse transcriptase by inorganic phosphate.
Leukemia
Purification of a trypsin-stable lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activity.
Leukemia
Purification of M-MLVH- RT on a 9-aminoethyladenine-(1,6-diamine-hexane)-triazine selected from a combinatorial library of dNTP-mimetic ligands.
Leukemia
Purification of RNA-directed DNA polymerase from mouse spleen infected with Rauscher leukemia virus.
Leukemia
Purification of RNA-directed DNA polymerase from spleens of BALB/C mice infected with Rauscher leukemia virus [proceedings]
Leukemia
Quick and Easy Assembly of a One-Step qRT-PCR Kit for COVID-19 Diagnostics Using In-House Enzymes.
Leukemia
Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.
Leukemia
Recombination during reverse transcription: an evaluation of the role of the nucleocapsid protein.
Leukemia
Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.
Leukemia
Reduction of transforming growth factor-?1 expression in leukemia its possible role in leukemia development.
Leukemia
Regulation of an H-ras-related transcript by parathyroid hormone in rat osteosarcoma cells.
Leukemia
Regulation of telomerase activity in camptothecin-induced apoptosis of human leukemia HL-60 cells.
Leukemia
Relationship between B-Cell-specific moloney murine leukemia virus integration site 1 (BMI-1) and homologous recombination regulatory genes in invasive ductal breast carcinomas.
Leukemia
Replacement of murine leukemia virus readthrough mechanism by human immunodeficiency virus frameshift allows synthesis of viral proteins and virus replication.
Leukemia
Resolution and characterization of intracytoplasmic forms of reverse transcriptase from Rauscher leukemia virus-producing cells.
Leukemia
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Leukemia
Retroviral reverse transcriptase inhibitory activity in Thai herbs and spices: screening with Moloney murine leukemia viral enzyme.
Leukemia
Reverse Transcriptase (EC 2.7.7.49) : The Use of Cloned Maloney Murine Leukemia Virus Reverse Transcriptase to Synthesize DNA from RNA.
Leukemia
Reverse transcriptase of Moloney murine leukemia virus binds to eukaryotic release factor 1 to modulate suppression of translational termination.
Leukemia
Reverse transcriptase. The use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA.
Leukemia
Reverse transcription of a naturally occurring nonretroviral RNA produces a precise deletion in the majority of its cDNA products.
Leukemia
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.
Leukemia
Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity.
Leukemia
Ribosomal frameshifting at the Gag-Pol junction in avian leukemia sarcoma virus forms a novel cleavage site.
Leukemia
Ribosomal protein S15 from Escherichia coli modulates its own translation by trapping the ribosome on the mRNA initiation loading site.
Leukemia
RNA degradation and primer selection by Moloney murine leukemia virus reverse transcriptase contribute to the accuracy of plus strand initiation.
Leukemia
RNA-dependent DNA polymerase activity in ocular granulocytic sarcoma associated to acute myelomonocytic leukemia in Turkish children. Biochemical and immunological characterization of the enzyme.
Leukemia
RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Leukemia
RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity.
Leukemia
Role of divalent ion complex formation in pyran--inhibition of nucleic acid biosynthesis.
Leukemia
Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Leukemia
Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Leukemia
Rt-PCR method for diagnosis and follow-up of hematological malignancies: first approach in Bangladesh.
Leukemia
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
Leukemia
Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain.
Leukemia
Secondary structure in the 3' UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR.
Leukemia
Selection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity.
Leukemia
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
Leukemia
Selective inactivation of M-MuLV RT RNase H activity by site-directed PEGylation: an improved ability to synthesize long cDNA molecules.
Leukemia
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Leukemia
Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Leukemia
Separation of cellular and viral DNA polymerases by affinity chromatography on polynucleotide-Sepharose.
Leukemia
Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Leukemia
Simultaneous purification of RNA-dependent DNA polymerase and gs-antigen from Rauscher leukemia virus.
Leukemia
Site-directed mutagenesis of Moloney murine leukemia virus reverse transcriptase. Demonstration of lysine 103 in the nucleotide binding site.
Leukemia
Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.
Leukemia
Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis
Leukemia
Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis.
Leukemia
Stabilization of Moloney murine leukemia virus reverse transcriptase by site-directed mutagenesis of surface residue Val433.
Leukemia
Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts.
Leukemia
Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Structural and energetic characterization of nucleic acid-binding to the fingers domain of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase.
Leukemia
Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus.
Leukemia
Structural studies of the RNA pseudoknot required for readthrough of the gag-termination codon of murine leukemia virus.
Leukemia
Structure of a pseudo-16-mer DNA with stacked guanines and two G-A mispairs complexed with the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase.
Leukemia
Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virus.
Leukemia
Structure-based moloney murine leukemia virus reverse transcriptase mutants with altered intracellular direct-repeat deletion frequencies.
Leukemia
Studies on the inhibition of Moloney murine leukemia virus reverse transcriptase by N-tritylamino acids and N-tritylamino acid-nucleotide compounds.
Leukemia
Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Leukemia
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.
Leukemia
Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
Leukemia
Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
Leukemia
Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Leukemia
Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
Leukemia
Synthesis of DNA by human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(deoxyadenosine) tracts.
Leukemia
Synthesis, spectroscopic studies and biological activity of a novel nucleopeptide with Moloney murine leukemia virus reverse transcriptase inhibitory activity.
Leukemia
Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells.
Leukemia
Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias.
Leukemia
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Leukemia
Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Leukemia
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival.
Leukemia
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Leukemia
Telomerase activity in peripheral blood mononuclear cells after whole body irradiation.
Leukemia
Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Leukemia
Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues.
Leukemia
Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation.
Leukemia
Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect.
Leukemia
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.
Leukemia
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
Leukemia
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Leukemia
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
Leukemia
Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors.
Leukemia
Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
Leukemia
Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Leukemia
Telomere length and telomerase activity: variations with advancing age and potential role in childhood malignancies.
Leukemia
Template activity of poly(2'-fluoro-2'-deoxyinosinic acid) for murine leukemia virus reverse transcriptase.
Leukemia
Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro.
Leukemia
The ability of a variety of polymerases to synthesize past site-specific cis-syn, trans-syn-II, (6-4), and Dewar photoproducts of thymidylyl-(3'-->5')-thymidine.
Leukemia
The basic loop of the RNase H domain of MLV RT is important both for RNase H and for polymerase activity.
Leukemia
The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
Leukemia
The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression.
Leukemia
The effect of silymarin on telomerase activity in the human leukemia cell line K562.
Leukemia
The expression levels of telomerase catalytic subunit hTERT and oncogenic MYC in essential thrombocythemia are affected by the molecular subtype.
Leukemia
The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
Leukemia
The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
Leukemia
The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.
Leukemia
The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease.
Leukemia
The role of Moloney murine leukemia virus RNase H activity in the formation of plus-strand primers.
Leukemia
The structure of an authentic spore photoproduct lesion in DNA suggests a basis for recognition.
Leukemia
The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Leukemia
Threshold number of provirus copies required per cell for efficient virus production and interference in moloney murine leukemia virus-infected NIH 3T3 cells.
Leukemia
Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.
Leukemia
Transduction of Schistosoma japonicum schistosomules with vesicular stomatitis virus glycoprotein pseudotyped murine leukemia retrovirus and expression of reporter human telomerase reverse transcriptase in the transgenic schistosomes.
Leukemia
Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Leukemia
Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA.
Leukemia
Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase.
Leukemia
Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus.
Leukemia
Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates.
Leukemia
Use of an N-terminal fragment from moloney murine leukemia virus reverse transcriptase to facilitate crystallization and analysis of a pseudo-16-mer DNA molecule containing G-A mispairs.
Leukemia
Valine of the YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the fidelity of DNA synthesis.
Leukemia
Varied Molecular Interactions at the Active Sites of Several DNA Polymerases: Nonpolar Nucleoside Isosteres as Probes.
Leukemia
Viral reverse transcriptase suppression associated with erythroid differentiation of Friend leukemia cells.
Leukemia
Viral RNA in middle ear mucosa and exudates in patients with chronic otitis media with effusion.
Leukemia
VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
Leukemia
Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells.
Leukemia
WT1 contributes to leukemogenesis: expression patterns in 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.
Leukemia
YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
Leukemia
[A quantitative assay for telomerase activity in peripheral blood mononuclear cells from patients with acute leukemia]
Leukemia
[Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells]
Leukemia
[Analysis of molecular mechanism involved in development of acute myeloid leukemia].
Leukemia
[Antisense hTERT inhibits gene expression and functional activity of telomerase in leukemia cell lines.]
Leukemia
[Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro]
Leukemia
[Construction of a cDNA library from liver tissue of rhesus monkey, Macaca mulatta]
Leukemia
[DNA topoisomerase and telomerase activity with relation to multi-drug resistance in leukemia--review]
Leukemia
[Effect of human telomerase reverse transcriptase gene antisense oligodeoxynucleotide on telomerase activity in leukemia cells]
Leukemia
[Effects of arsenic trioxide, ginseng saponin and beta-elemene on telomere-telomerase system in K562 cell line]
Leukemia
[Effects of AZT on leukemia cell line KG-1a proliferation and telomerase activity].
Leukemia
[Effects of Sodium Nitroprusside on P38MAPK/STAT3 Activation and Telomerase Reverse Transcriptase mRNA Expression in Inducing Apoptosis of K562 Cell Line.]
Leukemia
[Expression level of TRF1 protein in human acute leukemia and its relationship with activity of telomerase]
Leukemia
[Expression of human telomere repeat binding factor 1 (TRF1) in acute leukemia cells and its correlation with telomerase activities]
Leukemia
[Expressions of B-cell-specific monoclonal leukemia virus insert site 1 and human telomerase reverse transcriptase genes in CD34+ cells during ex vivo expansion process].
Leukemia
[Immunologic aspects of preparation of antiserum to the reverse transcriptase from avian myeloblastosis virus]
Leukemia
[Inhibiting effect of arsenic trioxide on telomerase activity of NB4 and Jurkat cell lines]
Leukemia
[Inhibition Effect of Diimide G-quadruplex Ligand on Proliferation of Leukemia Cells and Its Molecular Mechanisms.]
Leukemia
[Localization of RNA-dependent DNA polymerase in rat thymus cells infected with moloney leukemia virus]
Leukemia
[Plasmid-Mediated RNAi Targeting hTERT Inhibits Telomerase Activity in K562 Cell Line.]
Leukemia
[Preliminary analysis on human telomerase reverse transcriptase gene expression in acute leukemia]
Leukemia
[Prokaryotic expression and purification of moloney murine leukemia virus reverse transcriptase and verification of the activity]
Leukemia
[Relationship among telomerase activity, expression of human telomerase reverse transcriptase (hTERT), and expression of c-myc in acute leukemia]
Leukemia
[Study of Telomerase Activity in Bone Marrow Cells from Patients with Myelodysplastic Syndromes]
Leukemia
[The Effect and Mechanism of Novel Telomerase Inhibitor Nilo 22 on Leukemia Cells].
Leukemia
[The expression of human telomerase reverse transcriptase mRNA and its significance in acute leukemia]
Leukemia
[The relationship between telomerase activity and cell cyele in acute leukemia cells]
Leukemia
[To inhibit ERK for enhancing chemotherapy sensitivity of drug-resistance cell lines of leukemia and ovarian carcinoma]
Leukemia, B-Cell
CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Leukemia, B-Cell
Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells.
Leukemia, B-Cell
Evaluation of telomerase activity in patients with chronic B lymphocytic leukemia versus age matched controls. Correlation between telomerase activity and bone marrow infiltration.
Leukemia, Erythroblastic, Acute
Knockdown of hTERT Alters Biophysical Properties of K562 Cells Resulting in Decreased Migration Rate In Vitro.
Leukemia, Erythroblastic, Acute
The over-expression of aquaporin-1 alters erythroid gene expression in human erythroleukemia K562 cells.
Leukemia, Erythroblastic, Acute
Viral reverse transcriptase suppression associated with erythroid differentiation of Friend leukemia cells.
Leukemia, Feline
Molecular analysis of several classes of endogenous feline leukemia virus elements.
Leukemia, Feline
Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.
Leukemia, Feline
Nucleotide sequence of the gag gene and gag-pol junction of feline leukemia virus.
Leukemia, Lymphocytic, Chronic, B-Cell
CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
Leukemia, Lymphocytic, Chronic, B-Cell
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Leukemia, Lymphocytic, Chronic, B-Cell
Evaluation of telomerase activity in patients with chronic B lymphocytic leukemia versus age matched controls. Correlation between telomerase activity and bone marrow infiltration.
Leukemia, Lymphocytic, Chronic, B-Cell
Purification of RNA-instructed DNA polymerase from human leukemic spleens.
Leukemia, Lymphocytic, Chronic, B-Cell
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
Leukemia, Lymphocytic, Chronic, B-Cell
The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
Leukemia, Lymphocytic, Chronic, B-Cell
[Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia]
Leukemia, Lymphoid
Over-expression of the functional interleukin-11 alpha receptor in the development of B-cell chronic lymphocytic leukemia.
Leukemia, Lymphoid
Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Combined RT-PCR and metaphase-FISH posttransplant studies in pediatric patients with chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Erratum to: Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Functional genomics of hTERT gene in leukemic myelopoiesis.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interleukin-6, -8, and TGF-? Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/?-Catenin and P53 Pathways.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Real-time quantitative RT-PCR for human telomere elongation reverse transcriptase in chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Telomerase activity in myelodysplastic syndromes.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Telomerase: obviously activated in the accelerated phase of chronic myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Change of telomerase activity in bone marrow cells from chronic myeloid leukemia patients in different phases]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Effect of human telomerase reverse transcriptase gene antisense oligodeoxynucleotide on telomerase activity in leukemia cells]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
[Real-time reverse-transcriptase polymerase chain reaction in monitoring BCR/ABL transcript levels in chronic myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation]
Leukemia, Myeloid
A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Leukemia, Myeloid
Analysis of synthetic RNA-directed DNA polymerase activities in the spleen of a rat with myelogenous leukemia induced by N-nitroso-N-butylurea.
Leukemia, Myeloid
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Leukemia, Myeloid
Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.
Leukemia, Myeloid
Induced apoptosis by mild hyperthermia occurs via telomerase inhibition on the three human myeloid leukemia cell lines: TF-1, K562, and HL-60.
Leukemia, Myeloid
Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
Leukemia, Myeloid
Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Leukemia, Myeloid
Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.
Leukemia, Myeloid
[Study on the expression of tankyrase in malignant hematopoietic cells and its relation with telomerase activity]
Leukemia, Myeloid, Acute
A spectrum of severe familial liver disorders associate with telomerase mutations.
Leukemia, Myeloid, Acute
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Leukemia, Myeloid, Acute
APRIL gene expression in a cohort of Egyptian acute myeloid leukemia patients: Clinical and prognostic significance.
Leukemia, Myeloid, Acute
Association between TERT gene polymorphisms and acute myeloid leukemia susceptibility in a Chinese population: a case-control study.
Leukemia, Myeloid, Acute
Biological and clinical implications of telomere dysfunction in myeloid malignancies.
Leukemia, Myeloid, Acute
Clinical implications of telomerase activity levels in acute leukemia.
Leukemia, Myeloid, Acute
Clinical significance of telomerase genes (hTERC and hTERT) amplification in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Leukemia, Myeloid, Acute
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.
Leukemia, Myeloid, Acute
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia.
Leukemia, Myeloid, Acute
Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Leukemia, Myeloid, Acute
Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.
Leukemia, Myeloid, Acute
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Leukemia, Myeloid, Acute
Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor expression by acute myeloid leukemia cells.
Leukemia, Myeloid, Acute
Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia.
Leukemia, Myeloid, Acute
Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.
Leukemia, Myeloid, Acute
Molecular cytogenetics and multiplex reverse-transcriptase polymerase chain reaction for risk stratification in acute myeloid leukemia.
Leukemia, Myeloid, Acute
Multistep regulation of telomerase during differentiation of HL60 cells.
Leukemia, Myeloid, Acute
MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.
Leukemia, Myeloid, Acute
RETRACTED: Heterogeneous promoter activity of the telomerase reverse transcriptase gene in individual acute myeloid leukemia cells defined by lentiviral reporter assay.
Leukemia, Myeloid, Acute
Retraction. Heterogeneous promoter activity of the telomerase reverse transcriptase gene in individual acute myeloid leukemia cells defined by lentiviral reporter assay.
Leukemia, Myeloid, Acute
Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Leukemia, Myeloid, Acute
Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Leukemia, Myeloid, Acute
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4.
Leukemia, Myeloid, Acute
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.
Leukemia, Myeloid, Acute
Telomerase activity in normal leukocytes and in hematologic malignancies.
Leukemia, Myeloid, Acute
Telomerase activity in preleukemia and acute myelogenous leukemia.
Leukemia, Myeloid, Acute
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Leukemia, Myeloid, Acute
Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues.
Leukemia, Myeloid, Acute
Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Telomerase in Acute Myeloid Leukemia: A Molecular Update on Diagnosis, Prognosis, and Treatment.
Leukemia, Myeloid, Acute
Telomerase is limiting the growth of acute myeloid leukemia cells.
Leukemia, Myeloid, Acute
Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).
Leukemia, Myeloid, Acute
Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.
Leukemia, Myeloid, Acute
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
Leukemia, Myeloid, Acute
[Analysis of molecular mechanism involved in development of acute myeloid leukemia].
Leukemia, Myeloid, Acute
[Analysis of telomerase activity and telomere length in acute myelogenous leukemia]
Leukemia, Myeloid, Acute
[Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells]
Leukemia, Myeloid, Acute
[Effect of human telomerase reverse transcriptase gene antisense oligodeoxynucleotide on telomerase activity in leukemia cells]
Leukemia, Myeloid, Acute
[Effects of AZT on leukemia cell line KG-1a proliferation and telomerase activity].
Leukemia, Myeloid, Acute
[Expression of human telomere repeat binding factor 1 (TRF1) in acute leukemia cells and its correlation with telomerase activities]
Leukemia, Myelomonocytic, Acute
RNA-dependent DNA polymerase activity in ocular granulocytic sarcoma associated to acute myelomonocytic leukemia in Turkish children. Biochemical and immunological characterization of the enzyme.
Leukemia, Plasma Cell
Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Leukemia, Prolymphocytic, T-Cell
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.
Leukemia, Promyelocytic, Acute
A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Leukemia, Promyelocytic, Acute
Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Leukemia, Promyelocytic, Acute
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
Leukemia, Promyelocytic, Acute
Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.
Leukemia, Promyelocytic, Acute
Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Leukemia, Promyelocytic, Acute
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Leukemia, Promyelocytic, Acute
MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-?B pathway.
Leukemia, Promyelocytic, Acute
Overexpression of MiR-138 Inhibits Cell Growth and Induces Caspase-mediated Apoptosis in Acute Promyelocytic Leukemia Cell Line.
Leukemia, Promyelocytic, Acute
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Leukemia, Promyelocytic, Acute
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival.
Leukemia, Promyelocytic, Acute
Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
Leukemia, Promyelocytic, Acute
The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
Leukemia, T-Cell
Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition.
Leukemia, T-Cell
Free energy mapping of class I MHC molecules and structural determination of bound peptides.
Leukemia, T-Cell
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells.
Leukemia, T-Cell
Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure.
Leukemia, T-Cell
Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses.
Leukemia, T-Cell
Label-Free Telomerase Activity Detection via Electrochemical Impedance Spectroscopy.
Leukemia, T-Cell
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
Leukemia, T-Cell
Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-I).
Leukemia, T-Cell
Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells.
Leukemia, T-Cell
Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
Leukemia, T-Cell
Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
Leukemia, T-Cell
Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.
Leukemia, T-Cell
The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation.
Leukemia, T-Cell
Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses.
Leukemia, T-Cell
[Study on the expression of tankyrase in malignant hematopoietic cells and its relation with telomerase activity]
Leukemia-Lymphoma, Adult T-Cell
Correlation of telomerase activity with development and progression of adult T-cell leukemia.
Leukemia-Lymphoma, Adult T-Cell
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
Leukemia-Lymphoma, Adult T-Cell
HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
Leukemia-Lymphoma, Adult T-Cell
Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Leukemia-Lymphoma, Adult T-Cell
Pathogenesis and treatment of human T-cell leukemia virus infection.
Leukemia-Lymphoma, Adult T-Cell
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
Leukemia-Lymphoma, Adult T-Cell
Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries.
Leukemia-Lymphoma, Adult T-Cell
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Leukemia-Lymphoma, Adult T-Cell
Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.
Leukoencephalopathies
Changing patterns in the neuropathogenesis of HIV during the HAART era.
Leukoencephalopathy, Progressive Multifocal
Changing patterns in the neuropathogenesis of HIV during the HAART era.
Leukoplakia
Diffuse Mesangial Sclerosis in a Child With Dyskeratosis Congenita Leading to End-stage Renal Disease.
Leukoplakia
Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge.
Leukoplakia
Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Leukoplakia
Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Leukoplakia, Oral
Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Leukoplakia, Oral
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Leukoplakia, Oral
Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Li-Fraumeni Syndrome
Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.
Li-Fraumeni Syndrome
Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization.
Lichen Planus, Oral
hTR RNA Component as a Marker of Cellular Proliferation in Oral Lichen Planus.
Lichen Planus, Oral
Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.
Lipodystrophy
A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy.
Lipodystrophy
Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Lipodystrophy
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Lipodystrophy
Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
Lipodystrophy
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
Lipodystrophy
Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
Lipodystrophy
Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
Lipodystrophy
Different origin of adipogenic stem cells influences the response to antiretroviral drugs.
Lipodystrophy
Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.
Lipodystrophy
Effects of antiretroviral drug combinations on the differentiation of adipocytes.
Lipodystrophy
Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients.
Lipodystrophy
Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.
Lipodystrophy
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Lipodystrophy
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
Lipodystrophy
Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.
Lipodystrophy
Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors.
Lipodystrophy
Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.
Lipodystrophy
Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
Lipodystrophy
Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.
Lipodystrophy
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?
Lipodystrophy
Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
Lipodystrophy
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Lipodystrophy
Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy.
Lipodystrophy
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.
Lipodystrophy
The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Lipoma
Primary retroperitoneal lipoma: a soft tissue pathology heresy?: report of a case with classic histologic, cytogenetics, and molecular genetic features.
Lipomatosis
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Lipomatosis, Multiple Symmetrical
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Liposarcoma
A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT.
Liposarcoma
Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
Liposarcoma
Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Liposarcoma
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Liposarcoma
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma.
Liposarcoma
High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.
Liposarcoma
Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
Liposarcoma, Myxoid
Analysis of human telomerase reverse transcriptase mRNA (hTERT) expression in myxoid liposarcomas using LightCycler real-time quantitative reverse transcriptase-polymerase chain reaction.
Liposarcoma, Myxoid
High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.
Liposarcoma, Myxoid
Myxoid liposarcoma with transition to round-cell lesion-cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report.
Liver Cirrhosis
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Liver Cirrhosis
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.
Liver Cirrhosis
Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
Liver Cirrhosis
Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.
Liver Cirrhosis
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
Liver Cirrhosis
Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Liver Cirrhosis
Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma.
Liver Cirrhosis
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Liver Cirrhosis
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Liver Cirrhosis
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
Liver Cirrhosis
Transforming growth factor-?1 regulates the telomerase reverse transcriptase in rat hepatic stellate cells.
Liver Cirrhosis
Understanding telomere diseases through analysis of patient-derived iPS cells.
Liver Cirrhosis
[Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis]
Liver Cirrhosis
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Liver Cirrhosis, Biliary
T-cell receptor Vbeta gene utilization in primary biliary cirrhosis.
Liver Cirrhosis, Experimental
Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.
Liver Diseases
A spectrum of severe familial liver disorders associate with telomerase mutations.
Liver Diseases
Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Liver Diseases
Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.
Liver Diseases
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Liver Diseases
Determinants of Elevated Alkaline Phosphatase in Patients Infected with HIV.
Liver Diseases
Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.
Liver Diseases
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
Liver Diseases
Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
Liver Diseases
Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient.
Liver Diseases
Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection.
Liver Diseases
Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
Liver Diseases
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.
Liver Diseases
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Liver Diseases
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors.
Liver Diseases
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
Liver Diseases
Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Liver Diseases
Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis.
Liver Diseases
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Liver Diseases
Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Liver Diseases
Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Liver Diseases
Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.
Liver Diseases
Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
Liver Diseases
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.
Liver Diseases
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Liver Diseases
Telomerase activity in peripheral blood mononuclear cells as a universal scale for quantitative measurement of telomerase activation on the example of liver diseases.
Liver Diseases
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Liver Diseases
Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
Liver Diseases
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Liver Diseases
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Liver Diseases
Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
Liver Diseases
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?
Liver Diseases
Telomere Dysfunction Activates p53 and Represses HNF4? Expression Leading to Impaired Human Hepatocyte Development and Function.
Liver Diseases
[Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)]
Liver Diseases
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Liver Diseases, Alcoholic
Telomerase reverse transcriptase acts in a feedback loop with NF-?B pathway to regulate macrophage polarization in alcoholic liver disease.
Liver Failure
Detection of telomerase reverse transcriptase mRNA in peripheral blood mononuclear cells of patients with liver failure.
Liver Failure
High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Liver Failure, Acute
Establishment and characterization of immortalized porcine hepatocytes for the study of hepatocyte xenotransplantation.
Liver Neoplasms
A CRISPR-driven colorimetric code platform for highly accurate telomerase activity assay.
Liver Neoplasms
A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway.
Liver Neoplasms
A scalable and reproducible preparation for the antitumor protein TLC, a human-derived telomerase inhibitor.
Liver Neoplasms
A stable trypsin inhibitor from Chinese dull black soybeans with potentially exploitable activities.
Liver Neoplasms
Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice.
Liver Neoplasms
Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression.
Liver Neoplasms
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells.
Liver Neoplasms
Combination of HSV1-TK/shTERT by retrovirus vector inhibits hepatocellular carcinoma cell growth in vitro and in vivo.
Liver Neoplasms
Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Liver Neoplasms
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Liver Neoplasms
HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
Liver Neoplasms
Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically.
Liver Neoplasms
Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Liver Neoplasms
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
Liver Neoplasms
Sinusoidal swinging dynamics of the telomere repair and cell growth activation functions of telomerase in rat liver cancer cells.
Liver Neoplasms
Stabilizing G-quadruplex DNA by a scissors-shaped binaphthyl derivative through the entangling mode: cooperation of binaphthylene and the ethoxy chain.
Liver Neoplasms
Telomerase activity (TMA) in tumour and peritumoural tissues in a rat liver cancer model.
Liver Neoplasms
Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Liver Neoplasms
Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer.
Liver Neoplasms
The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
Liver Neoplasms
The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells.
Liver Neoplasms
[Circadian rhythms of DNA synthesis and telomerase expression in hepatic cancer transplanted in nude mice]
Liver Neoplasms
[Effects of tea polyphenols and tea pigments on telomerase activity of HepG2 cells]
Liver Neoplasms
[Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells]
Liver Neoplasms
[Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer]
Liver Neoplasms
[Reversing malignant phenotypes of liver cancer cell lines with antisense gene to human telomerase reverse transcriptase]
Liver Neoplasms
[TELOMERASE ACTIVITY AS A POTENTIAL BIOMARKER FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF CYSTIC NEOPLASMS OF THE LIVER].
Lung Abscess
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Lung Diseases
A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer.
Lung Diseases
Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.
Lung Diseases
Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.
Lung Diseases
hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer.
Lung Diseases
hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms.
Lung Diseases
Natural History of Pulmonary Fibrosis in Two Subjects with the Same Telomerase Mutation.
Lung Diseases
PINX1 and TERT Are Required for TNF-?-Induced Airway Smooth Muscle Chemokine Gene Expression.
Lung Diseases
Subclinical Lung Disease, Macrocytosis and Premature Graying in Kindreds with Telomerase (TERT) Mutations.
Lung Diseases
Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases.
Lung Diseases
Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs.
Lung Diseases
[A preliminary study on telomerase activity in lung cancer patients' bronchoscopically biopsied specimens.]
Lung Diseases
[Detection of telomerase activity in bronchoscopic brush-off cells in lung cancer patients]
Lung Diseases
[Determination of telomerase activity in BALF cells from lung cancer patients]
Lung Diseases
[Study on the clinical value of telomerase activity in exfoliated cells of sputum from lung cancer patients.]
Lung Diseases
[The clinical significance of detection of telomerase in bronchoalveolar lavage liquid in patients with lung cancer].
Lung Diseases, Interstitial
Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.
Lung Diseases, Interstitial
Rapid and Progressive Pulmonary Fibrosis in 2 Families with DNA Repair Deficiencies of Undetermined Etiology.
Lung Diseases, Interstitial
Telomerase deficiency does not alter bleomycin-induced fibrosis in mice.
Lung Diseases, Interstitial
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis.
Lung Diseases, Interstitial
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Lung Diseases, Interstitial
The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Lung Injury
Partial pneumonectomy of telomerase null mice carrying shortened telomeres initiates cell growth arrest resulting in a limited compensatory growth response.
Lung Injury
Proliferation of adult human bronchial epithelial cells without a telomere maintenance mechanism for over 200 population doublings.
Lung Injury
Regulation of PINX1 expression ameliorates lipopolysaccharide-induced lung injury and alleviates cell senescence during the convalescent phase through affecting the telomerase activity.
Lung Injury
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.
Lung Injury
[Role of pulmonary stem cells labeled with bromodeoxyuridine and telomerase reverse transcriptase in hyperoxic lung injury in neonatal rats]
Lung Neoplasms
17-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression.
Lung Neoplasms
A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer.
Lung Neoplasms
A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.
Lung Neoplasms
A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Lung Neoplasms
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
Lung Neoplasms
A tumor-activatable peptide supramolecular nanoplatform for the delivery of dual-gene targeted siRNAs for drug-resistant cancer treatment.
Lung Neoplasms
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Lung Neoplasms
Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity.
Lung Neoplasms
Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro.
Lung Neoplasms
Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Lung Neoplasms
Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.
Lung Neoplasms
Alternative splicing, but not allelic loss, of the FHIT gene increases with development of lung cancer.
Lung Neoplasms
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Lung Neoplasms
Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
Lung Neoplasms
Analysis of spontaneous tumor-specific CD4 T cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
Lung Neoplasms
Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
Lung Neoplasms
Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid.
Lung Neoplasms
Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
Lung Neoplasms
Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.
Lung Neoplasms
Association of genetic polymorphisms in TERT-CLPTM1L with lung cancer in a Chinese population.
Lung Neoplasms
Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Lung Neoplasms
Association of telomerase expression with successful heterotransplantation of lung cancer.
Lung Neoplasms
Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.
Lung Neoplasms
Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3.
Lung Neoplasms
BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Lung Neoplasms
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Lung Neoplasms
Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Lung Neoplasms
CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer.
Lung Neoplasms
Chidamide-induced ROS accumulation and miR-129-3p-dependent cell cycle arrest in non-small lung cancer cells.
Lung Neoplasms
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Lung Neoplasms
Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer.
Lung Neoplasms
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Lung Neoplasms
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Lung Neoplasms
Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Lung Neoplasms
Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
Lung Neoplasms
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Lung Neoplasms
Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
Lung Neoplasms
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Lung Neoplasms
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Lung Neoplasms
Combination of multiple gene markers to detect circulating tumor cells in the peripheral blood of patients with non-small cell lung cancer using real-time PCR.
Lung Neoplasms
Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
Lung Neoplasms
Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.
Lung Neoplasms
Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells.
Lung Neoplasms
Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Lung Neoplasms
Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Lung Neoplasms
Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer.
Lung Neoplasms
Correlation between morphology and human telomerase gene amplification in bronchial brushing cells for the diagnosis of lung cancer.
Lung Neoplasms
Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Lung Neoplasms
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Lung Neoplasms
Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells.
Lung Neoplasms
Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands.
Lung Neoplasms
Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Lung Neoplasms
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer: Results from Cancer and Leukemia Group B 159902.
Lung Neoplasms
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Lung Neoplasms
Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
Lung Neoplasms
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.
Lung Neoplasms
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Lung Neoplasms
Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Lung Neoplasms
Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model.
Lung Neoplasms
Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Lung Neoplasms
Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma.
Lung Neoplasms
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Lung Neoplasms
Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer.
Lung Neoplasms
Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis.
Lung Neoplasms
Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
Lung Neoplasms
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
Lung Neoplasms
EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non?small cell lung cancer cells.
Lung Neoplasms
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Lung Neoplasms
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
Lung Neoplasms
Epidermal growth factor activates telomerase activity by direct binding of Ets-2 to hTERT promoter in lung cancer cells.
Lung Neoplasms
Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Lung Neoplasms
Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.
Lung Neoplasms
Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Lung Neoplasms
Expression of human telomerase subunit genes in primary lung cancer and its clinical significance.
Lung Neoplasms
Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
Lung Neoplasms
Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Lung Neoplasms
Expression of telomeric repeat binding factor 1 protein in nonsmall cell lung cancer with human telomerase reverse transcriptase positive.
Lung Neoplasms
Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line.
Lung Neoplasms
Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line.
Lung Neoplasms
Genetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males.
Lung Neoplasms
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer-A case-control study in a Chinese population.
Lung Neoplasms
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case-control study in northeast Chinese male population.
Lung Neoplasms
Genetic polymorphisms of TERT and CLPTM1L, cooking oil fume exposure, and risk of lung cancer: a case-control study in a Chinese non-smoking female population.
Lung Neoplasms
Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
Lung Neoplasms
Ginger extract inhibits human telomerase reverse transcriptase and c-Myc expression in A549 lung cancer cells.
Lung Neoplasms
Ginger Extract Promotes Telomere Shortening and Cellular Senescence in A549 Lung Cancer Cells.
Lung Neoplasms
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Lung Neoplasms
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast.
Lung Neoplasms
hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer.
Lung Neoplasms
hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines.
Lung Neoplasms
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
Lung Neoplasms
Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.
Lung Neoplasms
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
Lung Neoplasms
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination.
Lung Neoplasms
In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy.
Lung Neoplasms
In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
Lung Neoplasms
Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Lung Neoplasms
Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.
Lung Neoplasms
Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls.
Lung Neoplasms
Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
Lung Neoplasms
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
Lung Neoplasms
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Lung Neoplasms
Inhibition of Telomerase Activity Using an EGFP-Intron Splicing System Encoding Multiple RNAi Sequences.
Lung Neoplasms
Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes.
Lung Neoplasms
Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study.
Lung Neoplasms
KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
Lung Neoplasms
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Lung Neoplasms
Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Lung Neoplasms
LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein.
Lung Neoplasms
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.
Lung Neoplasms
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Lung Neoplasms
Mechanistic in vitro studies: What they have told us about carcinogenic properties of elongated mineral particles (EMPs).
Lung Neoplasms
Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR.
Lung Neoplasms
Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Lung Neoplasms
Molecular markers in lung cancer: prognostic role and relationship to smoking.
Lung Neoplasms
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
Lung Neoplasms
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Lung Neoplasms
MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
Lung Neoplasms
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
Lung Neoplasms
nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice.
Lung Neoplasms
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer.
Lung Neoplasms
Nuclear translocation of telomerase reverse transcriptase and calcium signaling in repression of telomerase activity in human lung cancer cells by fungal immunomodulatory protein from Ganoderma tsugae.
Lung Neoplasms
Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Lung Neoplasms
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.
Lung Neoplasms
Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy.
Lung Neoplasms
Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity.
Lung Neoplasms
Polymorphisms in the TERT gene are associated with lung cancer risk in the Chinese Han population.
Lung Neoplasms
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Lung Neoplasms
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Lung Neoplasms
Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
Lung Neoplasms
Prognostic significance of telomerase polymorphism in non-small cell lung cancer.
Lung Neoplasms
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
Lung Neoplasms
Pterostilbene as a Potential Novel Telomerase Inhibitor: Molecular Docking Studies and its In Vitro Evaluation.
Lung Neoplasms
Purification and characterization of a novel lectin with antiphytovirus activities from the wild mushroom Paxillus involutus.
Lung Neoplasms
Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.
Lung Neoplasms
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
Lung Neoplasms
Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Lung Neoplasms
Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Lung Neoplasms
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications.
Lung Neoplasms
RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer.
Lung Neoplasms
Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Lung Neoplasms
RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells.
Lung Neoplasms
Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population.
Lung Neoplasms
Silencing tankyrase and telomerase promotes A549 human lung adenocarcinoma cell apoptosis and inhibits proliferation.
Lung Neoplasms
Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells.
Lung Neoplasms
Study of genetic variants in chromosome 5p15.33 region in non-smoker lung cancer patients.
Lung Neoplasms
Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Lung Neoplasms
Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
Lung Neoplasms
Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Lung Neoplasms
Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
Lung Neoplasms
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Lung Neoplasms
Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases.
Lung Neoplasms
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Lung Neoplasms
Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype (MS-0060).
Lung Neoplasms
Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer.
Lung Neoplasms
Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer.
Lung Neoplasms
Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Lung Neoplasms
Telomerase activity, telomere length and hTERT DNA methylation in peripheral blood mononuclear cells from monozygotic twins with discordant smoking habits.
Lung Neoplasms
Telomerase as a potential marker for inflammation and cancer detection in bronchial washing: A prospective study.
Lung Neoplasms
Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer.
Lung Neoplasms
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Lung Neoplasms
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Lung Neoplasms
Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.
Lung Neoplasms
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Lung Neoplasms
Telomerase reverse transcriptase rs2736098 polymorphism is associated with lung cancer: A meta-analysis.
Lung Neoplasms
Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity.
Lung Neoplasms
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance.
Lung Neoplasms
Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer.
Lung Neoplasms
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Lung Neoplasms
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.
Lung Neoplasms
Template-ready PCR method for detection of human telomerase reverse transcriptase mRNA in sputum.
Lung Neoplasms
TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.
Lung Neoplasms
The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Lung Neoplasms
The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
Lung Neoplasms
The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Lung Neoplasms
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
Lung Neoplasms
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Lung Neoplasms
The role of gene expression profiling in early-stage non-small cell lung cancer.
Lung Neoplasms
The value of chest CT scan and tumor markers detection in sputum for early diagnosis of peripheral lung cancer.
Lung Neoplasms
Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.
Lung Neoplasms
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
Lung Neoplasms
Treatment of lung cancer via telomerase inhibition: Self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.
Lung Neoplasms
Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Lung Neoplasms
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Lung Neoplasms
Ultrasensitive detection of telomerase activity in lung cancer cells with quencher-free molecular beacon-assisted quadratic signal amplification.
Lung Neoplasms
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Lung Neoplasms
Vorinostat represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Lung Neoplasms
[A preliminary study on telomerase activity in lung cancer patients' bronchoscopically biopsied specimens.]
Lung Neoplasms
[A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549]
Lung Neoplasms
[A study on the telomerase activity in lung cancer and its clinical significance.]
Lung Neoplasms
[An experimental study of telomerase reverse transcriptase (hTERT) DNAzyme on growth of A549/DDP cells.]
Lung Neoplasms
[An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter]
Lung Neoplasms
[Clinical Application and Challenges of Telomere and Telomerase Research ?in Lung Cancer].
Lung Neoplasms
[Cloning of human telomerase catalytic subunit gene promoter and studying on its specific transcriptional activities in human lung cancer cells.]
Lung Neoplasms
[Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy]
Lung Neoplasms
[Detection and significance of HPV16, 18 infection, P53 overexpression and telomerase activity in patients with lung cancer]
Lung Neoplasms
[Detection of telomerase activity in bronchoscopic brush-off cells in lung cancer patients]
Lung Neoplasms
[Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer]
Lung Neoplasms
[Detection of telomerase activity in the blood of patients with lung cancer.]
Lung Neoplasms
[Detection of telomerase activity level in human non-small-cell lung cancer]
Lung Neoplasms
[Detection of telomerase hTERT gene expression of exfoliated cell in broncho-alveolar lavage fluid]
Lung Neoplasms
[Determination of telomerase activity in BALF cells from lung cancer patients]
Lung Neoplasms
[Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]
Lung Neoplasms
[Diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer]
Lung Neoplasms
[Effect of selenium dioxide on proliferation, apoptosis, and elomerase activity of human lung cancer cell line in vitro]
Lung Neoplasms
[Epidemiology of lung cancer in former poison-gas workers and molecular approaches to lung cancer]
Lung Neoplasms
[Expression and clinical significance of telomerase catalytic subunit gene in lung cancer and its correlations with genes related to drug resistance and apoptosis]
Lung Neoplasms
[Expression of human telomerase in lung cancer:A meta-analysis of diagnostic test.]
Lung Neoplasms
[Expression of multidrug resistance-associated gene in non-small cell lung cancer and its correlations with telomerase reverse transcriptase and genes related to apoptosis]
Lung Neoplasms
[hTERT promoter-based conditionally replicative adenoviruses are useful for lung cancer and other solid cancer treatment]
Lung Neoplasms
[Human telomerase RNA (hTR) expression in lung cancer in the Gejiu and Xuanwei regions of Yunnan]
Lung Neoplasms
[Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumors]
Lung Neoplasms
[Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells]
Lung Neoplasms
[Inhibition of lung cancer cell line growth in vitro by telomerase anti-sense oligonucleotides.]
Lung Neoplasms
[Inhibition of telomerase activity and induction of apoptosis in lung cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide]
Lung Neoplasms
[Inhibitory effect of hTERT dsRNA on telomerase activity in lung carcinoma cell line A549]
Lung Neoplasms
[Location expression of human telomerase reverse transcriptase in lung cancer, benign lesion and normal lung tissue]
Lung Neoplasms
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 1. Telomere and telomerase, new targets for diagnosis and treatment of lung cancer]
Lung Neoplasms
[Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer]
Lung Neoplasms
[Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells]
Lung Neoplasms
[Study on growth inhibition of implanted tumor in nude mice by antisense oligodeoxynucleotide targeting telomerase RNA.]
Lung Neoplasms
[Study on telomerase activity and its clinical value in human non small cell lung cancer]
Lung Neoplasms
[Study on the clinical value of telomerase activity in exfoliated cells of sputum from lung cancer patients.]
Lung Neoplasms
[Study on the inhibitory effect of antisense PNA of telomerase for growth of lung cancer cell lines in vitro.]
Lung Neoplasms
[Study on the relationship between telomerase gene and telomerase activity in lung cancer tissue.]
Lung Neoplasms
[Telomerase activity in lung cancer and adjacent peritumoral tissues determined by TRAP-SYBR green assay]
Lung Neoplasms
[Telomerase in lung cancer. Testing the activity of the "immortaligy enzyme" bronchial biopsies increases the diagnostic yield in cases of suspected peripheral bronchogenic carcinomas]
Lung Neoplasms
[The advantage of an in situ TRAP assay for the detection of telomerase activity using bronchial washings obtained from lung cancer patients]
Lung Neoplasms
[The clinical significance of detection of telomerase in bronchoalveolar lavage liquid in patients with lung cancer].
Lung Neoplasms
[The diagnostic value of telomerase activity in bronchial biopsy specimen for lung cancer]
Lung Neoplasms
[The Expression of hTERT mRNA and p16 Protein in Non-small Cell Lung Cancer.]
Lung Neoplasms
[The value of detecting telomerase activity on early diagnosis of lung cancer.]
Lung Neoplasms
[Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer]
Lupus Erythematosus, Systemic
Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Evidence in patients with systemic lupus erythematosus of the presence of antibodies against RNA-dependent DNA polymerase of baboon endogenous virus.
Lupus Erythematosus, Systemic
Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.
Lupus Erythematosus, Systemic
Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients.
Lupus Erythematosus, Systemic
Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
The telomere/telomerase system in autoimmune and systemic diseases.
Lupus Erythematosus, Systemic
Type C oncornavirus isolation studies in systemic lupus erythematosus. II. Attempted detection by viral RNA-dependent DNA polymerase assay.
Lupus Erythematosus, Systemic
[Abnormalities in lymphocyte telomerase activity and telomere length in systemic lupus erythematosus]
Lupus Erythematosus, Systemic
[Telomerase activity and telomere length in CD4+,CD8+ and CD19+ lymphocytes from patients with systemic lupus erythematosus]
Lupus Erythematosus, Systemic
[Telomeres and telomerase: Relevance and future prospects in systemic lupus erythematosus.]
Lymphadenopathy
Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.
Lymphangioleiomyomatosis
Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Lymphatic Metastasis
An anti-apoptosis gene, survivin and telomerase expression in gastric cancer.
Lymphatic Metastasis
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Lymphatic Metastasis
Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy.
Lymphatic Metastasis
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Lymphatic Metastasis
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.
Lymphatic Metastasis
Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Lymphatic Metastasis
Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.
Lymphatic Metastasis
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
Lymphatic Metastasis
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Lymphatic Metastasis
Gastric cancer with high telomerase activity shows rapid development and invasiveness.
Lymphatic Metastasis
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Lymphatic Metastasis
Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
Lymphatic Metastasis
Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Lymphatic Metastasis
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Lymphatic Metastasis
Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma.
Lymphatic Metastasis
Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis.
Lymphatic Metastasis
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Lymphatic Metastasis
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
Lymphatic Metastasis
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Lymphatic Metastasis
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Lymphatic Metastasis
Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
Lymphatic Metastasis
Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.
Lymphatic Metastasis
Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma.
Lymphatic Metastasis
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
Lymphatic Metastasis
Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Lymphatic Metastasis
Telomerase activity of blood samples and recurrence of colorectal cancer.
Lymphatic Metastasis
Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Lymphatic Metastasis
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Lymphatic Metastasis
Telomerase expression in human breast cancer with and without lymph node metastases.
Lymphatic Metastasis
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.
Lymphatic Metastasis
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Lymphatic Metastasis
The clinical significance of PINX1 expression in papillary thyroid carcinoma.
Lymphatic Metastasis
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Lymphatic Metastasis
[Analysis of telomerase activity in esophageal carcinoma using microdissection telomeric repeat amplification protocol assay]
Lymphatic Metastasis
[Detection of telomerase activity in laryngeal carcinoma and the association between telomerase activity and lymphatic metastasis]
Lymphatic Metastasis
[Study on telomerase activity and its clinical value in human non small cell lung cancer]
Lymphatic Metastasis
[Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]
Lymphatic Metastasis
[The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer]
Lymphatic Metastasis
[The study on the role of telomerase activity in human nasopharyngeal carcinoma]
Lymphocytic Choriomeningitis
Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+ T cells.
Lymphocytosis
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Lymphocytosis
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Lymphoma
A novel ribonuclease with antiproliferative activity toward leukemia and lymphoma cells and HIV-1 reverse transcriptase inhibitory activity from the mushroom, Hohenbuehelia serotina.
Lymphoma
ALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor.
Lymphoma
Analysis of telomere length and function in radiosensitive mouse and human cells in response to DNA-PKcs inhibition.
Lymphoma
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer.
Lymphoma
Characterization of an RNA-directed DNA-polymerase from a cell line derived from a radiation-induced lymphoma in mice.
Lymphoma
Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
Lymphoma
Cytochrome P450 17 (CYP17) Is Involved in Endometrial Cancinogenesis Through Apoptosis and Invasion Pathways.
Lymphoma
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Lymphoma
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Lymphoma
Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse-transcriptase polymerase chain reaction in B-cell non-Hodgkin's lymphomas.
Lymphoma
Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.
Lymphoma
Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Lymphoma
Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
Lymphoma
Effects of irradiation on telomerase activity in human lymphoma and myeloma cell lines.
Lymphoma
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Lymphoma
Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation.
Lymphoma
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Lymphoma
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy.
Lymphoma
Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis.
Lymphoma
Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).
Lymphoma
High co-expression of PD-L1 and HIF-1? correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
Lymphoma
Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Lymphoma
Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1.
Lymphoma
Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.
Lymphoma
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values.
Lymphoma
Molecular cloning of the feline telomerase reverse transcriptase (TERT) gene and its expression in cell lines and normal tissues.
Lymphoma
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
Lymphoma
Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B?cell lymphoma cells.
Lymphoma
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Lymphoma
Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases.
Lymphoma
Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.
Lymphoma
Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.
Lymphoma
Regression of gastric mucosa-associated lymphoid tissue lymphoma with reduced telomerase activity after eradication of Helicobacter pylori.
Lymphoma
Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins.
Lymphoma
Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies.
Lymphoma
RNA-dependent DNA polymerase associated with a simian lymphoid cell line derived from a Herpesvirus saimiri-induced lymphoma.
Lymphoma
Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937.
Lymphoma
siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
Lymphoma
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma.
Lymphoma
Telomerase activity and related properties of normal canine lymph node and canine lymphoma*.
Lymphoma
Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: correlation with Ki67 immunoreactivity.
Lymphoma
Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Lymphoma
Telomerase activity in peripheral blood mononuclear cells after whole body irradiation.
Lymphoma
Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease.
Lymphoma
Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas.
Lymphoma
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Lymphoma
Telomerase Responsive Delivery of Doxorubicin from Mesoporous Silica Nanoparticles in Multiple Malignancies: Therapeutic Efficacies against Experimental Aggressive Murine Lymphoma.
Lymphoma
Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.
Lymphoma
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse.
Lymphoma
The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma.
Lymphoma
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Lymphoma
Trypsin isoinhibitors with antiproliferative activity toward leukemia cells from Phaseolus vulgaris cv "White Cloud Bean".
Lymphoma
Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
Lymphoma
[Telomere DNA and telomerase of lymphoma-derived cell lines--telomere hypothesis for cell growth control]
Lymphoma, B-Cell
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.
Lymphoma, B-Cell
Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma.
Lymphoma, B-Cell
Avian leukosis virus activation of an antisense RNA upstream of TERT in B-cell lymphomas.
Lymphoma, B-Cell
Cytochrome P450 17 (CYP17) Is Involved in Endometrial Cancinogenesis Through Apoptosis and Invasion Pathways.
Lymphoma, B-Cell
Differential cytotoxic effects of sodium meta-arsenite on human cancer cells, dental papilla stem cells and somatic cells correlate with telomeric properties and gene expression.
Lymphoma, B-Cell
G-quadruplex antibody attenuates human gastric cancer cell proliferation and promotes apoptosis through hTERT/telomerase pathway.
Lymphoma, B-Cell
Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.
Lymphoma, B-Cell
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.
Lymphoma, B-Cell
STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia.
Lymphoma, B-Cell
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma.
Lymphoma, B-Cell
Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers.
Lymphoma, B-Cell
[Study on the expression of tankyrase in malignant hematopoietic cells and its relation with telomerase activity]
Lymphoma, B-Cell, Marginal Zone
Clinical relevance of telomerase activity in primary gastric lymphoma.
Lymphoma, B-Cell, Marginal Zone
Regression of gastric mucosa-associated lymphoid tissue lymphoma with reduced telomerase activity after eradication of Helicobacter pylori.
Lymphoma, Large B-Cell, Diffuse
Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma.
Lymphoma, Large B-Cell, Diffuse
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma.
Lymphoma, Large-Cell, Anaplastic
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Lymphoma, Mantle-Cell
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Lymphoma, Mantle-Cell
Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage.
Lymphoma, Mantle-Cell
The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma.
Lymphoma, Non-Hodgkin
Clinical relevance of telomerase activity in primary gastric lymphoma.
Lymphoma, Non-Hodgkin
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Lymphoma, Non-Hodgkin
Molecular approaches to the diagnosis and evaluation of lymphoid malignancies.
Lymphoma, Non-Hodgkin
Presence of a high-molecular-weight RNA and RNA-directed DNA polymerase in rabbit hereditary lymphosarcoma.
Lymphoma, Non-Hodgkin
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.
Lymphoma, Non-Hodgkin
Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas.
Lymphoma, Non-Hodgkin
Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Lymphoma, Non-Hodgkin
Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease.
Lymphoma, Non-Hodgkin
Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas.
Lymphoma, Non-Hodgkin
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Lymphoma, Non-Hodgkin
TERC telomerase subunit gene copy number in different disease stages of non-hodgkin lymphoma and in hepatitis C.
Lymphoma, Primary Effusion
Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies.
Lymphoma, T-Cell
The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Lymphoma, T-Cell
Utilizing murine inducible telomerase alleles in the studies of tissue degeneration/regeneration and cancer.
Lymphoma, T-Cell, Cutaneous
Shortened telomere length is demonstrated in T-cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis.
Lymphoma, T-Cell, Cutaneous
Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Lymphoma, T-Cell, Cutaneous
Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.
Lymphoma, T-Cell, Peripheral
Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Lymphopenia
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita.
Lymphopenia
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
Lymphoproliferative Disorders
Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.
Lymphoproliferative Disorders
Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage.
Lymphoproliferative Disorders
Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage.
Macular Degeneration
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study.
Macular Degeneration
Possible therapy for age-related macular degeneration using human telomerase.
Macular Degeneration
Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity.
Macular Degeneration
Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.
Macular Degeneration
[Experimental and clinical studies of mechanisms of the anti-aging effects of chemical compounds in Astragalus membranaceus (review).]
Magnesium Deficiency
Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.
Malaria
Cellular aging dynamics after acute malaria infection: A 12-month longitudinal study.
Malaria
Plasmodium falciparum telomerase: de novo telomere addition to telomeric and nontelomeric sequences and role in chromosome healing.
Malaria
Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine.
Malignant Catarrh
Detection of ovine herpesvirus 2 major capsid gene transcripts as an indicator of virus replication in shedding sheep and clinically affected animals.
Marek Disease
Comparative functional study of the viral telomerase RNA based on natural mutations.
Marek Disease
Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1.
Marek Disease
Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.
Marek Disease
Telomerase flies the coop: the telomerase RNA component as a viral-encoded oncogene.
Marek Disease
Telomeres and Telomerase: Role in Marek's Disease Virus Pathogenesis, Integration and Tumorigenesis.
Marek Disease
The ICP27 protein of Marek's disease virus interacts with SR proteins and inhibits the splicing of cellular telomerase chTERT and viral vIL8 transcripts.
Marek Disease
Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
Measles
Detection of measles virus by reverse-transcriptase polymerase chain reaction in a placenta.
Measles
Diagnosis of Measles Pneumonia from Bronchoalveolar Lavage Fluid by Reverse-Transcriptase Polymerase Chain Reaction: Case Report.
Measles
Epidemiological and molecular investigation of a measles outbreak in Punjab, Pakistan, 2013-2015.
Measles
Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate.
Measles
[Diagnosis of adult measles pneumonia from bronchoalveolar lavage fluid by reverse-transcriptase polymerase chain reaction]
Mediastinal Diseases
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.
Medulloblastoma
All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells.
Medulloblastoma
hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Medulloblastoma
Immunohistochemical Profiling and Telomerase Activity of a Canine Medulloblastoma.
Medulloblastoma
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Medulloblastoma
Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
Medulloblastoma
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Medulloblastoma
Photodynamic effect in medulloblastoma: downregulation of matrix metalloproteinases and human telomerase reverse transcriptase expressions.
Medulloblastoma
Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
Medulloblastoma
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Medulloblastoma
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Medulloblastoma
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Melanoma
6-alkylthio-4-[1-(2,6-difluorophenyl)alkyl]-1H-[1,3,5]triazin-2-ones (ADATs): novel regulators of cell differentiation and proliferation.
Melanoma
6-Dithio-2'-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase.
Melanoma
Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Melanoma
Aberrant hTERT promoter methylation predicts prognosis in Chinese patients with acral and mucosal melanoma: A CONSORT-compliant article.
Melanoma
Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures.
Melanoma
Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
Melanoma
Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
Melanoma
Antitumor Activity of Small Double-Stranded Oligodeoxynucleotides Targeting Telomerase RNA in Malignant Melanoma Cells.
Melanoma
Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Melanoma
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase.
Melanoma
Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Melanoma
Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Melanoma
Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents.
Melanoma
Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
Melanoma
CCR7-expressing B16 melanoma cells downregulate interferon-?-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment.
Melanoma
Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity.
Melanoma
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes.
Melanoma
Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.
Melanoma
Clinicopathological relevance of NF?B1/p50 nuclear immunoreactivity and its relationship with the inflammatory environment of uveal melanoma.
Melanoma
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Melanoma
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Melanoma
Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands.
Melanoma
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.
Melanoma
Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
Melanoma
Detection of RNA-dependent DNA polymerase activity in the Xiphophorus melanoma system.
Melanoma
Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma.
Melanoma
Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Melanoma
Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
Melanoma
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Melanoma
Effect of prostaglandin A1 on proliferation and telomerase activity of human melanoma cells in vitro.
Melanoma
Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model.
Melanoma
Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.
Melanoma
Evaluation of combined h-TERT, bcl-2, and caspases 3 and 8 expression in cutaneous malignant melanoma based on tissue microarrays and computerized image analysis.
Melanoma
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Melanoma
Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
Melanoma
Expression of cytokine genes in a patient with conjunctival melanoma compared with other pigment cells.
Melanoma
Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Melanoma
Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases.
Melanoma
Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network.
Melanoma
Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
Melanoma
HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
Melanoma
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Melanoma
Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Melanoma
Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Melanoma
Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
Melanoma
IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
Melanoma
Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival.
Melanoma
In silico analysis of human Telomerase Reverse Transcriptase (hTERT) gene: identification of a distant homolog of Melanoma Antigen Family Gene (MAGE).
Melanoma
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
Melanoma
In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
Melanoma
Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Melanoma
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
Melanoma
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Melanoma
Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells.
Melanoma
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
Melanoma
Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
Melanoma
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.
Melanoma
Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Melanoma
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
Melanoma
Inhibition on telomerase activity and cytotoxic effects by cisplatin in cultured human choroidal melanoma cells.
Melanoma
Lack of prognostic importance of reverse-transcriptase polymerase chain reaction detection of circulating messenger RNA in patients with melanoma.
Melanoma
Malignancy without immortality? Evidence for cellular immortalization as a late event in melanoma progression.
Melanoma
MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases.
Melanoma
Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45(-) depletion and RNA extraction.
Melanoma
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF.
Melanoma
Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase.
Melanoma
Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR.
Melanoma
Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors.
Melanoma
Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
Melanoma
Murine and human melanomas containing a high molecular weight RNA associated with an RNA-instructed DNA polymerase.
Melanoma
Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
Melanoma
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Melanoma
Particle-associated RNA-directed DNA polymerase and 70S RNA in the hamster melanoma A Mel 3.
Melanoma
Pathology and genomics of pediatric melanoma: A critical reexamination and new insights.
Melanoma
Possible diagnostic role of telomerase activity evaluation in the differential diagnosis between spitz naevi and cutaneous malignant melanoma.
Melanoma
Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma.
Melanoma
Preclinical studies on detection of circulating melanoma cells in patients: telomerase as a recognition marker of malignancy.
Melanoma
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Melanoma
Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma.
Melanoma
Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
Melanoma
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
Melanoma
Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.
Melanoma
Rapid purification of an RNA tumor virus and proteins by high-performance steric exclusion chromatography on porous glass bead columns.
Melanoma
Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Melanoma
Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Melanoma
Screening of inhibitors of human telomerase reverse transcriptase in a cultured malignant melanoma cell line.
Melanoma
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach.
Melanoma
Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
Melanoma
Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.
Melanoma
Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Melanoma
T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.
Melanoma
Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Melanoma
Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Melanoma
Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Melanoma
Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.
Melanoma
Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.
Melanoma
Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.
Melanoma
Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma.
Melanoma
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Melanoma
Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Melanoma
Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
Melanoma
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Melanoma
TERT copy gain predicts the outcome of high-dose interferon ?-2b therapy in acral melanoma.
Melanoma
TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Melanoma
TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.
Melanoma
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Melanoma
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.
Melanoma
TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
Melanoma
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Melanoma
The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
Melanoma
The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells.
Melanoma
The relationship between telomerase activity and proliferation in cutaneous melanoma.
Melanoma
The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma.
Melanoma
The use of molecular profiling of early colorectal cancer to predict micrometastases.
Melanoma
Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes.
Melanoma
Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
Melanoma
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
Melanoma
Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
Melanoma
Unusually stable abnormal karyotype in a highly aggressive melanoma negative for telomerase activity.
Melanoma
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
Melanoma
[Correlation between the biological behavior and invasion potential in three mouse melanoma cell lines]
Melanoma, Experimental
Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
Memory Disorders
Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
Meningioma
A genetic strategy to overcome the senescence of primary meningioma cell cultures.
Meningioma
Adjunctive markers for classification and diagnosis of central nervous system tumors: results of a multi-center neuropathological survey in Korea.
Meningioma
Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Meningioma
Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas.
Meningioma
Differential telomerase expression and telomere length in primary intracranial tumors.
Meningioma
Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
Meningioma
Establishment of a benign meningioma cell line by hTERT-mediated immortalization.
Meningioma
Establishment of an in vivo meningioma model with human telomerase reverse transcriptase.
Meningioma
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Meningioma
hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
Meningioma
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis.
Meningioma
Immunohistochemical expression of h-telomerase reverse transcriptase in canine and feline meningiomas.
Meningioma
Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
Meningioma
Influence of Human Telomerase Reverse Transcriptase Mutation on the Aggressiveness and Recurrence in Meningiomas.
Meningioma
Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas.
Meningioma
Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
Meningioma
Molecular genetics of meningiomas: from basic research to potential clinical applications.
Meningioma
Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas.
Meningioma
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Meningioma
Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Meningioma
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Meningioma
Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Meningioma
Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Meningioma
Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Meningioma
TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Meningioma
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Meningioma
The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas.
Meningitis
Clinical characteristics of enteroviral meningitis without pleocytosis in children: a retrospective single center observational study in the Republic of Korea.
Menkes Kinky Hair Syndrome
Identification of three novel mutations in the MNK gene in three unrelated Japanese patients with classical Menkes disease.
Menkes Kinky Hair Syndrome
Novel mutation of L718X in the ATP7A gene in a Japanese patient with classical Menkes disease, and four novel polymorphisms in the Japanese population.
Mental Retardation, X-Linked
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.
Mental Retardation, X-Linked
Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
Mesothelioma
Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Mesothelioma
Mechanistic in vitro studies: What they have told us about carcinogenic properties of elongated mineral particles (EMPs).
Mesothelioma
Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
Mesothelioma
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.
Mesothelioma
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
Mesothelioma
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
Mesothelioma
Telomerase activity analyzed with trap in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
Mesothelioma
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Mesothelioma, Malignant
Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas.
Mesothelioma, Malignant
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities.
Mesothelioma, Malignant
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
Mesothelioma, Malignant
SV40 infection induces telomerase activity in human mesothelial cells.
Metabolic Diseases
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?
Metabolic Syndrome
Cell aging in relation to stress arousal and cardiovascular disease risk factors.
Metabolic Syndrome
Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome.
Metabolic Syndrome
Effect of Sechium edule var. nigrum spinosum (Chayote) on Telomerase Levels and Antioxidant Capacity in Older Adults with Metabolic Syndrome.
Metabolic Syndrome
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Metabolic Syndrome
TA-65, A Telomerase Activator, Improves Cardiovascular Markers in Patients with Metabolic Syndrome.
Metabolic Syndrome
The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study.
Mitochondrial Diseases
Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.
Mitochondrial Diseases
WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.
Mitochondrial Myopathies
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Mixed Connective Tissue Disease
Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
Mixed Tumor, Malignant
Cellular proliferative and telomerase activity in canine mammary gland tumors.
Monoclonal Gammopathy of Undetermined Significance
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
Monoclonal Gammopathy of Undetermined Significance
Expression Profile of Telomere-associated Genes in Multiple Myeloma.
Monoclonal Gammopathy of Undetermined Significance
Telomerase activity in plasma cell dyscrasias.
Mouth Neoplasms
Clinical significance of telomere length and associated proteins in oral cancer.
Mouth Neoplasms
Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy.
Mouth Neoplasms
Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo.
Mouth Neoplasms
Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.
Mouth Neoplasms
Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer.
Mouth Neoplasms
Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.
Mouth Neoplasms
Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Mouth Neoplasms
Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Mouth Neoplasms
Immunohistochemical expression of human telomerase reverse transcriptase in oral cancer and precancer: A case-control study.
Mouth Neoplasms
Lack of correlation of betel nut chewing, tobacco smoking, and alcohol consumption with telomerase activity and the severity of oral cancer.
Mouth Neoplasms
Oral cancer diagnosis via a ferrocenylnaphthalene diimide-based electrochemical telomerase assay.
Mouth Neoplasms
Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Mouth Neoplasms
Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma.
Mouth Neoplasms
Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
Mouth Neoplasms
Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-beta: but p53 mutations are not necessarily required.
Mouth Neoplasms
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
Mouth Neoplasms
Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Mouth Neoplasms
Telomere attrition and telomerase activity are associated with GSTM1 polymorphism in oral cancer.
Mouth Neoplasms
Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Mouth Neoplasms
[Identification of telomerase activity in the experimental carcinogenesis of oral cavity]
Mucocutaneous Lymph Node Syndrome
Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome.
Mucocutaneous Lymph Node Syndrome
Association between a novel human coronavirus and Kawasaki disease.
Multiple Myeloma
Cytokines modulate telomerase activity in a human multiple myeloma cell line.
Multiple Myeloma
Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.
Multiple Myeloma
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
Multiple Myeloma
Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Multiple Myeloma
Expression of interleukin-11 receptor in CD38-positive cells from patients with multiple myeloma.
Multiple Myeloma
Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.
Multiple Myeloma
Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules.
Multiple Myeloma
Prognostic relevance of telomere length and telomerase reverse transcriptase variant (rs2242652) on the multiple myeloma patients.
Multiple Myeloma
Research for the influence of telomerase inhibitors on myeloma cell and therapy.
Multiple Myeloma
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
Multiple Myeloma
Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha.
Multiple Myeloma
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Multiple Myeloma
Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
Multiple Myeloma
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Multiple Myeloma
Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.
Multiple Myeloma
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Multiple Myeloma
Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.
Multiple Myeloma
The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.
Multiple Myeloma
[A study of cellular telomerase activity in different stages of multiple myeloma cells]
Multiple Myeloma
[Effect of arsenic trioxide on telomerase and telomerase reverse transcriptase in KM3 cell line]
Mumps
Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.
Mumps
Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults.
Muscle Cramp
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease.
Muscular Atrophy, Spinal
SMN and coilin negatively regulate dyskerin association with telomerase RNA.
Muscular Diseases
Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Muscular Diseases
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy.
Muscular Diseases
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Muscular Diseases
Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy.
Muscular Dystrophies
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies.
Muscular Dystrophies
Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides.
Muscular Dystrophies
Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability.
Muscular Dystrophies
Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.
Mycosis Fungoides
Shortened telomere length is demonstrated in T-cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis.
Myelodysplastic Syndromes
A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome.
Myelodysplastic Syndromes
Characterization of In Vitro G-Quadruplex Formation of Imetelstat Telomerase Inhibitor.
Myelodysplastic Syndromes
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia.
Myelodysplastic Syndromes
Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Myelodysplastic Syndromes
Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.
Myelodysplastic Syndromes
Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis.
Myelodysplastic Syndromes
Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.
Myelodysplastic Syndromes
Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia.
Myelodysplastic Syndromes
Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Myelodysplastic Syndromes
Increase of telomerase activity and hTERT expression in myelodysplastic syndromes.
Myelodysplastic Syndromes
Lack of mutations of the human telomerase RNA gene (hTERC) in myelodysplastic syndrome.
Myelodysplastic Syndromes
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.
Myelodysplastic Syndromes
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Myelodysplastic Syndromes
MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.
Myelodysplastic Syndromes
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Myelodysplastic Syndromes
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency.
Myelodysplastic Syndromes
Telomerase activity in normal leukocytes and in hematologic malignancies.
Myelodysplastic Syndromes
Telomerase gene screening and telomere overhang detection in Chinese patients with myelodysplastic syndrome.
Myelodysplastic Syndromes
Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes.
Myelodysplastic Syndromes
Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging.
Myelodysplastic Syndromes
[Alterations of telomerase activity and apoptosis induced by 2-methoxyestradiol in human myelodysplastic syndrome cell line MUTZ-1]
Myelodysplastic Syndromes
[Analysis of molecular mechanism involved in development of acute myeloid leukemia].
Myelodysplastic Syndromes
[Expression of human telomerase reverse transcriptase and survivin gene in patients with myelodysplastic syndrome]
Myelodysplastic Syndromes
[Study of Telomerase Activity in Bone Marrow Cells from Patients with Myelodysplastic Syndromes]
Myelodysplastic Syndromes
[Telomere, telomerase and cytogenetic changes in myelodysplastic syndromes]
Myelolipoma
Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Myeloproliferative Disorders
Absence of pathogenic mutations of the human telomerase RNA gene (hTERC) in patients with chronic myeloproliferative disorders.
Myeloproliferative Disorders
Analysis of platelets from patients with thrombocythemia for reverse transcriptase and virus-like particles.
Myeloproliferative Disorders
Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disorders.
Myeloproliferative Disorders
Trial watch: Telomerase inhibitor shows promise in myeloproliferative disorders.
Myocardial Infarction
Bioinformatics analysis of key genes and signaling pathways associated with myocardial infarction following telomerase activation.
Myocardial Infarction
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Myocardial Infarction
Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity.
Myocardial Infarction
Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Myocardial Infarction
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors.
Myocardial Infarction
Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions.
Myocardial Infarction
Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury.
Myocardial Infarction
Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction.
Myocardial Infarction
TERT assists GDF11 to rejuvenate senescent VEGFR2+/CD133+ cells in elderly patients with myocardial infarction.
Myocardial Infarction
The association between dietary quality indices and serum telomerase activity in patient candidates for CABG.
Myocardial Infarction
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
Myocardial Infarction
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.
Myoma
Absence of the JAZF1/SUZ12 chimeric transcript in the immortalized non-neoplastic endometrial stromal cell line T HESCs.
Myopathies, Nemaline
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Myositis
Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity.
Myositis
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Myotonic Dystrophy
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts.
Nasal Polyps
Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.
Nasal Polyps
Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
Nasopharyngeal Carcinoma
A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population.
Nasopharyngeal Carcinoma
A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.
Nasopharyngeal Carcinoma
Antisense oligonucleotides targeting human telomerase mRNA increases the radiosensitivity of nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.
Nasopharyngeal Carcinoma
Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Differentiation of human nasopharyngeal carcinoma xenografts and repression of telomerase activity induced by arsenic trioxide.
Nasopharyngeal Carcinoma
Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Effect of trichosanthin on apoptosis and telomerase activity of nasopharyngeal carcinomas in nude mice.
Nasopharyngeal Carcinoma
Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture.
Nasopharyngeal Carcinoma
Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
Nasopharyngeal Carcinoma
Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-?B axis during nasopharyngeal carcinoma development.
Nasopharyngeal Carcinoma
Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Nasopharyngeal Carcinoma
Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways.
Nasopharyngeal Carcinoma
Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Pro-apoptotic and anti-proliferative effects of 3,3'-diindolylmethane in nasopharyngeal carcinoma cells via downregulation of telomerase activity.
Nasopharyngeal Carcinoma
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Nasopharyngeal Carcinoma
Regulation of telomerase activity by gamma-radiation in nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines.
Nasopharyngeal Carcinoma
Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
Nasopharyngeal Carcinoma
Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Nasopharyngeal Carcinoma
Telomerase assay and nested polymerase chain reaction from nasopharyngeal swabs for early noninvasive detection of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells.
Nasopharyngeal Carcinoma
The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Nasopharyngeal Carcinoma
[Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells]
Nasopharyngeal Carcinoma
[Down-regulation of telomerase and its RNA and apoptosis in the HNE1 cell line of nasopharyngeal carcinoma induced by retinoid]
Nasopharyngeal Carcinoma
[Effects of telomerase sense and antisense oligodeoxynucleotides on growth and differentiation of nasopharyngeal carcinoma cells]
Nasopharyngeal Carcinoma
[Expression of telomerase and its RNA in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin].
Nasopharyngeal Carcinoma
[Profile of telomerase and telomerase RNA expression in nasopharyngeal carcinogenesis of rats induced by N, N'dinitrosopiperazine (DNP)]
Nasopharyngeal Carcinoma
[Quantitative detection of plasma level of human telomerase reverse transcriptase mRNA in patients with nasopharyngeal carcinoma].
Nasopharyngeal Carcinoma
[Study on the relationship between TK gene regulated by enhanced suicide gene vector and telomerase activity in nasopharyngeal carcinoma cells]
Nasopharyngeal Carcinoma
[The effect of shRNA targeting hTERT on telomerase and the expression of PCNA and Caspase-3 in nasopharyngeal carcinoma cells]
Nasopharyngeal Carcinoma
[The inhibitory role of zhongjiefeng extracts, on apoptosis and telomerase activity of nasopharyngeal carcinoma cell line exnograf in nude mice]
Nasopharyngeal Carcinoma
[The study on the role of telomerase activity in human nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Tumor-targeted human telomerase reverse transcriptase promoter/tk gene therapy against human nasopharyngeal carcinoma cells in vitro.]
Nasopharyngeal Neoplasms
Cdc42/Rac1 participates in the control of telomerase activity in human nasopharyngeal cancer cells.
Nasopharyngeal Neoplasms
Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture.
Nasopharyngeal Neoplasms
Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
Nasopharyngeal Neoplasms
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.
Nasopharyngeal Neoplasms
Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells.
Neoplasm Metastasis
A second chance for telomerase reverse transcriptase in anticancer immunotherapy.
Neoplasm Metastasis
A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.
Neoplasm Metastasis
Aberrant telomerase expression in the endometrium of infertile women with deep endometriosis.
Neoplasm Metastasis
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.
Neoplasm Metastasis
An anti-apoptosis gene, survivin and telomerase expression in gastric cancer.
Neoplasm Metastasis
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Neoplasm Metastasis
Antidepressants, prostaglandins and the prevention and treatment of cancer.
Neoplasm Metastasis
Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Neoplasm Metastasis
Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Neoplasm Metastasis
Biodegradable Black Phosphorus Nanosheets Mediate Specific Delivery of hTERT siRNA for Synergistic Cancer Therapy.
Neoplasm Metastasis
Cascaded Electrochemiluminescence Signal Amplifier for the Detection of Telomerase Activity from Tumor Cells and Tissues.
Neoplasm Metastasis
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
Neoplasm Metastasis
Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.
Neoplasm Metastasis
Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.
Neoplasm Metastasis
Clinical evaluation of biologically targeted drugs: obstacles and opportunities.
Neoplasm Metastasis
Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Neoplasm Metastasis
Clinical significance of telomerase activity in gastric carcinoma and peritoneal dissemination.
Neoplasm Metastasis
Clinical significance of telomerase activity in peripheral blood of patients with esophageal squamous cell carcinoma.
Neoplasm Metastasis
Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Neoplasm Metastasis
Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy.
Neoplasm Metastasis
Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Neoplasm Metastasis
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Neoplasm Metastasis
Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.
Neoplasm Metastasis
Correlation between telomerase activity and DNA ploidy in gastric cancer.
Neoplasm Metastasis
Detection of cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
Neoplasm Metastasis
Detection of telomerase activity in saliva from oral squamous cell carcinoma patients.
Neoplasm Metastasis
Differential telomerase expression in human primary intracranial tumors.
Neoplasm Metastasis
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Neoplasm Metastasis
Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Neoplasm Metastasis
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
Neoplasm Metastasis
Epigenetic suppression of human telomerase (hTERT) is mediated by the metastasis suppressor NME2 in a G-quadruplex-dependent fashion.
Neoplasm Metastasis
Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis.
Neoplasm Metastasis
Evaluation of telomerase activity in cutaneous melanocytic proliferations.
Neoplasm Metastasis
Evaluation of telomerase in the development and progression of colon cancer.
Neoplasm Metastasis
Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma.
Neoplasm Metastasis
Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells.
Neoplasm Metastasis
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.
Neoplasm Metastasis
Fascinating chemo preventive story of wogonin: A chance to hit on the head in cancer treatment.
Neoplasm Metastasis
Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways.
Neoplasm Metastasis
Gastric cancer with high telomerase activity shows rapid development and invasiveness.
Neoplasm Metastasis
GeneSearch BLN Assay could replace frozen section and touch imprint cytology for intra-operative assessment of breast sentinel lymph nodes.
Neoplasm Metastasis
Genetic alterations in anaplastic thyroid carcinoma and targeted therapies.
Neoplasm Metastasis
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Neoplasm Metastasis
HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist.
Neoplasm Metastasis
hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a.
Neoplasm Metastasis
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Neoplasm Metastasis
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality.
Neoplasm Metastasis
hTERT promotes the invasion of telomerase-negative tumor cells in vitro.
Neoplasm Metastasis
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Neoplasm Metastasis
Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases.
Neoplasm Metastasis
Identification and functional characterization of nuclear mortalin in human carcinogenesis.
Neoplasm Metastasis
IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.
Neoplasm Metastasis
Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
Neoplasm Metastasis
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis.
Neoplasm Metastasis
Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Neoplasm Metastasis
Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.
Neoplasm Metastasis
In situ Analysis of Cancer Cells Based on DNA Signal Amplification and DNA Nanodevices.
Neoplasm Metastasis
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
Neoplasm Metastasis
Increased telomerase activities in human pancreatic duct adenocarcinomas.
Neoplasm Metastasis
Inhibition of telomerase activity by NME2: impact on metastasis suppression?
Neoplasm Metastasis
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Neoplasm Metastasis
Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
Neoplasm Metastasis
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
Neoplasm Metastasis
Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.
Neoplasm Metastasis
Lack of prognostic importance of reverse-transcriptase polymerase chain reaction detection of circulating messenger RNA in patients with melanoma.
Neoplasm Metastasis
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Neoplasm Metastasis
Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Neoplasm Metastasis
Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
Neoplasm Metastasis
Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Neoplasm Metastasis
Means to the ends: The role of telomeres and telomere processing machinery in metastasis.
Neoplasm Metastasis
Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells.
Neoplasm Metastasis
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Neoplasm Metastasis
Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Neoplasm Metastasis
Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis.
Neoplasm Metastasis
Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Neoplasm Metastasis
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
Neoplasm Metastasis
Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.
Neoplasm Metastasis
nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice.
Neoplasm Metastasis
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Neoplasm Metastasis
Noncoding telomeric repeat-containing RNA inhibits the progression of hepatocellular carcinoma by regulating telomerase-mediated telomere length.
Neoplasm Metastasis
Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC).
Neoplasm Metastasis
Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma.
Neoplasm Metastasis
Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro.
Neoplasm Metastasis
Part I. Telomerase levels in human metastatic brain tumors show four-fold logarithmic variability but no correlation with tumor type or interval to patient demise.
Neoplasm Metastasis
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Neoplasm Metastasis
Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis.
Neoplasm Metastasis
Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.
Neoplasm Metastasis
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness.
Neoplasm Metastasis
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Neoplasm Metastasis
Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features.
Neoplasm Metastasis
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
Neoplasm Metastasis
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Neoplasm Metastasis
Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.
Neoplasm Metastasis
Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
Neoplasm Metastasis
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Neoplasm Metastasis
Ratiometric Fluorescent Biosensor for Visual Discrimination of Cancer Cells with Different Telomerase Expression Levels.
Neoplasm Metastasis
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma.
Neoplasm Metastasis
Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Neoplasm Metastasis
Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
Neoplasm Metastasis
Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Neoplasm Metastasis
Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases.
Neoplasm Metastasis
siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.
Neoplasm Metastasis
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Neoplasm Metastasis
Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
Neoplasm Metastasis
Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Neoplasm Metastasis
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Neoplasm Metastasis
Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
Neoplasm Metastasis
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Neoplasm Metastasis
Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.
Neoplasm Metastasis
Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.
Neoplasm Metastasis
Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Neoplasm Metastasis
Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.
Neoplasm Metastasis
Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.
Neoplasm Metastasis
Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
Neoplasm Metastasis
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Neoplasm Metastasis
Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma.
Neoplasm Metastasis
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
Neoplasm Metastasis
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Neoplasm Metastasis
Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy.
Neoplasm Metastasis
Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Neoplasm Metastasis
Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Neoplasm Metastasis
Telomerase activity of blood samples and recurrence of colorectal cancer.
Neoplasm Metastasis
Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion.
Neoplasm Metastasis
Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Neoplasm Metastasis
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Neoplasm Metastasis
Telomerase as a diagnostic and predictive marker in colorectal carcinoma.
Neoplasm Metastasis
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Neoplasm Metastasis
Telomerase expression in human breast cancer with and without lymph node metastases.
Neoplasm Metastasis
Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Neoplasm Metastasis
Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
Neoplasm Metastasis
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases.
Neoplasm Metastasis
Telomerase reverse transcriptase mediates EMT through NF-?B signaling in tongue squamous cell carcinoma.
Neoplasm Metastasis
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.
Neoplasm Metastasis
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Neoplasm Metastasis
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Neoplasm Metastasis
Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
Neoplasm Metastasis
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Neoplasm Metastasis
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer.
Neoplasm Metastasis
The clinical significance of PINX1 expression in papillary thyroid carcinoma.
Neoplasm Metastasis
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Neoplasm Metastasis
The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Neoplasm Metastasis
Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Neoplasm Metastasis
Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
Neoplasm Metastasis
Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".
Neoplasm Metastasis
Upregulated long non-coding RNA BC032469 enhances carcinogenesis and metastasis of esophageal squamous cell carcinoma through regulating hTERT expression.
Neoplasm Metastasis
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Neoplasm Metastasis
[Contemporary study of strengthening body resistance and archaeus herbs on malignant tumor]
Neoplasm Metastasis
[Detection of telomerase activity in laryngeal carcinoma and the association between telomerase activity and lymphatic metastasis]
Neoplasm Metastasis
[Detection of telomerase activity in the blood of patients with lung cancer.]
Neoplasm Metastasis
[Establishment of a pulmonary metastasis model of melanoma with stably expressed hTERT/Luc].
Neoplasm Metastasis
[Prognostic and diagnostic value of telomerase in the head and neck cancer]
Neoplasm Metastasis
[Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer]
Neoplasm Metastasis
[Quantitative assay of telomerase activity in head and neck squamous cell carcinoma]
Neoplasm Metastasis
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Neoplasm Metastasis
[Significance of human telomerase RNA expression in situ in malignant melanoma]
Neoplasm Metastasis
[Significance of telomerase expression in diagnosis and treatment of breast tumor]
Neoplasm Metastasis
[Study on telomerase activity and its clinical value in human non small cell lung cancer]
Neoplasm Metastasis
[Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]
Neoplasm Metastasis
[The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer]
Neoplasm Metastasis
[The role of telomerase for pancreatic carcinogenesis in human and hamster]
Neoplasm Metastasis
[The study on the role of telomerase activity in human nasopharyngeal carcinoma]
Neoplasm Micrometastasis
Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Neoplasm Micrometastasis
Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy.
Neoplasm Micrometastasis
Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
Neoplasm Micrometastasis
Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.
Neoplasm Micrometastasis
Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Neoplasm Micrometastasis
Detection of hTERT mRNA in peripheral blood and its implication for diagnosis of early stage postoperative endometrial cancer micrometastasis.
Neoplasm Micrometastasis
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Neoplasm Micrometastasis
Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.
Neoplasm Micrometastasis
Molecular quantification and mapping of lymph-node micrometastases in cervical cancer.
Neoplasm Micrometastasis
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
Neoplasm Micrometastasis
Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.
Neoplasm Micrometastasis
Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
Neoplasm Micrometastasis
Telomerase activity in peripheral blood for diagnosis of hepatoma.
Neoplasm Micrometastasis
[Clinical significance of molecular biological detection of micrometastases in gastric carcinoma]
Neoplasm Micrometastasis
[Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction]
Neoplasm Micrometastasis
[Significance of detection of micrometastases in regional lymph nodes in cancer patients using RT-PCR]
Neoplasm, Residual
A t(16;21)(p11;q22) in Acute Myeloid Leukemia (AML) Resulting in Fusion of the FUS/TLS and ERG Genes: A Review of the Literature.
Neoplasm, Residual
Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.
Neoplasm, Residual
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Neoplasm, Residual
Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia.
Neoplasm, Residual
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
Neoplasm, Residual
Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.
Neoplasm, Residual
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Neoplasm, Residual
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Neoplasm, Residual
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Neoplasm, Residual
Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
Neoplasm, Residual
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
Neoplasm, Residual
[Allogenic bone marrow transplantation after reduced intensity conditioning regimens in therapy of patients with hemoblastoses]
Neoplasms
1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.
Neoplasms
1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents.
Neoplasms
1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
Neoplasms
12E2: a cloned murine dermal cell with features of dermal dendrocytes and capacity to produce pathologic changes resembling early Kaposi's sarcoma.
Neoplasms
17?-Ethynyl-androst-5-ene-3?,7?,17?-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease.
Neoplasms
2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Neoplasms
4-1BB-based Isolation and Expansion of CD8+ T Cells Specific for Self-Tumor and Non-Self-Tumor Antigens for Adoptive T-cell Therapy.
Neoplasms
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines.
Neoplasms
5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
Neoplasms
5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
Neoplasms
5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species.
Neoplasms
6-Dithio-2'-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase.
Neoplasms
A 4:1 stoichiometric binding and stabilization of mitoxantrone-parallel stranded G-quadruplex complex established by spectroscopy techniques.
Neoplasms
A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
Neoplasms
A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin.
Neoplasms
A Cisplatin Derivative Tetra-Pt(bpy) as an Oncotherapeutic Agent for Targeting ALT Cancer.
Neoplasms
A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
Neoplasms
A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
Neoplasms
A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
Neoplasms
A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus.
Neoplasms
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase.
Neoplasms
A comparative study of telomerase activity and malignant phenotype in multistage carcinogenesis of esophageal epithelial cells induced by human papillomavirus.
Neoplasms
A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line.
Neoplasms
A comparison between stem cells from the adult human brain and from brain tumors.
Neoplasms
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR.
Neoplasms
A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin.
Neoplasms
A conformational switch-based fluorescent biosensor for homogeneous detection of telomerase activity.
Neoplasms
A convenient synthesis of novel thiazolidin-4-one-linked pseudodisaccharides by tandem Staudinger/aza-Wittig/cyclization and their biological evaluation.
Neoplasms
A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death.
Neoplasms
A cytometric assay for ultrasensitive and robust detection of human telomerase RNA based on toehold strand displacement.
Neoplasms
A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
Neoplasms
A dual-colored ratiometric-fluorescent oligonucleotide probe for the detection of human telomerase RNA in cell extracts.
Neoplasms
A facile DNA/RNA nanoflower for sensitive imaging of telomerase RNA in living cells based on "zipper lock-and-key" strategy.
Neoplasms
A facile graphene oxide-based fluorescent nanosensor for the in situ "turn-on" detection of telomerase activity.
Neoplasms
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.
Neoplasms
A Fluorescent Anti-Cancer Agent, 3,6-bis(1-methyl-4-vinylpyridinium) Carbazole Diiodide, Stains G-Quadruplexes in Cells and Inhibits Tumor Growth.
Neoplasms
A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.
Neoplasms
A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
Neoplasms
A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Neoplasms
A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Neoplasms
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Neoplasms
A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.
Neoplasms
A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells.
Neoplasms
A high-throughput assay for a human telomerase protein-human telomerase RNA interaction.
Neoplasms
A highly selective telomerase inhibitor limiting human cancer cell proliferation.
Neoplasms
A highly sensitive and facile graphene oxide-based nucleic acid probe: Label-free detection of telomerase activity in cancer patient's urine using AIEgens.
Neoplasms
A Highly Sensitive Catalytic Hairpin Assembly-Based Dynamic Light-Scattering Biosensors for Telomerase Detection in Bladder Cancer Diagnosis.
Neoplasms
A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway.
Neoplasms
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Neoplasms
A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Neoplasms
A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.
Neoplasms
A label-free electrochemical biosensor for ultra-sensitively detecting telomerase activity based on the enhanced catalytic currents of acetaminophen catalyzed by Au nanorods.
Neoplasms
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.
Neoplasms
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
Neoplasms
A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-dimensional in vitro tumor spheroids as a screening model.
Neoplasms
A multi-recycling amplification-based sensor for label-free and highly sensitive detection of telomerase from cancer cells.
Neoplasms
A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma.
Neoplasms
A network of genetic events sufficient to convert normal human cells to a tumorigenic state.
Neoplasms
A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM.
Neoplasms
A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers.
Neoplasms
A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
Neoplasms
A non-isotopic method for the detection of telomerase activity in tumour tissues: TRAP-silver staining assay.
Neoplasms
A non-natural nucleotide uses a specific pocket to selectively inhibit telomerase activity.
Neoplasms
A novel antiangiogenic effect for telomerase-specific virotherapy through host immune system.
Neoplasms
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Neoplasms
A novel carbazole derivative, BMVC: a potential antitumor agent and fluorescence marker of cancer cells.
Neoplasms
A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells.
Neoplasms
A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-?B inactivation in colorectal cancer cells.
Neoplasms
A novel electrochemical biosensor for sensitive detection of telomerase activity based on structure-switching DNA.
Neoplasms
A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics.
Neoplasms
A novel homodimeric lactose-binding lectin from the edible split gill medicinal mushroom Schizophyllum commune.
Neoplasms
A Novel Liquid Biopsy Strategy to Detect Small Amounts of Cancer Cells Using Cancer-Specific Replication Adenoviruses.
Neoplasms
A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer.
Neoplasms
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Neoplasms
A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Neoplasms
A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer.
Neoplasms
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4.
Neoplasms
A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Neoplasms
A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
Neoplasms
A novel peptide-nucleotide dual vaccine of human telomerase reverse transcriptase induces a potent cytotoxic T-cell response in vivo.
Neoplasms
A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Neoplasms
A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Neoplasms
A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cells.
Neoplasms
A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter.
Neoplasms
A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
Neoplasms
A novel telomere structure in a human alternative lengthening of telomeres cell line.
Neoplasms
A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues.
Neoplasms
A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Neoplasms
A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.
Neoplasms
A PCR-free fluorescence strategy for detecting telomerase activity via double amplification strategy.
Neoplasms
A PCR-free voltammetric telomerase activity assay using a substrate primer on a gold electrode and DNA-triggered capture of gold nanoparticles.
Neoplasms
A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters.
Neoplasms
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.
Neoplasms
A Polyadenylation-Dependent 3' End Maturation Pathway Is Required for the Synthesis of the Human Telomerase RNA.
Neoplasms
A positive feedback loop between Wnt/?-catenin signaling and hTERT regulates the cancer stem cell-like traits in radioresistant nasopharyngeal carcinoma cells.
Neoplasms
A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
Neoplasms
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Neoplasms
A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol.
Neoplasms
A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance.
Neoplasms
A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.
Neoplasms
A Rare Variant P507L in TPP1 Interrupts TPP1-TIN2 Interaction, Influences Telomere Length, and Confers Colorectal Cancer Risk in Chinese Population.
Neoplasms
A resonance Rayleigh scattering sensor for sensitive differentiation of telomere DNA length and monitoring special motifs (G-quadruplex and i-motif) based on the Ag nanoclusters and NAND logic gate responding to chemical input signals.
Neoplasms
A Review of Molecular Mechanisms in the Development of Hepatocellular Carcinoma by Aflatoxin and Hepatitis B and C Viruses.
Neoplasms
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Neoplasms
A robust fluorescent probe for detection of telomerase activity in vitro and imaging in living cells via telomerase-triggering primer extension to desorb DNA from graphene oxide.
Neoplasms
A robust probe for lighting up intracellular telomerase via primer extension to open a nicked molecular beacon.
Neoplasms
A scalable and reproducible preparation for the antitumor protein TLC, a human-derived telomerase inhibitor.
Neoplasms
A second chance for telomerase reverse transcriptase in anticancer immunotherapy.
Neoplasms
A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
Neoplasms
A sensitive fluorescence strategy for telomerase detection in cancer cells based on T7 exonuclease-assisted target recycling amplification.
Neoplasms
A sensitive, label-free electrochemical detection of telomerase activity without modification or immobilization.
Neoplasms
A simple "mix-and-detection" method for the sensitive detection of telomerase from cancer cells under absolutely isothermal conditions.
Neoplasms
A simple and sensitive fluorescence method for detection of telomerase activity using fusion protein bouquets.
Neoplasms
A simple, fast, label-free colorimetric method for detection of telomerase activity in urine by using hemin-graphene conjugates.
Neoplasms
A single-molecule platform for investigation of interactions between G-quadruplexes and small-molecule ligands.
Neoplasms
A Static Magnetic Field Inhibits the Migration and Telomerase Function of Mouse Breast Cancer Cells.
Neoplasms
A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women.
Neoplasms
A Telomerase Responsive DNA-icosahedron for Precise Delivery of Platinum-nanodrug to Cisplatin-resistance Cancer.
Neoplasms
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
Neoplasms
A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Neoplasms
A Telomerase-Specific Doxorubicin-Releasing Molecular Beacon for Cancer Theranostics.
Neoplasms
A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization.
Neoplasms
A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
Neoplasms
A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy.
Neoplasms
A Triad of Telomerase, Androgen Receptor and Early Growth Response 1 in Prostate Cancer Cells.
Neoplasms
A triple helix within a pseudoknot is a conserved and essential element of telomerase RNA.
Neoplasms
A triple-amplification strategy for sensitive detection of telomerase at the single-cell level.
Neoplasms
A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type.
Neoplasms
A Unique Immunofluorescence Protocol to Detect Protein Expression in Vascular Tissues: Tacking a Long Standing Pathological Hitch.
Neoplasms
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.
Neoplasms
AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
Neoplasms
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Neoplasms
Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Neoplasms
Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Neoplasms
Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
Neoplasms
Abrupt disruption of capping and a single source for recombinationally elongated telomeres in Kluyveromyces lactis.
Neoplasms
Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Neoplasms
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
Neoplasms
Absence of correlation between telomerase activity and hepatic neoplasia in B6C3F1 mice.
Neoplasms
Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures.
Neoplasms
Absence of telomerase activity in malignant bone tumors and soft-tissue sarcomas.
Neoplasms
Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Neoplasms
Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
Neoplasms
Accurate Identification and Early Diagnosis of Osteosarcoma through CRISPR-Cas12a-Based Average Telomerase Activity Detection.
Neoplasms
Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression.
Neoplasms
Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
Neoplasms
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma.
Neoplasms
Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Neoplasms
Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.
Neoplasms
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Neoplasms
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
Neoplasms
Activation of telomerase is induced by a natural antigen in allergen-specific memory T lymphocytes in bronchial asthma.
Neoplasms
Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.
Neoplasms
Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification.
Neoplasms
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.
Neoplasms
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Neoplasms
Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer.
Neoplasms
Activity of the upstream component of tandem TERT/survivin promoters depends on features of the downstream component.
Neoplasms
Activity of Wnt/PCP Regulation Pathway Classifies Patients of Low-Grade Glioma Into Molecularly Distinct Subgroups With Prognostic Difference.
Neoplasms
ACV-TP-T, a thymidine analogue pro-drug activated by telomerase, reduces pancreatic tumor growth in mice.
Neoplasms
Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Neoplasms
ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells.
Neoplasms
Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma.
Neoplasms
Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations.
Neoplasms
Adenoviral mediated transduction of adenoid cystic carcinoma by human TRAIL gene driven with hTERT tumor specific promoter induces apoptosis.
Neoplasms
Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro.
Neoplasms
Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Neoplasms
Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
Neoplasms
Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.
Neoplasms
Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner.
Neoplasms
Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.
Neoplasms
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).
Neoplasms
Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Neoplasms
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Neoplasms
Affinity chromatography of RNA-dependent DNA polymerase from RNA tumor viruses on a solid phase immunoadsorbent.
Neoplasms
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.
Neoplasms
Aging of tissue-resident adult stem/progenitor cells and their pathological consequences.
Neoplasms
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC.
Neoplasms
Airborne polychlorinated biphenyls (PCBs) reduce telomerase activity and shorten telomere length in immortal human skin keratinocytes (HaCat).
Neoplasms
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Neoplasms
ALK-Positive Inflammatory Myofibroblastic Tumor of the Abdomen With Widespread Microscopic Multifocality.
Neoplasms
All-atomic simulations on human telomeric G-quadruplex DNA binding with thioflavin T.
Neoplasms
All-trans retinoic acid (atra) inhibits telomerase expression of BeWo choriocarcinoma cell (ATCC CCL-98).
Neoplasms
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
Neoplasms
Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
Neoplasms
Aloe emodin inhibits telomerase activity in breast cancer cells: transcriptional and enzymological mechanism.
Neoplasms
ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.
Neoplasms
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
Neoplasms
ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
Neoplasms
ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas.
Neoplasms
Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.
Neoplasms
Alteration of Telomere Length and Subtelomeric Methylation in Human Endothelial Cells under Different Levels of Hypoxia.
Neoplasms
Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Neoplasms
Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Neoplasms
Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication.
Neoplasms
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
Neoplasms
Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Neoplasms
Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Neoplasms
Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Neoplasms
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Neoplasms
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Neoplasms
Alternative lengthening of telomeres pathway: Recombination-mediated telomere maintenance mechanism in human cells.
Neoplasms
Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
Neoplasms
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Neoplasms
Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks.
Neoplasms
Alternative mechanisms of telomere lengthening: Permissive mutations, DNA repair proteins and tumorigenic progression.
Neoplasms
Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
Neoplasms
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.
Neoplasms
Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.
Neoplasms
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Neoplasms
Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation.
Neoplasms
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.
Neoplasms
Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells.
Neoplasms
Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice.
Neoplasms
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
Neoplasms
Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas.
Neoplasms
Amplification of MYCL in Atypical Ewing Tumor. Analysis of Metaphase and Microarray Comparative Genomic Hybridization.
Neoplasms
Amplification of telomerase reverse transcriptase gene in human mammary epithelial cells with limiting telomerase RNA expression levels.
Neoplasms
Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.
Neoplasms
Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.
Neoplasms
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.
Neoplasms
Amplification of the telomerase RNA component gene in the process of human esophageal carcinogenesis.
Neoplasms
Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer.
Neoplasms
Amplified chemiluminescence surface detection of DNA and telomerase activity using catalytic nucleic acid labels.
Neoplasms
Amplified detection of telomerase activity using electrochemical and quartz crystal microbalance measurements.
Neoplasms
Amplified telomerase analysis by using rotating magnetic particles: the rapid and sensitive detection of cancer cells.
Neoplasms
An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1.
Neoplasms
An all-in-one telomerase assay based on CRISPR-Cas12a trans-cleavage while telomere synthesis.
Neoplasms
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
Neoplasms
An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 Subunit.
Neoplasms
An atomistic investigation on the interaction of distamycin A and its derivative with the telomeric G-Quadruplex as anticancer agents by molecular dynamics simulation.
Neoplasms
An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles.
Neoplasms
An Eimeria acervulina OTU protease exhibits linkage-specific deubiquitinase activity.
Neoplasms
An enzyme-free electrochemical biosensor based on well monodisperse Au nanorods for ultra-sensitive detection of telomerase activity.
Neoplasms
An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
Neoplasms
An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells.
Neoplasms
An exonuclease I hydrolysis assay for evaluating G-quadruplex stabilization by small molecules.
Neoplasms
An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Neoplasms
An in vitro investigation of immunomodulatory properties of Lactobacillus plantarum and L. delbrueckii cells and their extracellular polysaccharides.
Neoplasms
An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
Neoplasms
An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cells.
Neoplasms
An oligonucleotide affinity column for RNA-dependent DNA polymerase from RNA tumor viruses.
Neoplasms
An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.
Neoplasms
An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors.
Neoplasms
An Oncolytic Adenovirus Targeting Transforming Growth Factor ? Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
Neoplasms
An RNA-seq-based gene expression profiling of radiation-induced tumorigenic mammary epithelial cells.
Neoplasms
An ultra-sensitive colorimetric assay for reliable visual detection of telomerase activity.
Neoplasms
An ultrasensitive and point-of-care sensor for the telomerase activity detection.
Neoplasms
An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity.
Neoplasms
Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis.
Neoplasms
Analysis of endogenous and exogenous tumor upregulated promoter expression in canine tumors.
Neoplasms
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Neoplasms
Analysis of spontaneous tumor-specific CD4 T cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
Neoplasms
Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Neoplasms
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Neoplasms
Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Neoplasms
Analysis of telomerase by the telomeric hemin/g-quadruplex-controlled aggregation of au nanoparticles in the presence of cysteine.
Neoplasms
Analysis of telomeric repeats and telomerase activity in human colon carcinoma cells with gene amplification.
Neoplasms
Analysis of two mechanisms of telomere maintenance based on the theory of g-Networks and stochastic automata networks.
Neoplasms
Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.
Neoplasms
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.
Neoplasms
Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells.
Neoplasms
Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
Neoplasms
Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.
Neoplasms
Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation.
Neoplasms
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
Neoplasms
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft.
Neoplasms
Anti-inflammatory and anti-oxidative activities of lemon myrtle (Backhousia citriodora) leaf extract.
Neoplasms
Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis.
Neoplasms
Anti-Proliferative and Anti-Telomerase Effects of Blackberry Juice and Berry-Derived Polyphenols on HepG2 Liver Cancer Cells and Normal Human Blood Mononuclear Cells.
Neoplasms
Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in Zebrafish.
Neoplasms
Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells.
Neoplasms
Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
Neoplasms
Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
Neoplasms
Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells.
Neoplasms
Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
Neoplasms
Antiangiogenesis gene armed tumor-targeting adenovirus yields multiple antitumor activities in human HCC xenografts in nude mice.
Neoplasms
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses.
Neoplasms
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.
Neoplasms
Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen.
Neoplasms
Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length.
Neoplasms
Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Neoplasms
Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells.
Neoplasms
Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.
Neoplasms
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Neoplasms
Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma.
Neoplasms
Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
Neoplasms
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
Neoplasms
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation.
Neoplasms
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer.
Neoplasms
Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma.
Neoplasms
Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells.
Neoplasms
Antitumor effect of a novel adeno-associated virus vector targeting to telomerase activity in tumor cells.
Neoplasms
Antitumor effect of COOH-terminal polypeptide of human TERT is associated with the declined expression of hTERT and NF-?B p65 in HeLa cells.
Neoplasms
Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression.
Neoplasms
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of hTERT.
Neoplasms
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Neoplasms
Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
Neoplasms
Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
Neoplasms
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer.
Neoplasms
Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts.
Neoplasms
Apoptosis and reduced cell proliferation of HL-60 cell line caused by human telomerase reverse transcriptase inhibition by siRNA.
Neoplasms
Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
Neoplasms
Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
Neoplasms
Application of a Y-type-DNA-functionalized nanogold probe featuring specific telomerase recognition and doxorubicin release in cancer cells.
Neoplasms
Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression.
Neoplasms
Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid.
Neoplasms
Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes.
Neoplasms
Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.
Neoplasms
ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
Neoplasms
Aromatic core extension in the series of N-cyclic bay-substituted perylene G-quadruplex ligands: increased telomere damage, antitumor activity, and strong selectivity for neoplastic over healthy cells.
Neoplasms
Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Neoplasms
Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Neoplasms
ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.
Neoplasms
Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Neoplasms
Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP).
Neoplasms
Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma.
Neoplasms
Assessment of telomerase activity in nonsegmental vitiligo tissue: a pilot study.
Neoplasms
Assessment of the Tumorigenic Potential of Spontaneously Immortalized and hTERT-Immortalized Cultured Dental Pulp Stem Cells.
Neoplasms
Assessment of tumourigenic potential in long-term cryopreserved human adipose-derived stem cells.
Neoplasms
Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Neoplasms
Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
Neoplasms
Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis.
Neoplasms
Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.
Neoplasms
Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.
Neoplasms
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Neoplasms
Association Between TERT rs2736098 Polymorphisms and Cancer Risk-A Meta-Analysis.
Neoplasms
Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls.
Neoplasms
Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
Neoplasms
Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line.
Neoplasms
Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk.
Neoplasms
Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.
Neoplasms
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
Neoplasms
Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Neoplasms
Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Neoplasms
Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases.
Neoplasms
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.
Neoplasms
Association of telomerase expression with successful heterotransplantation of lung cancer.
Neoplasms
Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.
Neoplasms
Associations between serum concentrations of perfluoroalkyl substances and DNA methylation in women exposed through drinking water: A pilot study in Ronneby, Sweden.
Neoplasms
Associations of TERT polymorphisms with hepatocellular carcinoma risk in a Han Chinese population.
Neoplasms
Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss.
Neoplasms
Attenuation of hyperplasia in lung parenchymal and colonic epithelial cells in DMBA-induced cancer by administering Andrographis paniculata Nees extract using animal model.
Neoplasms
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Neoplasms
Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
Neoplasms
Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Neoplasms
Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents.
Neoplasms
Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: Plausible predictive and diagnostic markers.
Neoplasms
Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Neoplasms
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Neoplasms
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.
Neoplasms
Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages.
Neoplasms
Azacitidine, as a DNMT inhibitor decreases hTERT gene expression and telomerase activity more effective compared with HDAC inhibitor in human Head and neck squamous cell carcinoma cell lines.
Neoplasms
Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors.
Neoplasms
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture.
Neoplasms
AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model.
Neoplasms
B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-?B.
Neoplasms
Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence.
Neoplasms
Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3.
Neoplasms
Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
Neoplasms
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
Neoplasms
Benzo[a]pyrene decreases global and gene specific DNA methylation during zebrafish development.
Neoplasms
Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116.
Neoplasms
beta-Lapachone (LAPA) Decreases Cell Viability and Telomerase Activity in Leukemia Cells: Suppression of Telomerase Activity by LAPA.
Neoplasms
Bidirectional regulation of telomerase activity in a subline derived from human lung adenocarcinoma.
Neoplasms
Binding of anticancer drug adriamycin to parallel G-quadruplex DNA [d-(TTAGGGT)]4 comprising human telomeric DNA leads to thermal stabilization: A multiple spectroscopy study.
Neoplasms
Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation.
Neoplasms
Binding properties of avian myeloblastosis virus DNA polymerases to nucleic acid affinity columns.
Neoplasms
Binding Studies of G-Quadruplex DNA and Porphyrins: Cu(T4) vs Sterically Friendly Cu(tD4).
Neoplasms
Biochemical and electron microscopical evidence for the presence of oncorna viruses in spleen tissue from two patients with haematological malignancies.
Neoplasms
Biochemical and immunological characterization of Suncus murinus mammary tumor virus DNA polymerase.
Neoplasms
Biodegradable Black Phosphorus Nanosheets Mediate Specific Delivery of hTERT siRNA for Synergistic Cancer Therapy.
Neoplasms
Biological and clinical implications of telomere dysfunction in myeloid malignancies.
Neoplasms
Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
Neoplasms
Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Neoplasms
Biological Differential Diagnosis of Follicular Thyroid Tumor and Hürthle Cell Tumor on the Basis of Telomere Length and hTERT Expression.
Neoplasms
Biological factors and therapeutic modulation in radiotherapy of head and neck cancer.
Neoplasms
Biological significance of PinX1 telomerase inhibitor in esophageal carcinoma treatment.
Neoplasms
Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.
Neoplasms
Biomedical applications of nanoflares: Targeted intracellular fluorescence probes.
Neoplasms
Biopsy diagnosis of malignant versus benign liver "nodules": new helpful markers. An update.
Neoplasms
Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
Neoplasms
Bioreducible polymer-delivered siRNA targeting human telomerase reverse transcriptase for human cancer gene therapy.
Neoplasms
Biosensor Techniques Used for Determination of Telomerase Activity in Cancer Cells.
Neoplasms
Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Neoplasms
Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.
Neoplasms
Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.
Neoplasms
Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity.
Neoplasms
Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Neoplasms
BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells.
Neoplasms
Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Neoplasms
Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.
Neoplasms
Bovine herpesvirus type 1 (BHV-1) up-regulates telomerase activity in MDBK cells.
Neoplasms
Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Neoplasms
Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice.
Neoplasms
Brca2 abrogation engages with the alternative lengthening of telomeres via break-induced replication.
Neoplasms
Breast Field Cancerization: Isolation and Comparison of Telomerase Expressing Cells in Tumor and Tumor Adjacent, Histologically Normal Breast Tissue.
Neoplasms
BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Neoplasms
BRIT-1 expression and its relationship with PARP-1 and CAF-1/p60 in cutaneous melanoma.
Neoplasms
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.
Neoplasms
Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Neoplasms
BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.
Neoplasms
Bufalin Induces Mitochondria-Dependent Apoptosis in Pancreatic and Oral Cancer Cells by Downregulating hTERT Expression via Activation of the JNK/p38 Pathway.
Neoplasms
Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA.
Neoplasms
Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
Neoplasms
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas.
Neoplasms
C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
Neoplasms
C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.
Neoplasms
Campesin, a thermostable antifungal peptide with highly potent antipathogenic activities.
Neoplasms
Camptothecin shows better promise than Curcumin in the inhibition of the Human Telomerase: A computational study.
Neoplasms
Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells?
Neoplasms
Cancer cell dynamics in presence of telomerase inhibitors: analysis of in vitro data.
Neoplasms
Cancer Cell Targeting with Mouse TERT-Specific Group I Intron of Tetrahymena thermophila.
Neoplasms
Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.
Neoplasms
Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.
Neoplasms
Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Neoplasms
Cancer-specific induction of adenoviral E1A expression by group I intron-based trans-splicing ribozyme.
Neoplasms
Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.
Neoplasms
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.
Neoplasms
Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Neoplasms
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Neoplasms
Candidate chromosomal regions for genes involved in activation of alternative lengthening of telomeres in human immortal cell lines.
Neoplasms
Canis familiaris telomerase reverse transcriptase undergoes alternative splicing.
Neoplasms
Carbon Nanocage/Fe3O4/DNA-Based Magnetically Targeted Intracellular Imaging of Telomerase via Catalyzed Hairpin Assembly and Photodynamic-Photothermal Combination Therapy of Tumor Cells.
Neoplasms
Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer.
Neoplasms
Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers.
Neoplasms
Cascaded Electrochemiluminescence Signal Amplifier for the Detection of Telomerase Activity from Tumor Cells and Tissues.
Neoplasms
Catalytic assembly of DNA nanostructures on a nanoporous gold array as 3D architectures for label-free telomerase activity sensing.
Neoplasms
Catalytic Hairpin Assembly-Assisted Rolling Circle Amplification for High-Sensitive Telomerase Activity Detection.
Neoplasms
Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase.
Neoplasms
Catechin from Burkea africana Hook. Exhibits in vitro inhibition of human telomerase activity.
Neoplasms
CCR7-expressing B16 melanoma cells downregulate interferon-?-mediated inflammation and increase lymphangiogenesis in the tumor microenvironment.
Neoplasms
CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors.
Neoplasms
Cdc42/Rac1 participates in the control of telomerase activity in human nasopharyngeal cancer cells.
Neoplasms
CDK1 differentially regulates G-overhang generation at leading- and lagging-strand telomeres in telomerase-negative cells in G 2 phase.
Neoplasms
CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Neoplasms
Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres.
Neoplasms
Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
Neoplasms
Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation.
Neoplasms
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.
Neoplasms
Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Neoplasms
Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics.
Neoplasms
Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.
Neoplasms
Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.
Neoplasms
Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
Neoplasms
Cellular immortality in brain tumours: An integration of the cancer stem cell paradigm.
Neoplasms
Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products.
Neoplasms
Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer.
Neoplasms
Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells.
Neoplasms
Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres.
Neoplasms
Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.
Neoplasms
Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer.
Neoplasms
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.
Neoplasms
Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound.
Neoplasms
Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome.
Neoplasms
Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Neoplasms
Changes in telomere length distribution in low-dose X-ray-irradiated human umbilical vein endothelial cells.
Neoplasms
Changes in the Expression of Pre-Replicative Complex Genes in hTERT and ALT Pediatric Brain Tumors.
Neoplasms
Changes of Telomerase Activity and Proliferation by Inhibition of Reverse Transcriptase Activity in Human Cancer Cell.
Neoplasms
Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.
Neoplasms
Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker.
Neoplasms
Characteristics of the major internal protein and RNA-dependent DNA polymerase of bovine leukaemia virus.
Neoplasms
CHARACTERISTICS OF TUMORS THAT DEVELOPED IN MICE AFTER TREATMENT WITH IRRADIATED SYNGENEIC MESENCHYMAL STEM CELLS OF BONE MARROW.
Neoplasms
Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor.
Neoplasms
Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins.
Neoplasms
Characterization and function of CREB homologue from Crassostrea ariakensis stimulated by rickettsia-like organism.
Neoplasms
Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells.
Neoplasms
Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
Neoplasms
Characterization of a hTERT sequence containing two antigentic epitopes with high affinity for HLA molecule.
Neoplasms
Characterization of a human telomerase reverse transcriptase sequence containing two antigenic epitopes with high affinity for human leucocyte antigen.
Neoplasms
Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
Neoplasms
Characterization of DNA polymerase and RNA associated with A-type particles from murine myeloma cells.
Neoplasms
Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non?small cell lung cancer.
Neoplasms
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
Neoplasms
Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies.
Neoplasms
Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Neoplasms
Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
Neoplasms
Characterization of Telomerase (hTERT) in Solid and Hematopoietic Cancer Cell Lines Reveals Different Expression Patterns.
Neoplasms
Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions.
Neoplasms
Chemical shift assignments and the secondary structure of the Est3 telomerase subunit in the yeast Hansenula polymorpha.
Neoplasms
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA.
Neoplasms
Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours.
Neoplasms
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatment.
Neoplasms
Chimeric bifunctional oligonucleotides as a novel tool to invade telomerase assembly.
Neoplasms
Chiral ruthenium(II) polypyridyl complexes: stabilization of g-quadruplex DNA, inhibition of telomerase activity and cellular uptake.
Neoplasms
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.
Neoplasms
Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
Neoplasms
Chromosomal disruption and rearrangements during murine sarcoma development converge to stable karyotypic formation kept by telomerase overexpression.
Neoplasms
Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: Effect of p53.
Neoplasms
Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.
Neoplasms
Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.
Neoplasms
Chronic in vitro exposure to 3'-azido-2', 3'-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells.
Neoplasms
Circadian telomerase activity and DNA synthesis for timing peptide administration.
Neoplasms
Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads.
Neoplasms
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.
Neoplasms
Circulating tumor cells are associated with recurrent disease in patients with early stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Neoplasms
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.
Neoplasms
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
Neoplasms
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Neoplasms
Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Neoplasms
Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Neoplasms
Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
Neoplasms
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Neoplasms
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Neoplasms
Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer.
Neoplasms
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer.
Neoplasms
Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Neoplasms
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
Neoplasms
Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Neoplasms
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Neoplasms
Clinical significance and usefulness of quantification of telomerase activity in oral malignant and nonmalignant lesions.
Neoplasms
Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Neoplasms
Clinical significance of hTERC and C-Myc genes amplification in a group of Egyptian patients with cancer cervix.
Neoplasms
Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
Neoplasms
Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
Neoplasms
Clinical significance of telomerase activity in biopsy specimens of gastric cancer.
Neoplasms
Clinical significance of telomerase activity in gastric carcinoma and peritoneal dissemination.
Neoplasms
Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers.
Neoplasms
Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma.
Neoplasms
Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
Neoplasms
Clinical significance of telomerase genes (hTERC and hTERT) amplification in patients with acute myeloid leukemia.
Neoplasms
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Neoplasms
Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Neoplasms
Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
Neoplasms
Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy.
Neoplasms
Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
Neoplasms
Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Neoplasms
Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Neoplasms
Clinicopathological Analysis of HIF-1alpha and TERT on Survival Outcome in Glioblastoma Patients: A Prospective, Single Institution Study.
Neoplasms
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma.
Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasms
Clonal cell populations unresponsive to radiosensitization induced by telomerase inhibition.
Neoplasms
Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines.
Neoplasms
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences.
Neoplasms
Cloning of hTERT cDNA fragment and application of anti-hTERT monoclonal antibody in mechanism of laryngeal carcinogenesis.
Neoplasms
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
Neoplasms
Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells.
Neoplasms
Co-expression of interleukin 12 enhances antitumor effects of a novel chimeric promoter-mediated suicide gene therapy in an immunocompetent mouse model.
Neoplasms
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy.
Neoplasms
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Neoplasms
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.
Neoplasms
Coevolution of telomerase activity and body mass in mammals: From mice to beavers.
Neoplasms
Coexistence of BRAF V600E and TERT Promoter Mutations in Low-grade Serous Carcinoma of Ovary Recurring as Carcinosarcoma in a Lymph Node: Report of a Case.
Neoplasms
Cognitive performance in survivors of breast cancer and markers of biological aging.
Neoplasms
Coilin phosphomutants disrupt Cajal body formation, reduce cell proliferation and produce a distinct coilin degradation product.
Neoplasms
Cold-inducible RNA-binding protein CIRP/hnRNP A18 regulates telomerase activity in a temperature-dependent manner.
Neoplasms
Colonic Diverticula Are Not Associated With Mucosal Inflammation or Chronic Gastrointestinal Symptoms.
Neoplasms
Colorectal Cancer Stem Cell States Uncovered by Simultaneous Single-Cell Analysis of Transcriptome and Telomeres.
Neoplasms
Combating oxidative stress as a hallmark of cancer and aging: Computational modeling and synthesis of phenylene diamine analogs as potential antioxidant.
Neoplasms
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination based on hTERT and survivin following ASCT for myeloma.
Neoplasms
Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
Neoplasms
Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
Neoplasms
Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma.
Neoplasms
Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy.
Neoplasms
Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Neoplasms
Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.
Neoplasms
Combination treatment with flavonoid morin and telomerase inhibitor MST?312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
Neoplasms
Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors.
Neoplasms
Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.
Neoplasms
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Neoplasms
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Neoplasms
Combined effect of cigarette smoke and mineral fibers on the gene expression of cytokine mRNA.
Neoplasms
Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Neoplasms
Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Neoplasms
Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
Neoplasms
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Neoplasms
Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Neoplasms
Comparative functional study of the viral telomerase RNA based on natural mutations.
Neoplasms
Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas.
Neoplasms
Comparative study of ¹?F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis.
Neoplasms
Comparing the Role of the p53 Gene and Telomerase Enzyme in 'Accelerated Aging Due to Cancer': A Literature Review.
Neoplasms
Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics.
Neoplasms
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Neoplasms
Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer.
Neoplasms
Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Neoplasms
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
Neoplasms
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Neoplasms
Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Neoplasms
Comparison of telomerase levels before and after differentiation of two cell lines of human neuroblastoma.
Neoplasms
Comparison of Telomere Length and Telomerase Activation between Breast Fibroadenoma and Infiltrating Ductal Carcinoma in Malaysian Women.
Neoplasms
Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
Neoplasms
Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
Neoplasms
Comprehensive Analysis of Interaction Networks of Telomerase Reverse Transcriptase with Multiple Bioinformatic Approaches: Deep Mining the Potential Functions of Telomere and Telomerase.
Neoplasms
Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
Neoplasms
Computational selection and experimental validation of allosteric ribozymes that sense a specific sequence of human telomerase reverse transcriptase mRNAs as universal anticancer therapy agents.
Neoplasms
Concatenated Catalytic Hairpin Assembly/Hyperbranched Hybridization Chain Reaction Based Enzyme-Free Signal Amplification for the Sensitive Photoelectrochemical Detection of Human Telomerase RNA.
Neoplasms
Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells.
Neoplasms
Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
Neoplasms
Concordant expression of the telomerase-associated genes in non-small cell lung cancer.
Neoplasms
Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix.
Neoplasms
Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.
Neoplasms
Conditional telomerase induction causes proliferation of hair follicle stem cells.
Neoplasms
Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF.
Neoplasms
Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
Neoplasms
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.
Neoplasms
Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Neoplasms
Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Neoplasms
Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.
Neoplasms
Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes.
Neoplasms
Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice.
Neoplasms
Construction of AIEgens-Based Bioprobe with Two Fluorescent Signals for Enhanced Monitor of Extracellular and Intracellular Telomerase Activity.
Neoplasms
Construction of the POT1 promoter report gene vector, and the effect and underlying mechanism of the POT1 promoter in regulating telomerase and telomere length.
Neoplasms
Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
Neoplasms
Contribution of telomere G-quadruplex stabilization to the inhibition of telomerase-mediated telomere extension by chemical ligands.
Neoplasms
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
Neoplasms
Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.
Neoplasms
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Neoplasms
Control of telomere length by a trimming mechanism that involves generation of t-circles.
Neoplasms
Convertible DNA ends-based silver nanoprobes for colorimetric detection human telomerase activity.
Neoplasms
Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.
Neoplasms
Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells.
Neoplasms
Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer.
Neoplasms
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Neoplasms
Correction to: Polymorphisms within the Telomerase Reverse Transcriptase gene (TERT) in four breeds of dogs selected for difference in lifespan and cancer susceptibility.
Neoplasms
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.
Neoplasms
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
Neoplasms
Correlation between morphology and telomerase activity in cells from exfoliative lung cytologic specimens.
Neoplasms
Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
Neoplasms
Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Neoplasms
Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma.
Neoplasms
Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining method.
Neoplasms
Correlation of dyskerin expression with active proliferation independent of telomerase.
Neoplasms
Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
Neoplasms
Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Neoplasms
Correlation of telomerase activity to apoptosis and survival in adult acute lymphoblastic leukemia: an Egyptian single-center study.
Neoplasms
Correlation of telomerase activity with development and progression of adult T-cell leukemia.
Neoplasms
Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Neoplasms
Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors.
Neoplasms
Correlations between the expression of hTERT and ? and ? splice variants in human brain tumors.
Neoplasms
Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
Neoplasms
Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Neoplasms
Correspondence re: S. M. Melana et al., Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res., 4: 693-696, 1998.
Neoplasms
Correspondence re: Seki et al., Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
Neoplasms
Cost-Effective Trap qPCR Approach to Evaluate Telomerase Activity: an Important Tool for Aging, Cancer, and Chronic Disease Research.
Neoplasms
Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Neoplasms
Coupling a DNA-Based Machine with Glucometer Readouts for Amplified Detection of Telomerase Activity in Cancer Cells.
Neoplasms
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Neoplasms
Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1.
Neoplasms
CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.
Neoplasms
CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery.
Neoplasms
Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
Neoplasms
Cross-Platform Cancer Cell Identification Using Telomerase-Specific Spherical Nucleic Acids.
Neoplasms
Cryptic EWSR1-FLI1 fusions in Ewing sarcoma: potential pitfalls in the diagnostic use of fluorescence in situ hybridization probes.
Neoplasms
Crystal structures of N-terminally truncated telomerase reverse transcriptase from fungi.
Neoplasms
CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: Identification of a novel enhancer region involved in the regulation of TERT gene.
Neoplasms
Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis.
Neoplasms
Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells.
Neoplasms
Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.
Neoplasms
Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity.
Neoplasms
Current Perspectives of Telomerase Structure and Function in Eukaryotes with Emerging Views on Telomerase in Human Parasites.
Neoplasms
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.
Neoplasms
Cyst fluid telomerase activity predicts the histologic grade of cystic neoplasms of the pancreas.
Neoplasms
Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Neoplasms
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Neoplasms
Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens.
Neoplasms
Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid.
Neoplasms
Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
Neoplasms
Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro.
Neoplasms
Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells.
Neoplasms
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
Neoplasms
Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients.
Neoplasms
ddTRAP: A Method for Sensitive and Precise Quantification of Telomerase Activity.
Neoplasms
Deactivation of Telomerase Enzyme and Telomere Destabilization by Natural Products: a Potential Target for Cancer Green Therapy.
Neoplasms
Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.
Neoplasms
Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.
Neoplasms
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
Neoplasms
Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells.
Neoplasms
Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.
Neoplasms
Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
Neoplasms
Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
Neoplasms
Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Neoplasms
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumors.
Neoplasms
Decreased production of transforming virus and altered antigenic behaviour in cultured avian sarcoma cells.
Neoplasms
Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Neoplasms
Decreasing telomerase activity of adenocarcinoma cancer cell line (AGS) is associated with different concentrations of sodium selenite and cadmium chloride and selenium l methionine.
Neoplasms
Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression.
Neoplasms
Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Neoplasms
Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma.
Neoplasms
Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.
Neoplasms
Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth.
Neoplasms
Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Neoplasms
Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
Neoplasms
Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe.
Neoplasms
Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma.
Neoplasms
Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Neoplasms
Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors.
Neoplasms
Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells.
Neoplasms
Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.
Neoplasms
Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
Neoplasms
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Neoplasms
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
Neoplasms
Design and development of PCR-free highly sensitive electrochemical assay for detection of telomerase activity using Nano-based (liposomal) signal amplification platform.
Neoplasms
Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells.
Neoplasms
Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.
Neoplasms
Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif.
Neoplasms
Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Neoplasms
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Neoplasms
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis.
Neoplasms
Detection of activity of telomerase in tumor cells using fiber optical biosensors.
Neoplasms
Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers.
Neoplasms
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay.
Neoplasms
Detection of breast cancer cells in the bone marrow or peripheral blood: methods and prognostic significance.
Neoplasms
Detection of cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
Neoplasms
Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
Neoplasms
Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
Neoplasms
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.
Neoplasms
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20.
Neoplasms
Detection of cytochrome P450-2A6, -3A5 and -4B1 with real-time polymerase chain reaction in prostate tissue.
Neoplasms
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Neoplasms
Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Neoplasms
Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer: Results from Cancer and Leukemia Group B 159902.
Neoplasms
Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Neoplasms
Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Neoplasms
Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Neoplasms
Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Neoplasms
Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity.
Neoplasms
Detection of micrometastasis through tissue-specific gene expression: its promise and problems.
Neoplasms
Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
Neoplasms
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.
Neoplasms
Detection of telomerase activity by the TRAP assay and its variants and alternatives.
Neoplasms
Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
Neoplasms
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Neoplasms
Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
Neoplasms
Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium.
Neoplasms
Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
Neoplasms
Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Neoplasms
Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression.
Neoplasms
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.
Neoplasms
Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads.
Neoplasms
Detection of telomerase activity in psoriasis lesional skin and correlation with Ki-67 expression and suppression by retinoic acid.
Neoplasms
Detection of telomerase by in situ hybridization and by the polymerase chain reaction-based telomerase activity assay.
Neoplasms
Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression.
Neoplasms
Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers.
Neoplasms
Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Neoplasms
Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Neoplasms
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.
Neoplasms
Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients.
Neoplasms
Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
Neoplasms
Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Neoplasms
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration.
Neoplasms
Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
Neoplasms
Determination of telomerase activity in stem cells and non-stem cells of breast cancer.
Neoplasms
Determination of telomere length and telomerase activity in cattle infected with bovine leukaemia virus (BLV).
Neoplasms
Determination of the activity of telomerase in cancer cells by using BSA-protected gold nanoclusters as a fluorescent probe.
Neoplasms
Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma.
Neoplasms
Development and immunopathological characteristics of an Alternaria-induced chronic rhinosinusitis mouse model.
Neoplasms
Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse-transcriptase beta-plus transcript.
Neoplasms
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Neoplasms
Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival.
Neoplasms
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
Neoplasms
Development of a novel telomerase assay using the PPDK-luciferin-luciferase detection system.
Neoplasms
Development of Automated Microscopy-Assisted High-Content Multiparametric Assays for Cell Cycle Staging and Foci Quantitation.
Neoplasms
Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere.
Neoplasms
Development of quantum-dot-encapsulated liposome-based optical nanobiosensor for detection of telomerase activity without target amplification.
Neoplasms
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.
Neoplasms
Developmental regulation of telomerase activity in human fetal tissues during gestation.
Neoplasms
Dexamethasone effect on the growth rate, the plasminogen activator, and the MMTV RNA dependent DNA polymerase in a mouse mammary tumor cell line.
Neoplasms
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Neoplasms
Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT.
Neoplasms
Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
Neoplasms
Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.
Neoplasms
Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.
Neoplasms
Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
Neoplasms
Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Neoplasms
Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer.
Neoplasms
Diagnostic Value of Methylated Human Telomerase Reverse Transcriptase in Human Cancers: A Meta-Analysis.
Neoplasms
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Neoplasms
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.
Neoplasms
Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitro.
Neoplasms
Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
Neoplasms
Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer.
Neoplasms
Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
Neoplasms
Different assessments of immunohistochemically stained Ki-67 and hTERT in glioblastoma multiforme yield variable results: a study with reference to survival prognosis.
Neoplasms
Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
Neoplasms
Different roles of p53 in the regulation of DNA damage caused by 1,2-heteroannelated anthraquinones and doxorubicin.
Neoplasms
Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Neoplasms
Differential Control of Growth, Apoptotic Activity, and Gene Expression in Human Breast Cancer Cells by Extracts Derived from Medicinal Herbs Zingiber officinale.
Neoplasms
Differential cytotoxic effects of sodium meta-arsenite on human cancer cells, dental papilla stem cells and somatic cells correlate with telomeric properties and gene expression.
Neoplasms
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Neoplasms
Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
Neoplasms
Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow.
Neoplasms
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Neoplasms
Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
Neoplasms
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
Neoplasms
Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
Neoplasms
Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene.
Neoplasms
Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation.
Neoplasms
Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture.
Neoplasms
Differential Lysis of Tumors by Polyclonal T Cell Lines and T Cell Clones Specific for hTERT.
Neoplasms
Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.
Neoplasms
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.
Neoplasms
Differential regulation of telomerase activity and TERT expression during brain development in mice.
Neoplasms
Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.
Neoplasms
Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms.
Neoplasms
Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors.
Neoplasms
Differential telomerase expression and telomere length in primary intracranial tumors.
Neoplasms
Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Neoplasms
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis.
Neoplasms
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Neoplasms
Differentially expressed genes throughout the cellular immortalization processes are quite different between normal human fibroblasts and endothelial cells.
Neoplasms
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Neoplasms
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
Neoplasms
Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
Neoplasms
Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line.
Neoplasms
Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation.
Neoplasms
Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS.
Neoplasms
Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Neoplasms
Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
Neoplasms
Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Neoplasms
Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma.
Neoplasms
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells.
Neoplasms
Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential.
Neoplasms
Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
Neoplasms
Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
Neoplasms
Distinct TERT promoter C228T and C250T mutations in a patient with an oligodendroglioma: A case report.
Neoplasms
Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan.
Neoplasms
Distribution and prognostic significance of human telomerase reverse transcriptase (hTERT) expression in giant-cell tumor of bone.
Neoplasms
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Neoplasms
Disubstituted 2-phenyl-benzopyranopyrimidine derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
Neoplasms
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Neoplasms
DNA damaging bystander signalling from stem cells, cancer cells and fibroblasts after Cr(VI) exposure and its dependence on telomerase.
Neoplasms
DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.
Neoplasms
DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Neoplasms
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Neoplasms
DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives.
Neoplasms
DNA repair proteins and telomerase reverse transcriptase in the cochlear lateral wall of cisplatin-treated rats.
Neoplasms
DNA tetrahedral scaffolds-based platform for the construction of electrochemiluminescence biosensor.
Neoplasms
DNA-fueled molecular machine for label-free and non-enzymatic ultrasensitive detection of telomerase activity.
Neoplasms
DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Neoplasms
Does structural commonality of metal complex formation by PAC-1 (anticancer), DHBNH (anti-HIV), AHL (autoinducer), and UCS1025A (anticancer) denote mechanistic similarity? Signal transduction and medical aspects.
Neoplasms
Does telomerase reverse transcriptase induce functional de-differentiation of human endothelial cells?
Neoplasms
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Neoplasms
Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Neoplasms
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Neoplasms
Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells.
Neoplasms
Down-regulation of telomerase activity by anticancer drugs in human ovarian cancer cells.
Neoplasms
Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol.
Neoplasms
Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Neoplasms
Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes.
Neoplasms
Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells.
Neoplasms
Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.
Neoplasms
Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.
Neoplasms
Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.
Neoplasms
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Neoplasms
Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
Neoplasms
Dramatic increase of telomerase activity during dendritic cell differentiation and maturation.
Neoplasms
Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Neoplasms
Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.
Neoplasms
Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]4 containing human telomeric DNA sequence induces thermal stabilization.
Neoplasms
Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models.
Neoplasms
Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT.
Neoplasms
Dual-Mode Au Nanoprobe Based on Surface Enhancement Raman Scattering and Colorimetry for Sensitive Determination of Telomerase Activity Both in Cell Extracts and in the Urine of Patients.
Neoplasms
Dynamics of human telomerase RNA structure revealed by antisense oligonucleotide technique.
Neoplasms
Dynamics of telomere erosion in transformed and non-transformed avian cells in vitro.
Neoplasms
Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.
Neoplasms
Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation.
Neoplasms
Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Neoplasms
Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
Neoplasms
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Neoplasms
Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
Neoplasms
Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.
Neoplasms
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: possible involvement in cancer-associated immunosuppression mechanism.
Neoplasms
E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
Neoplasms
E2F1 acts as a negative feedback regulator of c-Myc?induced hTERT transcription during tumorigenesis.
Neoplasms
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.
Neoplasms
Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
Neoplasms
Ectopic expression of c-myc fails to overcome downregulation of telomerase activity induced by herbimycin A, but ectopic hTERT expression overcomes it.
Neoplasms
Editorial retraction. Down-regulation of human telomerase reverse transcriptase through anti-c-myc siRNA in human colon cancer Colo 320 cells.
Neoplasms
Effect of 2'-deoxyisoguanosine on the growth of human tumor and normal cell lines.
Neoplasms
Effect of acetic acid on telomerase activity in cervical intraepithelial neoplasia.
Neoplasms
Effect of actinomycin D on nucleic acid hybridization: the cause of erroneous DNA elongation during DNA synthesis of RNA tumor viruses in vitro.
Neoplasms
Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells.
Neoplasms
Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma.
Neoplasms
Effect of blocking VEGF, hTERT and Bcl-xl by multiple shRNA expression vectors on the human laryngeal squamous carcinoma xenograft in nude mice.
Neoplasms
Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line.
Neoplasms
Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.
Neoplasms
Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 function.
Neoplasms
Effect of proinflammatory cytokines on the expression and regulation of human beta-defensin 2 in human dental pulp cells.
Neoplasms
Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Neoplasms
Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
Neoplasms
Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.
Neoplasms
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Neoplasms
Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.
Neoplasms
Effective gene-viral therapy for telomerase-positive cancers by selective replicative-competent adenovirus combining with endostatin gene.
Neoplasms
Effective Inhibition of Cancer Cell Growth by a Novel Tripartite Transfection Complex Containing Ribbon Antisense Molecules to hTR.
Neoplasms
Effectiveness of indomethacin as an antitumor agent in Colon 26-bearing conventional and nude mice, and telomerase activity in the tumors.
Neoplasms
Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray.
Neoplasms
Effects of AZT and RNA-protein complex (FA-2-b-beta) extracted from Liang Jin mushroom on apoptosis of gastric cancer cells.
Neoplasms
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Neoplasms
Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
Neoplasms
Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Neoplasms
Effects of Curcuminoid Pyrazoles on Cancer Cells and on the Expression of Telomerase Related Genes.
Neoplasms
Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line.
Neoplasms
Effects of gamma irradiation on cell cycle, apoptosis and telomerase activity in p53 wild-type and deficient HCT116 colon cancer cell lines.
Neoplasms
Effects of genomic imbalances on telomerase activity in gastric cancer: clues to telomerase regulation.
Neoplasms
Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells.
Neoplasms
Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model.
Neoplasms
Effects of PCB126 and PCB153 on telomerase activity and telomere length in undifferentiated and differentiated HL-60 cells.
Neoplasms
Effects of phosphorothioate anti-sense oligodeoxynucleotides on colorectal cancer cell growth and telomerase activity.
Neoplasms
Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells.
Neoplasms
Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Neoplasms
Effects of Reverse Transcriptase Inhibitors on Proliferation, Apoptosis, and Migration in Breast Carcinoma Cells.
Neoplasms
Effects of tea polyphenols on telomerase activity of a tongue cancer cell line: a preliminary study.
Neoplasms
Effects of telomerase activity on carcinogenesis and survival in laryngeal carcinoma.
Neoplasms
Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
Neoplasms
Effects of the central potassium ions on the G-quadruplex and stabilizer binding.
Neoplasms
Effects of three diterpenoids on tumour cell proliferation and telomerase activity.
Neoplasms
Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats.
Neoplasms
Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients.
Neoplasms
Efficient expression of recombinant human telomerase inhibitor 1 (hPinX1) in Pichia pastoris.
Neoplasms
Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Neoplasms
Efficient Inhibition of Human Telomerase Reverse Transcriptase Expression by RNA Interference Sensitizes Cancer Cells to Ionizing Radiation and Chemotherapy.
Neoplasms
Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy.
Neoplasms
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Neoplasms
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.
Neoplasms
EGFR Tyrosine Kinase Inhibitor Pelitinib Regulates Radiation-Induced p65-Dependent Telomerase Activation in Squamous Cell Carcinoma.
Neoplasms
eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase.
Neoplasms
Electrochemical determination of the activity and inhibition of telomerase based on the interaction of DNA with molybdate.
Neoplasms
Electron-transfer quenching of nucleic acid-functionalized CdSe/ZnS quantum dots by doxorubicin: A versatile system for the optical detection of DNA, aptamer-substrate complexes and telomerase activity.
Neoplasms
Electronic energy changes associated with Guanine quadruplex formation: an investigation at the atomic level.
Neoplasms
Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis.
Neoplasms
Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Neoplasms
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
Neoplasms
Embryo arrest and reactivation: potential candidates controlling embryonic diapause in the tammar wallaby and mink1.
Neoplasms
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Neoplasms
Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Neoplasms
Enantioselective Effects of o,p'-DDT on Cell Invasion and Adhesion of Breast Cancer Cells: Chirality in Cancer Development.
Neoplasms
Endogenous RNA-directed DNA polymerase activity in virions of RNA tumor viruses and in a fraction from normal chicken cells.
Neoplasms
Endogenous Telomerase Reverse Transcriptase N-Terminal Tagging Affects Human Telomerase Function at Telomeres In Vivo.
Neoplasms
Energetics of the human Tel-22 quadruplex-telomestatin interaction: a molecular dynamics study.
Neoplasms
Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Neoplasms
Enforced telomere elongation increases the sensitivity of human tumour cells to ionizing radiation.
Neoplasms
Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vaccination with chemotactic-hTERT gene-modified tumor cell and the combination with anti-4-1BB monoclonal antibodies.
Neoplasms
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Neoplasms
Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.
Neoplasms
Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study.
Neoplasms
Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L.
Neoplasms
Enhanced suicide gene therapy by chimeric tumor-specific promoter based on HSF1 transcriptional regulation.
Neoplasms
Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells.
Neoplasms
Enhancement of nanoparticle-mediated double suicide gene expression driven by 'E9-hTERT promoter' switch in dedifferentiated thyroid cancer cells.
Neoplasms
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.
Neoplasms
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity.
Neoplasms
Enterolactone Reduces Telomerase Activity and The Level of Its Catalytic Subunit in Breast Cancer Cells.
Neoplasms
Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells.
Neoplasms
Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation.
Neoplasms
Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer.
Neoplasms
Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway.
Neoplasms
Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
Neoplasms
Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia.
Neoplasms
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma.
Neoplasms
Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Neoplasms
Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.
Neoplasms
Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.
Neoplasms
Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review).
Neoplasms
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.
Neoplasms
Epigenetic targets of bioactive dietary components for cancer prevention and therapy.
Neoplasms
Epoxy-functionalized macroporous carbon with embedded platinum nanoparticles for electrochemical detection of telomerase activity via telomerase-triggered catalytic hairpin assembly.
Neoplasms
Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells.
Neoplasms
Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation.
Neoplasms
Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma.
Neoplasms
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.
Neoplasms
Erucin and Benzyl Isothiocyanate Suppress Growth of Late Stage Primary Human Ovarian Carcinoma Cells and Telomerase Activity In Vitro.
Neoplasms
Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver.
Neoplasms
Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis.
Neoplasms
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note.
Neoplasms
Establishment and characterization of a human cell line from paediatric cerebellar glioblastoma multiforme.
Neoplasms
Establishment and characterization of a new cell line derived from a human primary breast carcinoma.
Neoplasms
Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma.
Neoplasms
Establishment and characterization of MACL-1 and MGSO-3 cell lines derived from human primary breast cancer.
Neoplasms
Establishment and characterization of OCUT-1, an undifferentiated thyroid cancer cell line expressing high level of telomerase.
Neoplasms
Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
Neoplasms
Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies.
Neoplasms
Establishment of duck cell line derived from experimental tumor induced by 20-methylcholanthrene.
Neoplasms
Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
Neoplasms
Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.
Neoplasms
Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors.
Neoplasms
Estrogen Receptor-alpha Mediates the Effects of Estradiol on Telomerase Activity in Human Mesenchymal Stem Cells.
Neoplasms
Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes.
Neoplasms
Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
Neoplasms
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.
Neoplasms
Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs.
Neoplasms
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Neoplasms
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Neoplasms
Evaluation of combined h-TERT, bcl-2, and caspases 3 and 8 expression in cutaneous malignant melanoma based on tissue microarrays and computerized image analysis.
Neoplasms
Evaluation of Energy Balance on Human Telomerase Reverse Transcriptase (hTERT) Alternative Splicing by Semi-quantitative RT-PCR in Human Umbilical Vein Endothelial Cells.
Neoplasms
Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Neoplasms
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.
Neoplasms
Evaluation of serum human telomerase reverse transcriptase as a novel marker for cervical cancer.
Neoplasms
Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.
Neoplasms
Evaluation of telomerase activity in gingival fibroblasts of cyclosporine-treated patients.
Neoplasms
Evaluation of telomerase activity in patients with chronic B lymphocytic leukemia versus age matched controls. Correlation between telomerase activity and bone marrow infiltration.
Neoplasms
Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay.
Neoplasms
Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma.
Neoplasms
Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
Neoplasms
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Neoplasms
Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.
Neoplasms
Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
Neoplasms
Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers.
Neoplasms
Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles.
Neoplasms
Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Neoplasms
Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors.
Neoplasms
Evidence of particle-associated RNA-directed DNA polymerase and high molecular weight RNA in human gastrointestinal and lung malignancies.
Neoplasms
Evidence of recombinant ecotropic provirus integration in thymic lymphomas induced by direct or indirect radiation effects.
Neoplasms
Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.
Neoplasms
Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma.
Neoplasms
Exonuclease I manipulating primer-modified gold nanoparticles for colorimetric telomerase activity assay.
Neoplasms
Experimental infection of a cat kidney cell line with the mouse mammary tumor virus.
Neoplasms
Experimental study on anti-neoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas.
Neoplasms
Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.
Neoplasms
Exploring the mechanism of inhibition of human telomerase by cysteine-reactive compounds.
Neoplasms
Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.
Neoplasms
Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Neoplasms
Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma.
Neoplasms
Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Neoplasms
Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics.
Neoplasms
Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress.
Neoplasms
Expression of checkpoint kinase 2 in breast carcinomas: correlation with key regulators of tumor cell proliferation, angiogenesis, and survival.
Neoplasms
Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Neoplasms
Expression of functional alternative telomerase RNA component gene in mouse brain and in motor neurons cells protects from oxidative stress.
Neoplasms
Expression of HPV-16 E6 Protein and p53 Inactivation Increases the Uterine Cervical Cancer Invasion.
Neoplasms
Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway.
Neoplasms
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Neoplasms
Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation.
Neoplasms
Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma.
Neoplasms
Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms.
Neoplasms
Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.
Neoplasms
Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study.
Neoplasms
Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study with survivin and p53.
Neoplasms
Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
Neoplasms
Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
Neoplasms
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Neoplasms
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Neoplasms
Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Neoplasms
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
Neoplasms
Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease.
Neoplasms
Expression of targeted ribozyme against telomerase RNA causes altered expression of several other genes in tumor cells.
Neoplasms
Expression of telomerase & its significance in the diagnosis of pancreatic cancer.
Neoplasms
Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.
Neoplasms
Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas.
Neoplasms
Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation.
Neoplasms
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.
Neoplasms
Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
Neoplasms
Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.
Neoplasms
Expression of telomerase extends the lifespan and enhances osteogenic differentiation of adipose tissue-derived stromal cells.
Neoplasms
Expression of telomerase genes in cancer development in atypical hyperplasia of the mammary duct.
Neoplasms
Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts.
Neoplasms
Expression of telomerase reverse transcriptase in radiation-induced chronic human skin ulcer.
Neoplasms
Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.
Neoplasms
Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas.
Neoplasms
Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
Neoplasms
Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.
Neoplasms
Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection.
Neoplasms
Expression of telomerase-associated genes: reflection of telomerase activity in gastric cancer?
Neoplasms
Expression of Telomeres in Astrocytoma WHO Grade 2 to 4: TERRA Level Correlates with Telomere Length, Telomerase Activity, and Advanced Clinical Grade.
Neoplasms
Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Neoplasms
Expression of telomeric repeat binding factor 1 protein in nonsmall cell lung cancer with human telomerase reverse transcriptase positive.
Neoplasms
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
Neoplasms
Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Neoplasms
Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
Neoplasms
Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
Neoplasms
Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
Neoplasms
Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
Neoplasms
Expression of the immediate early IE180 protein under the control of the hTERT and CEA tumor-specific promoters in recombinant pseudorabies viruses: Effects of IE180 protein on promoter activity and apoptosis induction.
Neoplasms
Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells.
Neoplasms
Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.
Neoplasms
Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Neoplasms
Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Neoplasms
Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Neoplasms
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Neoplasms
Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.
Neoplasms
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Neoplasms
Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells.
Neoplasms
Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival.
Neoplasms
Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
Neoplasms
Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.
Neoplasms
Expression profiles of subtracted mRNAs during cellular senescence in human mesenchymal stem cells derived from bone marrow.
Neoplasms
Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes.
Neoplasms
Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Neoplasms
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.
Neoplasms
Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones.
Neoplasms
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress.
Neoplasms
Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.
Neoplasms
Extrachromosomal telomeric circles contribute to Rad52-, Rad50-, and polymerase delta-mediated telomere-telomere recombination in Saccharomyces cerevisiae.
Neoplasms
Facile assay of telomerase activity utilizing a DNA-detectable chemiluminogenic reagent.
Neoplasms
Facile synthesis of fluorescent tungsten oxide quantum dots for telomerase detection based on the inner filter effect.
Neoplasms
Facile, Fast-Responsive, and Photostable Imaging of Telomerase Activity in Living Cells with a Fluorescence Turn-On Manner.
Neoplasms
FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
Neoplasms
False elevation of human chorionic gonadotropin in a patient with testicular cancer.
Neoplasms
FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops.
Neoplasms
FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
Neoplasms
Fascinating chemo preventive story of wogonin: A chance to hit on the head in cancer treatment.
Neoplasms
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
Neoplasms
Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Neoplasms
Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line.
Neoplasms
Ferrocenylnaphthalene Diimide-Based Electrochemical Detection of Aberrant Methylation in hTERT Gene.
Neoplasms
Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.
Neoplasms
FIP-gts potentiate autophagic cell death against cisplatin-resistant urothelial cancer cells.
Neoplasms
FISH comets show that the salvage enzyme TK1 contributes to gene-specific DNA repair.
Neoplasms
Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia.
Neoplasms
Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells.
Neoplasms
Fluorescence detection of DNA, adenosine-5'-triphosphate (ATP), and telomerase activity by zinc(II)-protoporphyrin IX/G-quadruplex labels.
Neoplasms
Fluorescence detection of telomerase activity in cancer cell extracts based on autonomous exonuclease III-assisted isothermal cycling signal amplification.
Neoplasms
Fluorescence detection of telomerase activity in cancer cells based on isothermal circular strand-displacement polymerization reaction.
Neoplasms
Fluorescence detection of telomerase activity in high concentration of cell lysates based on strand-displacement mediated recycling.
Neoplasms
Fluorescence Imaging of Intracellular Telomerase Activity Using Enzyme-Free Signal Amplification.
Neoplasms
Fluorescence in situ hybridization analysis of the hTERC region in acute myeloid leukemia patients.
Neoplasms
Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
Neoplasms
Forever Young: Structural Stability of Telomeric Guanine Quadruplexes in the Presence of Oxidative DNA Lesions*.
Neoplasms
Formation of G-quadruplex-hemin DNAzyme based on human telomere elongation and its application in telomerase activity detection.
Neoplasms
Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
Neoplasms
Frequent loss of heterozygosity on chromosome 10p15, a putative telomerase repressor/senescence gene locus, in gastric cancer.
Neoplasms
Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.
Neoplasms
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
Neoplasms
FRET investigation toward DNA tetrahedron-based ratiometric analysis of intracellular telomerase activity.
Neoplasms
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
Neoplasms
Full length RTEL1 is required for the elongation of the single-stranded telomeric overhang by telomerase.
Neoplasms
Fumagillin treatment of hepatocellular carcinoma in rats: an in vivo study of antiangiogenesis.
Neoplasms
Functional benefit and molecular mechanism of vitamin C against perfluorooctanesulfonate-associated leukemia.
Neoplasms
Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells.
Neoplasms
Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
Neoplasms
Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.
Neoplasms
Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Neoplasms
Functional Self-Assembled DNA Nanohydrogels for Specific Telomerase Activity Imaging and Telomerase-Activated Antitumor Gene Therapy.
Neoplasms
Functionalization of Graphene Oxide with Porphyrins: Synthetic Routes and Biological Applications.
Neoplasms
Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways.
Neoplasms
Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells.
Neoplasms
G-quadruplex formation at the 3' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase.
Neoplasms
G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA.
Neoplasms
G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
Neoplasms
G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Neoplasms
G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Neoplasms
G-quadruplex structure: a target for anticancer therapy and a probe for detection of potassium.
Neoplasms
GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Neoplasms
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Neoplasms
Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Neoplasms
Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Neoplasms
Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells.
Neoplasms
Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.
Neoplasms
Gastric cancer with high telomerase activity shows rapid development and invasiveness.
Neoplasms
Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion.
Neoplasms
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1? and VEGF receptors.
Neoplasms
Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine a proliferation activity and a potential for aggressive biological behavior.
Neoplasms
Gastrointestinal stromal tumors of the vermiform appendix: clinicopathologic, immunohistochemical, and molecular study of 2 cases with literature review.
Neoplasms
Gastrointestinal tract antigenic profile of cotton-top tamarin, Saguinus oedipus, is similar to that of humans with inflammatory bowel disease.
Neoplasms
Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells.
Neoplasms
Gelatin nanoparticles transport DNA probes for detection and imaging of telomerase and microRNA in living cells.
Neoplasms
Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions.
Neoplasms
Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
Neoplasms
Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
Neoplasms
Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
Neoplasms
Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma.
Neoplasms
Genes associated with telomerase activity levels in esophageal carcinoma cell lines.
Neoplasms
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.
Neoplasms
Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Neoplasms
Genetic and epigenetic modulation of telomerase activity in development and disease.
Neoplasms
Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation.
Neoplasms
Genetic control of telomerase and replicative senescence in human and rodent cells.
Neoplasms
Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA.
Neoplasms
Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells.
Neoplasms
Genetic Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children.
Neoplasms
Genetic profile and biological implication of PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) in human cancers: an analysis using The Cancer Genome Atlas.
Neoplasms
Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population.
Neoplasms
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
Neoplasms
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Neoplasms
Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Neoplasms
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.
Neoplasms
Genomic instability is associated with lack of telomerase activation in ovarian cancer.
Neoplasms
Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Neoplasms
Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).
Neoplasms
Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint.
Neoplasms
Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors.
Neoplasms
GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates.
Neoplasms
Giant-cell tumor of skin with cytoplasmic human telomerase reverse transcriptase expression.
Neoplasms
Ginger extract inhibits human telomerase reverse transcriptase and c-Myc expression in A549 lung cancer cells.
Neoplasms
Ginger Extract Promotes Telomere Shortening and Cellular Senescence in A549 Lung Cancer Cells.
Neoplasms
Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma.
Neoplasms
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) induces cancer cell senescence by interacting with telomerase RNA component.
Neoplasms
Gold Nanoprobe Based Label-Free Detection of Human Telomerase Reverse Transcriptase (hTERT) Gene Expression: Gold Nanoprobe-Based Detection of hTERT Gene Expression.
Neoplasms
GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Graft expression of p38 and tumor necrosis factor-alpha in heart transplantation in rats.
Neoplasms
Graphene-Mesoporous Silica-Dispersed Palladium Nanoparticles-Based Probe Carrier Platform for Electrocatalytic Sensing of Telomerase Activity at Less Than Single-Cell Level.
Neoplasms
GRIM-19 Restores Cervical Cancer Cell Senescence by Repressing hTERT Transcription.
Neoplasms
Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Neoplasms
Growth Retardation of Poorly Transfectable Tumor by Multiple Injections of plasmids Encoding PE40 Based Targeted Toxin Complexed with Poly-ethylenimine.
Neoplasms
GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.
Neoplasms
GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.
Neoplasms
H. pylori induces a novel NF-?B/Lin28A/let-7a/hTERT axis to promote gastric carcinogenesis.
Neoplasms
H2O2 enhances the anticancer activity of TMPyP4 by ROS-mediated mitochondrial dysfunction and DNA damage.
Neoplasms
HAATI survivors replace canonical telomeres with blocks of generic heterochromatin.
Neoplasms
Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Neoplasms
Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
Neoplasms
Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells.
Neoplasms
HDAC9 regulates the alternative lengthening of telomere (ALT) pathway via the formation of ALT-associated PML bodies.
Neoplasms
Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine.
Neoplasms
Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells.
Neoplasms
Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues.
Neoplasms
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.
Neoplasms
Hepatic angiomyolipoma in a 26-year-old Caucasian woman with a history of tibial osteosarcoma.
Neoplasms
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.
Neoplasms
Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution.
Neoplasms
Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines.
Neoplasms
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Neoplasms
Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis.
Neoplasms
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.
Neoplasms
Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro.
Neoplasms
Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
Neoplasms
Heterozygous telomerase deficiency in mouse and man: when less is definitely not more.
Neoplasms
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Neoplasms
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.
Neoplasms
High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.
Neoplasms
High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Neoplasms
High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Neoplasms
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Neoplasms
High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives.
Neoplasms
High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma.
Neoplasms
High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
Neoplasms
High performance liquid chromatography with ultraviolet detection for the determination of SYUIQ-5, a novel telomerase inhibitor for cancer therapy: application to an enzyme kinetic study in rat liver microsomes.
Neoplasms
High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.
Neoplasms
High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Neoplasms
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
Neoplasms
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Neoplasms
High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Neoplasms
High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
Neoplasms
High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Neoplasms
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Neoplasms
High-throughput identification of telomere-binding ligands based on the fluorescence regulation of DNA-copper nanoparticles.
Neoplasms
Highly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity.
Neoplasms
Highly sensitive detection of telomerase activity in tumor cells by cascade isothermal signal amplification based on three-way junction and base-stacking hybridization.
Neoplasms
Highly sensitive detection of telomerase using a telomere-triggered isothermal exponential amplification-based DNAzyme biosensor.
Neoplasms
Highly sensitive electrochemical analysis of telomerase activity based on magnetic bead separation and exonuclease III-aided target recycling amplification.
Neoplasms
Highly sensitive electrochemical detection of human telomerase activity based on bio-barcode method.
Neoplasms
Highly sensitive fluorescence quantification of intracellular telomerase activity by repeat G-rich DNA enhanced silver nanoclusters.
Neoplasms
Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
Neoplasms
Highly-sensitive and fast detection of human telomeric G-Quadruplex DNA based on a hemin-conjugated fluorescent metal-organic framework platform.
Neoplasms
Histone Acetylation and Retinoic Acid Receptor beta DNA Methylation as Novel Targets for Gastric Cancer Therapy.
Neoplasms
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Neoplasms
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast.
Neoplasms
Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
Neoplasms
HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist.
Neoplasms
HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.
Neoplasms
HIV-Tat-mediated Delivery of an LPTS Functional Fragment Inhibits Telomerase Activity and Tumorigenecity of Hepatoma Cells.
Neoplasms
HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction.
Neoplasms
Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Neoplasms
Homogeneous and ultrasensitive detection of telomerase activity via gold nanorod-based fluorescence resonance energy transfer.
Neoplasms
Homogeneous Electrochemical Strategy for Human Telomerase Activity Assay at Single-Cell Level Based on T7 Exonuclease-Aided Target Recycling Amplification.
Neoplasms
Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.
Neoplasms
Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.
Neoplasms
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns.
Neoplasms
HOT1 is a mammalian direct telomere repeat-binding protein contributing to telomerase recruitment.
Neoplasms
How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle.
Neoplasms
How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.
Neoplasms
HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a.
Neoplasms
HPV E6 protein interacts physically and functionally with the cellular telomerase complex.
Neoplasms
HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides.
Neoplasms
HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
Neoplasms
HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
Neoplasms
Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.
Neoplasms
hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Neoplasms
hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells.
Neoplasms
hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer.
Neoplasms
hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines.
Neoplasms
Htert gene expression levels and telomerase activity in drug resistant mcf-7 cells.
Neoplasms
hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Neoplasms
hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Neoplasms
hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a.
Neoplasms
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.
Neoplasms
hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells.
Neoplasms
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes.
Neoplasms
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Neoplasms
hTERT mRNA expression correlates with telomerase activity in human breast cancer.
Neoplasms
HTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa.
Neoplasms
hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms.
Neoplasms
hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells.
Neoplasms
hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.
Neoplasms
hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Neoplasms
hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance.
Neoplasms
hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.
Neoplasms
hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.
Neoplasms
hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor.
Neoplasms
hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells.
Neoplasms
hTERT regulation by NF-?B and c-myc in irradiated HER2-positive breast cancer cells.
Neoplasms
hTERT-promoter driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions.
Neoplasms
HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene.
Neoplasms
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).
Neoplasms
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.
Neoplasms
Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres.
Neoplasms
Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer.
Neoplasms
Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
Neoplasms
Human fibroblasts from normal and malignant breast tissue grown in vitro show a distinct senescence profile and telomerase activity.
Neoplasms
Human Ku70/80 associates physically with telomerase through interaction with hTERT.
Neoplasms
Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
Neoplasms
Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy.
Neoplasms
Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma.
Neoplasms
Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Neoplasms
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells.
Neoplasms
Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase.
Neoplasms
Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
Neoplasms
Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
Neoplasms
Human Telomerase Gene and High-Risk Human Papillomavirus Infection are Related to Cervical Intraepithelial Neoplasia.
Neoplasms
Human telomerase represses ROS-dependent cellular responses to Tumor Necrosis Factor-? without affecting NF-?B activation.
Neoplasms
Human telomerase reverse transcriptase (hTERT) expression in borderline ovarian tumors: an immunohistochemical study.
Neoplasms
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Neoplasms
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
Neoplasms
Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity.
Neoplasms
Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1.
Neoplasms
Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression.
Neoplasms
Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors.
Neoplasms
Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Neoplasms
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
Neoplasms
Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Neoplasms
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells.
Neoplasms
Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Neoplasms
Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Neoplasms
Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Neoplasms
Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
Neoplasms
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Neoplasms
Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
Neoplasms
Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-?B-dependent transcription.
Neoplasms
Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).
Neoplasms
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes.
Neoplasms
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.
Neoplasms
Human telomerase RNA accumulation in cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation.
Neoplasms
Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal.
Neoplasms
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues.
Neoplasms
Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
Neoplasms
Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
Neoplasms
Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
Neoplasms
Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Neoplasms
Human telomeric DNA forms parallel-stranded intramolecular G-quadruplex in K+ solution under molecular crowding condition.
Neoplasms
Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer.
Neoplasms
Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution.
Neoplasms
Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
Neoplasms
Hybrids Based on Graphene Oxide and Porphyrin as Tools for Detection and Stabilization of DNA G-Quadruplexes.
Neoplasms
Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation.
Neoplasms
Hypoxia induces telomerase reverse transcriptase (TERT) gene expression in non-tumor fish tissues in vivo: the marine medaka (Oryzias melastigma) model.
Neoplasms
Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST.
Neoplasms
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.
Neoplasms
Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells.
Neoplasms
Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms.
Neoplasms
ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!
Neoplasms
Identification and functional characterization of nuclear mortalin in human carcinogenesis.
Neoplasms
Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host.
Neoplasms
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells.
Neoplasms
Identification of a New Cytotoxic T-Cell Epitope p675 of Human Telomerase Reverse Transcriptase.
Neoplasms
Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope.
Neoplasms
Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Neoplasms
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly.
Neoplasms
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.
Neoplasms
Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Neoplasms
Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging.
Neoplasms
Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERT.
Neoplasms
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Neoplasms
Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.
Neoplasms
Identification of IDH and TERTp mutation status using 1 H-MRS in 112 hemispheric diffuse gliomas.
Neoplasms
Identification of key processes underlying cancer phenotypes using biologic pathway analysis.
Neoplasms
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach.
Neoplasms
Identification of novel noncoding transcripts in telomerase-negative yeast using RNA-seq.
Neoplasms
Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
Neoplasms
Identification of zebrafish LPTS: a gene with similarities to human LPTS/PinX1 that inhibits telomerase activity.
Neoplasms
Identifying G-quadruplex-binding ligands using DNA-functionalized gold nanoparticles.
Neoplasms
IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
Neoplasms
IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.
Neoplasms
Imaging Mass Spectrometry and Proteome Analysis of Marek's Disease Virus-Induced Tumors.
Neoplasms
Imetelstat (a telomerase antagonist) exerts off?target effects on the cytoskeleton.
Neoplasms
Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis.
Neoplasms
Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Neoplasms
Immortal and mortal clonal lymphocyte lines from channel catfish: comparison of telomere length, telomerase activity, tumor suppressor and heat shock protein expression.
Neoplasms
Immortal phenotype of the esophageal epithelial cells in the process of immortalization.
Neoplasms
Immortality of cancers: A consequence of inherent karyotypic variations and selections for autonomy.
Neoplasms
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
Neoplasms
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.
Neoplasms
Immortalized bovine mammary epithelial cells express stem cell markers and differentiate in vitro.
Neoplasms
Immortalized mouse mammary cells in vivo do not exhibit increased telomerase activity.
Neoplasms
Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
Neoplasms
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase.
Neoplasms
Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Neoplasms
Immunodetection and clinico-pathological correlates of two tumour growth regulators in laryngeal carcinoma.
Neoplasms
Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses.
Neoplasms
Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice.
Neoplasms
Immunogenicity of gx301 cancer vaccine: Four (telomerase peptides) is better than one.
Neoplasms
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis.
Neoplasms
Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology.
Neoplasms
Immunohistochemical detection of hTERT protein in soft tissue sarcomas: correlation with tumor grade.
Neoplasms
Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach.
Neoplasms
Immunohistochemical detection of tankyrase 2 in human breast tumors and normal renal tissue.
Neoplasms
Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues.
Neoplasms
Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Neoplasms
Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa.
Neoplasms
Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Neoplasms
Immunohistochemical evaluation of salivary gland tumors differentiation and proliferation by using calponin and telomerase.
Neoplasms
Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasia.
Neoplasms
Immunohistochemical localization of telomerase in myomas and in uterine myometrium.
Neoplasms
Immunohistochemical Profiling and Telomerase Activity of a Canine Medulloblastoma.
Neoplasms
Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
Neoplasms
Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Neoplasms
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.
Neoplasms
Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells.
Neoplasms
Immunotherapy of tumors with human telomerase reverse transcriptase immortalized human umbilical vein endothelial cells.
Neoplasms
Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Neoplasms
Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
Neoplasms
Impaired telomere maintenance in Alazami syndrome patients with LARP7 deficiency.
Neoplasms
Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence.
Neoplasms
Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Neoplasms
Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
Neoplasms
Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase.
Neoplasms
Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer.
Neoplasms
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Neoplasms
Improved methods and standards for telomerase detection: quantitative histopathology using antibody staining.
Neoplasms
In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase.
Neoplasms
In situ Analysis of Cancer Cells Based on DNA Signal Amplification and DNA Nanodevices.
Neoplasms
In situ analysis of telomerase RNA gene expression as a marker for tumor progression.
Neoplasms
In Situ Detection and Imaging of Telomerase Activity in Cancer Cell Lines via Disassembly of Plasmonic Core-Satellites Nanostructured Probe.
Neoplasms
In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Neoplasms
In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
Neoplasms
In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis.
Neoplasms
In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.
Neoplasms
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Neoplasms
In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies.
Neoplasms
In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
Neoplasms
In situ imaging of intracellular human telomerase RNA with molecular beacon-functionalized gold nanoparticles.
Neoplasms
In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.
Neoplasms
In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion.
Neoplasms
In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
Neoplasms
In situ telomerase activity in pleural effusions: a promising marker for malignancy.
Neoplasms
In Situ Visualization of Telomere Length, Telomere Elongation, and TERT Expression in Single Cells.
Neoplasms
In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
Neoplasms
In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells.
Neoplasms
In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.
Neoplasms
In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.
Neoplasms
In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer.
Neoplasms
In vitro effects on proliferation, telomerase activity and apoptosis of an eremophilanoid sesquiterpene from Senecio oldhamianus maxim in cultured human tumor cell lines.
Neoplasms
In vitro Evaluation of the Therapeutic Potential of Nevirapine in Treatment of Human Thyroid Anaplastic Carcinoma.
Neoplasms
In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside.
Neoplasms
In vitro quantification of the cytotoxic T lymphocyte response against human telomerase reverse transcriptase in breast cancer.
Neoplasms
In vitro transformation of mesenchymal stem cells induces gradual genomic hypomethylation.
Neoplasms
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
Neoplasms
In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
Neoplasms
In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy.
Neoplasms
In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
Neoplasms
In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
Neoplasms
In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
Neoplasms
Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase.
Neoplasms
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
Neoplasms
Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Neoplasms
Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells.
Neoplasms
Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.
Neoplasms
Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
Neoplasms
Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.
Neoplasms
Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Neoplasms
Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line.
Neoplasms
Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.
Neoplasms
Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Neoplasms
Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction.
Neoplasms
Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats.
Neoplasms
Increased telomerase activity and comprehensive lifestyle changes: a pilot study.
Neoplasms
Increased telomerase activity and decreased telomere length in genital condylomata acuminata.
Neoplasms
Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
Neoplasms
Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Neoplasms
Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats.
Neoplasms
Increased telomerase activity in intrahepatic cholangiocellular carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
Neoplasms
Increased TERC gene copy number and cells in senescence in primary sclerosing cholangitis compared to colitis and control patients.
Neoplasms
Increased TERC gene copy number in amniocytes from fetuses with trisomy 18 or a sex chromosome aneuploidy.
Neoplasms
Increased TERRA levels and RNase H sensitivity are conserved hallmarks of post-senescent survivors in budding yeast.
Neoplasms
Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.
Neoplasms
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.
Neoplasms
Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state.
Neoplasms
Individual susceptibility to DNA telomerase inhibitors: a study on the chromosome instability induced by 3'-azido-3'-deoxythymidine in lymphocytes of elderly twins.
Neoplasms
Indomethacin suppresses the growth of colon 26, Meth-A and FM3A tumors in mice by reducing the prostaglandin E2 content and telomerase activity in tumor tissues.
Neoplasms
Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Neoplasms
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Neoplasms
Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
Neoplasms
Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways.
Neoplasms
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Neoplasms
Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
Neoplasms
Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells.
Neoplasms
Induction of nitric oxide synthase-dependent telomere shortening after functional inhibition of Hsp90 in human tumor cells.
Neoplasms
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
Neoplasms
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA.
Neoplasms
Induction of senescence in cancer cells by the G-quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity.
Neoplasms
Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation.
Neoplasms
Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines.
Neoplasms
Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1.
Neoplasms
Induction of telomerase activity in stimulated human lymphocytes precedes expression of topoisomerase II alpha.
Neoplasms
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Neoplasms
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
Neoplasms
Influence of Human Telomerase Reverse Transcriptase Mutation on the Aggressiveness and Recurrence in Meningiomas.
Neoplasms
Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis.
Neoplasms
Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.
Neoplasms
Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.
Neoplasms
Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT.
Neoplasms
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
Neoplasms
Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines.
Neoplasms
Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
Neoplasms
Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line.
Neoplasms
Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
Neoplasms
Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA.
Neoplasms
Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
Neoplasms
Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.
Neoplasms
Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
Neoplasms
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.
Neoplasms
Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
Neoplasms
Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
Neoplasms
Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability.
Neoplasms
Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.
Neoplasms
Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines.
Neoplasms
Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
Neoplasms
Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Neoplasms
Inhibition of telomerase activity and induction of apoptosis by Rhodospirillum rubrum L-asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes.
Neoplasms
Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Neoplasms
Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
Neoplasms
Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
Neoplasms
Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Neoplasms
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.
Neoplasms
Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture.
Neoplasms
Inhibition of telomerase activity correlates with a decrease in the RNA component of telomerase during differentiation.
Neoplasms
Inhibition of telomerase activity enhances hyperthermia-mediated radiosensitization.
Neoplasms
Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
Neoplasms
Inhibition of telomerase activity in endometrial cancer cells by selenium-cisplatin conjugate despite suppression of its DNA-damaging activity by sodium ascorbate.
Neoplasms
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.
Neoplasms
Inhibition of telomerase activity in renal cell carcinoma cells by doxorubicin and anti-Fas monoclonal antibody.
Neoplasms
Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.
Neoplasms
Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells.
Neoplasms
Inhibition of telomerase by site-specific ribonucleases in gastric and esophageal adenocarcinoma.
Neoplasms
Inhibition of telomerase in canine cancer cells following telomestatin treatment.
Neoplasms
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
Neoplasms
Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component.
Neoplasms
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
Neoplasms
Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.
Neoplasms
Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
Neoplasms
Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells.
Neoplasms
Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
Neoplasms
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Neoplasms
Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Neoplasms
Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
Neoplasms
Inhibition of the alternative lengthening of telomeres pathway by subtelomeric sequences in Saccharomyces cerevisiae.
Neoplasms
Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.
Neoplasms
Inhibition of tumour virus RNA-dependent DNA polymerase by the heteropolyan ion, silicotungstate.
Neoplasms
Inhibition of tumour virus RNA-dependent DNA polymerase by the heteropolyanion, silicotungstate.
Neoplasms
Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.
Neoplasms
Inhibitor of the human telomerase reverse trancriptase (hTERT) gene promoter induces cell apoptosis via a mitochondrial-dependent pathway.
Neoplasms
Inhibitory effect and mechanisms of microRNA-146b-5p on the proliferation and metastatic potential of Caski human cervical cancer cells.
Neoplasms
Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtype.
Neoplasms
Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
Neoplasms
Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Neoplasms
Inhibitory role of transcription factor COUP-TFII in expression of hTERT in HeLa cells.
Neoplasms
Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer.
Neoplasms
Insights into the biomedical effects of carboxylated single-wall carbon nanotubes on telomerase and telomeres.
Neoplasms
Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-?B axis during nasopharyngeal carcinoma development.
Neoplasms
Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.
Neoplasms
Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells.
Neoplasms
Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
Neoplasms
Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines.
Neoplasms
Integrated nanosensors to determine levels and functional activity of human telomerase.
Neoplasms
Integration of intracellular telomerase monitoring by electrochemiluminescence technology and targeted cancer therapy by reactive oxygen species.
Neoplasms
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
Neoplasms
Intensive Inhibition of hTERT Expression by a Ribozyme Induces Rapid Apoptosis of Cancer Cells through a Telomere Length-Independent Pathway.
Neoplasms
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Neoplasms
Interaction between Gambogic acid and dihydrofolate reductase and synergistic lethal effects with methotrexate on hepatoma cells.
Neoplasms
Interaction between human telomere and a carbazole derivative: a molecular dynamics simulation of a quadruplex stabilizer and telomerase inhibitor.
Neoplasms
Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Neoplasms
Interaction studies of carbon nanomaterials and plasma activated carbon nanomaterials solution with telomere binding protein.
Neoplasms
Interactions of ruthenium complexes containing indoloquinoline moiety with human telomeric G-quadruplex DNA.
Neoplasms
Interchromosomal homology searches drive directional ALT telomere movement and synapsis.
Neoplasms
Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.
Neoplasms
Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression.
Neoplasms
Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.
Neoplasms
Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Neoplasms
Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.
Neoplasms
Interweaving MicroRNAs and Proinflammatory Cytokines in Gastric Mucosa with Reference to H. pylori Infection.
Neoplasms
Intraoperative bacterial translocation detected by bacterium-specific ribosomal rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies.
Neoplasms
Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Neoplasms
Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Neoplasms
Intron 4-5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance.
Neoplasms
Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.
Neoplasms
Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
Neoplasms
Investigating the Effects of RBBP6 Gene Expression on Telomerase Activity in Cervical Cancer Cells.
Neoplasms
Investigating the impact of local inflammation on granulosa cells and follicular development in women with ovarian endometriosis.
Neoplasms
Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
Neoplasms
Investigation of telomerase activity and apoptosis on invasive ductal carcinoma of the breast using immunohistochemical and Western blot methods.
Neoplasms
Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells.
Neoplasms
Involvement of replicative polymerases, Tel1p, Mec1p, Cdc13p, and the Ku complex in telomere-telomere recombination.
Neoplasms
Involvement of SRSF11 in cell cycle-specific recruitment of telomerase to telomeres at nuclear speckles.
Neoplasms
Involvement of the NFX1-repressor complex in PKC-?-induced repression of hTERT transcription.
Neoplasms
Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.
Neoplasms
Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
Neoplasms
Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?
Neoplasms
Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer?
Neoplasms
Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
Neoplasms
Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Neoplasms
Isolation and characterization of RNA-directed DNA polymerase from a B-type RNA tumor virus.
Neoplasms
Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT).
Neoplasms
Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.
Neoplasms
Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
Neoplasms
It all comes together at the ends: Telomerase structure, function, and biogenesis.
Neoplasms
Japanese medaka: A new vertebrate model for studying telomere and telomerase biology.
Neoplasms
Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Neoplasms
Juglans mandshurica Maxim extracts exhibit antitumor activity on HeLa cells in vitro.
Neoplasms
Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
Neoplasms
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Neoplasms
Kinetic evidence for interaction of TMPyP4 with two different G-quadruplex conformations of human telomeric DNA.
Neoplasms
Kinetics of DNA replication and telomerase reaction at a single-seeded telomere in human cells.
Neoplasms
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
Neoplasms
Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.
Neoplasms
Knockdown of apoptosis-inducing factor disrupts function of respiratory complex I.
Neoplasms
Knockdown of hTERT Alters Biophysical Properties of K562 Cells Resulting in Decreased Migration Rate In Vitro.
Neoplasms
Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
Neoplasms
Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Neoplasms
Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Neoplasms
Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.
Neoplasms
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Neoplasms
Kruppel-Like Factor 9 Loss-of-Expression in Human Endometrial Carcinoma Links Altered Expression of Growth-Regulatory Genes with Aberrant Proliferative Response to Estrogen.
Neoplasms
Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells.
Neoplasms
Ku70 prevents genome instability resulting from heterozygosity of the telomerase RNA component in a vertebrate tumour line.
Neoplasms
Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy.
Neoplasms
Label-Free Detection of Telomerase Activity in Urine Using Telomerase-Responsive Porous Anodic Alumina Nanochannels.
Neoplasms
Label-free detection of telomerase activity using guanine electrochemical oxidation signal.
Neoplasms
Label-free electrochemical selection of G-quadruplex-binding ligands based on structure switching.
Neoplasms
Label-free electrochemiluminescence biosensor for ultrasensitive detection of telomerase activity in HeLa cells based on extension reaction and intercalation of Ru(phen)3 (2.).
Neoplasms
Label-free highly sensitive detection of telomerase activity in cancer cell by chemiluminescence imaging.
Neoplasms
Label-free molecular beacons-based cascade amplification DNA machine for sensitive detection of telomerase activity.
Neoplasms
Label-Free Telomerase Activity Detection via Electrochemical Impedance Spectroscopy.
Neoplasms
Label-Free Telomerase Detection in Single Cell Using a Five-Base Telomerase Product-Triggered Exponential Rolling Circle Amplification Strategy.
Neoplasms
Label-free, PCR-free chip-based detection of telomerase activity in bladder cancer cells.
Neoplasms
Lack of evidence for the involvement of type-C and type-B retroviruses in radiation leukemogenesis of NFS mice.
Neoplasms
Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Neoplasms
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Neoplasms
Lack of telomerase in desmoids occurring sporadically and in association with familial adenomatous polyposis.
Neoplasms
Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter.
Neoplasms
Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.
Neoplasms
Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways.
Neoplasms
Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas.
Neoplasms
Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.
Neoplasms
Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
Neoplasms
Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Neoplasms
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Neoplasms
Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays.
Neoplasms
Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
Neoplasms
Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab.
Neoplasms
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Neoplasms
Lobe-specific telomerase activity in the intact adult brown Norway rat prostate and its regional distribution within the prostatic ducts.
Neoplasms
Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body.
Neoplasms
Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues.
Neoplasms
Long telomeres are preferentially extended during recombination-mediated telomere maintenance.
Neoplasms
Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis.
Neoplasms
Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD).
Neoplasms
Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.
Neoplasms
Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells.
Neoplasms
Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity.
Neoplasms
Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Neoplasms
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.
Neoplasms
Long-term self-maintenance of hemopoietic precursors in bone marrow culture derived from tumor necrosis factor-deficient mice is not a result of neoplastic transformation.
Neoplasms
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.
Neoplasms
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
Neoplasms
Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma.
Neoplasms
Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers.
Neoplasms
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
Neoplasms
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Neoplasms
Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.
Neoplasms
LOSS OF THE MALIGNANT PHENOTYPE OF HUMAN NEUROBLASTOMA CELLS BY A CATALYTICALLY INACTIVE DOMINANT-NEGATIVE hTERT MUTANT.
Neoplasms
Loss of the tumor suppressor STAG2 promotes telomere recombination and extends the replicative lifespan of normal human cells.
Neoplasms
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.
Neoplasms
Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
Neoplasms
Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).
Neoplasms
Low Level of TERC Gene Amplification between Chronic Myeloid Leukaemia Patients Resistant and Respond to Imatinib Mesylate Treatment.
Neoplasms
Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma.
Neoplasms
Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
Neoplasms
Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.
Neoplasms
Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Neoplasms
LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention.
Neoplasms
Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression.
Neoplasms
Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
Neoplasms
Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene.
Neoplasms
Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
Neoplasms
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities.
Neoplasms
Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Neoplasms
Magnetic bead and nanoparticle based electrochemiluminescence amplification assay for direct and sensitive measuring of telomerase activity.
Neoplasms
Magnetic bead-enzyme assemble for triple-parameter telomerase detection at single-cell level.
Neoplasms
Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes.
Neoplasms
Magneto-mechanical detection of nucleic acids and telomerase activity in cancer cells.
Neoplasms
Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.
Neoplasms
Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction.
Neoplasms
Mammary epithelial cell transformation: insights from cell culture and mouse models.
Neoplasms
Mammary tumor virus induction by glucocorticoids. Characterization of specific transcriptional regulation.
Neoplasms
Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Neoplasms
Many disease-associated variants of hTERT retain high telomerase enzymatic activity.
Neoplasms
Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization.
Neoplasms
Marked difference in tumor necrosis factor-alpha expression in warm ischemia- and cold ischemia-reperfusion of the rat liver.
Neoplasms
Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms.
Neoplasms
MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity.
Neoplasms
MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.
Neoplasms
MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia.
Neoplasms
MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene.
Neoplasms
MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer.
Neoplasms
MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.
Neoplasms
Means to the ends: The role of telomeres and telomere processing machinery in metastasis.
Neoplasms
Measuring Telomerase Activity in Senescent Human T Cells Upon Genetic Modification.
Neoplasms
Measuring telomerase activity in various human tumors in routine histology and cytology.
Neoplasms
Mechanism for the reduction of telomerase expression during muscle cell differentiation.
Neoplasms
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses.
Neoplasms
Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Neoplasms
Mechanism of Human Telomerase Reverse Transcriptase (hTERT) Regulation and Clinical Impacts in Leukemia.
Neoplasms
Mechanisms for inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase (hTERT) down-regulation.
Neoplasms
Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
Neoplasms
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Neoplasms
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors.
Neoplasms
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Neoplasms
Mechanixm of Carcinogenesis By RNA Tumor Viruses, I. An RNA-Dependent DNA Polymerase In Murine Sarcoma Viruses.
Neoplasms
Meditation and vacation effects have an impact on disease-associated molecular phenotypes.
Neoplasms
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF.
Neoplasms
Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells.
Neoplasms
Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro.
Neoplasms
Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Neoplasms
Meta-analysis for diagnostic accuracy studies: a new statistical model using beta-binomial distributions and bivariate copulas.
Neoplasms
Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas.
Neoplasms
Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells.
Neoplasms
Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
Neoplasms
Metastatic retroperitoneal paraganglioma in a 16-year-old girl. Case report, molecular pathological and cytogenetic findings.
Neoplasms
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids.
Neoplasms
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Neoplasms
Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP.
Neoplasms
Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
Neoplasms
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging.
Neoplasms
Microanalytical system for determination of picogram quantities of metals in metalloenzymes, as illustrated with zinc-containing enzymes.
Neoplasms
Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
Neoplasms
Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity.
Neoplasms
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Neoplasms
MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets.
Neoplasms
MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells.
Neoplasms
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region.
Neoplasms
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: a Field as Much Unexplored as Potentially Promising.
Neoplasms
Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients.
Neoplasms
Minimizing the risk of cancer: tissue architecture and cellular replication limits.
Neoplasms
miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT.
Neoplasms
miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
Neoplasms
miR-138-5p acts as a tumor suppressor by targeting hTERT in human colorectal cancer.
Neoplasms
miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase.
Neoplasms
miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells.
Neoplasms
miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Neoplasms
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.
Neoplasms
miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.
Neoplasms
miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia.
Neoplasms
Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
Neoplasms
Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.
Neoplasms
Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis.
Neoplasms
Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Neoplasms
MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome.
Neoplasms
MNS16A Tandem Repeats Minisatellite of Human Telomerase Gene and Cancer Risk: A Meta-Analysis.
Neoplasms
MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer.
Neoplasms
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse.
Neoplasms
Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.
Neoplasms
Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach.
Neoplasms
Modelling the regulation of telomere length: the effects of telomerase and G-quadruplex stabilising drugs.
Neoplasms
Moderate stem-cell telomere shortening rate postpones cancer onset in a stochastic model.
Neoplasms
Modification of the hTERT promoter by heat shock elements enhances the efficiency and specificity of cancer targeted gene therapy.
Neoplasms
Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR.
Neoplasms
Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.
Neoplasms
Modulation of human epidermal cell response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by epidermal growth factor.
Neoplasms
Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Neoplasms
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.
Neoplasms
Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review.
Neoplasms
Modulation of telomerase activity in fish muscle by biological and environmental factors.
Neoplasms
Modulation of telomerase and signal transduction proteins by Hexyl-ALA-Photodynamic Therapy (PDT) in human doxorubicin resistant cancer cell models.
Neoplasms
Modulation of telomerase expression and function by miRNAs: Anti-cancer potential.
Neoplasms
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
Neoplasms
Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Neoplasms
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
Neoplasms
Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
Neoplasms
Molecular and Cellular Evidence for the Alternative Lengthening of Telomeres (ALT) Mechanism in Chicken.
Neoplasms
Molecular basis for the cellular senescence program and its application to anticancer therapy.
Neoplasms
Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay.
Neoplasms
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.
Neoplasms
Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
Neoplasms
Molecular characterization of a series of solitary fibrous tumors, including immunohistochemical expression of STAT6 and NATB2-STAT6 fusion transcripts, using Reverse Transcriptase(RT)-Polymerase chain reaction(PCR) technique: An Indian experience.
Neoplasms
Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Neoplasms
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
Neoplasms
Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.
Neoplasms
Molecular cloning of the feline telomerase reverse transcriptase (TERT) gene and its expression in cell lines and normal tissues.
Neoplasms
Molecular design of synthetic benzimidazoles for the switchover of the duplex to G-quadruplex DNA recognition.
Neoplasms
Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
Neoplasms
Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis.
Neoplasms
Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Neoplasms
Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Neoplasms
Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.
Neoplasms
Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Neoplasms
Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel.
Neoplasms
Molecular docking based screening of triterpenoids as potential G-quadruplex stabilizing ligands with anti-cancer activity.
Neoplasms
Molecular dynamics and principal components of potassium binding with human telomeric intra-molecular G-quadruplex.
Neoplasms
Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.
Neoplasms
Molecular imaging of telomerase and the enzyme activity-triggered drug release by using a conformation-switchable nanoprobe in cancerous cells.
Neoplasms
Molecular insight into the selective binding between human telomere G-quadruplex and a negatively charged stabilizer.
Neoplasms
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Neoplasms
Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.
Neoplasms
Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells.
Neoplasms
Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection.
Neoplasms
Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers.
Neoplasms
Molecular mechanisms for the p38-induced cellular senescence in normal human fibroblast.
Neoplasms
Molecular Modeling and Evaluation of Novel Dibenzopyrrole Derivatives as Telomerase Inhibitors and Potential Drug for Cancer Therapy.
Neoplasms
Molecular pathogenesis of aging and cancer: are telomeres and telomerase the connection?
Neoplasms
Molecular prognostic markers in resectable colorectal liver metastases: a systematic review.
Neoplasms
Molecular recognition of 3+1 hybrid human telomeric G-quadruplex DNA d-[AGGG(TTAGGG)3] by anticancer drugs epirubicin and adriamycin leads to thermal stabilization.
Neoplasms
Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
Neoplasms
Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Neoplasms
Molecular targets in cancer prevention by 4-(methylthio)butyl isothiocyanate - A comprehensive review.
Neoplasms
Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology.
Neoplasms
Molecularly imprinted gelatin nanoparticles for DNA delivery and in-situ fluorescence imaging of telomerase activity.
Neoplasms
Monitoring Telomerase Activity in Living Cells with High Sensitivity Using Cascade Amplification Reaction-Based Nanoprobe.
Neoplasms
Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application.
Neoplasms
Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte- and T-cell-derived lines.
Neoplasms
Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
Neoplasms
Mouse mammary tumour virus RNA-dependent DNA polymerase: requirements and products.
Neoplasms
MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter.
Neoplasms
MRI-Based Radiomics and Radiogenomics in the Management of Low-Grade Gliomas: Evaluating the Evidence for a Paradigm Shift.
Neoplasms
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.
Neoplasms
MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Neoplasms
MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-?B pathway.
Neoplasms
Multi-code magnetic beads based on DNAzyme-mediated double-cycling amplification for a point-of-care assay of telomerase activity.
Neoplasms
Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer.
Neoplasms
Multicenter Phase II trial of S-1 in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.
Neoplasms
Multicharged Phthalocyanines as Selective Ligands for G-Quadruplex DNA Structures.
Neoplasms
Multicolor Fluorescent Graphene Oxide Quantum Dots for Sensing Cancer Cell Biomarkers.
Neoplasms
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.
Neoplasms
Multiple factors influencing the release of hTERT mRNA from pancreatic cancer cell lines in in vitro culture.
Neoplasms
Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Neoplasms
Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
Neoplasms
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Neoplasms
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.
Neoplasms
Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway.
Neoplasms
Multivalent Self-Assembled DNA Polymer for Tumor-Targeted Delivery and Live Cell Imaging of Telomerase Activity.
Neoplasms
Mutant telomerase RNAs induce DNA damage and apoptosis via TRF2-ATM pathway in telomerase-overexpressing primary fibroblasts.
Neoplasms
Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Neoplasms
Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.
Neoplasms
Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer.
Neoplasms
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Neoplasms
Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cells.
Neoplasms
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Neoplasms
Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine.
Neoplasms
Myelosuppression in Patients Treated with the Telomerase Inhibitor Imetelstat Is Not Mediated through Activation of Toll-Like Receptors.
Neoplasms
Myxoid liposarcoma with transition to round-cell lesion-cell cycle regulator genes and telomerase activity characterizing tumor progression: a case report.
Neoplasms
N-(1-Pyrenyl) maleimide inhibits telomerase activity in a cell free system and induces apoptosis in Jurkat cells.
Neoplasms
N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells.
Neoplasms
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.
Neoplasms
NAC selectively inhibit cancer telomerase activity: A higher redox homeostasis threshold exists in cancer cells.
Neoplasms
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
Neoplasms
Naphthalenediimide-Linked Bisbenzimidazole Derivatives as Telomeric G-Quadruplex-Stabilizing Ligands with Improved Anticancer Activity.
Neoplasms
Neoplastic conversion of human colon smooth muscle cells: No requirement for telomerase.
Neoplasms
Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Neoplasms
Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications.
Neoplasms
Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
Neoplasms
Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line.
Neoplasms
New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement.
Neoplasms
New horizons for diagnostics and therapeutic applications of graphene and graphene oxide.
Neoplasms
New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay.
Neoplasms
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
Neoplasms
New perspectives for tumor pathology provided by comparative genomic hybridization.
Neoplasms
New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness.
Neoplasms
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
Neoplasms
New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Neoplasms
Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
Neoplasms
NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
Neoplasms
NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres.
Neoplasms
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
Neoplasms
Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages.
Neoplasms
nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice.
Neoplasms
NMR based structural studies decipher stacking of the alkaloid coralyne to terminal guanines at two different sites in parallel G-quadruplex DNA, [d(TTGGGGT)]
Neoplasms
No evidence for particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA in herpesvirus induced tumours of non-human primates.
Neoplasms
Non-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance.
Neoplasms
Non-canonical NF-?B signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.
Neoplasms
Non-homologous end-joining protein expression screen from radiosensitive cancer patients yields a novel DNA double strand break repair phenotype.
Neoplasms
Non-radioactive assay methods for the assessment of telomerase activity and telomere length.
Neoplasms
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Neoplasms
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Neoplasms
Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators.
Neoplasms
Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
Neoplasms
Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter.
Neoplasms
Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Neoplasms
Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Neoplasms
Noninvasive visualization of RNA delivery with 99mTc-radiolabeled small-interference RNA in tumor xenografts.
Neoplasms
Nonradioactive and Radioactive Telomerase Assays for Detecting Diminished Telomerase Activity in Cancer Cells after Treatment with Retinoid.
Neoplasms
Nonradioactive direct telomerase activity detection using biotin-labeled primers.
Neoplasms
Nonradioactive telomerase activity assay by microchip electrophoresis: privileges to the classical gel electrophoresis assay.
Neoplasms
Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
Neoplasms
Normal and Tumour Tissue mRNA Expressions of Telomerase Complex Genes in Several Types of Cancer.
Neoplasms
Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3,3-diindolylmethane,partly mediated via ER?/?-AP1 signaling.
Neoplasms
NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Neoplasms
Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules.
Neoplasms
Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803.
Neoplasms
Novel Efficient Cell-Penetrating, Peptide-Mediated Strategy for Enhancing Telomerase Inhibitor Oligonucleotides.
Neoplasms
Novel Oligopyrrole Carboxamide based Nickel(II) and Palladium(II) Salens, Their Targeting of Human G-Quadruplex DNA, and Selective Cancer Cell Toxicity.
Neoplasms
Novel plasma telomerase detection method to improve cancer diagnostic assessment.
Neoplasms
Novel platinum complexes as efficient G-quadruplex DNA binders and telomerase inhibitors.
Neoplasms
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
Neoplasms
Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis.
Neoplasms
Novel telomeric repeat elongation assay performed on zinc oxide nanorod array supports.
Neoplasms
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
Neoplasms
Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer.
Neoplasms
NSC746364, NSC746365, and NSC746366: the spectra of cytotoxicity and molecular correlates of response to telomerase activity.
Neoplasms
Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.
Neoplasms
Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer.
Neoplasms
Nuclear import of hTERT requires a bipartite nuclear localization signal mediated by Akt phosphorylation.
Neoplasms
Nuclear telomerase is less accessible to antibody probing than known nuclear antigens: retrieval with new immunostaining buffer.
Neoplasms
Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis.
Neoplasms
Nuclear-Shell Biopolymers Initiated by Telomere Elongation for Individual Cancer Cell Imaging and Drug Delivery.
Neoplasms
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
Neoplasms
Nucleolin-Targeted DNA Nanotube for Precise Cancer Therapy through Förster Resonance Energy Transfer-Indicated Telomerase Responsiveness.
Neoplasms
Observation of processive telomerase catalysis using high-resolution optical tweezers.
Neoplasms
Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
Neoplasms
Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
Neoplasms
Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent.
Neoplasms
Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Neoplasms
Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agents.
Neoplasms
Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides.
Neoplasms
Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy.
Neoplasms
Omega-3 supplementation and stress reactivity of cellular aging biomarkers: an ancillary substudy of a randomized, controlled trial in midlife adults.
Neoplasms
On the comparative biology of mammalian telomeres: Telomere length co-evolves with body mass, lifespan and cancer risk.
Neoplasms
Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer.
Neoplasms
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres.
Neoplasms
Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice.
Neoplasms
Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Neoplasms
Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
Neoplasms
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer.
Neoplasms
One-Step High-Throughput Telomerase Activity Measurement of Cell Populations, Single Cells, and Single-Enzyme Complexes.
Neoplasms
One-step immortalization of primary human airway epithelial cells capable of oncogenic transformation.
Neoplasms
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.
Neoplasms
Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
Neoplasms
Optimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in mice.
Neoplasms
Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Neoplasms
Oral cancer diagnosis via a ferrocenylnaphthalene diimide-based electrochemical telomerase assay.
Neoplasms
ORCA/LRWD1 Regulates Homologous Recombination at ALT-Telomeres by Modulating Heterochromatin Organization.
Neoplasms
Organismal propagation in the absence of a functional telomerase pathway in Caenorhabditis elegans.
Neoplasms
Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Neoplasms
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.
Neoplasms
Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Neoplasms
Overexpression of Beclin1 gene leads to reduction of telomerase activity in MDCK cells and enhances apoptosis.
Neoplasms
Overexpression of cellular telomerase RNA enhances virus-induced cancer formation.
Neoplasms
Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro.
Neoplasms
Overexpression of human telomerase RNA in Helicobacter pylori-infected human gastric mucosa.
Neoplasms
Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis.
Neoplasms
Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Neoplasms
Overexpression of the p21 sdi1 gene induces senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer.
Neoplasms
Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer.
Neoplasms
Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.
Neoplasms
Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides.
Neoplasms
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation.
Neoplasms
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer.
Neoplasms
Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation.
Neoplasms
Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.
Neoplasms
Oxidative Stress: Role and Response of Short Guanine Tracts at Genomic Locations.
Neoplasms
Oxymatrine improves intestinal epithelial barrier function involving NF-?B-mediated signaling pathway in CCl4-induced cirrhotic rats.
Neoplasms
P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases.
Neoplasms
p21(WAF1) is involved in interferon-?- induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer.
Neoplasms
P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Neoplasms
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Neoplasms
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.
Neoplasms
PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase.
Neoplasms
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
Neoplasms
Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.
Neoplasms
PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells.
Neoplasms
Part I. Telomerase levels in human metastatic brain tumors show four-fold logarithmic variability but no correlation with tumor type or interval to patient demise.
Neoplasms
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Neoplasms
Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.
Neoplasms
Particles containing RNA-instructed DNA polymerase and virus-related RNA in human breast cancers.
Neoplasms
Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring.
Neoplasms
Pathology and genomics of pediatric melanoma: A critical reexamination and new insights.
Neoplasms
PCR-free and label-free fluorescent detection of telomerase activity at single-cell level based on triple amplification.
Neoplasms
Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from Rhodospirillum rubrum to Inhibit Telomerase.
Neoplasms
Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder.
Neoplasms
Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease.
Neoplasms
PES1 is a critical component of telomerase assembly and regulates cellular senescence.
Neoplasms
Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
Neoplasms
Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Neoplasms
Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Neoplasms
Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Neoplasms
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.
Neoplasms
Phenolic compounds, saponins and alkaloids on cancer progression: emphasis on p53 expression and telomere length.
Neoplasms
Phosphorothioate?modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.
Neoplasms
Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes.
Neoplasms
Physical Connectivity Mapping by Circular Permutation of Human Telomerase RNA Reveals New Regions Critical for Activity and Processivity.
Neoplasms
Physiological and pathological significance of human telomerase reverse transcriptase splice variants.
Neoplasms
Physiological relevance of telomeric G-quadruplex formation: a potential drug target.
Neoplasms
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
Neoplasms
Pif1 helicase and Pol? promote recombination-coupled DNA synthesis via bubble migration.
Neoplasms
Pif1- and Exo1-dependent nucleases coordinate checkpoint activation following telomere uncapping.
Neoplasms
Pigmented epithelioid melanocytoma (animal-type melanoma): An institutional experience.
Neoplasms
Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres.
Neoplasms
Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
Neoplasms
Pin2/TRF1?binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor??B signaling pathway.
Neoplasms
Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression.
Neoplasms
PinX1 gene transfection enhances the sensitivity of gastric carcinoma cell line to 5-fluorouracil.
Neoplasms
PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-?B/MMP-9 signaling pathway.
Neoplasms
PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.
Neoplasms
PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-?B-dependent transcription.
Neoplasms
PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Neoplasms
PinX1 without the G-patch motif suppresses proliferation, induces senescence, but does not inhibit telomerase activity in colorectal cancer SW480 cells.
Neoplasms
Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
Neoplasms
Plant alkaloid chelerythrine induced aggregation of human telomere sequence--a unique mode of association between a small molecule and a quadruplex.
Neoplasms
Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer.
Neoplasms
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.
Neoplasms
Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells.
Neoplasms
Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.
Neoplasms
PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Neoplasms
Point-of-Care Assay of Telomerase Activity at Single-Cell Level via Gas Pressure Readout.
Neoplasms
Polo-like Kinase 1 (Plk1) Up-regulates Telomerase Activity by Affecting Human Telomerase Reverse Transcriptase (hTERT) Stability.
Neoplasms
Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity.
Neoplasms
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.
Neoplasms
Polyamidoamine starburst dendrimer-activated chromatography paper-based assay for sensitive detection of telomerase activity.
Neoplasms
Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity.
Neoplasms
Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males.
Neoplasms
Polymorphisms of the TERT-CLPTM1L Gene Are Associated with Pharynx-Larynx Cancer.
Neoplasms
Polymorphisms within the Telomerase Reverse Transcriptase gene (TERT) in four breeds of dogs selected for difference in lifespan and cancer susceptibility.
Neoplasms
Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach.
Neoplasms
Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.
Neoplasms
Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.
Neoplasms
Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
Neoplasms
Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.
Neoplasms
Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Neoplasms
Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Neoplasms
Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays.
Neoplasms
Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
Neoplasms
Potent inhibitory activity of chimeric oligonucleotides targeting two different sites of human telomerase.
Neoplasms
Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.
Neoplasms
Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
Neoplasms
Potential involvement of tumor suppressor gene expression in the formation of estrogen-inducible pituitary tumors in rats.
Neoplasms
Potential mouse tumor model for pre-clinical testing of mage-specific breast cancer vaccines.
Neoplasms
Potential of Naturally Derived Compounds in Telomerase and Telomere Modulation in Skin Senescence and Aging.
Neoplasms
Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Neoplasms
Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer.
Neoplasms
Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus.
Neoplasms
Preclinical studies on detection of circulating melanoma cells in patients: telomerase as a recognition marker of malignancy.
Neoplasms
Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.
Neoplasms
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Neoplasms
Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level.
Neoplasms
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Neoplasms
Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure.
Neoplasms
Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Neoplasms
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.
Neoplasms
Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.
Neoplasms
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert.
Neoplasms
Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
Neoplasms
Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells.
Neoplasms
Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.
Neoplasms
Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.
Neoplasms
Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
Neoplasms
Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
Neoplasms
Preparation and characterization of candidate reference materials for telomerase assays.
Neoplasms
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
Neoplasms
Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows.
Neoplasms
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness.
Neoplasms
Presence of telomerase activity with undetectable p16 gene mutation in Malaysian patients with brain tumor.
Neoplasms
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.
Neoplasms
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Neoplasms
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
Neoplasms
Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.
Neoplasms
Primate RNA tumor virus-like DNA synthesized endogenously by RNA-dependent DNA polymerase in virus-like particles from fresh human acute leukemic blood cells.
Neoplasms
Primer-Modified G-Quadruplex-Au Nanoparticles for Colorimetric Assay of Human Telomerase Activity and Initial Screening of Telomerase Inhibitors.
Neoplasms
Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions.
Neoplasms
Production of spindle cell carcinoma by transduction of H-Ras 61L into immortalized human mammary epithelial cells.
Neoplasms
Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
Neoplasms
Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion.
Neoplasms
Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis.
Neoplasms
Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.
Neoplasms
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Neoplasms
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
Neoplasms
Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in Glioblastoma.
Neoplasms
Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.
Neoplasms
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Neoplasms
Prognostic Significance of Quantitative Carcinoembryonic Antigen and Cytokeratin 20 mRNA Detection in Peritoneal Washes of Gastric Cancer Patients.
Neoplasms
Prognostic significance of reactivation of telomerase in breast core biopsy specimens.
Neoplasms
Prognostic Significance of Telomerase Activity and Human Telomerase Reverse Transcriptase Expression in Ampullary Carcinoma.
Neoplasms
Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
Neoplasms
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
Neoplasms
Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
Neoplasms
Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell Tumors.
Neoplasms
Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
Neoplasms
Progress of experimental researches on Chinese herbal compounds for inducing tumor cell apoptosis.
Neoplasms
Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.
Neoplasms
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
Neoplasms
Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase.
Neoplasms
Proinflammatory cytokine TNF? promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Neoplasms
Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis.
Neoplasms
Promoter CpG methylation inhibits Krüppel-like factor 2 (KLF2)-Mediated repression of hTERT gene expression in human T-cells.
Neoplasms
Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Neoplasms
Promoter trapping method: transcription factor purification using human telomerase reverse transcriptase promoter.
Neoplasms
Propagation of mouse mammary tumor cell lines and production of mouse mammary tumor virus in a serum-free medium.
Neoplasms
Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy.
Neoplasms
Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis.
Neoplasms
Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
Neoplasms
Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.
Neoplasms
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Neoplasms
Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: possible relationship to steroid hormone receptors.
Neoplasms
Prostatic androgen repressed message-1 (PARM-1) may play a role in prostatic cell immortalisation.
Neoplasms
Protein composition of catalytically active human telomerase from immortal cells.
Neoplasms
Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells.
Neoplasms
Proteins with antifungal properties and other medicinal applications from plants and mushrooms.
Neoplasms
Proteomic and microRNA data clarifying the effects of telomere shortening on cancer cells.
Neoplasms
Proteomic identification of proteins differentially expressed following overexpression of hTERT (human telomerase reverse transcriptase) in cancer cells.
Neoplasms
Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.
Neoplasms
Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase ? in the Alternative Lengthening of Telomeres.
Neoplasms
Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.
Neoplasms
Proximity binding-triggered multipedal DNA walker for the electrochemiluminescence detection of telomerase activity.
Neoplasms
PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Neoplasms
Pterostilbene as a Potential Novel Telomerase Inhibitor: Molecular Docking Studies and its In Vitro Evaluation.
Neoplasms
Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Neoplasms
Purification and biochemical characterization of a virus-specific reverse transcriptase from human osteosarcoma tissue.
Neoplasms
Purification and Characterization of a Laccase with Inhibitory Activity toward HIV-1 Reverse Transcriptase and Tumor Cells from an Edible Mushroom (Pleurotus cornucopiae).
Neoplasms
Purification and characterization of a lectin from the Indian cultivar of French bean seeds.
Neoplasms
Purification and characterization of a novel lectin with antiphytovirus activities from the wild mushroom Paxillus involutus.
Neoplasms
Purification and properties of RNA-dependent DNA polymerase from cytoplasmic A-type particles of murine mammary tumor virus.
Neoplasms
Purification of diseased cells from Barrett's esophagus and related lesions by laser capture microdissection.
Neoplasms
Putative telomere-recruiting domain in the catalytic subunit of human telomerase.
Neoplasms
Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
Neoplasms
Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study.
Neoplasms
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
Neoplasms
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
Neoplasms
Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma.
Neoplasms
Quantification of telomerase activity in sporadic colorectal carcinoma: association with tumor growth and venous invasion.
Neoplasms
Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Neoplasms
Quantifying interactions between G-quadruplex DNA and transition-metal complexes.
Neoplasms
Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy.
Neoplasms
Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection.
Neoplasms
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
Neoplasms
Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver.
Neoplasms
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells.
Neoplasms
Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens.
Neoplasms
Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
Neoplasms
Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
Neoplasms
Quantitative analysis of telomerase activity and telomere length in domestic animal clones.
Neoplasms
Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Neoplasms
Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.
Neoplasms
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Neoplasms
Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Neoplasms
Quantitative assays for measuring human telomerase activity and DNA binding properties.
Neoplasms
Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
Neoplasms
Quantitative Biology of Human Shelterin and Telomerase: Searching for the Weakest Point.
Neoplasms
Quantitative detection of disseminated cancer cells in the greater omentum of gastric carcinoma patients with real-time RT-PCR: a comparison with peritoneal lavage cytology.
Neoplasms
Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients.
Neoplasms
Quantitative Determination of Telomerase Activity by Combining Fluorescence Correlation Spectroscopy with Telomerase Repeat Amplification Protocol.
Neoplasms
Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Neoplasms
Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions.
Neoplasms
Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens.
Neoplasms
Quantitative measurement of telomerase activity and localization of its catalytic subunit (hTERT) in chronic inflammation of capsule formation around various model implants and in sarcomas in a rat model.
Neoplasms
Quantitative proteomic profiling of tumor cell response to telomere dysfunction using isotope-coded protein labeling (ICPL) reveals interaction network of candidate senescence markers.
Neoplasms
Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues.
Neoplasms
Quantitative telomerase activity in malignant, benign and normal gynecological tissues.
Neoplasms
Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution.
Neoplasms
Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.
Neoplasms
Quencher group induced high specificity detection of telomerase in clear and bloody urines by AIEgens.
Neoplasms
Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor.
Neoplasms
Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity.
Neoplasms
Radiation-induced progressive decreasing in the expression of reverse transcriptase gene of hEST2 and telomerase activity.
Neoplasms
Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.
Neoplasms
Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.
Neoplasms
Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.
Neoplasms
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
Neoplasms
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
Neoplasms
Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
Neoplasms
Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
Neoplasms
Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
Neoplasms
Rapid progression of an IDH-wild type histological low-grade glioma harbouring TERT promoter mutation and diffuse CD34 expression: a case report.
Neoplasms
Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.
Neoplasms
Ratiometric Fluorescent Biosensor for Visual Discrimination of Cancer Cells with Different Telomerase Expression Levels.
Neoplasms
Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Neoplasms
Rational Designed Bipolar, Conjugated Polymer-DNA Composite Beacon for the Sensitive Detection of Proteins and Ions.
Neoplasms
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Re: Cancer cells in mesenteric vein and peripheral vessels by measuring telomerase activity in patients with colorectal cancer.
Neoplasms
Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360-6: Telomerase Expression and Stem Cells: Urologic Epithelial Perspective.
Neoplasms
Reactivation of Tert in the medial prefrontal cortex and hippocampus rescues aggression and depression of Tert(-/-) mice.
Neoplasms
Real-Time Detection of Telomerase Activity in Cancer Cells using a Label-Free Electrochemical Impedimetric Biosensing Microchip.
Neoplasms
Real-time detection of telomerase activity using the exponential isothermal amplification of telomere repeat assay.
Neoplasms
Real-time determination of telomerase activity in cell extracts using an optical biosensor.
Neoplasms
Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Neoplasms
Real-time PCR detection of telomerase activity using specific molecular beacon probes.
Neoplasms
Real-time PCR hTERT mRNA pattern in tumor core, edge, resection margin, and lymph nodes in laryngeal tumors: relation to proliferative index and impact on prognosis.
Neoplasms
Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients.
Neoplasms
Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues.
Neoplasms
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Neoplasms
Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay.
Neoplasms
Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders.
Neoplasms
Real-time quantitative RT-PCR for human telomere elongation reverse transcriptase in chronic myeloid leukemia.
Neoplasms
Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.
Neoplasms
Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Neoplasms
Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: The high sensitive and accurate method for quantification of telomerase activity.
Neoplasms
Real-Time, Quantitative Lighting-up Detection of Telomerase in Urines of Bladder Cancer Patients by AIEgens.
Neoplasms
Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.
Neoplasms
Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Neoplasms
Recent advances in the development of telomerase inhibitors for the treatment of cancer.
Neoplasms
Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.
Neoplasms
Recent Developments in the Chemistry and Biology of G-Quadruplexes with Reference to the DNA Groove Binders.
Neoplasms
Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications.
Neoplasms
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
Neoplasms
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
Neoplasms
Recognition and Stabilization of Quadruplex DNA by a Potent New Telomerase Inhibitor: NMR Studies of the 2:1 Complex of a Pentacyclic Methylacridinium Cation with d(TTAGGGT)(4) We thank the EPSRC of the UK and AstraZeneca for financial support to E.G. M.F.G.S. and R.A.H. are supported by the Cancer Research Campaign of the UK.
Neoplasms
Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.
Neoplasms
Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA.
Neoplasms
Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Neoplasms
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
Neoplasms
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.
Neoplasms
Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells.
Neoplasms
Recruitment of Rad51 and Rad52 to short telomeres triggers a Mec1-mediated hypersensitivity to double-stranded DNA breaks in senescent budding yeast.
Neoplasms
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Neoplasms
Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Neoplasms
Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer.
Neoplasms
Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.
Neoplasms
Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
Neoplasms
Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Neoplasms
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
Neoplasms
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition.
Neoplasms
Refined secondary-structure models of the core of yeast and human telomerase RNAs directed by SHAPE.
Neoplasms
Regression of gastric mucosa-associated lymphoid tissue lymphoma with reduced telomerase activity after eradication of Helicobacter pylori.
Neoplasms
Regulation of Cellular Immortalization and Steady-State Levels of the Telomerase Reverse Transcriptase through Its Carboxy-Terminal Domain.
Neoplasms
Regulation of hTERT transcription: a target of cellular and viral mechanisms for immortalization and carcinogenesis.
Neoplasms
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Neoplasms
Regulation of multiple energy transfer processes in a simple nano-system for sensitive telomerase detection.
Neoplasms
Regulation of signal transduction cascades by Pterostilbenes in different cancers: Is it a death knell for oncogenic pathways.
Neoplasms
Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
Neoplasms
Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor.
Neoplasms
Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.
Neoplasms
Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
Neoplasms
Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.
Neoplasms
Regulatory mechanisms of human and mouse telomerase reverse transcriptase gene transcription: distinct dependency on c-Myc.
Neoplasms
Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Neoplasms
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications.
Neoplasms
Relationship between dyskerin expression and telomerase activity in human breast cancer.
Neoplasms
Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Neoplasms
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma.
Neoplasms
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Neoplasms
Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
Neoplasms
Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol.
Neoplasms
Reliable Förster Resonance Energy Transfer Probe Based on Structure-Switching DNA for Ratiometric Sensing of Telomerase in Living Cells.
Neoplasms
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Neoplasms
Renoprotective Effects of Carbon Monoxide-Releasing Molecule 3 in Ischemia-Reperfusion Injury and Cisplatin-Induced Toxicity.
Neoplasms
Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Neoplasms
Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres.
Neoplasms
Replication stress as a source of telomere recombination during replicative senescence in Saccharomyces cerevisiae.
Neoplasms
Replicative senescence and senescence-like state induced in cancer-derived cells.
Neoplasms
Repression of human telomerase reverse transcriptase using artificial zinc finger transcription factors.
Neoplasms
Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.
Neoplasms
Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer.
Neoplasms
Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.
Neoplasms
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
Neoplasms
Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Neoplasms
Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
Neoplasms
Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Neoplasms
Retinoic acid-induced downmodulation of telomerase activity in human cancer cells.
Neoplasms
Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Neoplasms
Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood.
Neoplasms
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.
Neoplasms
Reversible downregulation of telomerase activity by hyperthermia in osteosarcoma cells.
Neoplasms
Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.
Neoplasms
Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo.
Neoplasms
Rhodospirillum rubruml-asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition.
Neoplasms
RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
Neoplasms
Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Neoplasms
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Neoplasms
RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Neoplasms
RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line.
Neoplasms
RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells.
Neoplasms
RNA-dependent DNA polymerase activity in intracytoplasmic type-a particles of mouse mammary tumors.
Neoplasms
RNA-dependent DNA polymerase activity of RNA tumor virus. VI. Processive mode of action of avian myeloblastosis virus polymerase.
Neoplasms
RNA-dependent DNA polymerase activity of RNA tumor viruses. I. Directing influence of DNA in the reaction.
Neoplasms
RNA-dependent DNA polymerase activity of RNA tumor viruses. II. Directing influence of RNA in the reaction.
Neoplasms
RNA-dependent DNA polymerase activity of RNA tumor viruses. V. Rous sarcoma virus single-stranded RNA-DNA covalent hybrids in infected chicken embryo fibroblast cells.
Neoplasms
RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19.
Neoplasms
RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity.
Neoplasms
RNAi-hTERT Inhibition Hepatocellular Carcinoma Cell Proliferation via Decreasing Telomerase Activity.
Neoplasms
RNase H and RNA-directed DNA polymerase: associated enzymatic activities of murine mammary tumor virus.
Neoplasms
Rnr1's role in telomere elongation cannot be replaced by Rnr3: a role beyond dNTPs?
Neoplasms
Robinin modulates TLR/NF-?B signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells.
Neoplasms
Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.
Neoplasms
Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical Cancer.
Neoplasms
Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Neoplasms
Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937.
Neoplasms
Role of DNA methylation and CpG sites in the viral telomerase RNA promoter during Gallid herpesvirus 2 pathogenesis.
Neoplasms
Role of GLTSCR2 in the regulation of telomerase activity and chromosome stability.
Neoplasms
Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Neoplasms
Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.
Neoplasms
Role of menin in the regulation of telomerase activity in normal and cancer cells.
Neoplasms
Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta.
Neoplasms
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
Neoplasms
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and FISH.
Neoplasms
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential.
Neoplasms
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Neoplasms
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Neoplasms
Ruthenium-arene complexes bearing naphthyl-substituted 1,3-dioxoindan-2-carboxamides ligands for G-quadruplex DNA recognition.
Neoplasms
Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle.
Neoplasms
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.
Neoplasms
Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs.
Neoplasms
Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.
Neoplasms
Sarcomatoid Renal Cell Carcinoma With Unusual Metastasis to the Small Intestine Manifesting as Perforated Appendicitis.
Neoplasms
Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells.
Neoplasms
Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells.
Neoplasms
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Neoplasms
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
Neoplasms
Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate.
Neoplasms
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
Neoplasms
Selective inhibition of human cancer cells by drugs which inhibit the RNA-dependent DNA polymerase enzyme.
Neoplasms
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Neoplasms
Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis.
Neoplasms
Selective recognition of specific G-quadruplex vs. duplex DNA by a phenanthroline derivative.
Neoplasms
Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.
Neoplasms
Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Neoplasms
Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity.
Neoplasms
Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Neoplasms
Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Neoplasms
Sensitive and bidirectional detection of urine telomerase based on the four detection-color states of difunctional gold nanoparticle probe.
Neoplasms
Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
Neoplasms
Sensitive detection of intracellular RNA of human telomerase by using graphene oxide as a carrier to deliver the assembly element of hybridization chain reaction.
Neoplasms
Sensitive detection of intracellular telomerase activity via double signal amplification and ratiometric fluorescence resonance energy transfer.
Neoplasms
Sensitive detection of telomerase activity in cancer cells using portable pH meter as readout.
Neoplasms
Sensitive detection of telomerase activity in cells using a DNA-based fluorescence resonance energy transfer nanoprobe.
Neoplasms
Sensitive multicolor visual detection of telomerase activity based on catalytic hairpin assembly and etching of Au nanorods.
Neoplasms
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Neoplasms
Sequence variation and mRNA expression of the TWIST1 gene in cats with mammary hyperplasia and neoplasia.
Neoplasms
Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.
Neoplasms
Sequential 5-Aza-2'-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1.
Neoplasms
Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patients.
Neoplasms
Serine/threonine-protein phosphatase 2A physically interacts with human telomerase reverse transcriptase hTERT and regulates its subcellular distribution.
Neoplasms
SERS-based copper-mediated signal amplification strategy for simple and sensitive detection of telomerase activity.
Neoplasms
Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Neoplasms
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
Neoplasms
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Neoplasms
Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase.
Neoplasms
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
Neoplasms
Short hairpin ribonucleic acid targeting the telomerase catalytic unit of messenger ribonucleic acid significantly limits the growth of laryngeal squamous cell carcinoma in nude mice.
Neoplasms
Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Neoplasms
Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines.
Neoplasms
Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
Neoplasms
Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes.
Neoplasms
ShRNA-mediated BMI-1 gene silencing inhibits gastrointestinal stromal tumor cell telomerase activity and enhances apoptosis.
Neoplasms
shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Neoplasms
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
Neoplasms
Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells.
Neoplasms
Signal-On Dual-Potential Electrochemiluminescence Based on Luminol-Gold Bifunctional Nanoparticles for Telomerase Detection.
Neoplasms
Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown.
Neoplasms
Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastresophageal junction.
Neoplasms
Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.
Neoplasms
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.
Neoplasms
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients.
Neoplasms
Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cells.
Neoplasms
Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.
Neoplasms
Silencing tankyrase and telomerase promotes A549 human lung adenocarcinoma cell apoptosis and inhibits proliferation.
Neoplasms
Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells.
Neoplasms
Simple and fast screening of G-quadruplex ligands with electrochemical detection system.
Neoplasms
Simultaneous detection of telomerase and miRNA with graphene oxide-based fluorescent aptasensor in living cells and tissue samples.
Neoplasms
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Neoplasms
Single cell measurement of telomerase expression and splicing using microfluidic emulsion cultures.
Neoplasms
Single clonal glandular stem cells derived from human parotid glands do not attain malignant phenotype during long-term in vitro culture.
Neoplasms
Single living cell detection of telomerase over-expression for cancer detection by an optical fiber nanobiosensor.
Neoplasms
Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
Neoplasms
Single-Molecule Analysis of Human Telomere Sequence Interactions with G-quadruplex Ligand.
Neoplasms
Single-molecule FRET-Rosetta reveals RNA structural rearrangements during human telomerase catalysis.
Neoplasms
Single-Molecule Imaging of Telomerase RNA Reveals a Recruitment-Retention Model for Telomere Elongation.
Neoplasms
Single-Strand DNA-Binding Protein SSB1 Facilitates TERT Recruitment to Telomeres and Maintains Telomere G-Overhangs.
Neoplasms
SiO2 nanoparticles modified CPE as a biosensor for determination of i-motif DNA/Tamoxifen interaction.
Neoplasms
siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.
Neoplasms
siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.
Neoplasms
siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.
Neoplasms
siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
Neoplasms
siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma.
Neoplasms
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Neoplasms
Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress.
Neoplasms
SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
Neoplasms
Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with Trans-Splicing Ribozyme.
Neoplasms
Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin.
Neoplasms
Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death.
Neoplasms
Smart vesicle kit for in situ monitoring of intracellular telomerase activity using a telomerase-responsive probe.
Neoplasms
Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells.
Neoplasms
Solid-Phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors.
Neoplasms
Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation.
Neoplasms
Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.
Neoplasms
Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.
Neoplasms
Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
Neoplasms
Specific Binding of Anionic Porphyrin and Phthalocyanine to the G-Quadruplex with a Variety of in Vitro and in Vivo Applications.
Neoplasms
Specific binding of telomeric G-quadruplexes by hydrosoluble perylene derivatives inhibits repeat addition processivity of human telomerase.
Neoplasms
Specific expression of short-interfering RNA driven by human telomerase reverse transcriptase promoter in tumor cells.
Neoplasms
Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
Neoplasms
Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Neoplasms
Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Neoplasms
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Neoplasms
Spinal cord long-term potentiation (LTP) is associated with increased dorsal horn gene expression of IL-1beta, GDNF and iNOS.
Neoplasms
Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Neoplasms
SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
Neoplasms
Stability and free energy calculation of LNA modified quadruplex: a molecular dynamics study.
Neoplasms
Stabilization of c-myc G-Quadruplex DNA, inhibition of telomerase activity, disruption of mitochondrial functions and tumor cell apoptosis by platinum(II) complex with 9-amino-oxoisoaporphine.
Neoplasms
Stabilization of G-quadruplex DNA and inhibition of telomerase activity studies of ruthenium(II) complexes.
Neoplasms
Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(II) Complexes.
Neoplasms
Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine.
Neoplasms
Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Neoplasms
Stable expression in a Chinese hamster ovary (CHO) cell line of bioactive recombinant chelonianin, which plays an important role in protecting fish against pathogenic infection.
Neoplasms
Stable expression of promyelocytic leukaemia (PML) protein in telomerase positive MCF7 cells results in alternative lengthening of telomeres phenotype.
Neoplasms
Stem cell function and maintenance - ends that matter: Role of telomeres and telomerase.
Neoplasms
Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Neoplasms
STRATEGIES OF TREATING CANCER BY CYTOKINE REGULATION OF CHROMOSOME END REMODELLING.
Neoplasms
Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.
Neoplasms
Structural and biophysical insight into dual site binding of the protoberberine alkaloid palmatine to parallel G-quadruplex DNA using NMR, fluorescence and Circular Dichroism spectroscopy.
Neoplasms
Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Neoplasms
Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Neoplasms
Structural, functional, and stability change predictions in human telomerase upon specific point mutations.
Neoplasms
Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
Neoplasms
Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Neoplasms
Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme.
Neoplasms
Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Neoplasms
Study of the expressions of p53 and bcl-2 genes, the telomerase activity and apoptosis in GIST patients.
Neoplasms
Sublethal hemorrhage blunts the inflammatory cytokine response to endotoxin in a rat model.
Neoplasms
Subnuclear shuttling of human telomerase induced by transformation and DNA damage.
Neoplasms
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells.
Neoplasms
Successful pre-operative diagnosis of malignant intraductal papillary mucinous tumor of the pancreas by detecting telomerase activity.
Neoplasms
Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
Neoplasms
Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Neoplasms
Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
Neoplasms
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Neoplasms
Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
Neoplasms
Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.
Neoplasms
Suppression of hPOT1 in Diploid Human Cells Results in an hTERT-Dependent Alteration of Telomere Length Dynamics.
Neoplasms
Suppression of Ku80 Correlates with Radiosensitivity and Telomere Shortening in the U2OS Telomerase-negative Osteosarcoma Cell Line.
Neoplasms
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-?B.
Neoplasms
Suppression of PinX1 resulted in telomere dysfunction and enhanced radiosensitivity in osteosarcoma cell lines.
Neoplasms
Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
Neoplasms
Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.
Neoplasms
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Neoplasms
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
Neoplasms
Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Neoplasms
Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.
Neoplasms
Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
Neoplasms
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
Neoplasms
Survival of diffuse astrocytic glioma, IDH1/2-wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.
Neoplasms
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation.
Neoplasms
Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Neoplasms
Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
Neoplasms
Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.
Neoplasms
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
Neoplasms
Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
Neoplasms
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Neoplasms
Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Neoplasms
Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Neoplasms
Synergistic Effect of Free and Nano-encapsulated Chrysin-Curcumin on Inhibition of hTERT Gene Expression in SW480 Colorectal Cancer Cell Line.
Neoplasms
Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line.
Neoplasms
Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer.
Neoplasms
Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.
Neoplasms
Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Neoplasms
Synthesis and discovery of 18?-GAMG as anticancer agent in vitro and in vivo via down expression of protein p65.
Neoplasms
Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones.
Neoplasms
Synthesis of 6-formyl-pyridine-2-carboxylate derivatives and their telomerase inhibitory activities.
Neoplasms
Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.
Neoplasms
Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues.
Neoplasms
Synthesis, G-Quadruplex Stabilisation, Docking Studies, and Effect on Cancer Cells of Indolo[3,2-b]quinolines with One, Two, or Three Basic Side Chains.
Neoplasms
Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Neoplasms
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
Neoplasms
Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.
Neoplasms
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
Neoplasms
Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells.
Neoplasms
Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy.
Neoplasms
Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Neoplasms
Systematic review of genetic variation in chromosome 5p15.33 and telomere length as predictive and prognostic biomarkers for lung cancer.
Neoplasms
T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil.
Neoplasms
T cell receptor Vbeta repertoire of tumour-infiltrating lymphocytes in oral squamous-cell carcinoma.
Neoplasms
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy.
Neoplasms
Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell.
Neoplasms
Target induced framework nucleic acid nanomachine with doxorubicin-spherical nucleic acid tags for electrochemical determination of human telomerase activity.
Neoplasms
Target-controlled in situ formation of G-quadruplex DNAzyme for a sensitive visual assay of telomerase activity.
Neoplasms
Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
Neoplasms
Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus.
Neoplasms
Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.
Neoplasms
Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
Neoplasms
Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
Neoplasms
Targeted inhibition of telomerase in human cancer: will it be a double-edged sword?
Neoplasms
Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.
Neoplasms
Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Neoplasms
Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Neoplasms
Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.
Neoplasms
Targeting ALT: the role of alternative lengthening of telomeres in pathogenesis and prevention of cancer.
Neoplasms
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.
Neoplasms
Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Neoplasms
Targeting cancer with telomerase: commentary re Q. Huang et al., a novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin. Cancer Res., 10: 1439-1445, 2004.
Neoplasms
Targeting cell cycle by ?-carboline alkaloids in vitro: Novel therapeutic prospects for the treatment of cancer.
Neoplasms
Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Neoplasms
Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study.
Neoplasms
Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.
Neoplasms
Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo.
Neoplasms
Targeting human telomerase RNA component using antisense oligonucleotide induces rapid cell death and increases ATO-induced apoptosis in APL cells.
Neoplasms
Targeting human telomeric G-quadruplex DNA and inhibition of telomerase activity with [(dmb)2Ru(obip)Ru(dmb)2](4+).
Neoplasms
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Neoplasms
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma.
Neoplasms
Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models.
Neoplasms
Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
Neoplasms
Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies.
Neoplasms
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Neoplasms
Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Neoplasms
Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells.
Neoplasms
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives.
Neoplasms
TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.
Neoplasms
TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
Neoplasms
TCTP overexpression reverses age-associated telomere attrition by upregulating telomerase activity in mouse oocytes.
Neoplasms
Technical improvement in determining telomerase activity in hematologic neoplasias: a possibility of single cell determination of telomerase activity.
Neoplasms
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Neoplasms
Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Neoplasms
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
Neoplasms
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Neoplasms
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid.
Neoplasms
Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.
Neoplasms
Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.
Neoplasms
Telomerase activation as a possible mechanism of action for psychopharmacological interventions.
Neoplasms
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes.
Neoplasms
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.
Neoplasms
Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension.
Neoplasms
Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.
Neoplasms
Telomerase activation during the linear evolution of human fibroblasts to tumorigenicity in nude mice.
Neoplasms
Telomerase activation in endometrial epithelial cells by paracrine effectors from stromal cells in primary cultured human endometrium.
Neoplasms
Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde?
Neoplasms
Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
Neoplasms
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Neoplasms
Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.
Neoplasms
Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.
Neoplasms
Telomerase activity (TMA) in tumour and peritumoural tissues in a rat liver cancer model.
Neoplasms
Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
Neoplasms
Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study.
Neoplasms
Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage.
Neoplasms
Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
Neoplasms
Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Neoplasms
Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.
Neoplasms
Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Neoplasms
Telomerase Activity and Expression of hTR and TERT in Human Soft Tissue Sarcomas.
Neoplasms
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Neoplasms
Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Neoplasms
Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Neoplasms
Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.
Neoplasms
Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Neoplasms
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Neoplasms
Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.
Neoplasms
Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas.
Neoplasms
Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Neoplasms
Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Neoplasms
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Neoplasms
Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Neoplasms
Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
Neoplasms
Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.
Neoplasms
Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.
Neoplasms
Telomerase activity and microsatellite instability in colorectal cancer and adenoma.
Neoplasms
Telomerase activity and patient survival after surgery for gastric and oesophageal cancer.
Neoplasms
Telomerase activity and phenotypic characterization in harvested bone marrow from a child with a germline cell cancer.
Neoplasms
Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers.
Neoplasms
Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.
Neoplasms
Telomerase activity and survival of late-stage South African esophageal carcinoma patients.
Neoplasms
Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Neoplasms
Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: correlation with Ki67 immunoreactivity.
Neoplasms
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
Neoplasms
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Neoplasms
Telomerase activity and telomere length in benign and malignant human thyroid tissues.
Neoplasms
Telomerase activity and telomere length in different areas of renal cell carcinoma.
Neoplasms
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.
Neoplasms
Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Neoplasms
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Neoplasms
Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Neoplasms
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival.
Neoplasms
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Neoplasms
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Neoplasms
Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Neoplasms
Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
Neoplasms
Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
Neoplasms
Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation.
Neoplasms
Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor.
Neoplasms
Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Neoplasms
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
Neoplasms
Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
Neoplasms
Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases.
Neoplasms
Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.
Neoplasms
Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy.
Neoplasms
Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Neoplasms
Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.
Neoplasms
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Neoplasms
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Neoplasms
Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Neoplasms
Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
Neoplasms
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
Neoplasms
Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Neoplasms
Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
Neoplasms
Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma.
Neoplasms
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.
Neoplasms
Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Neoplasms
Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.
Neoplasms
Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.
Neoplasms
Telomerase Activity Detection with Amplification-Free Single Molecule Stochastic Binding Assay.
Neoplasms
Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Neoplasms
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Neoplasms
Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.
Neoplasms
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Neoplasms
Telomerase activity in a specific cell subset co-expressing integrinbeta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells.
Neoplasms
Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features.
Neoplasms
Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine.
Neoplasms
Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer.
Neoplasms
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype.
Neoplasms
Telomerase activity in candidate stem cells from fetal liver and adult bone marrow.
Neoplasms
Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions.
Neoplasms
Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
Neoplasms
Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway.
Neoplasms
Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis.
Neoplasms
Telomerase activity in esophageal squamous cell carcinoma and lesions unstained with Lugol's solution.
Neoplasms
Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent.
Neoplasms
Telomerase Activity in Gastric Adenocarcinomas: Frozen Tissues Versus Methacarn-fixed Paraffin-embedded Tissues.
Neoplasms
Telomerase activity in gliomas with the use of non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol.
Neoplasms
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Neoplasms
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus.
Neoplasms
Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
Neoplasms
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.
Neoplasms
Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas.
Neoplasms
Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
Neoplasms
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Neoplasms
Telomerase activity in human solid tumors. Diagnostic utility and clinical applications.
Neoplasms
Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Neoplasms
Telomerase activity in immortalized endothelial cells undergoing p53-mediated apoptosis.
Neoplasms
Telomerase activity in Indian patients with carcinomas of the aerodigestive tract.
Neoplasms
Telomerase activity in juxtacortical and conventional high-grade osteosarcomas: correlation with grade, proliferative activity and clinical response to chemotherapy.
Neoplasms
Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.
Neoplasms
Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates.
Neoplasms
Telomerase activity in malignant ovarian tumors with deregulation of cell cycle regulatory proteins.
Neoplasms
Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Neoplasms
Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha.
Neoplasms
Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Neoplasms
Telomerase activity in needle biopsies from prostate cancer and benign prostates.
Neoplasms
Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
Neoplasms
Telomerase activity in non-small cell lung carcinomas correlates with smoking status.
Neoplasms
Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.
Neoplasms
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Neoplasms
Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy.
Neoplasms
Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Neoplasms
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Neoplasms
Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
Neoplasms
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.
Neoplasms
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Neoplasms
Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Neoplasms
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Neoplasms
Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens.
Neoplasms
Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.
Neoplasms
Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease.
Neoplasms
Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer.
Neoplasms
Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
Neoplasms
Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer.
Neoplasms
Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues.
Neoplasms
Telomerase activity in the differentiation of benign and malignant adrenal tumors.
Neoplasms
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
Neoplasms
Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.
Neoplasms
Telomerase activity in the vaginal margins of radical hysterectomy in patients with carcinoma of the cervix: correlation with histology and human papillomavirus.
Neoplasms
Telomerase activity in thymomas and mammary gland adenocarcinomas induced by polyoma virus in AKR mice.
Neoplasms
Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens.
Neoplasms
Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer.
Neoplasms
Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Neoplasms
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
Neoplasms
Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.
Neoplasms
Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
Neoplasms
Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
Neoplasms
Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Neoplasms
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neoplasms
Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
Neoplasms
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Neoplasms
Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription.
Neoplasms
Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Neoplasms
Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.
Neoplasms
Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.
Neoplasms
Telomerase activity is not altered by regular strenuous exercise in skeletal muscle or by sarcoma in liver of rats.
Neoplasms
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Neoplasms
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.
Neoplasms
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.
Neoplasms
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Neoplasms
Telomerase activity levels for evaluating the surgical margin in breast-conserving surgery.
Neoplasms
Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck.
Neoplasms
Telomerase activity measurement in magnetically captured epithelial cells: comparison of slab-gel and capillary electrophoresis.
Neoplasms
Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion.
Neoplasms
Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures.
Neoplasms
Telomerase activity of needle-biopsied liver samples: its usefulness for diagnosis and judgement of efficacy of treatment of small hepatocellular carcinoma.
Neoplasms
Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues.
Neoplasms
Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.
Neoplasms
Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.
Neoplasms
Telomerase activity predicts malignancy in percutaneous image-guided needle biopsy specimens of the abdomen and pelvis.
Neoplasms
Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinomas.
Neoplasms
Telomerase activity Simplification of assay and detection in bladder tumor and urinary exfoliated cells.
Neoplasms
Telomerase activity with concurrent loss of cell cycle regulation in feline post-traumatic ocular sarcomas.
Neoplasms
Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients.
Neoplasms
Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.
Neoplasms
Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.
Neoplasms
Telomerase activity, Ki-67, cyclin D1 and A expression, and apoptosis in solitary fibrous tumors: additional features of a predictable course?
Neoplasms
Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
Neoplasms
Telomerase activity, Myc and Bcl-2: possible indicators of effective therapy of prostate cancer with 9-nitrocamptothecin.
Neoplasms
Telomerase activity, P53 mutation and Ki-ras codon 12 point mutation of the peripheral blood in patients with hepato pancreato biliary diseases.
Neoplasms
Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Neoplasms
Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma.
Neoplasms
Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Neoplasms
Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Neoplasms
Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
Neoplasms
Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Neoplasms
Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Neoplasms
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Neoplasms
Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Neoplasms
Telomerase and cancer. The Fifth International Symposium of the Hiroshima Cancer Seminar October 1995, Hiroshima, Japan.
Neoplasms
Telomerase and Cancer: Kirk A. Landon--AACR prize for basic cancer research lecture.
Neoplasms
Telomerase and cancer: time to move from a promising target to a clinical reality.
Neoplasms
Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again.
Neoplasms
Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
Neoplasms
Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.
Neoplasms
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.
Neoplasms
Telomerase and poly(ADP-ribose) polymerase-1 activity sensing based on the high fluorescence selectivity and sensitivity of TOTO-1 towards G bases in single-stranded DNA and poly(ADP-ribose).
Neoplasms
Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.
Neoplasms
Telomerase and Retrotransposons: Reverse Transcriptases That Shaped Genomes Special Feature Sackler Colloquium: Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.
Neoplasms
Telomerase and telomere biology in hematological diseases: A new therapeutic target.
Neoplasms
Telomerase and telomere dynamics in ageing and cancer: current status and future directions.
Neoplasms
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Neoplasms
Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Neoplasms
Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks.
Neoplasms
Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Neoplasms
Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo.
Neoplasms
Telomerase as a new target for the treatment of hormone-refractory prostate cancer.
Neoplasms
Telomerase as a potential anticancer target: growth inhibition and genomic instability.
Neoplasms
Telomerase as a potential marker for inflammation and cancer detection in bronchial washing: A prospective study.
Neoplasms
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Neoplasms
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.
Neoplasms
Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Neoplasms
Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Neoplasms
Telomerase as an emerging target to fight cancer - Opportunities and challenges for nanomedicine.
Neoplasms
Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Neoplasms
Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.
Neoplasms
Telomerase assay as a possible predictor of the response to anticancer chemotherapy.
Neoplasms
Telomerase assay using biotinylated-primer extension and magnetic separation of the products.
Neoplasms
Telomerase Biogenesis and Activities from the Perspective of Its Direct Interacting Partners.
Neoplasms
Telomerase Cajal body protein 1 depletion inhibits telomerase trafficking to telomeres and induces G1 cell cycle arrest in A549 cells.
Neoplasms
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Neoplasms
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.
Neoplasms
Telomerase deficiency affects the formation of chromosomal translocations by homologous recombination in Saccharomyces cerevisiae.
Neoplasms
Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Neoplasms
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Neoplasms
Telomerase efficiently elongates highly transcribing telomeres in human cancer cells.
Neoplasms
Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Neoplasms
Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells.
Neoplasms
Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin.
Neoplasms
Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Neoplasms
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.
Neoplasms
Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.
Neoplasms
Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits.
Neoplasms
Telomerase expression in human breast cancer with and without lymph node metastases.
Neoplasms
Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Neoplasms
Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer.
Neoplasms
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Neoplasms
Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Neoplasms
Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.
Neoplasms
Telomerase expression is differentially regulated in birds of differing life span.
Neoplasms
Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer.
Neoplasms
Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Neoplasms
Telomerase flies the coop: the telomerase RNA component as a viral-encoded oncogene.
Neoplasms
Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.
Neoplasms
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
Neoplasms
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer.
Neoplasms
Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
Neoplasms
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
Neoplasms
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
Neoplasms
Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
Neoplasms
Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Neoplasms
Telomerase Inhibition and Human Telomeric G-Quadruplex DNA Stabilization by a ?-Carboline-Benzimidazole Derivative at Low Concentrations.
Neoplasms
Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy.
Neoplasms
Telomerase Inhibition and Telomere Targeting in Hematopoietic Cancer Cell Lines with Small Non-Nucleosidic Synthetic Compounds (BIBR1532).
Neoplasms
Telomerase inhibition as an adjuvant anticancer therapy: it is more than just a waiting game.
Neoplasms
Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
Neoplasms
Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells.
Neoplasms
Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.
Neoplasms
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts.
Neoplasms
Telomerase inhibition by sulfoquinovosyldiacylglycerol from edible purple laver (Porphyra yezoensis).
Neoplasms
Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Neoplasms
Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion.
Neoplasms
Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells.
Neoplasms
Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma.
Neoplasms
Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Neoplasms
Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Neoplasms
Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas.
Neoplasms
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Neoplasms
Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Neoplasms
Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
Neoplasms
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Neoplasms
Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
Neoplasms
Telomerase Inhibition, Telomere Shortening, and Cellular Uptake of the Perylene Derivatives PM2 and PIPER in Prostate Cancer Cells.
Neoplasms
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
Neoplasms
Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Neoplasms
Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
Neoplasms
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Neoplasms
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.
Neoplasms
Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery.
Neoplasms
Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length.
Neoplasms
Telomerase inhibitors in anticancer therapy: gossypol as a potential telomerase inhibitor.
Neoplasms
Telomerase inhibitory effects of medicinal mushrooms and lichens, and their anticancer activity.
Neoplasms
Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions.
Neoplasms
Telomerase is activated in the prostate and seminal vesicles of the castrated rat.
Neoplasms
Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions.
Neoplasms
Telomerase is not activated in human hyperplastic and adenomatous parathyroid tissue.
Neoplasms
Telomerase is not required for experimental tumorigenesis of human and bovine adrenocortical cells.
Neoplasms
Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells.
Neoplasms
Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells.
Neoplasms
Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
Neoplasms
Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.
Neoplasms
Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
Neoplasms
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Neoplasms
Telomerase Plays a Pivotal Role in Collateral Growth Under Ischemia by Suppressing Age-Induced Oxidative Stress, Expression of p53, and Pro-Apoptotic Proteins.
Neoplasms
Telomerase promoter mutations and copy number alterations in solitary fibrous tumours.
Neoplasms
Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia.
Neoplasms
Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells.
Neoplasms
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases.
Neoplasms
Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promoters.
Neoplasms
Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity.
Neoplasms
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Neoplasms
Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
Neoplasms
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma.
Neoplasms
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells.
Neoplasms
Telomerase Responsive Delivery of Doxorubicin from Mesoporous Silica Nanoparticles in Multiple Malignancies: Therapeutic Efficacies against Experimental Aggressive Murine Lymphoma.
Neoplasms
Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
Neoplasms
Telomerase reverse transcriptase (TERT) expression and role of vincristine sulfate in mouse model of malignancy related peritoneal ascites: an experimental metastatic condition.
Neoplasms
Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
Neoplasms
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection.
Neoplasms
Telomerase reverse transcriptase (TERT) is a novel target of Wnt/?-catenin pathway in human cancer.
Neoplasms
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Neoplasms
Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity.
Neoplasms
Telomerase reverse transcriptase alterations in human cancers: Diagnosis, prognosis, and therapeutic implications.
Neoplasms
Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.
Neoplasms
Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.
Neoplasms
Telomerase Reverse Transcriptase Contains a BH3-Like Motif and Interacts with BCL-2 Family Members.
Neoplasms
Telomerase reverse transcriptase downregulation by RNA interference modulates endoplasmic reticulum stress and mitochondrial energy production.
Neoplasms
Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.
Neoplasms
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Neoplasms
Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Neoplasms
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
Neoplasms
Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Neoplasms
Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects.
Neoplasms
Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor?related apoptosis?inducing ligand?induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.
Neoplasms
Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells.
Neoplasms
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
Neoplasms
Telomerase reverse transcriptase mediates EMT through NF-?B signaling in tongue squamous cell carcinoma.
Neoplasms
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.
Neoplasms
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase.
Neoplasms
Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Neoplasms
Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis.
Neoplasms
Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.
Neoplasms
Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients.
Neoplasms
Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
Neoplasms
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Neoplasms
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Neoplasms
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Neoplasms
Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.
Neoplasms
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Neoplasms
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Neoplasms
Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy.
Neoplasms
Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
Neoplasms
Telomerase reverse transcriptase synergizes with calorie restriction to increase health span and extend mouse longevity.
Neoplasms
Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes.
Neoplasms
Telomerase RNA expression and DNA ploidy as prognostic markers of prostate carcinomas.
Neoplasms
Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Neoplasms
Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
Neoplasms
Telomerase stability and evaluation of real-time telomeric repeat amplification protocol.
Neoplasms
Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions.
Neoplasms
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
Neoplasms
Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
Neoplasms
Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Neoplasms
Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
Neoplasms
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Neoplasms
Telomerase therapeutics: telomeres recognized as a DNA damage signal: commentary re: K. Kraemer et al., antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
Neoplasms
Telomerase Triggered DNA Walker with a Superhairpin Structure for Human Telomerase Activity Sensing.
Neoplasms
Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.
Neoplasms
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
Neoplasms
Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
Neoplasms
Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Neoplasms
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.
Neoplasms
Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.
Neoplasms
Telomerase-Driven Expression of the Sodium Iodide Symporter (NIS) for in Vivo Radioiodide Treatment of Cancer: A New Broad-Spectrum NIS-Mediated Antitumor Approach.
Neoplasms
Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate.
Neoplasms
Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development.
Neoplasms
Telomerase-independent senescence of human immortal cells induced by microcell-mediated chromosome transfer.
Neoplasms
Telomerase-Mediated Apoptosis of Chicken Lymphoblastoid Tumor Cell Line by Lanthanum Chloride.
Neoplasms
Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Neoplasms
Telomerase-specific attenuated viruses, a definitive strategy or just one more in circulating tumor cells detection anthology?
Neoplasms
Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma.
Neoplasms
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice.
Neoplasms
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
Neoplasms
Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Neoplasms
Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance.
Neoplasms
Telomerase-specific virotherapy in an animal model of human head and neck cancer.
Neoplasms
Telomerase-targeting antisense oligonucleotides carried by polycation liposomes enhance the growth inhibition effect on tumor cells.
Neoplasms
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Neoplasms
Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review.
Neoplasms
Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.
Neoplasms
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Neoplasms
Telomere attrition and telomerase activity are associated with GSTM1 polymorphism in oral cancer.
Neoplasms
Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.
Neoplasms
Telomere dynamics and cytogenetic changes in human hematologic neoplasias: a working hypothesis.
Neoplasms
Telomere dynamics and genome stability in the human pancreatic tumor cell line MIAPaCa-2.
Neoplasms
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Neoplasms
Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
Neoplasms
Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
Neoplasms
Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
Neoplasms
Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells.
Neoplasms
Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells.
Neoplasms
Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.
Neoplasms
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Neoplasms
Telomere elongation-based DNA-Catalytic amplification strategy for sensitive SERS detection of telomerase activity.
Neoplasms
Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.
Neoplasms
Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
Neoplasms
Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells.
Neoplasms
Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation.
Neoplasms
Telomere G-Quadruplex as a Potential Target to Accelerate Telomere Shortening by Expanding the Incomplete End-Replication of Telomere DNA.
Neoplasms
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases.
Neoplasms
Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.
Neoplasms
Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence.
Neoplasms
Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.
Neoplasms
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Neoplasms
Telomere length and telomerase activity during oocyte maturation and early embryo development in mammalian species.
Neoplasms
Telomere Length and Telomerase Activity Impact the UV Sensitivity Syndrome Xeroderma Pigmentosum C.
Neoplasms
Telomere length and telomerase activity in bladder and prostate cancer cell lines.
Neoplasms
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse.
Neoplasms
Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Neoplasms
Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Neoplasms
Telomere length and telomerase activity: variations with advancing age and potential role in childhood malignancies.
Neoplasms
Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas.
Neoplasms
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.
Neoplasms
Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice.
Neoplasms
Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Neoplasms
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.
Neoplasms
Telomere Length in Peripheral Blood Lymphocytes Contributes to the Development of HPV-Associated Oropharyngeal Carcinoma.
Neoplasms
Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
Neoplasms
Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
Neoplasms
Telomere length of cord blood-derived CD34(+) progenitors predicts erythroid proliferative potential.
Neoplasms
Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer.
Neoplasms
Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
Neoplasms
Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology.
Neoplasms
Telomere maintenance in interplay with DNA repair in pathogenesis and treatment of colorectal cancer.
Neoplasms
Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
Neoplasms
Telomere maintenance in wilms tumors: First evidence for the presence of alternative lengthening of telomeres mechanism.
Neoplasms
Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
Neoplasms
Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.
Neoplasms
Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.
Neoplasms
Telomere protection mechanisms change during neurogenesis and neuronal maturation: newly generated neurons are hypersensitive to telomere and DNA damage.
Neoplasms
Telomere Recombination and the ALT Pathway: a Therapeutic Perspective for Cancer.
Neoplasms
Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes.
Neoplasms
Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Neoplasms
Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Neoplasms
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Neoplasms
Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Neoplasms
Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Neoplasms
Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
Neoplasms
Telomere shortening in gastric carcinoma with aging despite telomerase activation.
Neoplasms
Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
Neoplasms
Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Neoplasms
Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.
Neoplasms
Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
Neoplasms
Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.
Neoplasms
Telomere structure and telomerase expression during mouse development and tumorigenesis.
Neoplasms
Telomere Terminal G/C Strand Synthesis: Measuring Telomerase Action and C-Rich Fill-In.
Neoplasms
Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Neoplasms
Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression.
Neoplasms
Telomere-dependent and telomere-independent origins of endogenous DNA damage in tumor cells.
Neoplasms
Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.
Neoplasms
Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice.
Neoplasms
Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae.
Neoplasms
Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: Pathogenic and clinical implications.
Neoplasms
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.
Neoplasms
Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing.
Neoplasms
Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis and aging.
Neoplasms
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Neoplasms
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Neoplasms
Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Neoplasms
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
Neoplasms
Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.
Neoplasms
Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy.
Neoplasms
Telomeres and Telomerase: Role in Marek's Disease Virus Pathogenesis, Integration and Tumorigenesis.
Neoplasms
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.
Neoplasms
Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
Neoplasms
Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer.
Neoplasms
Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer.
Neoplasms
Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Neoplasms
Telomeric repeat amplification protocol: measuring the activity of the telomerase.
Neoplasms
Telomestatin: formal total synthesis and cation-mediated interaction of its seco-derivatives with G-quadruplexes.
Neoplasms
TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
Neoplasms
TERRA mimicking ssRNAs prevail over the DNA substrate for telomerase in vitro due to interactions with the alternative binding site.
Neoplasms
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Neoplasms
TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
Neoplasms
TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Neoplasms
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti-CTLA4 treatment.
Neoplasms
TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Neoplasms
TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Neoplasms
TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
Neoplasms
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Neoplasms
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.
Neoplasms
TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Neoplasms
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours.
Neoplasms
TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas.
Neoplasms
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Neoplasms
TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients.
Neoplasms
TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Neoplasms
TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Neoplasms
TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Neoplasms
TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
Neoplasms
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Neoplasms
TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors.
Neoplasms
TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Neoplasms
TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.
Neoplasms
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Neoplasms
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.
Neoplasms
TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer.
Neoplasms
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.
Neoplasms
TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.
Neoplasms
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Neoplasms
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.
Neoplasms
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Neoplasms
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Neoplasms
TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.
Neoplasms
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
Neoplasms
TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
Neoplasms
TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
Neoplasms
TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.
Neoplasms
TERT Promoter Mutations in Skin Cancer: the Effects of Sun Exposure and X-Irradiation.
Neoplasms
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Neoplasms
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
Neoplasms
TERT promotes cellular and organismal survival independently of telomerase activity.
Neoplasms
TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
Neoplasms
TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability.
Neoplasms
Tetracationic porphyrins inhibit angiogenesis induced by human tumor cells in vivo.
Neoplasms
TGF beta1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights.
Neoplasms
TGF-?-mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells.
Neoplasms
The 'other' telomerase inhibitors: non-G-quadruplex interactive agent, non-antisense, non-reverse transcriptase telomerase inhibitors.
Neoplasms
The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Neoplasms
The ?-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype.
Neoplasms
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
Neoplasms
The addition of a spin column step in the telomeric repeat application protocol removes telomerase inhibitors.
Neoplasms
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
Neoplasms
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
Neoplasms
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.
Neoplasms
The Anticancer Efficacy of Platinum Azidothymidin on Hepatocellular Carcinoma Via Affecting the Telomerase and the BcL-2 Genes Expression.
Neoplasms
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Neoplasms
The association between telomerase activity and expression of its RNA component (hTR) in breast cancer patients: the importance of DNase treatment.
Neoplasms
The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
Neoplasms
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer.
Neoplasms
The association between telomerase, p53, and clinical staging in colorectal cancer.
Neoplasms
The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population.
Neoplasms
The Association of Aging-Related Polymorphisms with Susceptibility to Lung Cancer: A Case-Control Study in a Japanese Population.
Neoplasms
The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America.
Neoplasms
The C-terminal extension of human telomerase reverse transcriptase is necessary for high affinity binding to telomeric DNA.
Neoplasms
The canine telomerase catalytic subunit (dogTERT): characterisation of the gene promoter and identification of proximal core sequences necessary for specific transcriptional activity in canine telomerase positive cell lines.
Neoplasms
The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.
Neoplasms
The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis.
Neoplasms
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Neoplasms
The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival.
Neoplasms
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer.
Neoplasms
The clinical implications of telomerase activity in upper tract urothelial cancer and washings.
Neoplasms
The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells.
Neoplasms
The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell line.
Neoplasms
The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods.
Neoplasms
The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration.
Neoplasms
The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanations.
Neoplasms
The differential regulation of human telomerase reverse transcriptase and vascular endothelial growth factor may contribute to the clinically more aggressive behavior of p63-positive breast carcinomas.
Neoplasms
The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
Neoplasms
The disparity between human cell senescence in vitro and lifelong replication in vivo.
Neoplasms
The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression.
Neoplasms
The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
Neoplasms
The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma.
Neoplasms
The effect of raloxifene on telomerase expression in breast carcinoma samples from postmenopausal women.
Neoplasms
The effect of silymarin on telomerase activity in the human leukemia cell line K562.
Neoplasms
The Effect of Telomerase Template Antagonist GRN163L on Bone-Marrow-Derived Rat Mesenchymal Stem Cells is Reversible and Associated with Altered Expression of Cyclin d1, cdk4 and cdk6.
Neoplasms
The Effect of Temperature on the Interaction of Phenanthroline-based Ligands with G-quadruplex: In Silico Viewpoint.
Neoplasms
The Effect of Ubiquitin on Immune Response After Controlled Cortical Impact Injury.
Neoplasms
The effects of erythropoietin signaling on telomerase regulation in non-erythroid malignant and non-malignant cells.
Neoplasms
The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.
Neoplasms
The effects of telomere shortening on cancer cells: a network model of proteomic and microRNA analysis.
Neoplasms
The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Neoplasms
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.
Neoplasms
The evidences of human orphan receptor COUP-TFII inhibiting telomerase activity through decreasing hTERT transcription.
Neoplasms
The evolving role of one-step nucleic acid amplification (OSNA) for the intra-operative detection of lymph node metastases: A diagnostic accuracy meta-analysis.
Neoplasms
The expression levels of telomerase catalytic subunit hTERT and oncogenic MYC in essential thrombocythemia are affected by the molecular subtype.
Neoplasms
The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome.
Neoplasms
The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.
Neoplasms
The expression of messenger RNA for tumor necrosis factor-?; interleukins 1?, 6, 8, and 10; tissue growth factor-?; and interferon-? in bronchoalveolar lavage fluid cells from horses challenged with lipopolysaccharide and treated with clenbuterol
Neoplasms
The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
Neoplasms
The Expression of the Phosphatase Regenerating Liver 3 Gene is Associated with Outcome in Patients with Colorectal Cancer.
Neoplasms
The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance.
Neoplasms
The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
Neoplasms
The G-quadruplex ligand, SYUIQ-FM05, targets proto-oncogene c-kit transcription and induces apoptosis in K562 cells.
Neoplasms
The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Neoplasms
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.
Neoplasms
The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation.
Neoplasms
The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
Neoplasms
The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells.
Neoplasms
The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor.
Neoplasms
The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.
Neoplasms
The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals.
Neoplasms
The human and canine TERT promoters function equivalently in human and canine cells.
Neoplasms
The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells.
Neoplasms
The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions.
Neoplasms
The human telomere and its relationship to human disease, therapy, and tissue engineering.
Neoplasms
The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
Neoplasms
The importance of the telomere and telomerase system in hematological malignancies.
Neoplasms
The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Neoplasms
The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma.
Neoplasms
The inhibitory effect of helenalin on telomerase activity is attributed to the alkylation of the CYS445 residue: evidence from QM/MM simulations.
Neoplasms
The Insertion in Fingers Domain in Human Telomerase Can Mediate Enzyme Processivity and Telomerase Recruitment to Telomeres in a TPP1-Dependent Manner.
Neoplasms
The interaction of telomere DNA G-quadruplex with three bis-benzyltetrahydroisoquinoline alkaloids.
Neoplasms
The interactions of phenanthroline compounds with DNAs: Preferential binding to telomeric quadruplex over duplex.
Neoplasms
The intragraft cytokine mRNA pattern reflects the efficacy of steroid antirejection therapy.
Neoplasms
The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Neoplasms
The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
Neoplasms
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.
Neoplasms
The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.
Neoplasms
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Neoplasms
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Neoplasms
The levels of telomere-binding proteins in human tumours and therapeutic implications.
Neoplasms
The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.
Neoplasms
The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.
Neoplasms
The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells.
Neoplasms
The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Neoplasms
The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
Neoplasms
The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 protein.
Neoplasms
The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review).
Neoplasms
The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.
Neoplasms
The nuclear pore complex prevents sister chromatid recombination during replicative senescence.
Neoplasms
The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.
Neoplasms
The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Neoplasms
The Polymorfisms of DNA G-Quadruplex investigated by Docking Experiments with Telomestatin Enantiomers.
Neoplasms
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Neoplasms
The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.
Neoplasms
The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis.
Neoplasms
The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis.
Neoplasms
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
Neoplasms
The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
Neoplasms
The promise of telomere length, telomerase activity and its regulation in the translocation-dependent cancer ESFT; clinical challenges and utility.
Neoplasms
The Promoter of Human Telomerase Reverse Transcriptase is Activated during Liver Regeneration and Hepatocyte Proliferation.
Neoplasms
The protective effects of Acanthus ilicifolius alkaloid A and its derivatives on pro- and anti-inflammatory cytokines in rats with hepatic fibrosis.
Neoplasms
The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
Neoplasms
The region upstream of the telomerase reverse transcriptase gene is essential for in planta telomerase complementation.
Neoplasms
The Regulation of ROS- and BECN1-Mediated Autophagy by Human Telomerase Reverse Transcriptase in Glioblastoma.
Neoplasms
The relationship between ligand aggregation and G-quadruplex DNA selectivity in a series of 3,4,9,10-perylenetetracarboxylic acid diimides.
Neoplasms
The relationship between telomerase activity and proliferation in cutaneous melanoma.
Neoplasms
The relationship between telomere length and telomerase activity in gynecologic cancers.
Neoplasms
The RNA accordion model for template positioning by telomerase RNA during telomeric DNA synthesis.
Neoplasms
The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Neoplasms
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications.
Neoplasms
The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics.
Neoplasms
The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer.
Neoplasms
The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Neoplasms
The role of interferon-gamma and vitamin-A in modulating telomerase activity in breast cancer patients.
Neoplasms
The role of telomerase activation in the regulation of vascular smooth muscle cell proliferation.
Neoplasms
The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
Neoplasms
The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Neoplasms
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation.
Neoplasms
The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Neoplasms
The Roles of Telomerase in the Generation of Polyploidy during Neoplastic Cell Growth.
Neoplasms
The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
Neoplasms
The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.
Neoplasms
The significance of telomerase activation and cellular immortalization in human cancer.
Neoplasms
The significance of telomerase activity in cancer lesions and the noncancerous epithelium of the esophagus.
Neoplasms
The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.
Neoplasms
The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT.
Neoplasms
The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
Neoplasms
The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus.
Neoplasms
The spontaneous regression of neoplasms in mammals: possible mechanisms and their application in immunotherapy.
Neoplasms
The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.
Neoplasms
The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.
Neoplasms
The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Neoplasms
The Telomerase and Alternative Lengthening of Telomeres Mechanisms Regulate Laryngeal Cancer Cell Apoptosis via the PI3K/Akt Pathway.
Neoplasms
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.
Neoplasms
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes.
Neoplasms
The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2(+) breast cancer cells.
Neoplasms
The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines.
Neoplasms
The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells.
Neoplasms
The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice.
Neoplasms
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Neoplasms
The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Neoplasms
The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
Neoplasms
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide.
Neoplasms
The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
Neoplasms
The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma.
Neoplasms
The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
Neoplasms
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?
Neoplasms
The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma.
Neoplasms
The TERT MNS16A polymorphism contributes to cancer susceptibility: Meta-analysis of the current studies.
Neoplasms
The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Neoplasms
The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Neoplasms
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
Neoplasms
The Truncated Human Telomeric Sequence forms a Hybrid-Type Intramolecular Mixed Parallel/antiparallel G-quadruplex Structure in K(+) Solution.
Neoplasms
The use of molecular profiling of early colorectal cancer to predict micrometastases.
Neoplasms
The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Neoplasms
The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response.
Neoplasms
The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.
Neoplasms
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.
Neoplasms
Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Neoplasms
Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage.
Neoplasms
Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Neoplasms
Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses.
Neoplasms
This month in investigative urology. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Neoplasms
Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, Thymidine Phosphorylase, Orotate Phosphoribosyltransferase mRNA Expression in Lung Cancer Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration - A Pilot Study.
Neoplasms
Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review.
Neoplasms
Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Neoplasms
Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.
Neoplasms
Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.
Neoplasms
Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor.
Neoplasms
TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes.
Neoplasms
TOA02, a Recombinant Adenovirus with Tumor-specific GM-CSF Expression, has Limited Biodistribution and Low Toxicity in Rhesus Monkeys.
Neoplasms
Topoisomerase II alpha and telomerase expression in papillary thyroid carcinomas.
Neoplasms
Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
Neoplasms
Total synthesis of the dictyodendrins as an arena to highlight emerging synthetic technologies.
Neoplasms
Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.
Neoplasms
Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data.
Neoplasms
TPP1 OB-Fold Domain Controls Telomere Maintenance by Recruiting Telomerase to Chromosome Ends.
Neoplasms
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
Neoplasms
Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results.
Neoplasms
Training Performed Above Lactate Threshold Decreases p53 and Shelterin Expression in Mice.
Neoplasms
Transcript regulation of human telomerase reverse transcriptase by c-myc and mad1.
Neoplasms
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Neoplasms
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Neoplasms
Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.
Neoplasms
Transcriptional regulation of telomeric non-coding RNA: Implications on telomere biology, replicative senescence and cancer.
Neoplasms
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
Neoplasms
Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
Neoplasms
Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Neoplasms
Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene.
Neoplasms
Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors.
Neoplasms
Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
Neoplasms
Transient activation of the ALT pathway in human primary fibroblasts exposed to high-LET radiation.
Neoplasms
Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts.
Neoplasms
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination.
Neoplasms
Transient Telomerase Inhibition with Imetelstat Impacts DNA Damage Signals and Cell-Cycle Kinetics.
Neoplasms
Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.
Neoplasms
TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
Neoplasms
TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines.
Neoplasms
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.
Neoplasms
Trend of telomerase activity change during human iPSC self-renewal and differentiation revealed by a quartz crystal microbalance based assay.
Neoplasms
TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts.
Neoplasms
Triptolide inhibits transcription of hTERT through down-regulation of transcription factor specificity protein 1 in primary effusion lymphoma cells.
Neoplasms
Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.
Neoplasms
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
Neoplasms
Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase.
Neoplasms
Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells.
Neoplasms
Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures.
Neoplasms
Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".
Neoplasms
Tumor size-independence of telomere length indicates an aggressive feature of HCC.
Neoplasms
Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens.
Neoplasms
Tumor suppressors p53, p63TA?, p63TAy, p73?, and p73? use distinct pathways to repress telomerase expression.
Neoplasms
Tumor targeted radionuclide imaging and therapy using human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Neoplasms
Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system.
Neoplasms
Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Neoplasms
Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways.
Neoplasms
Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.
Neoplasms
Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.
Neoplasms
Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
Neoplasms
Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Neoplasms
Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1?-VEGF signaling axis.
Neoplasms
Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Neoplasms
Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.
Neoplasms
Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review).
Neoplasms
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.
Neoplasms
Tumour morphology--interplay between chromosome aberrations and founder cell differentiation.
Neoplasms
Tumour progression: random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?
Neoplasms
Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization.
Neoplasms
Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.
Neoplasms
Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cells.
Neoplasms
Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging.
Neoplasms
Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells.
Neoplasms
Two-step mechanism involving active-site conformational changes regulates human telomerase DNA binding.
Neoplasms
Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
Neoplasms
UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in esophageal cancer.
Neoplasms
Ultrasensitive Assay for Telomerase Activity via Self-Enhanced Electrochemiluminescent Ruthenium Complex Doped Metal-Organic Frameworks with High Emission Efficiency.
Neoplasms
Ultrasensitive detection of telomerase activity in a single cell using stem-loop primer-mediated exponential amplification (SPEA) with near zero nonspecific signal.
Neoplasms
Ultrasensitive detection of telomerase activity in lung cancer cells with quencher-free molecular beacon-assisted quadratic signal amplification.
Neoplasms
Ultrasensitive Telomerase Activity Detection by Telomeric Elongation Controlled Surface Enhanced Raman Scattering.
Neoplasms
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer.
Neoplasms
Ultrastructural immunolocalization of telomerase and hyaluronate in migrating keratinocytes in a case of oro-pharyngeal squamous cancer.
Neoplasms
Ultraviolet irradiation- and dimethyl sulfoxide-induced telomerase activity in ovarian epithelial cell lines.
Neoplasms
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
Neoplasms
Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor.
Neoplasms
Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention.
Neoplasms
Unusually stable abnormal karyotype in a highly aggressive melanoma negative for telomerase activity.
Neoplasms
Up-regulating telomerase and tumor suppressors: focusing on anti-aging interventions at the population level.
Neoplasms
Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells.
Neoplasms
Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis.
Neoplasms
Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Neoplasms
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.
Neoplasms
Updated Understanding of Cancer as a Metabolic and Telomere-Driven Disease, and Proposal for Complex Personalized Treatment, a Hypothesis.
Neoplasms
Upregulated miR-155 inhibits inflammatory response induced by C. albicans in human monocytes derived dendritic cells via targeting p65 and BCL-10.
Neoplasms
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Neoplasms
Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase.
Neoplasms
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Neoplasms
Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
Neoplasms
Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Neoplasms
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.
Neoplasms
Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report.
Neoplasms
Use of 3D QSAR methodology for data mining the National Cancer Institute Repository of Small Molecules: application to HIV-1 reverse transcriptase inhibition.
Neoplasms
Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan Assays in Combination for Diagnosing High-Grade Cervical Lesions and Malignant Tumors.
Neoplasms
Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
Neoplasms
Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.
Neoplasms
Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic Malignancy.
Neoplasms
Usefulness of immunological detection of the human telomerase reverse transcriptase.
Neoplasms
Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology.
Neoplasms
Using PCR coupled to PAGE for detection and semiquantitative evaluation of telomerase activity.
Neoplasms
USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT/P53 pathway.
Neoplasms
Utilizing murine inducible telomerase alleles in the studies of tissue degeneration/regeneration and cancer.
Neoplasms
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Neoplasms
Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.
Neoplasms
Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.
Neoplasms
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
Neoplasms
Vertebrate marine species as model systems for studying telomeres and telomerase.
Neoplasms
Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells.
Neoplasms
Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene.
Neoplasms
Visual and sensitive detection of telomerase activity via hydrogen peroxide test strip.
Neoplasms
Visual, Label-Free Telomerase Activity Monitor via Enzymatic Etching of Gold Nanorods.
Neoplasms
Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Neoplasms
Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct.
Neoplasms
Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence Techniques.
Neoplasms
Visualizing telomerase activity for tumour identification by hybridization-triggered ratiometric fluorescence.
Neoplasms
Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis.
Neoplasms
Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model.
Neoplasms
Water soluble cationic perylene derivatives as possible telomerase inhibitors: the search for selective G-quadruplex targeting.
Neoplasms
Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme.
Neoplasms
Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis.
Neoplasms
Weak telomerase activity in malignant cells in metastatic serous effusions: correlation to short survival time.
Neoplasms
What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.
Neoplasms
When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.
Neoplasms
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Neoplasms
Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Neoplasms
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.
Neoplasms
Wnt/?-Catenin Signaling Exacerbates Keloid Cell Proliferation by Regulating Telomerase.
Neoplasms
WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts.
Neoplasms
X-rays Activate Telomeric Homologous Recombination Mediated Repair in Primary Cells.
Neoplasms
Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line.
Neoplasms
Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
Neoplasms
YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability.
Neoplasms
Zero-Background Helicase-Dependent Amplification and Its Application to Reliable Assay of Telomerase Activity in Cancer Cell by Eliminating Primer-Dimer Artifacts.
Neoplasms
Zidovudine, abacavir and lamivudine increase the radiosensitivity of human esophageal squamous cancer cell lines.
Neoplasms
Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.
Neoplasms
ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.
Neoplasms
Zscan4 interacts directly with human Rap1 in cancer cells regardless of telomerase status.
Neoplasms
[5,10,15,20-Tetra-(N-methyl-3-pyridyl)porphyrin destabilizes the anti-parallel telomeric quadruplex d(TTAGGG)4].
Neoplasms
[A discovery that can result in new therapies. The enzyme telomerase is an important factor in the development of cancer]
Neoplasms
[A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3]
Neoplasms
[A preliminary study on anti-liver cancer immunity of the virus-like particulate peptide-nucleic acid vaccine]
Neoplasms
[Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen]
Neoplasms
[An experimental study of telomerase reverse transcriptase (hTERT) DNAzyme on growth of A549/DDP cells.]
Neoplasms
[Analysis of telomerase activity in esophageal carcinoma using microdissection telomeric repeat amplification protocol assay]
Neoplasms
[Antisense hTERT inhibits gene expression and functional activity of telomerase in leukemia cell lines.]
Neoplasms
[Apoptosis of laryngeal carcinoma cell line Hep2 induced by tumor-specific expression of TRAIL gene.]
Neoplasms
[Apoptotic endonuclease EndoG induces alternative splicing of telomerase catalytic subunit hTERT and death of tumor cells].
Neoplasms
[Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy]
Neoplasms
[Application of Van-Clear and xylene in the detection of cervical hTERC gene by fluorescence in situ hybridization].
Neoplasms
[Biochemical and physiocochemical characteristics of a type C virus isolated from spontaneous lymphosarcoma of CC57Br strain mice]
Neoplasms
[Characterization of telomerase regulation association gene TRAP and cancer biology]
Neoplasms
[Circadian rhythms of DNA synthesis and telomerase expression in hepatic cancer transplanted in nude mice]
Neoplasms
[Circulating DNA, telomerase of circulating tumor cells and early diagnosis of tumors]
Neoplasms
[Clinical Application and Challenges of Telomere and Telomerase Research ?in Lung Cancer].
Neoplasms
[Clinical implications of telomerase activity in breast cancer fine-needle aspirates]
Neoplasms
[Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma]
Neoplasms
[Clinical significance of human telomerase reverse transcriptase in patients with colon cancer]
Neoplasms
[Cloning of alternative isoforms of the catalytic subunit of the human thelomerase (htert)].
Neoplasms
[Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy]
Neoplasms
[Cloning, expression of a segment of hTERT gene and detection of telomerase and hTERT by anti-hTERT polyclonal antibody]
Neoplasms
[Construction and identification of eukaryotic expression vector for sense and antisense human telomerase reverse transcriptase]
Neoplasms
[Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells]
Neoplasms
[Construction of tumor cell-specific expression vector modulated by human telomerase reserse transcription gene core promoter.]
Neoplasms
[Contemporary study of strengthening body resistance and archaeus herbs on malignant tumor]
Neoplasms
[Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]
Neoplasms
[Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma]
Neoplasms
[Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells]
Neoplasms
[CTLs induced by hTERT-related multiepitope peptide-sensitived mDCs specifically kill HLA-A24(+); tumor cells.]
Neoplasms
[Current views on the mechanism of oncogenic cell transformation in ovine pulmonary adenocarcinoma]
Neoplasms
[Detection and effect of telomerase activity in oral mucosal squamous cell carcinoma]
Neoplasms
[Detection and quantification of human papillomavirus genital infections: Virological, epidemiological, and clinical applications.]
Neoplasms
[Detection and significance of HPV16, 18 infection, P53 overexpression and telomerase activity in patients with lung cancer]
Neoplasms
[Detection of telomerase activity in cervical lesions by non-radioactive telomeric repeat amplification protocol (TRAP)]
Neoplasms
[Detection of telomerase activity in intestinal lavage solution from colorectal carcinoma patients]
Neoplasms
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Neoplasms
[Development of noninvasive bladder cancer diagnosis on basis of telomerase and it's subunits hTERT and hTR detection].
Neoplasms
[Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]
Neoplasms
[Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer]
Neoplasms
[Doxycycline Sensitive Two-Promoter Integrator Based on the TET-ON 3G Transactivator].
Neoplasms
[Effect of antisense epidermal growth factor receptor cDNA transfection on telomerase activity of glioblastomas cells]
Neoplasms
[Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus]
Neoplasms
[Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell]
Neoplasms
[Effect of inhibition of polyamine biosynthesis on the growth and telomerase activity of human laryngeal carcinoma cells Hep-2]
Neoplasms
[Effect of selenium dioxide on proliferation, apoptosis, and elomerase activity of human lung cancer cell line in vitro]
Neoplasms
[Effects of antisense human telomerase reverse-transcript protein subunit (hTERT) gene on biological characteristics of hepatoblastoma cell line in vitro]
Neoplasms
[Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line]
Neoplasms
[Effects of hTERT RNAi on apoptosis of hepatocellular carcinoma cells induced by TRAIL]
Neoplasms
[Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy]
Neoplasms
[Effects of matrine on the growth inhibition, c-myc and hTERT protein expression in human adenocarcinoma lung cancer cell line A549.]
Neoplasms
[Effects of tea polyphenols and tea pigments on telomerase activity of HepG2 cells]
Neoplasms
[Effects of telomerase sense and antisense oligodeoxynucleotides on growth and differentiation of nasopharyngeal carcinoma cells]
Neoplasms
[Effects of wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity]
Neoplasms
[Epidemiology of lung cancer in former poison-gas workers and molecular approaches to lung cancer]
Neoplasms
[Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors]
Neoplasms
[EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION].
Neoplasms
[Expression of antisense telomerase genes suppressing human cancer malignant phenotypes]
Neoplasms
[Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil]
Neoplasms
[Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres]
Neoplasms
[Expression of human telomerase in lung cancer:A meta-analysis of diagnostic test.]
Neoplasms
[Expression of human telomerase reverse transcriptase in cervix cancer and its significance]
Neoplasms
[Expression of osm gene driven by hTERT gene promoter inhibits cancer cells proliferation in vitro]
Neoplasms
[Expression of TEIF protein in colorectal tumors and its correlation with centrosome abnormality]
Neoplasms
[Expression of telomerase activity in thymoma and thymiccarcinoma tissues; a clinicopathological study]
Neoplasms
[Expression of telomerase and telomerase associated-regulation protein and proliferating cell nuclear antigen in ovarian epithelial tumors]
Neoplasms
[Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC]
Neoplasms
[Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue]
Neoplasms
[Extension of life-span of normal human fibroblasts by reconstitution of telomerase activity]
Neoplasms
[Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]
Neoplasms
[hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice]
Neoplasms
[hTERT promoter-based conditionally replicative adenoviruses are useful for lung cancer and other solid cancer treatment]
Neoplasms
[Human telomerase reverse transcriptase as a novel target for tumor immunotherapy]
Neoplasms
[Identification of telomerase activity in the experimental carcinogenesis of oral cavity]
Neoplasms
[IL-4 gene transfer induces the differentiation of cells and inhibits the activity of telomerase in hepatoblastoma cells]
Neoplasms
[Immunohistochemical study on telomerase activity in ovarian sex-cord stromal tumors]
Neoplasms
[Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin].
Neoplasms
[Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumors]
Neoplasms
[Inhibiting expression of human telomerase reverse transcriptase promotes degradation of survivin protein]
Neoplasms
[Inhibition effects of phosphorothioate-modified antisense hTR on the telomerase activity and the growth of P3 cells derived from pancreatic cancer in culture]
Neoplasms
[Inhibition of hTR activity for suppression of lung cancer cell proliferation using antisense phosphorothioate oligonucleotides]
Neoplasms
[Inhibition of lung cancer cell line growth in vitro by telomerase anti-sense oligonucleotides.]
Neoplasms
[Inhibition of proliferation of salivary adenoid cystic carcinoma by targeting gene transfer]
Neoplasms
[Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase]
Neoplasms
[Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)]
Neoplasms
[Inhibitory effect of lentivirus-mediated hTERTp-TK combined with hTERTp-tumstatin on human hepatocarcinoma HepG2 cells].
Neoplasms
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 1. Telomere and telomerase, new targets for diagnosis and treatment of lung cancer]
Neoplasms
[Measurement of telomerase activity and telomerase reverse transcriptase expression in gastric fluid and tissue for early diagnosis of stomach cancer]
Neoplasms
[Methods of measuring telomere length and telomerase activity--practice and problems]
Neoplasms
[Modified quantitative determination of telomerase activity in human head and neck malignant tumor]
Neoplasms
[Monoclonal antibodies against human telomerase reverse transcriptase: preparation, characterization, and application]
Neoplasms
[Preliminary research on the effect of antisense oligodeoxynucleotides of tankyrase 1 on tumor growth following intratumoral injection in mice]
Neoplasms
[Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer]
Neoplasms
[PTEN tumor suppressor gene combined with doxycycline inhibites telomerase activity in human mucoepidermoid carcinoma cell line].
Neoplasms
[Quantitation of telomerase activity using the polymerase chain reaction-based enzyme immunoassay and its clinical application]
Neoplasms
[Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma]
Neoplasms
[Quantitative assay of telomerase activity in head and neck squamous cell carcinoma]
Neoplasms
[Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer]
Neoplasms
[Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck]
Neoplasms
[Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri]
Neoplasms
[Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia]
Neoplasms
[Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]
Neoplasms
[Relationship between telomerase activity and clinicopathological findings in gastric cancer]
Neoplasms
[Relationship between telomere length and clinical and biological characteristics of the cancers with telomerase reactivation]
Neoplasms
[Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer.]
Neoplasms
[Replicative senescence as a model of aging: the role of oxidative stress and telomere shortening--an overview]
Neoplasms
[Significance of telomerase activity detection by fine-needle aspiration in patients with breast cancer]
Neoplasms
[Significance of telomerase expression in diagnosis and treatment of breast tumor]
Neoplasms
[Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell]
Neoplasms
[Study on apoptosis of human cervical carcinoma HeLa cells with RNA interference targeting hTERT.]
Neoplasms
[Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells]
Neoplasms
[Study on growth inhibition of implanted tumor in nude mice by antisense oligodeoxynucleotide targeting telomerase RNA.]
Neoplasms
[Study on telomerase activity and its clinical value in human non small cell lung cancer]
Neoplasms
[Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]
Neoplasms
[Study on telomerase inhibition by ribozyme targeted to telomerase RNA component]
Neoplasms
[Study on the correlation between the different papillomavirus type and telomerase in cervical cancer]
Neoplasms
[Study on the inhibition of nude mice transplantation tumor growth by telomerase ribozyme]
Neoplasms
[Study on the relationship between TK gene regulated by enhanced suicide gene vector and telomerase activity in nasopharyngeal carcinoma cells]
Neoplasms
[Suppression of alternative telomere lengthening in cancer cells with reverse transcriptase inhibitors].
Neoplasms
[Techniques for detection of telomerase activity in tissue samples. Diagnostic and prognosis importance]
Neoplasms
[Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application]
Neoplasms
[Telomerase activity and telomere length as diagnostic tumor marker for ovarian tumors]
Neoplasms
[TELOMERASE ACTIVITY AS A POTENTIAL BIOMARKER FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF CYSTIC NEOPLASMS OF THE LIVER].
Neoplasms
[Telomerase activity in cervical carcinoma and cervical intraepithelial neoplasia and its correlation to classification of koilocytosis]
Neoplasms
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]
Neoplasms
[Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]
Neoplasms
[Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications]
Neoplasms
[Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues]
Neoplasms
[Telomerase activity in lung cancer and adjacent peritumoral tissues determined by TRAP-SYBR green assay]
Neoplasms
[Telomerase activity, mTert gene expression and the telomere length in mouse mesenchymal stem cells in the late period after ?- and ?,n-irradiation and in the tumors developed from these cells].
Neoplasms
[Telomerase and cancer: importance of detection of telomerase activity in pathology]
Neoplasms
[Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo]
Neoplasms
[Telomerase expression in colorectal tubular adenoma determined by immunohistochemical staining]
Neoplasms
[Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells]
Neoplasms
[Telomerase in lung cancer. Testing the activity of the "immortaligy enzyme" bronchial biopsies increases the diagnostic yield in cases of suspected peripheral bronchogenic carcinomas]
Neoplasms
[Telomerase reverse transcriptase (TERT) promoter mutations in the tumors of human endocrine organs: Biological and prognostic value].
Neoplasms
[Telomere DNA and telomerase of lymphoma-derived cell lines--telomere hypothesis for cell growth control]
Neoplasms
[Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach]
Neoplasms
[Telomeres and telomerase activity: their role in aging and in neoplastic development]
Neoplasms
[Telomeres and telomerase: Relevance and future prospects in systemic lupus erythematosus.]
Neoplasms
[The diagnostic value of telomerase activity in differentiating benign and malignant ascitic fluid]
Neoplasms
[The direct effect of anticancer agents on the telomerase activity in human cancer cell lines]
Neoplasms
[The effect of As2O3 on induction of apoptosis and inhibition of telomerase activity in colon cancer LS-174T cells]
Neoplasms
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Neoplasms
[The influence of compound aITEL1296 on telomerase activity and the growth of cancer cells].
Neoplasms
[The inhibitory effect of antisense adenovirus vector of telomerase on telomerase activity in breast cancer cells MCF-7]
Neoplasms
[The study of RNA markers in blood of patients with malignant tumors of gastrointestinal tract].
Neoplasms
[Tumor-targeted human telomerase reverse transcriptase promoter/tk gene therapy against human nasopharyngeal carcinoma cells in vitro.]
Neoplasms, Germ Cell and Embryonal
Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
Neoplasms, Germ Cell and Embryonal
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Telomerase activity and alterations in telomere length in human brain tumors.
Neoplasms, Germ Cell and Embryonal
Telomerase activity in germ cell cancers and mature teratomas.
Neoplasms, Germ Cell and Embryonal
The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
Neoplasms, Glandular and Epithelial
Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
Neoplasms, Muscle Tissue
The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase.
Neoplasms, Neuroepithelial
Differential telomerase expression and telomere length in primary intracranial tumors.
Neoplasms, Neuroepithelial
Telomerase activity and alterations in telomere length in human brain tumors.
Neoplasms, Neuroepithelial
[Telomerase activity and regulation in human neuroepithelial tumors]
Neoplasms, Squamous Cell
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.
Neoplasms, Squamous Cell
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Neoplasms, Squamous Cell
Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Neoplasms, Squamous Cell
The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
Neoplastic Cells, Circulating
A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
Neoplastic Cells, Circulating
A second chance for telomerase reverse transcriptase in anticancer immunotherapy.
Neoplastic Cells, Circulating
Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Neoplastic Cells, Circulating
Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer.
Neoplastic Cells, Circulating
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.
Neoplastic Cells, Circulating
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.
Neoplastic Cells, Circulating
Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
Neoplastic Cells, Circulating
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Neoplastic Cells, Circulating
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.
Neoplastic Cells, Circulating
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Neoplastic Cells, Circulating
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Neoplastic Cells, Circulating
High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.
Neoplastic Cells, Circulating
Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
Neoplastic Cells, Circulating
Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Neoplastic Cells, Circulating
Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis.
Neoplastic Cells, Circulating
Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Neoplastic Cells, Circulating
Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Neoplastic Cells, Circulating
Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse.
Neoplastic Cells, Circulating
Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.
Neoplastic Cells, Circulating
Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
Neoplastic Cells, Circulating
The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
Neoplastic Cells, Circulating
[Circulating DNA, telomerase of circulating tumor cells and early diagnosis of tumors]
Nephrotic Syndrome
Down-regulation of manganese-superoxide dismutase gene expression in idiopathic nephrotic syndrome.
Neuralgia
?-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Neuralgia
A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy.
Neuralgia
A rodent model of HIV protease inhibitor indinavir induced peripheral neuropathy.
Neuralgia
Identification of Key Genes and Pathways in Mouse Spinal Cord Involved in ddC-Induced Neuropathic Pain by Transcriptome Sequencing.
Neuralgia
IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats.
Neuralgia
Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner.
Neuralgia
Influence of Phosphatidylinositol-3-Kinase/Protein Kinase B-Mammalian Target of Rapamycin Signaling Pathway on the Neuropathic Pain Complicated by Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection.
Neuralgia
Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by herpes simplex virus vector through the SDF1?/CXCR4 system in rats.
Neuralgia
Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats.
Neuralgia
TNF? is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats.
Neurilemmoma
Differential telomerase expression and telomere length in primary intracranial tumors.
Neurilemmoma
Implication of telomere length as a proliferation-associated marker in schwannomas.
Neurilemmoma
[Significance of modern methods for laboratory detection of rabies agents and identification of the zoonose immunological survey].
Neuroblastoma
A novel GDNF-inducible gene, BMZF3, encodes a transcriptional repressor associated with KAP-1.
Neuroblastoma
Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.
Neuroblastoma
Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.
Neuroblastoma
ALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor.
Neuroblastoma
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome.
Neuroblastoma
ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
Neuroblastoma
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.
Neuroblastoma
Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas.
Neuroblastoma
Comparison of telomerase levels before and after differentiation of two cell lines of human neuroblastoma.
Neuroblastoma
Curcumin regulates low-linear energy transfer ?-radiation-induced NF?B-dependent telomerase activity in human neuroblastoma cells.
Neuroblastoma
Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR.
Neuroblastoma
Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
Neuroblastoma
Epigenetic Targeting of TERT-Associated Gene Expression Signature in Human Neuroblastoma with TERT Overexpression.
Neuroblastoma
Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
Neuroblastoma
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
Neuroblastoma
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Neuroblastoma
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.
Neuroblastoma
Inhibition of telomerase causes vulnerability to endoplasmic reticulum stress-induced neuronal cell death.
Neuroblastoma
Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells.
Neuroblastoma
miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
Neuroblastoma
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
Neuroblastoma
Nuclear condensation and cell cycle arrest induced by telomerase siRNA in neuroblastoma cells.
Neuroblastoma
Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
Neuroblastoma
Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
Neuroblastoma
Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
Neuroblastoma
Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.
Neuroblastoma
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Neuroblastoma
Sequential hTERT Knockdown and Apigenin Treatment Inhibited Invasion and Proliferation and Induced Apoptosis in Human Malignant Neuroblastoma SK-N-DZ and SK-N-BE2 Cells.
Neuroblastoma
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
Neuroblastoma
Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
Neuroblastoma
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
Neuroblastoma
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Neuroblastoma
Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
Neuroblastoma
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Neuroblastoma
Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Neuroblastoma
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
Neuroblastoma
Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments.
Neuroblastoma
TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing.
Neuroblastoma
XAV939 promotes apoptosis in a neuroblastoma cell line via telomere shortening.
Neurodegenerative Diseases
Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy.
Neurodegenerative Diseases
Mesenchymal Stem Cells Could Be Considered as a Candidate for Further Studies in Cell-Based Therapy of Alzheimer's Disease via Targeting the Signaling Pathways.
Neurodegenerative Diseases
Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.
Neurodegenerative Diseases
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Neurodegenerative Diseases
Potential roles of telomeres and telomerase in neurodegenerative diseases.
Neurodegenerative Diseases
Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases.
Neurodegenerative Diseases
Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons.
Neurodegenerative Diseases
Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases.
Neuroectodermal Tumors, Primitive
Differential telomerase expression in human primary intracranial tumors.
Neuroectodermal Tumors, Primitive
Telomerase activity and alterations in telomere length in human brain tumors.
Neuroectodermal Tumors, Primitive
Telomere maintenance in childhood primitive neuroectodermal brain tumors.
Neuroectodermal Tumors, Primitive
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Neuroectodermal Tumors, Primitive, Peripheral
Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
Neuroectodermal Tumors, Primitive, Peripheral
In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
Neuroendocrine Tumors
Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations.
Neuroendocrine Tumors
Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype (MS-0060).
Neuroendocrine Tumors
Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
Neuroendocrine Tumors
Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors.
Neurofibroma
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neurofibroma, Plexiform
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neurofibromatoses
Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
Neurofibromatoses
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neurofibromatosis 1
Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
Neurofibromatosis 1
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neurofibromatosis 2
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.
Neurofibrosarcoma
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Neurofibrosarcoma
Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.
Neurofibrosarcoma
Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.
Neuroinflammatory Diseases
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Induce Pathological Pain through Wnt5a-Mediated Neuroinflammation in Aging Mice.
Neuroma, Acoustic
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
Neutropenia
A non-canonical function of telomerase RNA in the regulation of developmental myelopoiesis in zebrafish.
Neutropenia
Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.
Neutropenia
Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.
Nevi and Melanomas
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Nevi and Melanomas
Telomerase activity in melanocytic lesions: A potential marker of tumor biology.
Nevus
Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Nevus
Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
Nevus
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Nevus
Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
Nevus
Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
Nevus
Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Nevus
Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.
Nevus, Intradermal
Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Nevus, Pigmented
Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
Nevus, Pigmented
Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.
Newcastle Disease
Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
Newcastle Disease
RNA-dependent DNA polymerase activity in preparations of a mutant of Newcastle disease virus arising from persistently infected L cells.
Nijmegen Breakage Syndrome
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit.
Nijmegen Breakage Syndrome
Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures.
Non-alcoholic Fatty Liver Disease
Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.
Non-alcoholic Fatty Liver Disease
Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
Non-alcoholic Fatty Liver Disease
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors.
Non-alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators.
Non-alcoholic Fatty Liver Disease
Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease.
Non-alcoholic Fatty Liver Disease
Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
Non-alcoholic Fatty Liver Disease
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?
Obesity
A genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance.
Obesity
Association of telomere length and telomerase methylation with n-3 fatty acids in preschool children with obesity.
Obesity
Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Obesity
Atorvastatin reverses high cholesterol-induced cardiac remodelling and regulates mitochondrial quality-control in a cholesterol-independent manner: An experimental study.
Obesity
Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
Obesity
High-fat diet induced obesity and age influence the telomere shelterin complex and telomerase gene expression in mouse adipose tissue.
Obesity
Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Obesity
Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer.
Obesity, Abdominal
Prevalence and factors associated with physical function limitation in older West African people living with HIV.
Obesity, Abdominal
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
Obstetric Labor, Premature
Maternal human telomerase reverse transcriptase variants are associated with preterm labor and preterm premature rupture of membranes.
Oligodendroglioma
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Oligodendroglioma
Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Oligodendroglioma
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.
Oligodendroglioma
Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.
Oligodendroglioma
Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas.
Oligodendroglioma
Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis.
Oligodendroglioma
Non-invasive assessment of telomere maintenance mechanisms in brain tumors.
Oligodendroglioma
Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
Oligodendroglioma
Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis.
Oligodendroglioma
Telomerase activity and alterations in telomere length in human brain tumors.
Oligodendroglioma
Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Oligodendroglioma
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas.
Oligodendroglioma
The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
Opportunistic Infections
Changing patterns in the neuropathogenesis of HIV during the HAART era.
Opportunistic Infections
Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation.
Opportunistic Infections
Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.
Opportunistic Infections
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Opportunistic Infections
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
Oral Submucous Fibrosis
Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Osteoarthritis
Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.
Osteoarthritis
Heparanase is expressed in adult human osteoarthritic cartilage and drives catabolic responses in primary chondrocytes.
Osteoarthritis
Telomerase activity in rheumatoid synovium correlates with the mononuclear cell infiltration level and disease aggressiveness of rheumatoid arthritis.
Osteoarthritis
Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.
Osteoarthritis
Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.
Osteonecrosis
Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan.
Osteonecrosis
Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
Osteoporosis
A common variant in the telomerase RNA component is associated with short telomere length.
Osteoporosis
Extracellular vesicles from deciduous pulp stem cells recover bone loss by regulating telomerase activity in an osteoporosis mouse model.
Osteoporosis
In vitro proliferation and differentiation potential of bone marrow-derived mesenchymal stem cells from ovariectomized rats.
Osteoporosis
LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2.
Osteoporosis
Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection.
Osteoporosis
Telomerase-deficient mice exhibit bone loss due to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
Osteoporosis, Postmenopausal
Extracellular vesicles from deciduous pulp stem cells recover bone loss by regulating telomerase activity in an osteoporosis mouse model.
Osteosarcoma
Accurate Identification and Early Diagnosis of Osteosarcoma through CRISPR-Cas12a-Based Average Telomerase Activity Detection.
Osteosarcoma
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Osteosarcoma
Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Osteosarcoma
Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma.
Osteosarcoma
Content Determination of Active Component in Huangqi Yinyanghuo Group and Its Effects on hTERT and Bcl-2 Protein in Osteosarcoma.
Osteosarcoma
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Osteosarcoma
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity.
Osteosarcoma
Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Osteosarcoma
Hepatic angiomyolipoma in a 26-year-old Caucasian woman with a history of tibial osteosarcoma.
Osteosarcoma
hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.
Osteosarcoma
Increased telomerase activity is not directly related to metastatic potential in rat transplantable osteosarcomas.
Osteosarcoma
Inhibition of cell growth and telomerase activity in osteosarcoma cells by DN-hTERT.
Osteosarcoma
Kruppel-Like Factor 9 Loss-of-Expression in Human Endometrial Carcinoma Links Altered Expression of Growth-Regulatory Genes with Aberrant Proliferative Response to Estrogen.
Osteosarcoma
Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin.
Osteosarcoma
Postradiation malignant fibrous histiocytoma and osteosarcoma of a patient with high telomerase activities.
Osteosarcoma
Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness.
Osteosarcoma
Purification and biochemical characterization of a virus-specific reverse transcriptase from human osteosarcoma tissue.
Osteosarcoma
Repression of telomerase activity during in vitro differentiation of osteosarcoma cells.
Osteosarcoma
Reversible downregulation of telomerase activity by hyperthermia in osteosarcoma cells.
Osteosarcoma
shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells.
Osteosarcoma
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Osteosarcoma
Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro.
Osteosarcoma
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Osteosarcoma
Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
Osteosarcoma
Telomerase activity in juxtacortical and conventional high-grade osteosarcomas: correlation with grade, proliferative activity and clinical response to chemotherapy.
Osteosarcoma
Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells.
Osteosarcoma
Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase.
Osteosarcoma
The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.
Osteosarcoma
ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.
Osteosarcoma, Juxtacortical
Telomerase activity in juxtacortical and conventional high-grade osteosarcomas: correlation with grade, proliferative activity and clinical response to chemotherapy.
Otosclerosis
Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate.
Ovarian Cysts
Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Ovarian Cysts
Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions.
Ovarian Diseases
Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ovarian Neoplasms
1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.
Ovarian Neoplasms
2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
Ovarian Neoplasms
A Study of hTERT Promoter Methylation in Circulating Tumour DNAs of Patients with Ovarian Magnificent Tumour.
Ovarian Neoplasms
Activity of telomerase and extracellular regulated protein kinases in parental and drug resistant cells of leukemia and ovarian cancer.
Ovarian Neoplasms
Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
Ovarian Neoplasms
Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.
Ovarian Neoplasms
Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells.
Ovarian Neoplasms
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
Ovarian Neoplasms
Autocatalytic caspase-3 driven by human telomerase reverse transcriptase promoter suppresses human ovarian carcinoma growth in vitro and in mice.
Ovarian Neoplasms
Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity.
Ovarian Neoplasms
Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
Ovarian Neoplasms
Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer.
Ovarian Neoplasms
Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Ovarian Neoplasms
Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
Ovarian Neoplasms
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.
Ovarian Neoplasms
Down-regulation of telomerase activity by anticancer drugs in human ovarian cancer cells.
Ovarian Neoplasms
Dynamic telomerase gene suppression via network effects of GSK3 inhibition.
Ovarian Neoplasms
Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer.
Ovarian Neoplasms
Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells.
Ovarian Neoplasms
Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
Ovarian Neoplasms
Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.
Ovarian Neoplasms
Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Ovarian Neoplasms
Genomic instability is associated with lack of telomerase activation in ovarian cancer.
Ovarian Neoplasms
Growth Arrest in Ovarian Cancer Cells by hTERT Inhibition Short-Hairpin RNA Targeting Human Telomerase Reverse Transcriptase Induces Immediate Growth Inhibition but not Necessarily Induces Apoptosis in Ovarian Cancer Cells.
Ovarian Neoplasms
Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Ovarian Neoplasms
Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines.
Ovarian Neoplasms
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.
Ovarian Neoplasms
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Ovarian Neoplasms
In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Ovarian Neoplasms
In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
Ovarian Neoplasms
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.
Ovarian Neoplasms
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
Ovarian Neoplasms
Inhibition of human telomerase reverse transcriptase gene expression by BRCA1 in human ovarian cancer cells.
Ovarian Neoplasms
Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
Ovarian Neoplasms
Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Ovarian Neoplasms
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.
Ovarian Neoplasms
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.
Ovarian Neoplasms
Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
Ovarian Neoplasms
MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.
Ovarian Neoplasms
MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin.
Ovarian Neoplasms
Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex.
Ovarian Neoplasms
p21(WAF1) is involved in interferon-?- induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer.
Ovarian Neoplasms
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Ovarian Neoplasms
Polygala tenuifolia polysaccharide (PTP) inhibits cell proliferation by repressing Bmi-1 expression and downregulating telomerase activity.
Ovarian Neoplasms
Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor.
Ovarian Neoplasms
Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions.
Ovarian Neoplasms
Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.
Ovarian Neoplasms
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Ovarian Neoplasms
Selective suppression of autocatalytic caspase-3 driven by two-step transcriptional amplified human telomerase reverse transcriptase promoter on ovarian carcinoma growth in vitro and in mice.
Ovarian Neoplasms
Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
Ovarian Neoplasms
Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Ovarian Neoplasms
Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Ovarian Neoplasms
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Ovarian Neoplasms
Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer.
Ovarian Neoplasms
Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Ovarian Neoplasms
The effect of 17 sesquiterpenes on cell viability and telomerase activity in the human ovarian cancer cell line HO-8910.
Ovarian Neoplasms
The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Ovarian Neoplasms
VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
Ovarian Neoplasms
Vitamin D suppresses leptin stimulation of cancer growth through microRNA.
Ovarian Neoplasms
[Antisense oligodeoxynucleotides of human telomerse catalytic sub-unit inhibits telomerase activity and proliferation in SKOV3 and COC1]
Ovarian Neoplasms
[Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]
Ovarian Neoplasms
[Construction of TRAIL gene eukaryotic expression vector modulated by hTERT gene core promoter and its effect on apoptosis of ovarian cancer cells.]
Ovarian Neoplasms
[Effects of wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity]
Ovarian Neoplasms
[Expression of TRAIL gene eukaryotic expression vector modulated by the human telomerase reverse transcriptase gene core promoter in ovarian cancer cell line SKOV3]
Ovarian Neoplasms
[In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]
Ovarian Neoplasms
[Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]
Ovarian Neoplasms
[Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
Ovarian Neoplasms
[The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]
Ovarian Neoplasms
[Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter]
Overweight
Increased telomerase activity and vitamin D supplementation in overweight African Americans.
Paget Disease, Extramammary
Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease.
Pancreatic Cyst
Cyst fluid telomerase activity predicts the histologic grade of cystic neoplasms of the pancreas.
Pancreatic Diseases
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Pancreatic Diseases
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Pancreatic Diseases
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Pancreatic Diseases
In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
Pancreatic Diseases
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Pancreatic Diseases
Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis.
Pancreatic Diseases
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Pancreatic Diseases
Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
Pancreatic Diseases
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Pancreatic Diseases
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Pancreatic Diseases
[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice]
Pancreatic Diseases
[Telomerase activity in pancreatic juice for the preoperative diagnosis of pancreatic cancer]
Pancreatic Intraductal Neoplasms
Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Pancreatic Neoplasms
9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.
Pancreatic Neoplasms
ABO blood group and other genetic variants associated with pancreatic cancer.
Pancreatic Neoplasms
ACV-TP-T, a thymidine analogue pro-drug activated by telomerase, reduces pancreatic tumor growth in mice.
Pancreatic Neoplasms
Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
Pancreatic Neoplasms
Adrenomedullin is Upregulated in Patients with Pancreatic Cancer and Causes Insulin Resistance in ? Cells and Mice.
Pancreatic Neoplasms
Antitumor efficacy of human telomerase reverse transcriptase gene antisense oligonucleotide in pancreatic cancer cells.
Pancreatic Neoplasms
Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population.
Pancreatic Neoplasms
Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Pancreatic Neoplasms
Can inhibition of telomerase increase pancreatic cancer cell's susceptibility to chemotherapeutic reagents?
Pancreatic Neoplasms
Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells.
Pancreatic Neoplasms
Circular RNA PCDH10 regulates the tumorigenesis of pancreatic cancer through the miR-338-3p/hTERT axis.
Pancreatic Neoplasms
Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients.
Pancreatic Neoplasms
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Pancreatic Neoplasms
Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.
Pancreatic Neoplasms
Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration.
Pancreatic Neoplasms
Diagnosis of pancreatic cancer by cytology and telomerase activity in exfoliated cells obtained by pancreatic duct brushing during endoscopy.
Pancreatic Neoplasms
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Pancreatic Neoplasms
Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells.
Pancreatic Neoplasms
Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein.
Pancreatic Neoplasms
Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Pancreatic Neoplasms
Expression of telomerase & its significance in the diagnosis of pancreatic cancer.
Pancreatic Neoplasms
Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion.
Pancreatic Neoplasms
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Pancreatic Neoplasms
Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
Pancreatic Neoplasms
Genetic diagnosis of pancreatic cancer using specimens obtained by EUS-FNA.
Pancreatic Neoplasms
hTERT-siRNA Could Potentiate the Cytotoxic Effect of Gemcitabine to Pancreatic Cancer Cells Bxpc-3.
Pancreatic Neoplasms
In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
Pancreatic Neoplasms
Increased telomerase activities in human pancreatic duct adenocarcinomas.
Pancreatic Neoplasms
Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways.
Pancreatic Neoplasms
Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.
Pancreatic Neoplasms
Inhibition of Telomerase Activity by Oleanane Triterpenoid CDDO-Me in Pancreatic Cancer Cells is ROS-Dependent.
Pancreatic Neoplasms
Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells.
Pancreatic Neoplasms
Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro.
Pancreatic Neoplasms
KLF4? Up-Regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer.
Pancreatic Neoplasms
Knockdown of hTERT by SiRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2.
Pancreatic Neoplasms
Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juice.
Pancreatic Neoplasms
Multiple factors influencing the release of hTERT mRNA from pancreatic cancer cell lines in in vitro culture.
Pancreatic Neoplasms
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
Pancreatic Neoplasms
Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
Pancreatic Neoplasms
PCDH10 Interacts With hTERT and Negatively Regulates Telomerase Activity.
Pancreatic Neoplasms
Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
Pancreatic Neoplasms
Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
Pancreatic Neoplasms
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Pancreatic Neoplasms
Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
Pancreatic Neoplasms
RBM10 regulates human TERT gene splicing and inhibits pancreatic cancer progression.
Pancreatic Neoplasms
Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders.
Pancreatic Neoplasms
Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Pancreatic Neoplasms
Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells.
Pancreatic Neoplasms
Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.
Pancreatic Neoplasms
Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma.
Pancreatic Neoplasms
Stable expression of antisense hTR inhibits in vitro pancreatic cancer cell growth.
Pancreatic Neoplasms
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Pancreatic Neoplasms
Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis.
Pancreatic Neoplasms
Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.
Pancreatic Neoplasms
Telomerase activity for the preoperative diagnosis of pancreatic cancer.
Pancreatic Neoplasms
Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
Pancreatic Neoplasms
Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
Pancreatic Neoplasms
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Pancreatic Neoplasms
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.
Pancreatic Neoplasms
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Pancreatic Neoplasms
Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
Pancreatic Neoplasms
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study.
Pancreatic Neoplasms
Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
Pancreatic Neoplasms
Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.
Pancreatic Neoplasms
Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.
Pancreatic Neoplasms
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Pancreatic Neoplasms
The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration.
Pancreatic Neoplasms
The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines.
Pancreatic Neoplasms
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Pancreatic Neoplasms
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide.
Pancreatic Neoplasms
Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic Malignancy.
Pancreatic Neoplasms
Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.
Pancreatic Neoplasms
[Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell]
Pancreatic Neoplasms
[Inhibition effects of phosphorothioate-modified antisense hTR on the telomerase activity and the growth of P3 cells derived from pancreatic cancer in culture]
Pancreatic Neoplasms
[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice]
Pancreatic Neoplasms
[Telomerase activity in pancreatic juice for the preoperative diagnosis of pancreatic cancer]
Pancreaticobiliary Maljunction
Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study.
Pancreatitis
A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Pancreatitis
Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Pancreatitis
Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Pancreatitis
Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage.
Pancreatitis
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.
Pancreatitis
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
Pancreatitis
Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
Pancreatitis
Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
Pancreatitis
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
Pancreatitis
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
Pancreatitis
[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice]
Pancreatitis, Chronic
Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.
Pancreatitis, Chronic
Diagnosis of pancreatic cancer by cytology and telomerase activity in exfoliated cells obtained by pancreatic duct brushing during endoscopy.
Pancreatitis, Chronic
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
Pancreatitis, Chronic
Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma.
Pancreatitis, Chronic
Real-time quantitative PCR of telomerase mRNA is useful for the differentiation of benign and malignant pancreatic disorders.
Pancreatitis, Chronic
Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis.
Pancreatitis, Chronic
Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
Pancreatitis, Chronic
Telomerase activity in periampullary tumors correlates with aggressive malignancy.
Pancreatitis, Chronic
Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
Pancytopenia
A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis.
Pancytopenia
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Pancytopenia
[Clinical significance of telomerase activity detection of myeloid element in immune related hematocytopenia].
Papilloma
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection.
Papilloma
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Papilloma
Combinatorial expression of cell cycle regulators is more suitable for immortalization than oncogenic methods in dermal papilla cells.
Papilloma
Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer.
Papilloma
Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Papilloma
High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions.
Papilloma
Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support.
Papilloma
Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas.
Papilloma
piggyBac Transposon-Based Immortalization of Human Deciduous Tooth Dental Pulp Cells with Multipotency and Non-Tumorigenic Potential.
Papilloma
Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Papilloma
Senescence-Derived Extracellular Molecules as Modulators of Oral Cancer Development: A Mini-Review.
Papilloma
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
Papilloma
Synthesis, spectral characterization, DNA interaction, anticancer and molecular docking studies on some transition metal complexes with bidentate ligand.
Papilloma
Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.
Papilloma
The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair.
Papilloma
The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
Papilloma, Inverted
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Papilloma, Inverted
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Papillomavirus Infections
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Papillomavirus Infections
Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
Papillomavirus Infections
Expression of HPV-16 E6 Protein and p53 Inactivation Increases the Uterine Cervical Cancer Invasion.
Papillomavirus Infections
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Papillomavirus Infections
High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Papillomavirus Infections
HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients.
Papillomavirus Infections
Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
Papillomavirus Infections
Human Telomerase Gene and High-Risk Human Papillomavirus Infection are Related to Cervical Intraepithelial Neoplasia.
Papillomavirus Infections
Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load.
Papillomavirus Infections
Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.
Papillomavirus Infections
Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Papillomavirus Infections
Telomerase activity and expression of its RNA component in cervical lesions.
Papillomavirus Infections
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Papillomavirus Infections
Telomerase activity in condyloma acuminatum tissue with different HPV types.
Papillomavirus Infections
Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses.
Papillomavirus Infections
Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Papillomavirus Infections
The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
Paraganglioma
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Paraganglioma
Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma.
Paralysis
Detection of enteroviruses by reverse-transcriptase polymerase chain reaction in cell culture negative stool specimens of patients with acute flaccid paralysis.
Paramyxoviridae Infections
Association of Human Metapneumovirus with Radiologically Diagnosed Community-Acquired Alveolar Pneumonia in Young Children.
Paramyxoviridae Infections
The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005.
Paraproteinemias
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
Parapsoriasis
Shortened telomere length is demonstrated in T-cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis.
Parapsoriasis
Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Parasitic Diseases
HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites.
Parathyroid Neoplasms
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture.
Parathyroid Neoplasms
Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Parathyroid Neoplasms
Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe.
Parathyroid Neoplasms
Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT.
Parathyroid Neoplasms
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid.
Parathyroid Neoplasms
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma.
Paratuberculosis
Mycobacterial cell wall components induce the production of TNF-alpha, IL-1, and IL-6 by bovine monocytes and the murine macrophage cell line RAW 264.7.
Parkinson Disease
Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice.
Parkinson Disease
Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson's disease associated with enhanced autophagy.
Parkinson Disease
The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America.
Peptic Ulcer
Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Peptic Ulcer
Detection of telomerase activity in gastric lavage fluid: a novel method to detect gastric cancer.
Periodontitis
A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis.
Periodontitis
Aggressive periodontitis: An appraisal of systemic effects on its etiology-genetic aspect.
Peripheral Nervous System Diseases
Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity.
Peripheral Nervous System Diseases
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.
Peripheral Nervous System Diseases
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
Peripheral Nervous System Diseases
Caspase signalling in neuropathic and inflammatory pain in the rat.
Peripheral Nervous System Diseases
Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.
Peripheral Nervous System Diseases
Genome-Wide Screen Identifies Drug-Induced Regulation of the Gene Giant Axonal Neuropathy (Gan) in a Mouse Model of Antiretroviral-Induced Painful Peripheral Neuropathy.
Peripheral Nervous System Diseases
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
Peripheral Nervous System Diseases
High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.
Peripheral Nervous System Diseases
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
Peripheral Nervous System Diseases
Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
Peripheral Nervous System Diseases
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.
Peripheral Nervous System Diseases
Neurological and psychiatric adverse effects of antiretroviral drugs.
Peripheral Nervous System Diseases
Neuropathic and neurocongnitive complications of antiretroviral therapy among HIV-infected patients.
Peripheral Nervous System Diseases
Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
Peripheral Nervous System Diseases
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
Peripheral Nervous System Diseases
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
Peripheral Nervous System Diseases
Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.
Peripheral Nervous System Diseases
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.
Peripheral Nervous System Diseases
The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial.
Peripheral Nervous System Diseases
Will pharmacogenomic discoveries improve HIV therapeutics?
Peritoneal Neoplasms
Telomerase assay for differentiating between malignancy-related and nonmalignant ascites.
Peritonitis
Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats.
Persistent Infection
Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and Replication.
Pharyngitis
Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea.
Pheochromocytoma
A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.
Pheochromocytoma
A subcellular distribution of estrogen receptor-alpha is changed during artificially induced senescence of PC12 pheochromocytoma cells.
Pheochromocytoma
Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
Pheochromocytoma
Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
Pheochromocytoma
Glucagon does not affect catecholamine release in primary cultures of bovine adrenal chromaffin cells.
Pheochromocytoma
HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
Pheochromocytoma
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Pheochromocytoma
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Pheochromocytoma
Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features.
Pheochromocytoma
Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling.
Pheochromocytoma
Withdrawal. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
Phyllodes Tumor
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
Pituitary Diseases
Circulating microRNA as a biomarker of human growth hormone administration to patients.
Pituitary Neoplasms
Differential telomerase expression in human primary intracranial tumors.
Pituitary Neoplasms
Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT.
Pituitary Neoplasms
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
Pituitary Neoplasms
Prognostic implications of telomerase expression in pituitary adenomas.
Pituitary Neoplasms
Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics.
Pituitary Neoplasms
Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation.
Pituitary Neoplasms
Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.
Pituitary Neoplasms
Telomerase expression in clinically non-functioning pituitary adenomas.
Pituitary Neoplasms
The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape.
Placenta Previa
Increased Levels of Cell-Free Human Placental Lactogen mRNA at 28-32 Gestational Weeks in Plasma of Pregnant Women With Placenta Previa and Invasive Placenta.
Plasmacytoma
Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Pleural Effusion
Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
Pleural Effusion
Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Pleural Effusion
Diagnostic implications of telomerase activity in pleural effusions.
Pleural Effusion
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Pleural Effusion
hTERT Gene Amplification and Clinical Significance in Pleural Effusions of Patients With Lung Cancer.
Pleural Effusion
In situ telomerase activity in pleural effusions: a promising marker for malignancy.
Pleural Effusion
Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Pleural Effusion
Tuberculin purified protein derivative up-regulates the telomerase activity of peripheral blood mononuclear cells from patients with pulmonary tuberculosis.
Pleural Effusion
[Application of combined telomerase activity analysis and immunocytochemistry in cytopathologic diagnosis].
Pleural Effusion
[Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions]
Pleural Effusion
[Detection of telomerase activity of exfoliated cells in bile and its clinical impact]
Pleural Effusion
[Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]
Pleural Effusion
[Diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer]
Pleural Effusion, Malignant
Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.
Pleural Effusion, Malignant
Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
Pleural Effusion, Malignant
Diagnostic implications of telomerase activity in pleural effusions.
Pleural Effusion, Malignant
Telomerase activity assay for the diagnosis of malignant pleural effusion: A meta-analysis.
Pleural Effusion, Malignant
Telomerase activity in pleural effusions: diagnostic significance.
Pleural Effusion, Malignant
[Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions]
Pleural Effusion, Malignant
[Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]
Pneumonia
COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results.
Pneumonia
Diagnosis of Measles Pneumonia from Bronchoalveolar Lavage Fluid by Reverse-Transcriptase Polymerase Chain Reaction: Case Report.
Pneumonia
Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.
Pneumonia
Human metapneumovirus associated with community-acquired pneumonia in children in Beijing, China.
Pneumonia
Initial Clinical Management of Symptomatic Adult Patients during Influenza A (H1N1) Epidemics.
Pneumonia
Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness.
Pneumonia
Telomerase activity in peripheral blood mononuclear cells from senile patients with pneumonia.
Pneumonia
The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Pneumonia
[Detection of telomerase activity in bronchoscopic brush-off cells in lung cancer patients]
Pneumonia
[Diagnosis of adult measles pneumonia from bronchoalveolar lavage fluid by reverse-transcriptase polymerase chain reaction]
Pneumonia
[Two patients with novel influenza A virus (H1N1) pneumonia treated with steroid therapy after an incorrect diagnosis of rapid progressive interstitial pneumonia due to the negative results of a rapid-antigen test].
Pneumonia, Progressive Interstitial, of Sheep
Differential levels of mRNAs for cytokines, the interleukin-2 receptor and class II DR/DQ genes in ovine interstitial pneumonia induced by maedi visna virus infection.
poly(a)-specific ribonuclease deficiency
PARN modulates Y RNA stability, 3' end formation and its modification.
poly(a)-specific ribonuclease deficiency
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Polycystic Kidney Diseases
Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Ca2+ signaling in human ADPKD cyst epithelial cells.
Polycystic Kidney, Autosomal Dominant
A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1.
Polycystic Kidney, Autosomal Dominant
Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Ca2+ signaling in human ADPKD cyst epithelial cells.
Polycystic Kidney, Autosomal Dominant
Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease.
Polycystic Ovary Syndrome
Telomere Length and Telomerase Activity in Immature Oocytes and Cumulus Cells of Women with Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS.
Polycythemia Vera
Drug Development Pipeline for Myeloproliferative Neoplasms: Potential Future Impact on Guidelines and Management.
Polycythemia Vera
High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia.
Polycythemia Vera
Particle-associated RNA dependent DNA polymerase and high-molecular-weight RNA in a human cell line derived from polycythemia vera bone marrow.
Polycythemia Vera
RNA-dependent DNA polymerase from a cell line derived from the bone marrow of a patient with polycythemia vera.
Polycythemia Vera
The expression levels of telomerase catalytic subunit hTERT and oncogenic MYC in essential thrombocythemia are affected by the molecular subtype.
Polymyositis
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Polyneuropathies
Effect of Stavudine-Based Antiretroviral Therapy on the Severity of Polyneuropathy in HIV/AIDS Patients: A Preliminary Report From Zaria, Northern Nigeria.
Polyneuropathies
Pharmacokinetics of Acetyl-L-Carnitine Given in Single or Multiple Doses to HIV-1 Infected Patients with Toxic Peripheral Polyneuropathy.
Polyradiculoneuropathy
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
Porcine Reproductive and Respiratory Syndrome
Evaluation of the Risk of PRRSV Transmission via Ingestion of Muscle from Persistently Infected Pigs.
Porcine Reproductive and Respiratory Syndrome
Human telomerase reverse transcriptase-immortalized porcine monomyeloid cell lines for the production of porcine reproductive and respiratory syndrome virus.
Pre-Eclampsia
Comparative Analysis of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells between Preeclampsia and Normal Pregnant Women.
Pre-Eclampsia
Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole.
Precancerous Conditions
Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis.
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Telomerase Inhibition by Non-Nucleosidic Compound (BIBR1532) Causes Rapid Cell Death in Pre-B Acute Lymphoblastic Leukemia Cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Clinical implications of telomerase activity levels in acute leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Correlation of telomerase activity to apoptosis and survival in adult acute lymphoblastic leukemia: an Egyptian single-center study.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Does p16ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Methylation of CDKN2B CpG islands is associated with upregulated telomerase activity in children with acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Telomerase Inhibition by Non-Nucleosidic Compound (BIBR1532) Causes Rapid Cell Death in Pre-B Acute Lymphoblastic Leukemia Cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Isolation of a RNA-dependent DNA polymerase from lymphocytes of a cow suffering from lymphoblastic leukemia]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[The relationship between telomerase activity and cell cyele in acute leukemia cells]
Prediabetic State
Assessment of autonomic functions and its association with telomerase level, oxidative stress and inflammation in complete glycemic spectrum- an exploratory study.
Prediabetic State
Pistachio consumption modulates DNA oxidation and genes related to telomere maintenance: a crossover randomized clinical trial.
Premature Birth
Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.
Premature Birth
Telomere Length and Telomerase Activity in Foetal Membranes from Term and Spontaneous Preterm Births.
Primary Myelofibrosis
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.
Primary Myelofibrosis
Characterization of In Vitro G-Quadruplex Formation of Imetelstat Telomerase Inhibitor.
Primary Myelofibrosis
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.
Primary Myelofibrosis
Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disorders.
Primary Myelofibrosis
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis.
Primary Myelofibrosis
Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.
Primary Myelofibrosis
Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Primary Myelofibrosis
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
Primary Ovarian Insufficiency
Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency.
Primary Ovarian Insufficiency
Investigation of the role of serum telomerase levels in patients with occult primary ovarian insufficiency: a prospective cross-sectional study.
Primary Ovarian Insufficiency
Telomerase activity in normal ovaries and premature ovarian failure.
Primary Ovarian Insufficiency
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature.
Progeria
Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Progeria
Fibroblast clones from patients with Hutchinson-Gilford progeria can senesce despite the presence of telomerase.
Progeria
Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.
Progeria
Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
Prostatic Diseases
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?
Prostatic Hyperplasia
Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest region.
Prostatic Hyperplasia
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Prostatic Hyperplasia
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?
Prostatic Hyperplasia
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Prostatic Hyperplasia
Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Prostatic Hyperplasia
Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Prostatic Hyperplasia
Oncornavirus-like particles released by human prostatic explant cultures.
Prostatic Hyperplasia
Patients with benign prostatic hyperplasia show shorter leukocyte telomere length but no association with telomerase gene polymorphisms in Han Chinese males.
Prostatic Hyperplasia
Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages.
Prostatic Hyperplasia
Telomerase activity in needle biopsies from prostate cancer and benign prostates.
Prostatic Hyperplasia
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Prostatic Hyperplasia
Telomerase as a new target for the treatment of hormone-refractory prostate cancer.
Prostatic Hyperplasia
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Prostatic Intraepithelial Neoplasia
Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Prostatic Intraepithelial Neoplasia
Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Prostatic Intraepithelial Neoplasia
Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Prostatic Intraepithelial Neoplasia
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Prostatic Intraepithelial Neoplasia
Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens.
Prostatic Intraepithelial Neoplasia
Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Prostatic Intraepithelial Neoplasia
Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Prostatic Intraepithelial Neoplasia
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
Prostatic Intraepithelial Neoplasia
[Detection of telomerase activity in prostate needle-biopsy samples]
Prostatic Intraepithelial Neoplasia
[Prostate-specific antigen and telomerase in prostatic cancers]
Prostatic Neoplasms
1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
Prostatic Neoplasms
A comparison of proteomic profiles changes during 17beta-estradiol treatment in human prostate cancer PC-3 cell line.
Prostatic Neoplasms
A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
Prostatic Neoplasms
A novel human cell culture model for the study of familial prostate cancer.
Prostatic Neoplasms
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Prostatic Neoplasms
A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Prostatic Neoplasms
A Triad of Telomerase, Androgen Receptor and Early Growth Response 1 in Prostate Cancer Cells.
Prostatic Neoplasms
Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
Prostatic Neoplasms
Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta.
Prostatic Neoplasms
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
Prostatic Neoplasms
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Prostatic Neoplasms
Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors.
Prostatic Neoplasms
Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.
Prostatic Neoplasms
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Prostatic Neoplasms
BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.
Prostatic Neoplasms
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.
Prostatic Neoplasms
Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.
Prostatic Neoplasms
Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate.
Prostatic Neoplasms
Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
Prostatic Neoplasms
Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells.
Prostatic Neoplasms
Conversion of nested reverse-transcriptase polymerase chain reaction from positive to negative status at peripheral blood during androgen ablation therapy is associated with long progression-free survival in stage D2 prostate cancer patients.
Prostatic Neoplasms
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans.
Prostatic Neoplasms
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
Prostatic Neoplasms
Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.
Prostatic Neoplasms
Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
Prostatic Neoplasms
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.
Prostatic Neoplasms
Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?
Prostatic Neoplasms
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Prostatic Neoplasms
Determination of the enzyme telomerase in needle biopsies and fine needle aspiration cytology samples of the prostate in the diagnosis of prostate cancer.
Prostatic Neoplasms
Diagnosing the miR-141 prostate cancer biomarker using nucleic acid-functionalized CdSe/ZnS QDs and telomerase.
Prostatic Neoplasms
Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer.
Prostatic Neoplasms
Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.
Prostatic Neoplasms
Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells.
Prostatic Neoplasms
Disruption of an hTERT-mTOR-RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin.
Prostatic Neoplasms
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Prostatic Neoplasms
Effect of Achillea wilhelmsii extract on expression of the human telomerase reverse transcriptase mRNA in the PC3 prostate cancer cell line.
Prostatic Neoplasms
Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
Prostatic Neoplasms
Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro.
Prostatic Neoplasms
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Prostatic Neoplasms
ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples.
Prostatic Neoplasms
Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens.
Prostatic Neoplasms
Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Prostatic Neoplasms
Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
Prostatic Neoplasms
Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Prostatic Neoplasms
Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57(kip2a)).
Prostatic Neoplasms
Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Prostatic Neoplasms
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Prostatic Neoplasms
Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
Prostatic Neoplasms
Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Prostatic Neoplasms
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Prostatic Neoplasms
Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells.
Prostatic Neoplasms
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Prostatic Neoplasms
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
Prostatic Neoplasms
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
Prostatic Neoplasms
Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Prostatic Neoplasms
Identification of bone marrow micrometastases in patients with prostate cancer.
Prostatic Neoplasms
In vivo regulation of hTERT expression and telomerase activity by androgen.
Prostatic Neoplasms
Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines.
Prostatic Neoplasms
Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
Prostatic Neoplasms
Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells.
Prostatic Neoplasms
Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells.
Prostatic Neoplasms
Inhibition of telomerase potentiates enzalutamide efficiency of androgen-sensitive human prostate cancer cells.
Prostatic Neoplasms
Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
Prostatic Neoplasms
Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.
Prostatic Neoplasms
Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells.
Prostatic Neoplasms
LNCaP prostate cancer cells are insensitive to zinc-induced senescence.
Prostatic Neoplasms
Low p16(INK4a) Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.
Prostatic Neoplasms
Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles.
Prostatic Neoplasms
MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer.
Prostatic Neoplasms
MNS16A tandem repeats minisatellite of human telomerase gene and prostate cancer susceptibility.
Prostatic Neoplasms
Modulation of telomerase activity by zinc in human prostatic and renal cancer cells.
Prostatic Neoplasms
Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Prostatic Neoplasms
MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
Prostatic Neoplasms
Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Prostatic Neoplasms
Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells.
Prostatic Neoplasms
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.
Prostatic Neoplasms
Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
Prostatic Neoplasms
Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Prostatic Neoplasms
Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes.
Prostatic Neoplasms
Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase.
Prostatic Neoplasms
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells.
Prostatic Neoplasms
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.
Prostatic Neoplasms
Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival.
Prostatic Neoplasms
Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy.
Prostatic Neoplasms
Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype.
Prostatic Neoplasms
Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.
Prostatic Neoplasms
Prostate tumor-initiating cells: A new target for telomerase inhibition therapy?
Prostatic Neoplasms
Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection.
Prostatic Neoplasms
Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer.
Prostatic Neoplasms
Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
Prostatic Neoplasms
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Prostatic Neoplasms
Research into molecular and genetic mechanisms underlying prostate carcinogenesis would be greatly advanced by in vitro prostate cell models.
Prostatic Neoplasms
Role of telomerase in anticancer activity of pristimerin in prostate cancer cells.
Prostatic Neoplasms
Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells.
Prostatic Neoplasms
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.
Prostatic Neoplasms
SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
Prostatic Neoplasms
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model.
Prostatic Neoplasms
Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Prostatic Neoplasms
Superiority of an Asymmetric Perylene Diimide in Terms of Hydrosolubility, G-Quadruplex Binding, Cellular Uptake, and Telomerase Inhibition in Prostate Cancer Cells.
Prostatic Neoplasms
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Prostatic Neoplasms
Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.
Prostatic Neoplasms
Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis.
Prostatic Neoplasms
Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
Prostatic Neoplasms
Telomerase activity in needle biopsies from prostate cancer and benign prostates.
Prostatic Neoplasms
Telomerase activity in needle biopsies from prostate cancer and benign prostates: the influence of sampling bias.
Prostatic Neoplasms
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Prostatic Neoplasms
Telomerase activity in prostate sextant needle cores from radical prostatectomy specimens.
Prostatic Neoplasms
Telomerase activity, Myc and Bcl-2: possible indicators of effective therapy of prostate cancer with 9-nitrocamptothecin.
Prostatic Neoplasms
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Prostatic Neoplasms
Telomerase as a new target for the treatment of hormone-refractory prostate cancer.
Prostatic Neoplasms
Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Prostatic Neoplasms
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
Prostatic Neoplasms
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.
Prostatic Neoplasms
Telomerase expression as a marker in prostate cancer: correlation to clinicopathologic predictors.
Prostatic Neoplasms
Telomerase Inhibition, Telomere Shortening, and Cellular Uptake of the Perylene Derivatives PM2 and PIPER in Prostate Cancer Cells.
Prostatic Neoplasms
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Prostatic Neoplasms
Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer.
Prostatic Neoplasms
Telomere length and telomerase activity in bladder and prostate cancer cell lines.
Prostatic Neoplasms
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
Prostatic Neoplasms
TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Prostatic Neoplasms
The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.
Prostatic Neoplasms
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells.
Prostatic Neoplasms
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells.
Prostatic Neoplasms
The potential utility of telomere-related markers for cancer diagnosis.
Prostatic Neoplasms
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Prostatic Neoplasms
The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
Prostatic Neoplasms
The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Prostatic Neoplasms
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Prostatic Neoplasms
Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens.
Prostatic Neoplasms
Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.
Prostatic Neoplasms
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
Prostatic Neoplasms
[Clinical significance of serum telomerase mRNA in patients with prostate cancer].
Prostatic Neoplasms
[Expressions of telomerase reverse transcriptase and vascular endothelial growth factor and their correlation in prostate cancer]
Prostatic Neoplasms
[Inhibition of telomerase with hTERT antisense enhances TNF-alpha-induced apoptosis in prostate cancer cells PC3]
Prostatic Neoplasms
[Telomerase activity in association with the pathological differentiation of prostate cancer]
Prostatic Neoplasms
[The animal research of recombinant adenovirus controlled by human telomerase reverse transcriptase promoter in the treatment of human prostate cancer]
Psoriasis
Detection of telomerase activity in psoriasis lesional skin and correlation with Ki-67 expression and suppression by retinoic acid.
Psoriasis
In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin.
Psoriasis
Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis.
Pterygium
Relative gene expression analysis of human pterygium tissues and UV radiation-evoked gene expression patterns in corneal and conjunctival cells.
Pulmonary Alveolar Proteinosis
Pulmonary alveolar proteinosis revealing a telomerase disease.
Pulmonary Disease, Chronic Obstructive
Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of Lung Cancer: Findings from the Fukuoka Tobacco-Related Lung Disease (FOLD) Registry.
Pulmonary Disease, Chronic Obstructive
Long-term tobacco exposure and immunosenescence: Paradoxical effects on T-cells telomere length and telomerase activity.
Pulmonary Disease, Chronic Obstructive
Mild catalytic defects of tert rs61748181 polymorphism affect the clinical presentation of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
miRNA-486-5p Promotes COPD Progression by Targeting HAT1 to Regulate the TLR4-Triggered Inflammatory Response of Alveolar Macrophages.
Pulmonary Disease, Chronic Obstructive
Significance of viral infections detected by reverse-transcriptase - multiplex PCR on hospital-related outcomes in acute exacerbations of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Telomerase mutations in smokers with severe emphysema.
Pulmonary Disease, Chronic Obstructive
TERT gene polymorphisms are associated with chronic obstructive pulmonary disease risk in the Chinese Li population.
Pulmonary Edema
Shorter telomere length, higher telomerase activity in association with Tankyrase gene Polymorphism contribute to High-altitude pulmonary edema.
Pulmonary Emphysema
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Pulmonary Fibrosis
A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis.
Pulmonary Fibrosis
A spectrum of severe familial liver disorders associate with telomerase mutations.
Pulmonary Fibrosis
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Pulmonary Fibrosis
Acute graft-versus-host disease following lung transplantation in a patient with a novel
Pulmonary Fibrosis
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.
Pulmonary Fibrosis
Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis.
Pulmonary Fibrosis
Clinical outcomes of lung transplant recipients with telomerase mutations.
Pulmonary Fibrosis
Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.
Pulmonary Fibrosis
Constitutional telomerase mutations are genetic risk factors for cirrhosis.
Pulmonary Fibrosis
Disease-associated human telomerase RNA variants show loss of function for telomere synthesis without dominant-negative interference.
Pulmonary Fibrosis
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Pulmonary Fibrosis
Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611.
Pulmonary Fibrosis
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.
Pulmonary Fibrosis
Genetic predisposition to respiratory diseases: infiltrative lung diseases.
Pulmonary Fibrosis
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
Pulmonary Fibrosis
Induction of telomerase activity in fibroblasts from bleomycin-injured lungs.
Pulmonary Fibrosis
Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants.
Pulmonary Fibrosis
Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
Pulmonary Fibrosis
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.
Pulmonary Fibrosis
Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.
Pulmonary Fibrosis
Many disease-associated variants of hTERT retain high telomerase enzymatic activity.
Pulmonary Fibrosis
Natural History of Pulmonary Fibrosis in Two Subjects with the Same Telomerase Mutation.
Pulmonary Fibrosis
New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?
Pulmonary Fibrosis
Phenotypes in mTERT+/- and mTERT-/- mice are due to short telomeres, not telomere-independent functions of TERT.
Pulmonary Fibrosis
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.
Pulmonary Fibrosis
Reply: Telomerase Makes Connections between Pulmonary Fibrosis and Emphysema.
Pulmonary Fibrosis
Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.
Pulmonary Fibrosis
Short telomeres in pulmonary fibrosis: from genetics to clinical significance.
Pulmonary Fibrosis
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.
Pulmonary Fibrosis
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.
Pulmonary Fibrosis
Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.
Pulmonary Fibrosis
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.
Pulmonary Fibrosis
Telomerase-related monogenic lung fibrosis presenting with subacute onset: a case report and review of literature.
Pulmonary Fibrosis
Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis.
Pulmonary Fibrosis
Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.
Pulmonary Fibrosis
Telomere shortening and DNA damage in culprit cells of different types of progressive fibrosing interstitial lung disease.
Pulmonary Fibrosis
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Pulmonary Fibrosis
Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres.
Pulmonary Fibrosis
Understanding telomere diseases through analysis of patient-derived iPS cells.
Pulmonary Fibrosis
ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation.
Purpura, Thrombocytopenic, Idiopathic
Methylation of CDKN2B CpG islands is associated with upregulated telomerase activity in children with acute lymphoblastic leukemia.
Purpura, Thrombocytopenic, Idiopathic
Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.
Purpura, Thrombocytopenic, Idiopathic
Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia.
Pyuria
Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: Causative factors affecting sensitivity and specificity.
Rabies
Antibodies to rabies virus in terrestrial wild mammals in native rainforest on the north coast of São Paulo State, Brazil.
Rabies
Heminested reverse-transcriptase polymerase chain reaction (hnRT-PCR) as a tool for rabies virus detection in stored and decomposed samples.
Rabies
Rapid identification of the raccoon rabies virus variant using a real-time reverse-transcriptase polymerase chain reaction.
Rabies
Re-assessment of direct fluorescent antibody negative brain tissues with a real-time PCR assay to detect the presence of raccoon rabies virus RNA.
Rabies
Use of reverse transcription-polymerase chain reaction to determine the stability of rabies virus genome in brains kept at room temperature.
Rabies
[Significance of modern methods for laboratory detection of rabies agents and identification of the zoonose immunological survey].
Rectal Neoplasms
Author Correction: The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Rectal Neoplasms
Change of telomerase activity in rectal cancer with chemoradiation therapy.
Rectal Neoplasms
Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival.
Rectal Neoplasms
Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes.
Rectal Neoplasms
Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
Rectal Neoplasms
Telomerase expression as a predictive marker of radiotherapy response in rectal cancer.
Rectal Neoplasms
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Relative Energy Deficiency in Sport
Comparative Biological Properties and Mineralization Potential of 3 Endodontic Materials for Vital Pulp Therapy: Theracal PT, Theracal LC, and Biodentine on Human Dental Pulp Stem Cells.
Relative Energy Deficiency in Sport
Effect of iRoot Fast Set root repair material on the proliferation, migration and differentiation of human dental pulp stem cells in vitro.
Relative Energy Deficiency in Sport
Highly osteogenic PDL stem cell clones specifically express elevated levels of ICAM1, ITGB1 and TERT.
Renal Insufficiency
Is there a connection between inflammation, telomerase activity and the transcriptional status of telomerase reverse transcriptase in renal failure?
Renal Insufficiency, Chronic
Telomerase activity in patients with stage 2-5D chronic kidney disease.
Reoviridae Infections
Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts.
Reperfusion Injury
Effects of hUCB-MSCs on recovery of neurological function and TERT expression in brain tissue of rats with cerebral ischemia-reperfusion injury.
Reperfusion Injury
Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity.
Reperfusion Injury
Protection against ischemia-reperfusion injury in aged liver donor by the induction of exogenous human telomerase reverse transcriptase gene.
Reperfusion Injury
Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy.
Reperfusion Injury
Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury.
Respiratory Tract Infections
Clinical outcomes of lung transplant recipients with telomerase mutations.
Respiratory Tract Infections
Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction.
Respiratory Tract Infections
Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction.
Respiratory Tract Infections
Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
Respiratory Tract Infections
Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction.
Retinal Degeneration
Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.
Retinal Neovascularization
Expression profile and regulation of telomerase reverse transcriptase on oxygen-induced retinal neovascularization.
Retinoblastoma
Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability.
Retinoblastoma
Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.
Retinoblastoma
Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.
Retinoblastoma
Correction: Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.
Retinoblastoma
Detection of mutations in the RB1 gene by single strand conformation polymorphism (SSCP) analysis, amplification mismatch detection (AMD) analysis and polymerase chain reaction sequencing.
Retinoblastoma
Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.
Retinoblastoma
Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression.
Retinoblastoma
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1.
Retinoblastoma
Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.
Retinoblastoma
Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity.
Retinoblastoma
Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells.
Retinoblastoma
NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
Retinoblastoma
Order of genetic events is critical determinant of aberrations in chromosome count and structure.
Retinoblastoma
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition.
Retinoblastoma
Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin.
Retinoblastoma
Telomerase activation as a repair response to radiation-induced DNA damage in Y79 retinoblastoma cells.
Retinoblastoma
Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Retinoblastoma
Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Retinoblastoma
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.
Retinoblastoma
The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.
Retinoblastoma
The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinoma.
Retinoblastoma
The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.
Retinoblastoma
USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT/P53 pathway.
Retinoblastoma
Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture.
Retinoblastoma
[Experimental study on effect of epimedium flavonoids in protecting telomere length of senescence cells HU]
Retinoblastoma
[The effects of matrine on cell proliferation and telomerase activity in retinoblastoma cells in vitro]
Retinoblastoma
[The study on the correlation between telomerase and histopathologic features of retinoblastoma]
Retroviridae Infections
Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.
Retroviridae Infections
[Establishment and application of oncogene over expressed human epithelial cell transformation model]
Rhabdoid Tumor
Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.
Rhabdoid Tumor
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Rhabdomyolysis
Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity.
Rhabdomyolysis
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
Rhabdomyosarcoma
Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1).
Rhabdomyosarcoma
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Rhabdomyosarcoma
Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma.
Rhabdomyosarcoma
Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Rhabdomyosarcoma, Alveolar
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Rhabdomyosarcoma, Alveolar
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Rhabdomyosarcoma, Alveolar
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Rhabdomyosarcoma, Embryonal
Telomerase activity in cell lines of pediatric soft tissue sarcomas.
Rheumatic Diseases
Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases.
Rhinitis, Allergic, Seasonal
Nasal messenger RNA expression of interleukins 2, 4, and 5 in patients with allergic rhinitis.
rna-directed dna polymerase deficiency
A genetic interaction between RAP1 and telomerase reveals an unanticipated role for RAP1 in telomere maintenance.
rna-directed dna polymerase deficiency
A method for efficient quantitative analysis of genomic subtelomere Y' element abundance in yeasts.
rna-directed dna polymerase deficiency
A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features.
rna-directed dna polymerase deficiency
A possible role for telomerase RNA and telomere length in global mitotic recombination.
rna-directed dna polymerase deficiency
Aberrant gene expression profiles, during in vitro osteoblast differentiation, of telomerase deficient mouse bone marrow stromal stem cells (mBMSCs).
rna-directed dna polymerase deficiency
An enhanced H/ACA RNP assembly mechanism for human telomerase RNA.
rna-directed dna polymerase deficiency
An essential role for functional telomeres in mouse germ cells during fertilization and early development.
rna-directed dna polymerase deficiency
An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.
rna-directed dna polymerase deficiency
Bone Marrow Stromal Cell (BMSC) and skeletal aging: Role of telomerase enzyme.
rna-directed dna polymerase deficiency
Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice.
rna-directed dna polymerase deficiency
Clonal cell populations unresponsive to radiosensitization induced by telomerase inhibition.
rna-directed dna polymerase deficiency
Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes.
rna-directed dna polymerase deficiency
Correction to: Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
rna-directed dna polymerase deficiency
Cytogenetic Analysis of Telomere Dysfunction.
rna-directed dna polymerase deficiency
Defective repair of oxidative base lesions by the DNA glycosylase Nth1 associates with multiple telomere defects.
rna-directed dna polymerase deficiency
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia.
rna-directed dna polymerase deficiency
Deficiency of colonic telomerase in ulcerative colitis.
rna-directed dna polymerase deficiency
Diminished telomeric 3' overhangs are associated with telomere dysfunction in hoyeraal-hreidarsson syndrome.
rna-directed dna polymerase deficiency
Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.
rna-directed dna polymerase deficiency
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
rna-directed dna polymerase deficiency
DNA synthesis generates terminal duplications that seal end-to-end chromosome fusions.
rna-directed dna polymerase deficiency
DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse.
rna-directed dna polymerase deficiency
Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
rna-directed dna polymerase deficiency
Dyskeratosis congenita: a genetic disorder of many faces.
rna-directed dna polymerase deficiency
Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
rna-directed dna polymerase deficiency
Engineered telomere degradation models dyskeratosis congenita.
rna-directed dna polymerase deficiency
Familial myelodysplastic syndromes - a review of the literature.
rna-directed dna polymerase deficiency
Genetic analysis of myc and telomerase interactions in vivo.
rna-directed dna polymerase deficiency
Heterozygous telomerase deficiency in mouse and man: when less is definitely not more.
rna-directed dna polymerase deficiency
Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
rna-directed dna polymerase deficiency
Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
rna-directed dna polymerase deficiency
Interstitial lung disease in the elderly: pathogenesis, diagnosis and management.
rna-directed dna polymerase deficiency
Investigation of human telomerase holoenzyme assembly, activity, and processivity using disease-linked subunit variants.
rna-directed dna polymerase deficiency
ISH ADA-01 Critical role of telomerase in regulating cerebral vascular function and redox environment.
rna-directed dna polymerase deficiency
Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita.
rna-directed dna polymerase deficiency
Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production.
rna-directed dna polymerase deficiency
Mutual reinforcement between telomere capping and canonical Wnt signalling in the intestinal stem cell niche.
rna-directed dna polymerase deficiency
Nephrotoxic Effects in Zebrafish after Prolonged Exposure to Aristolochic Acid.
rna-directed dna polymerase deficiency
PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres.
rna-directed dna polymerase deficiency
Pathogenic TERT promoter variants in telomere diseases.
rna-directed dna polymerase deficiency
Pathophysiologic mechanisms in acquired aplastic anemia.
rna-directed dna polymerase deficiency
Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.
rna-directed dna polymerase deficiency
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
rna-directed dna polymerase deficiency
Requirement of functional telomeres for metaphase chromosome alignments and integrity of meiotic spindles.
rna-directed dna polymerase deficiency
Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
rna-directed dna polymerase deficiency
Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
rna-directed dna polymerase deficiency
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
rna-directed dna polymerase deficiency
SMUG1 Promotes Telomere Maintenance through Telomerase RNA Processing.
rna-directed dna polymerase deficiency
Specificity and Stoichiometry of Subunit Interactions in the Human Telomerase Holoenzyme Assembled In vivo.
rna-directed dna polymerase deficiency
Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme.
rna-directed dna polymerase deficiency
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
rna-directed dna polymerase deficiency
Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway.
rna-directed dna polymerase deficiency
Telomerase Deficiency Affects Normal Brain Functions in Mice.
rna-directed dna polymerase deficiency
Telomerase deficiency affects the formation of chromosomal translocations by homologous recombination in Saccharomyces cerevisiae.
rna-directed dna polymerase deficiency
Telomerase deficiency and cancer susceptibility syndromes.
rna-directed dna polymerase deficiency
Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
rna-directed dna polymerase deficiency
Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs.
rna-directed dna polymerase deficiency
Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy.
rna-directed dna polymerase deficiency
Telomerase deficiency does not alter bleomycin-induced fibrosis in mice.
rna-directed dna polymerase deficiency
Telomerase deficiency impairs differentiation of mesenchymal stem cells.
rna-directed dna polymerase deficiency
Telomerase deficiency impairs glucose metabolism and insulin secretion.
rna-directed dna polymerase deficiency
Telomerase deficiency in a colonial ascidian after prolonged asexual propagation.
rna-directed dna polymerase deficiency
Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation.
rna-directed dna polymerase deficiency
Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury.
rna-directed dna polymerase deficiency
Telomerase deficiency promotes oxidative stress by reducing catalase activity.
rna-directed dna polymerase deficiency
Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
rna-directed dna polymerase deficiency
Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice.
rna-directed dna polymerase deficiency
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases.
rna-directed dna polymerase deficiency
Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
rna-directed dna polymerase deficiency
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.
rna-directed dna polymerase deficiency
Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.
rna-directed dna polymerase deficiency
Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.
rna-directed dna polymerase deficiency
Telomerase-deficient mice exhibit bone loss due to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
rna-directed dna polymerase deficiency
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
rna-directed dna polymerase deficiency
Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype.
rna-directed dna polymerase deficiency
Telomere Length is a Determinant of Emphysema Susceptibility.
rna-directed dna polymerase deficiency
Telomeres in aging and disease: lessons from zebrafish.
rna-directed dna polymerase deficiency
TERT regulates telomere-related senescence and apoptosis through DNA damage response in male germ cells exposed to BPDE in vitro and to B[a]P in vivo.
rna-directed dna polymerase deficiency
The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres.
rna-directed dna polymerase deficiency
The genome-wide transcription response to telomerase deficiency in the thermotolerant yeast Hansenula polymorpha DL-1.
rna-directed dna polymerase deficiency
The mTOR pathway is necessary for survival of mice with short telomeres.
rna-directed dna polymerase deficiency
The role of telomerase expression and telomere length maintenance in human and mouse.
rna-directed dna polymerase deficiency
Ulcerative Typhlocolitis Associated With Helicobacter mastomyrinus in Telomerase-Deficient Mice.
rna-directed dna polymerase deficiency
Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.
Sarcoidosis
Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer.
Sarcoma
A comparative evaluation of methods for isolation of RNA-directed DNA polymerase from cells in a reconstituted system.
Sarcoma
Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
Sarcoma
Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Sarcoma
Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy.
Sarcoma
Chromosomal disruption and rearrangements during murine sarcoma development converge to stable karyotypic formation kept by telomerase overexpression.
Sarcoma
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma.
Sarcoma
Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
Sarcoma
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.
Sarcoma
Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas.
Sarcoma
Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma.
Sarcoma
Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Sarcoma
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Sarcoma
Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
Sarcoma
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Sarcoma
Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Sarcoma
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Sarcoma
Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas.
Sarcoma
Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.
Sarcoma
Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations: A case report.
Sarcoma
Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
Sarcoma
High co-expression of PD-L1 and HIF-1? correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
Sarcoma
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Sarcoma
Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Sarcoma
Immunohistochemical detection of hTERT protein in soft tissue sarcomas: correlation with tumor grade.
Sarcoma
Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
Sarcoma
In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
Sarcoma
In vitro transcription of 70S RNA by the RNA-directed DNA polymerase of Rouse sarcoma virus: lack of influence of RNase H.
Sarcoma
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses.
Sarcoma
Mechanixm of Carcinogenesis By RNA Tumor Viruses, I. An RNA-Dependent DNA Polymerase In Murine Sarcoma Viruses.
Sarcoma
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Sarcoma
Murine sarcoma virus defectiveness. Viral polymerase expression in murine and nonmurine host cells transformed by S + L - type murine sarcoma virus.
Sarcoma
Mutation of TP53 gene is involved in carcinogenesis of hepatic undifferentiated (embryonal) sarcoma of the adult, in contrast with Wnt or telomerase pathways: an immunohistochemical study of three cases with genomic relation in two cases.
Sarcoma
On chip electrochemical detection of sarcoma protein kinase and HIV-1 reverse transcriptase.
Sarcoma
Quantitative measurement of telomerase activity and localization of its catalytic subunit (hTERT) in chronic inflammation of capsule formation around various model implants and in sarcomas in a rat model.
Sarcoma
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Sarcoma
Ribosomal frameshifting at the Gag-Pol junction in avian leukemia sarcoma virus forms a novel cleavage site.
Sarcoma
RNA-dependent DNA polymerase activity of RNA tumor viruses. V. Rous sarcoma virus single-stranded RNA-DNA covalent hybrids in infected chicken embryo fibroblast cells.
Sarcoma
Strandedness and complementarity of DNA from long-term RNA-dependent DNA polymerase reactions of Soehner-Dmochowski murine sarcoma virus.
Sarcoma
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.
Sarcoma
Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas.
Sarcoma
Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas.
Sarcoma
Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Sarcoma
Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
Sarcoma
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Sarcoma
Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Sarcoma
Telomerase activity is not altered by regular strenuous exercise in skeletal muscle or by sarcoma in liver of rats.
Sarcoma
Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.
Sarcoma
Telomerase activity with concurrent loss of cell cycle regulation in feline post-traumatic ocular sarcomas.
Sarcoma
Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Sarcoma
Template specificities of a RNA-directed DNA polymerase from a human homologous mixed mesodermal sarcoma.
Sarcoma
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Sarcoma
The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells.
Sarcoma
Utility of sarcoma-specific fusion gene analysis in paraffin-embedded material for routine diagnosis at a specialist centre.
Sarcoma
[Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
Sarcoma
[Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations].
Sarcoma, Avian
Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants.
Sarcoma, Avian
Detection of RNA-dependent DNA polymerase activity in the Xiphophorus melanoma system.
Sarcoma, Avian
Detection of RNA-instructed DNA polymerase in the mitochondria of Rous sarcoma cells using sephadex G-150 thin-layer gel filtration.
Sarcoma, Avian
DNA-processing activities associated with the purified alpha, beta 2, and alpha beta molecular forms of avian sarcoma virus RNA-dependent DNA polymerase.
Sarcoma, Avian
Effect of isonicotinic acid hydrazide-copper complex on Rous sarcoma virus and its genome RNA.
Sarcoma, Avian
Effect of p15-associated protease from an avian RNA tumor virus on avian virus-specific polyprotein precursors.
Sarcoma, Avian
Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.
Sarcoma, Avian
Elongation of DNA complementary to the 5' end of the avian sarcoma virus genome by the virion-associated RNA-dependent DNA polymerase.
Sarcoma, Avian
Endogenous DNA polymerase of a transformation-defective rous sarcoma virus: characterization and comparison with the enzyme of the non-defective parent.
Sarcoma, Avian
Extent of transcription by the RNA-dependent DNA polymerase of Rous sarcoma virus.
Sarcoma, Avian
Impaired cleavage of the joint gag-pol polyprotein precursor and virion assembly in a temperature-sensitive mutant of Rous sarcoma virus.
Sarcoma, Avian
In vitro transcription of 70S RNA by the RNA-directed DNA polymerase of Rouse sarcoma virus: lack of influence of RNase H.
Sarcoma, Avian
In vitro transcription of DNA from the 70S RNA of Rous sarcoma virus: identification and characterization of various size classes of DNA transcripts.
Sarcoma, Avian
Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations.
Sarcoma, Avian
Inhibition of the RNA dependent DNA polymerase and the malignant transforming ability of Rous sarcoma virus by thiosemicarbazone-transition metal complexes.
Sarcoma, Avian
Initiation of DNA synthesis by the avian oncornavirus RNA-directed DNA polymerase: tryptophan tRNA as the major species of primer RNA.
Sarcoma, Avian
Interaction between the negative regulator of splicing element and a 3' splice site: requirement for U1 small nuclear ribonucleoprotein and the 3' splice site branch point/pyrimidine tract.
Sarcoma, Avian
Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Sarcoma, Avian
N-Methyl isatin beta-thiosemicarbazone-copper complex inhibits RNA-dependent DNA polymerase but not ribonuclease H of Rous sarcoma virus.
Sarcoma, Avian
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.
Sarcoma, Avian
Nucleotide sequence that binds primer for DNA synthesis to the avian sarcoma virus genome.
Sarcoma, Avian
Presence of viral RNA-instructed DNA polymerase in the oncogenic subviral particles (virosomes) isolated from the mitochondria of rous sarcoma cells.
Sarcoma, Avian
Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.
Sarcoma, Avian
Regulation of Rous sarcoma virus RNA-dependent DNA polymerase isoenzymes by in vitro phosphorylation-dephosphorylation.
Sarcoma, Avian
Reverse transcriptase associated with avian sarcoma-leukosis viruses. I. Comparison of intra-virion content of multiple enzyme forms.
Sarcoma, Avian
Reverse transcriptase associated with avian sarcoma-leukosis viruses. II. Comparison of subunit structure and catalytic properties.
Sarcoma, Avian
Ribosomal frameshifting at the Gag-Pol junction in avian leukemia sarcoma virus forms a novel cleavage site.
Sarcoma, Avian
RNA-dependent DNA polymerase activity of RNA tumor viruses. V. Rous sarcoma virus single-stranded RNA-DNA covalent hybrids in infected chicken embryo fibroblast cells.
Sarcoma, Avian
RNA-dependent DNA polymerase of avian sarcoma virus B77. I. Isolation and partial characterization of the alpha, beta2, and alphabeta forms of the enzyme.
Sarcoma, Avian
RNA-dependent DNA polymerase of avian sarcoma virus B77. II. Comparison of the catalytic properties of the alpha, beta2, and alphabeta enzyme forms.
Sarcoma, Avian
RNA-directed DNA polymerase of Rous sarcoma virus: initiation of synthesis with 70 S viral RNA as template.
Sarcoma, Avian
RNA-directed DNA synthesis by the DNA polymerase of Rous sarcoma virus: structural and functional identification of 4S primer RNA in uninfected cells.
Sarcoma, Avian
Rous sarcoma virus RNA stability requires an open reading frame in the gag gene and sequences downstream of the gag-pol junction.
Sarcoma, Avian
Secondary structure and mutational analysis of the ribosomal frameshift signal of rous sarcoma virus.
Sarcoma, Avian
Sequence and comparative structural analysis of the murine leukaemia virus amphotropic strain 4070A RNase H domain.
Sarcoma, Avian
Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.
Sarcoma, Avian
Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses.
Sarcoma, Avian
The RNA-dependent DNA polymerase of avian sarcoma virus B77. Binding of viral and nonviral ribonucleic acids to the alpha, beta2, and alphabeta forms of the enzyme.
Sarcoma, Avian
Thermodynamic stability and statistical significance of potential stem-loop structures situated at the frameshift sites of retroviruses.
Sarcoma, Avian
Two avian sarcoma virus mutants with defects in the DNA polymerase-RNase H complex.
Sarcoma, Avian
Viral RNA-dependent DNA polymerase RNA-dependent DNA polymerase in virions of Rous sarcoma virus.
Sarcoma, Clear Cell
Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
Sarcoma, Clear Cell
Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
Sarcoma, Ewing
Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.
Sarcoma, Ewing
Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
Sarcoma, Ewing
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Sarcoma, Ewing
Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
Sarcoma, Ewing
Enhanced expression of PP1gamma1, a catalytic subunit isoform of protein phosphatase type1 and expression of telomerase activity in Ewing's sarcoma cells.
Sarcoma, Ewing
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Sarcoma, Ewing
hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Sarcoma, Ewing
Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor.
Sarcoma, Ewing
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Sarcoma, Ewing
Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Sarcoma, Kaposi
Spindle cells from Acquired Immune Deficiency Syndrome (AIDS)-associated Kaposi's sarcoma (KS) lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor (FGF)-2.
Sarcoma, Kaposi
Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Sarcoma, Kaposi
Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.
Sarcoma, Kaposi
Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia.
Sarcoma, Myeloid
RNA-dependent DNA polymerase activity in ocular granulocytic sarcoma associated to acute myelomonocytic leukemia in Turkish children. Biochemical and immunological characterization of the enzyme.
Sarcoma, Synovial
Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.
Sarcoma, Synovial
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Sarcoma, Synovial
Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma.
Sarcoma, Synovial
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Sarcopenia
Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision.
Schistosomiasis
Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
Schistosomiasis
Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
Scleroderma, Systemic
Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis.
Scleroderma, Systemic
The polymorphism of telomerase RNA component gene in patients with systemic sclerosis.
Seminoma
Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
Seminoma
Expression of a telomerase-associated gene in normal, atrophic, and tumorous testes.
Seminoma
Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors.
Sepsis
Study on the functions and mechanism of immune functions of human telomerase reverse transcriptase regulating dendritic cells treating sepsis.
Sertoli Cell-Only Syndrome
Highly sensitive quantitative telomerase assay of diagnostic testicular biopsy material predicts the presence of haploid spermatogenic cells in therapeutic testicular biopsy in men with Sertoli cell-only syndrome.
Sertoli Cell-Only Syndrome
Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients.
Sertoli-Leydig Cell Tumor
[Immunohistochemical study on telomerase activity in ovarian sex-cord stromal tumors]
Severe Acute Respiratory Syndrome
Accuracy of Emergency Department Clinical Findings for Diagnosis of Coronavirus Disease 2019.
Severe Acute Respiratory Syndrome
Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak.
Severe Acute Respiratory Syndrome
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Severe Acute Respiratory Syndrome
Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population.
Severe Acute Respiratory Syndrome
Experience of an Orthopaedic Surgery Department Early During the COVID-19 Outbreak in Japan Including Real-Time Polymerase Chain Reaction Assay Results for SARS-CoV-2.
Severe Acute Respiratory Syndrome
Experience With Pretravel Testing for SARS-CoV-2 at an Academic Medical Center.
Severe Acute Respiratory Syndrome
False-Negative Nasopharyngeal Swab RT-PCR Assays in Typical COVID-19: Role of Ultra-low-dose Chest CT and Bronchoscopy in Diagnosis.
Severe Acute Respiratory Syndrome
False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases.
Severe Acute Respiratory Syndrome
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
Severe Acute Respiratory Syndrome
Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
Severe Acute Respiratory Syndrome
Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan.
Sex Cord-Gonadal Stromal Tumors
Telomerase activity in sex cord-stromal tumors of the ovary.
Shwachman-Diamond Syndrome
Shwachman-Diamond Syndrome Protein SBDS Maintains Human Telomeres by Regulating Telomerase Recruitment.
Silicosis
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis.
Sinusitis
Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model.
Skin Diseases
Detection of telomerase activity in psoriasis lesional skin and correlation with Ki-67 expression and suppression by retinoic acid.
Skin Neoplasms
Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression.
Skin Neoplasms
Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.
Skin Neoplasms
Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Skin Neoplasms
Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits.
Skin Neoplasms
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Skin Neoplasms
The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Skin Neoplasms
The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
Skin Ulcer
Expression of telomerase reverse transcriptase in radiation-induced chronic human skin ulcer.
Sleep Apnea, Obstructive
Coexistence of obstructive sleep apnea and telomerase activity, concentration of selected adipose tissue hormones and vascular endothelial function in patients with arterial hypertension.
Small Cell Lung Carcinoma
Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Small Cell Lung Carcinoma
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Small Cell Lung Carcinoma
Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Small Cell Lung Carcinoma
Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype (MS-0060).
Small Cell Lung Carcinoma
[Study on telomerase activity and its clinical value in human non small cell lung cancer]
Smoldering Multiple Myeloma
Expression Profile of Telomere-associated Genes in Multiple Myeloma.
Smooth Muscle Tumor
Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Solitary Fibrous Tumors
Expression profile of telomerase subunits in human pleural mesothelioma.
Solitary Fibrous Tumors
Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation.
Solitary Fibrous Tumors
Telomerase activity, Ki-67, cyclin D1 and A expression, and apoptosis in solitary fibrous tumors: additional features of a predictable course?
Solitary Fibrous Tumors
Telomerase promoter mutations and copy number alterations in solitary fibrous tumours.
Solitary Pulmonary Nodule
The value of chest CT scan and tumor markers detection in sputum for early diagnosis of peripheral lung cancer.
Somatostatinoma
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma.
Spinal Cord Injuries
Role of telomerase reverse transcriptase in glial scar formation after spinal cord injury in rats.
Spinal Cord Injuries
Telomerase expression in the glial scar of rats with spinal cord injury.
Spinal Cord Injuries
Transplantation of human telomerase reverse transcriptase gene-transfected Schwann cells for repairing spinal cord injury.
Spinal Cord Injuries
[Experimental study of the correlation of telomerase and intramedullary scar after spinal cord injury in rats].
Spinal Stenosis
SIRT6 enhances telomerase activity to protect against DNA damage and senescence in hypertrophic ligamentum flavum cells from lumbar spinal stenosis patients.
Squamous Cell Carcinoma of Head and Neck
67-kDa laminin receptor in human laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression.
Squamous Cell Carcinoma of Head and Neck
ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis.
Squamous Cell Carcinoma of Head and Neck
Association between clincopathological characteristics and hTERT expression as well as telomere length in ameloblastoma.
Squamous Cell Carcinoma of Head and Neck
Azacitidine, as a DNMT inhibitor decreases hTERT gene expression and telomerase activity more effective compared with HDAC inhibitor in human Head and neck squamous cell carcinoma cell lines.
Squamous Cell Carcinoma of Head and Neck
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.
Squamous Cell Carcinoma of Head and Neck
Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: a pilot study.
Squamous Cell Carcinoma of Head and Neck
Change of the Expression of Human Telomerase Reverse Transcriptase mRNA and Human Telomerase RNA after Cisplatin and 5-Fluorouracil Exposure in Head and Neck Squamous Cell Carcinoma Cell Lines.
Squamous Cell Carcinoma of Head and Neck
Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Squamous Cell Carcinoma of Head and Neck
Correlation of dyskerin expression with active proliferation independent of telomerase.
Squamous Cell Carcinoma of Head and Neck
Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.
Squamous Cell Carcinoma of Head and Neck
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Detection of telomerase activity in saliva from oral squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
Squamous Cell Carcinoma of Head and Neck
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Squamous Cell Carcinoma of Head and Neck
Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Squamous Cell Carcinoma of Head and Neck
Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Squamous Cell Carcinoma of Head and Neck
Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Squamous Cell Carcinoma of Head and Neck
Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.
Squamous Cell Carcinoma of Head and Neck
Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Squamous Cell Carcinoma of Head and Neck
Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour.
Squamous Cell Carcinoma of Head and Neck
Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.
Squamous Cell Carcinoma of Head and Neck
Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis.
Squamous Cell Carcinoma of Head and Neck
Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Quantitative assay of telomerase activity in head and neck squamous cell carcinoma and other tissues.
Squamous Cell Carcinoma of Head and Neck
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Squamous Cell Carcinoma of Head and Neck
Regulation of Epithelial Cell Proliferation, Differentiation, and Plasticity by Grainyhead-Like 2 During Oral Carcinogenesis.
Squamous Cell Carcinoma of Head and Neck
Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.
Squamous Cell Carcinoma of Head and Neck
Short hairpin ribonucleic acid targeting the telomerase catalytic unit of messenger ribonucleic acid significantly limits the growth of laryngeal squamous cell carcinoma in nude mice.
Squamous Cell Carcinoma of Head and Neck
Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Squamous Cell Carcinoma of Head and Neck
Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in oral and maxillofacial tumors.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase activity is upregulated in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Squamous Cell Carcinoma of Head and Neck
Telomerase in saliva: An assistant marker for oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection.
Squamous Cell Carcinoma of Head and Neck
Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor?related apoptosis?inducing ligand?induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.
Squamous Cell Carcinoma of Head and Neck
Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.
Squamous Cell Carcinoma of Head and Neck
Telomerase: An exploration toward the end of cancer.
Squamous Cell Carcinoma of Head and Neck
Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Squamous Cell Carcinoma of Head and Neck
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients.
Squamous Cell Carcinoma of Head and Neck
TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.
Squamous Cell Carcinoma of Head and Neck
The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC.
Squamous Cell Carcinoma of Head and Neck
The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT.
Squamous Cell Carcinoma of Head and Neck
YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability.
Squamous Cell Carcinoma of Head and Neck
[Expression of telomerase genes hTRTmRNA in oral squamous cell carcinomas.]
Squamous Cell Carcinoma of Head and Neck
[Expression of telomerase reverse transcriptase and its relationship with expression of c-myc in laryngeal squamous cell carcinomas]
Squamous Cell Carcinoma of Head and Neck
[Genic alterations in oral and head and neck squamous cell carcinomas: analysis of international literature]
Squamous Cell Carcinoma of Head and Neck
[hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice]
Squamous Cell Carcinoma of Head and Neck
[Inhibitory Effect of Silencing hTERT Gene by Short Hairpin RNA on Growth of Human Laryngeal Squamous Cell Carcinoma Xenograft in Nude Mice.]
Squamous Cell Carcinoma of Head and Neck
[Quantitative assay of telomerase activity in head and neck squamous cell carcinoma]
Squamous Cell Carcinoma of Head and Neck
[Research on expression of human papillomavirus type 16 and telomerase in oral lesions]
Squamous Cell Carcinoma of Head and Neck
[Study and detection of telomerase activity in oral squamous cell carcinomas and precancerous lesions]
Squamous Cell Carcinoma of Head and Neck
[Targeted therapy of human laryngeal squamous cell carcinoma in vitro with telomerase catalytic subunit mRNA]
Squamous Cell Carcinoma of Head and Neck
[Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues]
Squamous Cell Carcinoma of Head and Neck
[Telomerase activity in oral squamous cell carcinoma and leukoplakia]
Squamous Cell Carcinoma of Head and Neck
[Telomerase SiRNA inhibits KB cell growth in human oral squamous cell carcinoma.]
Squamous Cell Carcinoma of Head and Neck
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Starvation
Glutamine starvation of murine leukaemia virus-infected cells inhibits the readthrough of the gag-pol genes and proteolytic processing of the gag polyprotein.
Starvation
Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells.
Starvation
Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle.
Starvation
The rice transcription factor IDEF1 is essential for the early response to iron deficiency, and induces vegetative expression of late embryogenesis abundant genes.
Stevens-Johnson Syndrome
Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.
Stillbirth
Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.
Stomach Diseases
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Stomach Diseases
[Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]
Stomach Neoplasms
A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
Stomach Neoplasms
A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
Stomach Neoplasms
Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.
Stomach Neoplasms
Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression.
Stomach Neoplasms
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.
Stomach Neoplasms
AKT Activation and Telomerase Reverse Transcriptase Expression are Concurrently Associated with Prognosis of Gastric Cancer.
Stomach Neoplasms
Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions.
Stomach Neoplasms
An anti-apoptosis gene, survivin and telomerase expression in gastric cancer.
Stomach Neoplasms
Antiproliferative effect of octreotide on gastric cancer cells mediated by inhibition of Akt/PKB and telomerase.
Stomach Neoplasms
Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E2 synthesis in AGS human gastric cancer cells.
Stomach Neoplasms
Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Stomach Neoplasms
Calcium-sensing receptor bridges calcium and telomerase reverse transcriptase in gastric cancers via Akt.
Stomach Neoplasms
Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer.
Stomach Neoplasms
Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer.
Stomach Neoplasms
Clinical significance of telomerase activity in biopsy specimens of gastric cancer.
Stomach Neoplasms
Clinical significance of telomerase activity in gastric carcinoma and peritoneal dissemination.
Stomach Neoplasms
Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Stomach Neoplasms
Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
Stomach Neoplasms
Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Stomach Neoplasms
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Stomach Neoplasms
Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer.
Stomach Neoplasms
Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
Stomach Neoplasms
Cyclooxygenase-2 inhibitor nimesulide suppresses telomerase activity by blocking Akt/PKB activation in gastric cancer cell line.
Stomach Neoplasms
Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Stomach Neoplasms
Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
Stomach Neoplasms
Detection of telomerase activity in gastric lavage fluid: a novel method to detect gastric cancer.
Stomach Neoplasms
Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads.
Stomach Neoplasms
Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers.
Stomach Neoplasms
DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Stomach Neoplasms
Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines.
Stomach Neoplasms
Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.
Stomach Neoplasms
Effects of genomic imbalances on telomerase activity in gastric cancer: clues to telomerase regulation.
Stomach Neoplasms
Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.
Stomach Neoplasms
Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions.
Stomach Neoplasms
Expression of human telomerase RNA is an early event of stomach carcinogenesis.
Stomach Neoplasms
Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions.
Stomach Neoplasms
Expression of Tankyrase 1 in Gastric Cancer and Its Correlation with Telomerase Activity.
Stomach Neoplasms
Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.
Stomach Neoplasms
Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.
Stomach Neoplasms
Expression of telomerase-associated genes: reflection of telomerase activity in gastric cancer?
Stomach Neoplasms
Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Stomach Neoplasms
Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
Stomach Neoplasms
Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Stomach Neoplasms
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
Stomach Neoplasms
Frequent loss of heterozygosity on chromosome 10p15, a putative telomerase repressor/senescence gene locus, in gastric cancer.
Stomach Neoplasms
G-quadruplex antibody attenuates human gastric cancer cell proliferation and promotes apoptosis through hTERT/telomerase pathway.
Stomach Neoplasms
Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.
Stomach Neoplasms
Gastric cancer with high telomerase activity shows rapid development and invasiveness.
Stomach Neoplasms
Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer.
Stomach Neoplasms
Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
Stomach Neoplasms
H. pylori induces a novel NF-?B/Lin28A/let-7a/hTERT axis to promote gastric carcinogenesis.
Stomach Neoplasms
Helicobacter pylori and telomerase activity in intestinal metaplasia of the stomach.
Stomach Neoplasms
Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.
Stomach Neoplasms
Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues.
Stomach Neoplasms
Histone Acetylation and Retinoic Acid Receptor beta DNA Methylation as Novel Targets for Gastric Cancer Therapy.
Stomach Neoplasms
Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression.
Stomach Neoplasms
Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.
Stomach Neoplasms
Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest.
Stomach Neoplasms
Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
Stomach Neoplasms
Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtype.
Stomach Neoplasms
Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer.
Stomach Neoplasms
Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population.
Stomach Neoplasms
Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma.
Stomach Neoplasms
miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
Stomach Neoplasms
miR-199a Regulates the Tumor Suppressor Mitogen-Activated Protein Kinase Kinase Kinase 11 in Gastric Cancer.
Stomach Neoplasms
Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Stomach Neoplasms
Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection.
Stomach Neoplasms
mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study.
Stomach Neoplasms
Normal and Tumour Tissue mRNA Expressions of Telomerase Complex Genes in Several Types of Cancer.
Stomach Neoplasms
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer.
Stomach Neoplasms
Overexpression of human telomerase RNA in Helicobacter pylori-infected human gastric mucosa.
Stomach Neoplasms
PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.
Stomach Neoplasms
Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Stomach Neoplasms
Polymorphisms in human telomerase reverse transcriptase (hTERT) gene, gene- gene and gene-smoking interaction with susceptibility to gastric cancer in Chinese Han population.
Stomach Neoplasms
Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients: a prospective study.
Stomach Neoplasms
Prognostic Role of Estrogen Receptor alpha and Estrogen Receptor beta in Gastric Cancer.
Stomach Neoplasms
Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
Stomach Neoplasms
Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer.
Stomach Neoplasms
Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Stomach Neoplasms
Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance.
Stomach Neoplasms
Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer.
Stomach Neoplasms
RESISTIN EFFECT ON TELOMERASE GENE EXPRESSION IN GASTRIC CANCER CELL LINE AGS.
Stomach Neoplasms
Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line.
Stomach Neoplasms
Telomerase activity and its clinicopathological significance in gastric cancer.
Stomach Neoplasms
Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.
Stomach Neoplasms
Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Stomach Neoplasms
Telomerase Activity in Gastric Adenocarcinomas: Frozen Tissues Versus Methacarn-fixed Paraffin-embedded Tissues.
Stomach Neoplasms
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Stomach Neoplasms
Telomerase and hTERT: can they serve as markers for gastric cancer diagnosis?
Stomach Neoplasms
Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.
Stomach Neoplasms
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer.
Stomach Neoplasms
The hypoxia/IL1A axis promotes gastric cancer progression and drug resistance.
Stomach Neoplasms
Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".
Stomach Neoplasms
Visfatin effects on telomerase gene expression in AGS gastric cancer cell line.
Stomach Neoplasms
[Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]
Stomach Neoplasms
[Detection of telomerase activity in gastric cancer and adjacent tissues]
Stomach Neoplasms
[Effect of exopolysaccharide from Bifidobacterium bifidum on cell of gastric cancer and human telomerase reverse transcriptase]
Stomach Neoplasms
[Effects of antisense human telomerase RNA on growth of human gastric cancer cells]
Stomach Neoplasms
[Expression of telomere and telomerase in human primary gastric carcinoma]
Stomach Neoplasms
[Measurement of telomerase activity and telomerase reverse transcriptase expression in gastric fluid and tissue for early diagnosis of stomach cancer]
Stomach Neoplasms
[miR-29b Reduces Cisplatin Resistance of Gastric Cancer Cell by Targeting PI3K/Akt Pathway].
Stomach Neoplasms
[Nimesulide, a selective cyclooxygenase-2 inhibitor inhibits telomerase activity by blocking activation of PKB in gastric cancer cell line]
Stomach Neoplasms
[Preoperative diagnostic laparoscopy with local anesthesia and lavage telomerase activity for advanced gastric cancer]
Stomach Neoplasms
[Relationship between telomerase activity and clinicopathological findings in gastric cancer]
Stomach Neoplasms
[Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance]
Stomach Neoplasms
[Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach]
Stomatitis
Increased in vitro glial fibrillary acidic protein expression, telomerase activity, and telomere length after productive human immunodeficiency virus-1 infection in murine astrocytes.
Stroke
Cerebellar fastigial nucleus electrical stimulatin protects against cerebral ischemic damage by upregulating telomerase activity.
Stroke
Deficiency of telomerase activity aggravates the blood-brain barrier disruption and neuroinflammatory responses in a model of experimental stroke.
Stroke
TELOMERE LENGTH, TELOMERASE ACTIVITY, HEART RATE VARIABILITY, OR OXIDATIVE STRESS: WHICH ONE IS MOST ASSOCIATED WITH THE ATHEROTHROMBOTIC STROKE IN THE ELDERLY?
Synovitis
Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation.
Synovitis, Pigmented Villonodular
Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation.
Tauopathies
LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer's Disease Cell Culture Models.
Telangiectasis
ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase.
Telangiectasis
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems.
Teratocarcinoma
Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.
Teratocarcinoma
Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays.
Teratocarcinoma
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Teratoma
Amniotic Fluid Cells Are More Efficiently Reprogrammed to Pluripotency Than Adult Cells.
Teratoma
Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
Teratoma
Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research.
Teratoma
Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
Teratoma
Efficient method for slow cryopreservation of human embryonic stem cells in xeno-free conditions.
Teratoma
Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Teratoma
Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.
Teratoma
Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1alpha promoter system.
Teratoma
Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors.
Teratoma
Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine.
Teratoma
Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Teratoma
Human neural crest-derived postnatal cells exhibit remarkable embryonic attributes either in vitro or in vivo.
Teratoma
Multipotential differentiation of human urine-derived stem cells: Potential for therapeutic applications in urology.
Teratoma
Muse Cells: Nontumorigenic Pluripotent Stem Cells Present in Adult Tissues-A Paradigm Shift in Tissue Regeneration and Evolution.
Teratoma
Parthenogenetic Embryo-Like Structures in the Human Ovarian Surface Epithelium Cell Culture in Postmenopausal Women with No Naturally Present Follicles and Oocytes.
Teratoma
Porcine induced pluripotent stem cells analogous to naïve and primed embryonic stem cells of the mouse.
Teratoma
The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
Testicular Neoplasms
Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
Testicular Neoplasms
Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Testicular Neoplasms
Inhibition of telomerase activity by cisplatin in human testicular cancer cells.
Tetanus
Differential regulation of human, antigen-specific Th1 and Th2 responses by the B-7 homologues, CD80 and CD86.
Thanatophoric Dysplasia
Telomere length, telomerase activity, and expression of human telomerase reverse transcriptase mRNA in growth plate of epiphyseal articular cartilage in femoral head during normal human development and in thanatophoric dysplasia.
Thrombocythemia, Essential
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Thrombocythemia, Essential
Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis.
Thrombocythemia, Essential
High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia.
Thrombocythemia, Essential
Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.
Thrombocythemia, Essential
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
Thrombocythemia, Essential
The expression levels of telomerase catalytic subunit hTERT and oncogenic MYC in essential thrombocythemia are affected by the molecular subtype.
Thrombocytosis
Analysis of platelets from patients with thrombocythemia for reverse transcriptase and virus-like particles.
Thrombocytosis
Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis.
Thromboinflammation
Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.
Thrombosis
Serologic survey for hantavirus infection in domestic animals and coyotes from New Mexico and northeastern Arizona.
Thrombosis
Silymarin Inhibits Endothelial Progenitor Cells Senescence and Protects Against the Antiproliferative Activity of Rapamycin. Preliminary Study.
Thymoma
Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study.
Thymoma
Telomerase activity in thymomas and mammary gland adenocarcinomas induced by polyoma virus in AKR mice.
Thymoma
[Expression of telomerase activity in thymoma and thymiccarcinoma tissues; a clinicopathological study]
Thyroid Cancer, Papillary
Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
Thyroid Cancer, Papillary
BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
Thyroid Cancer, Papillary
BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
Thyroid Cancer, Papillary
Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.
Thyroid Cancer, Papillary
Co-Occurrence of Hotspot Point Mutation and Novel Deletion Mutation of TERT Promoter in Solid Variant Papillary Thyroid Carcinoma in a Patient with Synchronous Esophageal Cancer.
Thyroid Cancer, Papillary
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Thyroid Cancer, Papillary
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.
Thyroid Cancer, Papillary
Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
Thyroid Cancer, Papillary
In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer.
Thyroid Cancer, Papillary
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres.
Thyroid Cancer, Papillary
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Thyroid Cancer, Papillary
Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Thyroid Cancer, Papillary
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer.
Thyroid Cancer, Papillary
Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules.
Thyroid Cancer, Papillary
Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.
Thyroid Cancer, Papillary
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Thyroid Cancer, Papillary
Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter.
Thyroid Cancer, Papillary
Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Thyroid Cancer, Papillary
Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Thyroid Cancer, Papillary
Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.
Thyroid Cancer, Papillary
TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Thyroid Cancer, Papillary
TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
The clinical significance of PINX1 expression in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Thyroid Cancer, Papillary
Topoisomerase II alpha and telomerase expression in papillary thyroid carcinomas.
Thyroid Cancer, Papillary
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Thyroid Cancer, Papillary
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer.
Thyroid Cancer, Papillary
Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations.
Thyroid Carcinoma, Anaplastic
Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Thyroid Carcinoma, Anaplastic
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Thyroid Carcinoma, Anaplastic
Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Thyroid Carcinoma, Anaplastic
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.
Thyroid Carcinoma, Anaplastic
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Thyroid Carcinoma, Anaplastic
The effects of thymoquinone and genistein treatment on telomerase activity, apoptosis, angiogenesis, and survival in thyroid cancer cell lines.
Thyroid Diseases
In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Thyroid Diseases
Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Thyroid Diseases
[Puncture hystobiopsy with tissue telomerase activity measurement in preoperative thyroid nodes diagnostics]
Thyroid Dysgenesis
Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Thyroid Neoplasms
A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
Thyroid Neoplasms
Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.
Thyroid Neoplasms
Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.
Thyroid Neoplasms
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.
Thyroid Neoplasms
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.
Thyroid Neoplasms
Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
Thyroid Neoplasms
BRAF and TERT promoter mutations: clinical application in thyroid cancer.
Thyroid Neoplasms
Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
Thyroid Neoplasms
Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Thyroid Neoplasms
Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Thyroid Neoplasms
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Thyroid Neoplasms
Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study.
Thyroid Neoplasms
Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Thyroid Neoplasms
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Thyroid Neoplasms
Decrease of telomere length in thyroid adenomas without telomerase activity.
Thyroid Neoplasms
Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Thyroid Neoplasms
Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.
Thyroid Neoplasms
Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Thyroid Neoplasms
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Thyroid Neoplasms
Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells.
Thyroid Neoplasms
Effects of Coexistent BRAF(V600E) and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Thyroid Neoplasms
Establishment and characterization of OCUT-1, an undifferentiated thyroid cancer cell line expressing high level of telomerase.
Thyroid Neoplasms
Expression of human telomerase reverse transcriptase (hTERT) in thyroid neoplasms.
Thyroid Neoplasms
Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Thyroid Neoplasms
hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Thyroid Neoplasms
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Thyroid Neoplasms
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
Thyroid Neoplasms
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Thyroid Neoplasms
Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Thyroid Neoplasms
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.
Thyroid Neoplasms
LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer.
Thyroid Neoplasms
Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma.
Thyroid Neoplasms
Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma.
Thyroid Neoplasms
miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase.
Thyroid Neoplasms
Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers.
Thyroid Neoplasms
New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement.
Thyroid Neoplasms
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Thyroid Neoplasms
Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Thyroid Neoplasms
Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations.
Thyroid Neoplasms
Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential: Advantages of the Digital Droplet PCR Technique.
Thyroid Neoplasms
Telomerase activity and telomere length in benign and malignant human thyroid tissues.
Thyroid Neoplasms
Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
Thyroid Neoplasms
Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Thyroid Neoplasms
Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Thyroid Neoplasms
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid.
Thyroid Neoplasms
Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
Thyroid Neoplasms
Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Thyroid Neoplasms
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
Thyroid Neoplasms
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Thyroid Neoplasms
Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
Thyroid Neoplasms
Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
Thyroid Neoplasms
Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review.
Thyroid Neoplasms
Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
Thyroid Neoplasms
TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.
Thyroid Neoplasms
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Thyroid Neoplasms
TERT promoter mutation predicts radioiodine refractory in distant metastatic differentiated thyroid cancer.
Thyroid Neoplasms
TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer.
Thyroid Neoplasms
TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
Thyroid Neoplasms
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Thyroid Neoplasms
TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Thyroid Neoplasms
The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Thyroid Neoplasms
The effects of thymoquinone and genistein treatment on telomerase activity, apoptosis, angiogenesis, and survival in thyroid cancer cell lines.
Thyroid Neoplasms
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.
Thyroid Neoplasms
The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer.
Thyroid Neoplasms
Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Thyroid Neoplasms
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Thyroid Neoplasms
Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
Thyroid Neoplasms
[Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations].
Thyroid Nodule
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Thyroid Nodule
Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
Thyroid Nodule
Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules.
Thyroid Nodule
Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma.
Thyroiditis
Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Thyroiditis, Autoimmune
Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Tics
Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.
Tongue Neoplasms
Effects of tea polyphenols on telomerase activity of a tongue cancer cell line: a preliminary study.
Tongue Neoplasms
[Construction of antisense human tankyrase-1 RNA retroviral vector and its inhibition on tongue cancer cells]
Tongue Neoplasms
[Effects of arsenic trioxideon the cell apoptosis and hTERT mRNA of human tongue cancer cells]
Tongue Neoplasms
[The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer]
Toxoplasmosis
Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii.
Triple Negative Breast Neoplasms
Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent ?-H2AX and telomerase regulation in triple-negative breast cancer.
Triple Negative Breast Neoplasms
Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532.
Trophoblastic Neoplasms
Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors.
Trophoblastic Neoplasms
Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor.
Tuberculosis
Antimycobacterial and HIV-1 Reverse Transcriptase Activity of Julianaceae and Clusiaceae Plant Species from Mexico.
Tuberculosis
Can an optimization/scoring procedure in ligand-protein docking be employed to probe drug-resistant mutations in proteins?
Tuberculosis
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.
Tuberculosis
Differential expression of PE and PE_PGRS genes in Mycobacterium tuberculosis strains.
Tuberculosis
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Tuberculosis
Dysregulation of serine biosynthesis contributes to the growth defect of a Mycobacterium tuberculosis crp mutant.
Tuberculosis
Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.
Tuberculosis
HIGH FREQUENCY GENETIC TRANSFORMATION OF CICHORIUM INTYBUS L. USING nptII GENE AS A SELECTIVE MARKER.
Tuberculosis
Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy-Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India.
Tuberculosis
Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives.
Tuberculosis
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Tuberculosis
Risk assessment of Soulatrolide and Mammea (A/BA+A/BB) coumarins from Calophyllum brasiliense by a toxicogenomic and toxicological approach.
Tuberculosis
Risk factors for tuberculosis after highly active antiretroviral treatment (HAART) initiation among HIV patients: A systematic review.
Tuberculosis
Toxicogenomic analysis of pharmacological active coumarins isolated from Calophyllum brasiliense.
Tuberculosis
[A study on the telomerase activity in lung cancer and its clinical significance.]
Tuberculosis, Pulmonary
Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid.
Tuberculosis, Pulmonary
Tuberculin purified protein derivative up-regulates the telomerase activity of peripheral blood mononuclear cells from patients with pulmonary tuberculosis.
Urethral Stricture
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Urinary Bladder Calculi
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Urinary Bladder Diseases
Diagnosis of bladder cancer using telomerase activity in voided urine.
Urinary Bladder Neoplasms
A highly sensitive and facile graphene oxide-based nucleic acid probe: Label-free detection of telomerase activity in cancer patient's urine using AIEgens.
Urinary Bladder Neoplasms
A Highly Sensitive Catalytic Hairpin Assembly-Based Dynamic Light-Scattering Biosensors for Telomerase Detection in Bladder Cancer Diagnosis.
Urinary Bladder Neoplasms
A portable dual-mode sensor based on a TiO2 nanotube membrane for the evaluation of telomerase activity.
Urinary Bladder Neoplasms
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Urinary Bladder Neoplasms
A study comparing various noninvasive methods of detecting bladder cancer in urine.
Urinary Bladder Neoplasms
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients.
Urinary Bladder Neoplasms
Accurate urine telomerase test for detecting bladder cancer.
Urinary Bladder Neoplasms
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
Urinary Bladder Neoplasms
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Urinary Bladder Neoplasms
Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.
Urinary Bladder Neoplasms
Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.
Urinary Bladder Neoplasms
Bayesian bivariate meta-analysis of diagnostic test studies with interpretable priors.
Urinary Bladder Neoplasms
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatment.
Urinary Bladder Neoplasms
Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
Urinary Bladder Neoplasms
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Urinary Bladder Neoplasms
Comparative Study of NMP-22, Telomerase, and BTA in the Detection of Bladder Cancer.
Urinary Bladder Neoplasms
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Urinary Bladder Neoplasms
Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Urinary Bladder Neoplasms
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
Urinary Bladder Neoplasms
Comparison of screening methods in the detection of bladder cancer.
Urinary Bladder Neoplasms
Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Urinary Bladder Neoplasms
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Urinary Bladder Neoplasms
Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
Urinary Bladder Neoplasms
Construction of AIEgens-Based Bioprobe with Two Fluorescent Signals for Enhanced Monitor of Extracellular and Intracellular Telomerase Activity.
Urinary Bladder Neoplasms
Current bladder tumor tests: does their projected utility fulfill clinical necessity?
Urinary Bladder Neoplasms
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Urinary Bladder Neoplasms
Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Urinary Bladder Neoplasms
Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Urinary Bladder Neoplasms
Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Urinary Bladder Neoplasms
Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling.
Urinary Bladder Neoplasms
Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
Urinary Bladder Neoplasms
Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
Urinary Bladder Neoplasms
Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method.
Urinary Bladder Neoplasms
Diagnosis of bladder cancer using telomerase activity in voided urine.
Urinary Bladder Neoplasms
Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.
Urinary Bladder Neoplasms
Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation.
Urinary Bladder Neoplasms
Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors.
Urinary Bladder Neoplasms
Editorial Comment from Dr Kurobe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Urinary Bladder Neoplasms
Editorial Comment from Dr Urabe to Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Urinary Bladder Neoplasms
Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Urinary Bladder Neoplasms
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Urinary Bladder Neoplasms
Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
Urinary Bladder Neoplasms
Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Urinary Bladder Neoplasms
Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Urinary Bladder Neoplasms
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Urinary Bladder Neoplasms
Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Urinary Bladder Neoplasms
Facile Probe Design: Fluorescent Amphiphilic Nucleic Acid Probes without Quencher Providing Telomerase Activity Imaging Inside Living Cells.
Urinary Bladder Neoplasms
Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
Urinary Bladder Neoplasms
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Urinary Bladder Neoplasms
Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
Urinary Bladder Neoplasms
Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.
Urinary Bladder Neoplasms
Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Urinary Bladder Neoplasms
Label-free, PCR-free chip-based detection of telomerase activity in bladder cancer cells.
Urinary Bladder Neoplasms
Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Urinary Bladder Neoplasms
Meta-analysis for diagnostic accuracy studies: a new statistical model using beta-binomial distributions and bivariate copulas.
Urinary Bladder Neoplasms
Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients.
Urinary Bladder Neoplasms
Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.
Urinary Bladder Neoplasms
Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Urinary Bladder Neoplasms
Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer.
Urinary Bladder Neoplasms
Molecular markers and bladder carcinoma: Schistosomal and non-schistosomal.
Urinary Bladder Neoplasms
Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis.
Urinary Bladder Neoplasms
New diagnostic strategies in the detection and staging of bladder cancer.
Urinary Bladder Neoplasms
Non-invasive diagnosis of bladder cancer by detecting telomerase activity in human urine using hybridization chain reaction and dynamic light scattering.
Urinary Bladder Neoplasms
Non-invasive diagnostic tests for bladder cancer: a review of the literature.
Urinary Bladder Neoplasms
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Urinary Bladder Neoplasms
Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
Urinary Bladder Neoplasms
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy.
Urinary Bladder Neoplasms
Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients.
Urinary Bladder Neoplasms
Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Urinary Bladder Neoplasms
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Urinary Bladder Neoplasms
Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
Urinary Bladder Neoplasms
Quantitative measurement of telomerase reverse transcriptase mRNA and chromosomal analysis of urine by M-FISH in the diagnosis and follow-up of bladder cancer.
Urinary Bladder Neoplasms
Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360-6: Telomerase Expression and Stem Cells: Urologic Epithelial Perspective.
Urinary Bladder Neoplasms
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Urinary Bladder Neoplasms
Real-Time, Quantitative Lighting-up Detection of Telomerase in Urines of Bladder Cancer Patients by AIEgens.
Urinary Bladder Neoplasms
Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Urinary Bladder Neoplasms
Relevance of urine telomerase in the diagnosis of bladder cancer.
Urinary Bladder Neoplasms
Rs401681 polymorphism in TERT-CLPTM1L was associated with bladder cancer risk: A meta-analysis.
Urinary Bladder Neoplasms
Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray.
Urinary Bladder Neoplasms
Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Urinary Bladder Neoplasms
Sensitive and bidirectional detection of urine telomerase based on the four detection-color states of difunctional gold nanoparticle probe.
Urinary Bladder Neoplasms
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Urinary Bladder Neoplasms
shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Urinary Bladder Neoplasms
Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.
Urinary Bladder Neoplasms
Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection.
Urinary Bladder Neoplasms
Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells.
Urinary Bladder Neoplasms
Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
Urinary Bladder Neoplasms
Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
Urinary Bladder Neoplasms
Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
Urinary Bladder Neoplasms
Target-Driven Nanozyme Growth in TiO2 Nanochannels for Improving Selectivity in Electrochemical Biosensing.
Urinary Bladder Neoplasms
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer.
Urinary Bladder Neoplasms
Telomerase activity as a potential marker in preneoplastic bladder lesions.
Urinary Bladder Neoplasms
Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.
Urinary Bladder Neoplasms
Telomerase activity in bilharzial bladder cancer. Prognostic implications.
Urinary Bladder Neoplasms
Telomerase activity in bladder cancer, bladder washings and in urine.
Urinary Bladder Neoplasms
Telomerase activity in human bladder tumors and bladder washing specimens.
Urinary Bladder Neoplasms
Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
Urinary Bladder Neoplasms
Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer.
Urinary Bladder Neoplasms
Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.
Urinary Bladder Neoplasms
Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
Urinary Bladder Neoplasms
Telomerase activity Simplification of assay and detection in bladder tumor and urinary exfoliated cells.
Urinary Bladder Neoplasms
Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.
Urinary Bladder Neoplasms
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Urinary Bladder Neoplasms
Telomerase and other novel approaches to bladder cancer detection.
Urinary Bladder Neoplasms
Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Urinary Bladder Neoplasms
Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.
Urinary Bladder Neoplasms
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Urinary Bladder Neoplasms
Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Urinary Bladder Neoplasms
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer.
Urinary Bladder Neoplasms
Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data.
Urinary Bladder Neoplasms
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome.
Urinary Bladder Neoplasms
Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Urinary Bladder Neoplasms
Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
Urinary Bladder Neoplasms
Telomerase therapeutics: telomeres recognized as a DNA damage signal: commentary re: K. Kraemer et al., antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
Urinary Bladder Neoplasms
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Urinary Bladder Neoplasms
Telomerase: its clinical relevance in the diagnosis of bladder cancer.
Urinary Bladder Neoplasms
Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence.
Urinary Bladder Neoplasms
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
Urinary Bladder Neoplasms
The clinical significance of PINX1 expression in papillary thyroid carcinoma.
Urinary Bladder Neoplasms
The current role of telomerase in the diagnosis of bladder cancer.
Urinary Bladder Neoplasms
The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
Urinary Bladder Neoplasms
The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.
Urinary Bladder Neoplasms
The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Urinary Bladder Neoplasms
This month in investigative urology. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer.
Urinary Bladder Neoplasms
Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Urinary Bladder Neoplasms
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Urinary Bladder Neoplasms
Tumor markers in the detection of recurrent transitional cell carcinoma of the bladder: a brief review.
Urinary Bladder Neoplasms
Tumor markers in the diagnosis of primary bladder cancer. A systematic review.
Urinary Bladder Neoplasms
Urinary telomerase and its possible role as a marker for bladder cancer.
Urinary Bladder Neoplasms
Urine telomerase activity for the detection of bladder cancer in females.
Urinary Bladder Neoplasms
Urine telomerase for diagnosis and surveillance of bladder cancer.
Urinary Bladder Neoplasms
Urine telomerase: an important marker in the diagnosis of bladder cancer.
Urinary Bladder Neoplasms
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Urinary Bladder Neoplasms
[Development of noninvasive bladder cancer diagnosis on basis of telomerase and it's subunits hTERT and hTR detection].
Urinary Bladder Neoplasms
[Diagnosis of human bladder cancer by detecting the telomerase activity in exfoliated urothelial cells]
Urinary Bladder Neoplasms
[Effect of hTERT antisense oligodeoxynucleotide on telomerase activity in bladder cancer cells in vitro.]
Urinary Bladder Neoplasms
[Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line]
Urinary Bladder Neoplasms
[Prospects for molecular research in urological oncology: bladder cancer]
Urinary Bladder Neoplasms
[Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma]
Urinary Bladder Neoplasms
[Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
Urinary Bladder Neoplasms
[Telomerase activity as marker of superficial tumor of the bladder]
Urinary Bladder Neoplasms
[Telomerase activity: a molecular marker for early diagnosis of bladder tumor]
Urinary Bladder Neoplasms
[The role of telomerase activity in non-invasive diagnostics of bladder cancer].
Urinary Tract Infections
Diagnosis of bladder cancer using telomerase activity in voided urine.
Urogenital Diseases
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Urogenital Neoplasms
hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.
Urogenital Neoplasms
Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Urologic Diseases
Telomerase activity in solid transitional cell carcinoma, bladder washings, and voided urine.
Uterine Cervical Diseases
Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Uterine Cervical Dysplasia
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Uterine Cervical Dysplasia
Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Uterine Cervical Neoplasms
2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Uterine Cervical Neoplasms
A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.
Uterine Cervical Neoplasms
A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7.
Uterine Cervical Neoplasms
Accuracy of telomerase in cervical lesions: a systematic review.
Uterine Cervical Neoplasms
Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer.
Uterine Cervical Neoplasms
Amplification of the telomerase RNA component gene in the process of human esophageal carcinogenesis.
Uterine Cervical Neoplasms
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection.
Uterine Cervical Neoplasms
Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa).
Uterine Cervical Neoplasms
Application of telomerase assay for the screening of cervical lesions.
Uterine Cervical Neoplasms
Artemisinin Represses Telomerase Subunits and Induces Apoptosis in HPV-39 Infected Human Cervical Cancer Cells.
Uterine Cervical Neoplasms
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Uterine Cervical Neoplasms
Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Uterine Cervical Neoplasms
Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Uterine Cervical Neoplasms
Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
Uterine Cervical Neoplasms
Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus 16 E6 expressing keratinocytes.
Uterine Cervical Neoplasms
Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Uterine Cervical Neoplasms
Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer.
Uterine Cervical Neoplasms
Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions.
Uterine Cervical Neoplasms
Early growth response-1 mediates downregulation of telomerase in cervical cancer.
Uterine Cervical Neoplasms
Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro.
Uterine Cervical Neoplasms
Efficient Inhibition of Human Telomerase Reverse Transcriptase Expression by RNA Interference Sensitizes Cancer Cells to Ionizing Radiation and Chemotherapy.
Uterine Cervical Neoplasms
Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy.
Uterine Cervical Neoplasms
Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Uterine Cervical Neoplasms
Evaluation of serum human telomerase reverse transcriptase as a novel marker for cervical cancer.
Uterine Cervical Neoplasms
Expression of HPV-16 E6 Protein and p53 Inactivation Increases the Uterine Cervical Cancer Invasion.
Uterine Cervical Neoplasms
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Uterine Cervical Neoplasms
Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Uterine Cervical Neoplasms
Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
Uterine Cervical Neoplasms
Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Uterine Cervical Neoplasms
Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Uterine Cervical Neoplasms
GRIM-19 Restores Cervical Cancer Cell Senescence by Repressing hTERT Transcription.
Uterine Cervical Neoplasms
HIF-1-mediated activation of telomerase in cervical cancer cells.
Uterine Cervical Neoplasms
Highly Sensitive Telomerase Assay Insusceptible to Telomerase and Polymerase Chain Reaction Inhibitors for Cervical Cancer Screening Using Scraped Cells.
Uterine Cervical Neoplasms
hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
Uterine Cervical Neoplasms
hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
Uterine Cervical Neoplasms
Human papillomavirus and human telomerase RNA component gene in cervical cancer progression.
Uterine Cervical Neoplasms
Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Uterine Cervical Neoplasms
Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Uterine Cervical Neoplasms
IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
Uterine Cervical Neoplasms
Immunohistochemical expression of ubiquitin and telomerase in cervical cancer.
Uterine Cervical Neoplasms
Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Uterine Cervical Neoplasms
Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice.
Uterine Cervical Neoplasms
Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway.
Uterine Cervical Neoplasms
Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
Uterine Cervical Neoplasms
Inula Viscosa Extracts Induces Telomere Shortening and Apoptosis in Cancer Cells and Overcome Drug Resistance.
Uterine Cervical Neoplasms
Investigating the Effects of RBBP6 Gene Expression on Telomerase Activity in Cervical Cancer Cells.
Uterine Cervical Neoplasms
Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells.
Uterine Cervical Neoplasms
Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways.
Uterine Cervical Neoplasms
Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Uterine Cervical Neoplasms
Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Uterine Cervical Neoplasms
Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
Uterine Cervical Neoplasms
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Uterine Cervical Neoplasms
MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
Uterine Cervical Neoplasms
NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells.
Uterine Cervical Neoplasms
PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT.
Uterine Cervical Neoplasms
PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells.
Uterine Cervical Neoplasms
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Uterine Cervical Neoplasms
Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
Uterine Cervical Neoplasms
Protein kinase C modulates telomerase activity in human cervical cancer cells.
Uterine Cervical Neoplasms
Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical Cancer.
Uterine Cervical Neoplasms
Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Uterine Cervical Neoplasms
Significance of human telomerase RNA gene amplification detection for cervical cancer screening.
Uterine Cervical Neoplasms
siRNA-mediated Inhibition of hTERC Enhances Radiosensitivity of Cervical Cancer.
Uterine Cervical Neoplasms
STRATEGIES OF TREATING CANCER BY CYTOKINE REGULATION OF CHROMOSOME END REMODELLING.
Uterine Cervical Neoplasms
Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid.
Uterine Cervical Neoplasms
Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
Uterine Cervical Neoplasms
Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.
Uterine Cervical Neoplasms
Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears.
Uterine Cervical Neoplasms
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
Uterine Cervical Neoplasms
Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.
Uterine Cervical Neoplasms
Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Uterine Cervical Neoplasms
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Uterine Cervical Neoplasms
Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer.
Uterine Cervical Neoplasms
Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions.
Uterine Cervical Neoplasms
Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.
Uterine Cervical Neoplasms
Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening.
Uterine Cervical Neoplasms
Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
Uterine Cervical Neoplasms
Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
Uterine Cervical Neoplasms
Telomerase, p53 and human papillomavirus infection in the uterine cervix.
Uterine Cervical Neoplasms
The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines.
Uterine Cervical Neoplasms
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Uterine Cervical Neoplasms
Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Uterine Cervical Neoplasms
ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity.
Uterine Cervical Neoplasms
[Cloning of alternative isoforms of the catalytic subunit of the human thelomerase (htert)].
Uterine Cervical Neoplasms
[Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth]
Uterine Cervical Neoplasms
[Expression of human telomerase reverse transcriptase in cervix cancer and its significance]
Uterine Cervical Neoplasms
[Study on the correlation between the different papillomavirus type and telomerase in cervical cancer]
Uterine Cervical Neoplasms
[Telomerase activity in cervical cancer and its precursor lesion]
Uterine Neoplasms
[Telomerase activity of uterine cancer examined by telomeric repeat amplification protocol assay]
Uveitis
Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats.
Vaccinia
A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.
Vaccinia
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
Vaccinia
Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.
Vaccinia
Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
Vaccinia
Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
Vaccinia
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Vaccinia
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
Vaccinia
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
Vaccinia
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
Vaccinia
Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Vaccinia
Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus.
Vaccinia
Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.
Vaccinia
Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
Vaccinia
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Vaccinia
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
Vaccinia
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.
Vaccinia
Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
Vaccinia
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
Vaccinia
Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.
Vaccinia
Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen.
Vaccinia
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.
Vaccinia
Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
Vaccinia
Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques.
Vaccinia
Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
Vaccinia
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Vaccinia
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.
Vaccinia
Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
Vaccinia
Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
Vaccinia
Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Vaccinia
Variable proteolytic cleavage of gag precursor expressed after infection of several cell lines with an HIV-2 gag-pol recombinant vaccinia virus.
Vaccinia
[Expression of human immunodeficiency virus gag antigens and formation of virus-like particles in a cell culture, infected with recombinant vaccinia virus strains (an electron-microscopic study)]
Vaccinia
[Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus]
Varicocele
Role of testicular tissue telomerase assay for the prediction of the presence of testicular spermatozoa in azoospermic men with varicoceles, pre- and post-varicocelectomy.
Vascular Diseases
Evidence for Telomerase Activation in VSMCs Exposed to Hyperglycemic and Hyperhomocysteinemic Conditions.
Vascular Diseases
Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
Vascular System Injuries
Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
Vascular System Injuries
Nuclear Factor {kappa}B-Mediated Transactivation of Telomerase Prevents Intimal Smooth Muscle Cell From Replicative Senescence During Vascular Repair.
Vascular System Injuries
Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension.
Vascular System Injuries
The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
Vesicular Stomatitis
A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.
Vesicular Stomatitis
Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Vesicular Stomatitis
Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
Vesicular Stomatitis
Gene therapy using the human telomerase catalytic subunit gene promoter enables targeting of the therapeutic effects of vesicular stomatitis virus matrix protein against human lung adenocarcinoma.
Vesicular Stomatitis
Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery.
Vesicular Stomatitis
Transduction of Schistosoma japonicum schistosomules with vesicular stomatitis virus glycoprotein pseudotyped murine leukemia retrovirus and expression of reporter human telomerase reverse transcriptase in the transgenic schistosomes.
Vesicular Stomatitis
VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Viremia
Bluetongue virus detection: a safer reverse-transcriptase polymerase chain reaction for prediction of viremia in sheep.
Viremia
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Viremia
Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection.
Viremia
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
Viremia
Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
Viremia
Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
Viremia
Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT.
Viremia
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Viremia
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
Viremia
Phenotypic Coreceptor Tropism in Perinatally HIV-infected Youth Failing Antiretroviral Therapy.
Viremia
Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.
Viremia
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects.
Viremia
Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
Viremia
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Viremia
Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2287: an animal model with implications for maternal-neonatal HIV transmission.
Viremia
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.
Viremia
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.
Viremia
Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.
Virus Diseases
A new Akirin1 gene in turbot (Scophthalmus maximus): Molecular cloning, characterization and expression analysis in response to bacterial and viral immunological challenge.
Virus Diseases
Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: a new disease entity?
Virus Diseases
Bovine herpesvirus type 1 (BHV-1) up-regulates telomerase activity in MDBK cells.
Virus Diseases
Classification of COVID-19 by Compressed Chest CT Image through Deep Learning on a Large Patients Cohort.
Virus Diseases
Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.
Virus Diseases
Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias.
Virus Diseases
Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
Virus Diseases
Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity.
Virus Diseases
Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Virus Diseases
Differential levels of mRNAs for cytokines, the interleukin-2 receptor and class II DR/DQ genes in ovine interstitial pneumonia induced by maedi visna virus infection.
Virus Diseases
Effect of productive in vitro human immunodeficiency virus or simian immunodeficiency virus infection on telomerase activity in lymphoid and nonlymphoid cells.
Virus Diseases
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006.
Virus Diseases
Epidemiology of Influenza in Fars Province, Southern Iran; a Population-Based Study (2015-2019).
Virus Diseases
Evaluation of reverse-transcriptase PCR as a diagnostic tool to confirm Japanese encephalitis virus infection.
Virus Diseases
Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase.
Virus Diseases
Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Virus Diseases
Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity.
Virus Diseases
IFN-? Inhibits Telomerase in Human CD8+ T Cells by Both hTERT Downregulation and Induction of p38 MAPK Signaling.
Virus Diseases
In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.
Virus Diseases
Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
Virus Diseases
Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.
Virus Diseases
Measuring Telomerase Activity in Senescent Human T Cells Upon Genetic Modification.
Virus Diseases
Modulation of telomerase activity, bTERT and c-Myc induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin during Bovine Herpesvirus 1 infection in MDBK cells.
Virus Diseases
Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
Virus Diseases
Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.
Virus Diseases
Profile of Leukocyte-Endothelial Cell Interactions Induced in Venules and Arterioles by Nucleoside Reverse-Transcriptase Inhibitors In Vivo.
Virus Diseases
Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases.
Virus Diseases
Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage.
Virus Diseases
Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infection.
Virus Diseases
Significance of viral infections detected by reverse-transcriptase - multiplex PCR on hospital-related outcomes in acute exacerbations of chronic obstructive pulmonary disease.
Virus Diseases
Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
Virus Diseases
Synthesis of Pyrazine-1,3-thiazine Hybrid Analogues as Antiviral Agent Against HIV-1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3).
Virus Diseases
Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.
Virus Diseases
Telomerase Biology Associations offer Keys to Cancer and Aging Therapeutics.
Virus Diseases
Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India.
Virus Diseases
The antiretroviral 2',3'-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures.
Virus Diseases
The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.
Virus Diseases
Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells.
Virus Diseases
Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties.
Virus Diseases
Variations of telomerase activity in cultured mouse fibroblasts upon proliferation of polyomavirus.
Virus Diseases
[The inhibitory effect of antisense adenovirus vector of telomerase on telomerase activity in breast cancer cells MCF-7]
Visna
Characterization of the nucleic acid product of the visna virus RNA dependent DNA polymerase.
Visna
Differential levels of mRNAs for cytokines, the interleukin-2 receptor and class II DR/DQ genes in ovine interstitial pneumonia induced by maedi visna virus infection.
Visna
Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.
Visna
Genetic variation among lentiviruses: homology between visna virus and caprine arthritis-encephalitis virus is confined to the 5' gag-pol region and a small portion of the env gene.
Visna
[Immunologic aspects of preparation of antiserum to the reverse transcriptase from avian myeloblastosis virus]
Vitamin B 12 Deficiency
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.
Vitreoretinopathy, Proliferative
The anti-proliferative effect of inhibitor of telomerase on cultured retinal pigment epithelial cells.
von Hippel-Lindau Disease
Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region.
Werner Syndrome
Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients.
Werner Syndrome
Essential role of limiting telomeres in the pathogenesis of Werner syndrome.
Werner Syndrome
Evidence that a RecQ helicase slows senescence by resolving recombining telomeres.
Werner Syndrome
Influence of aging and cell senescence on telomerase activity in keratinocytes.
Werner Syndrome
Telomerase expression prevents replicative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains.
Werner Syndrome
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts.
Werner Syndrome
Telomerase protects werner syndrome lineage-specific stem cells from premature aging.
Werner Syndrome
The effect of resveratrol on the werner syndrome RecQ helicase gene and telomerase activity.
Werner Syndrome
WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts.
Wilms Tumor
Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
Wilms Tumor
Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Wilms Tumor
Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.
Wilms Tumor
High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Wilms Tumor
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Wilms Tumor
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
Wilms Tumor
Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.
Wilms Tumor
The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.
Wilms Tumor
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.
Xeroderma Pigmentosum
DNA repair proteins and telomerase reverse transcriptase in the cochlear lateral wall of cisplatin-treated rats.
Xeroderma Pigmentosum
Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins.
Xeroderma Pigmentosum
Telomere Length and Telomerase Activity Impact the UV Sensitivity Syndrome Xeroderma Pigmentosum C.
Yellow Fever
Development of multiplex real-time reverse-transcriptase polymerase chain reaction assay for simultaneous detection of Zika, dengue, yellow fever, and chikungunya viruses in a single tube.
Zika Virus Infection
Pregnancy outcomes after maternal Zika virus infection in a non-endemic region: prospective cohort study.
html completed
